
<html lang="en"     class="pb-page"  data-request-id="022f4b84-885f-453d-a0a6-8164293df0e3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm400533t;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer" /></meta><meta name="dc.Creator" content="Ferdinando  Fiorino" /></meta><meta name="dc.Creator" content="Beatrice  Severino" /></meta><meta name="dc.Creator" content="Elisa  Magli" /></meta><meta name="dc.Creator" content="Antonio  Ciano" /></meta><meta name="dc.Creator" content="Giuseppe  Caliendo" /></meta><meta name="dc.Creator" content="Vincenzo  Santagada" /></meta><meta name="dc.Creator" content="Francesco  Frecentese" /></meta><meta name="dc.Creator" content="Elisa  Perissutti" /></meta><meta name="dc.Description" content="The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacologically characterized. This receptor subtype has long been object of intense research and is implica..." /></meta><meta name="Description" content="The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacologically characterized. This receptor subtype has long been object of intense research and is implica..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 10, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400533t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400533t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400533t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400533t" /></link>
        
    
    

<title>5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400533t" /></meta><meta property="og:title" content="5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0019.jpeg" /></meta><meta property="og:description" content="The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacologically characterized. This receptor subtype has long been object of intense research and is implicated in the pathogenesis and treatment of anxiety and depressive disorders. In recent years, new chemical entities targeting the 5-HT1A receptor (alone or in combination with other molecular targets) have been proposed for novel therapeutic uses in neuroprotection, cognitive impairment, Parkinson’s disease, pain treatment, malignant carcinoid syndrome, and prostate cancer. This Perspective compares existing data on expression and signaling activity of the 5-HT1A receptor to a ligand with an intrinsic agonist or antagonist profile. Our purpose is also to make a complete overview, useful for underlining the features needed to select a specific pharmacological profile rather than another one. This aspect could be really interesting to consider and justify the 5-HT1A receptor as a new attractive target for drug discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400533t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400533t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400533t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400533t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400533t&amp;href=/doi/10.1021/jm400533t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4407-4426</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm401427c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">5-HT<sub>1A</sub> Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ferdinando++Fiorino">Ferdinando Fiorino</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatrice++Severino">Beatrice Severino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Magli">Elisa Magli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Ciano">Antonio Ciano</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Caliendo">Giuseppe Caliendo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Santagada">Vincenzo Santagada</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Frecentese">Francesco Frecentese</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Perissutti">Elisa Perissutti</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Dipartimento di Farmacia, Università degli Studi di Napoli “Federico II”, Via D. Montesano, 49, 80131, Napoli, Italy</span></div><div class="corresp-info"><strong>*</strong>Phone/Fax: +39(81)679825. E-mail: <a href="/cdn-cgi/l/email-protection#b6d0d3d0dfd9c4dfd8f6c3d8dfd8d798dfc2"><span class="__cf_email__" data-cfemail="94f2f1f2fdfbe6fdfad4e1fafdfaf5bafde0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400533t&amp;href=/doi/10.1021%2Fjm400533t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4407–4426</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 2, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 April 2013</li><li><span class="item_label"><b>Published</b> online</span>10 December 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400533t" title="DOI URL">https://doi.org/10.1021/jm400533t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4407%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFerdinando%2BFiorino%252C%2BBeatrice%2BSeverino%252C%2BElisa%2BMagli%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D11%26contentID%3Djm400533t%26title%3D5-HT1A%2BReceptor%253A%2BAn%2BOld%2BTarget%2Bas%2Ba%2BNew%2BAttractive%2BTool%2Bin%2BDrug%2BDiscovery%2Bfrom%2BCentral%2BNervous%2BSystem%2Bto%2BCancer%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4426%26publicationDate%3DJune%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400533t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2336</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">58</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400533t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ferdinando&quot;,&quot;last_name&quot;:&quot;Fiorino&quot;},{&quot;first_name&quot;:&quot;Beatrice&quot;,&quot;last_name&quot;:&quot;Severino&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Magli&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Ciano&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Caliendo&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Santagada&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Frecentese&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Perissutti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4407-4426&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400533t&quot;},&quot;abstract&quot;:&quot;The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacologically characterized. This receptor subtype has long been object of intense research and is implicated in the pathogenesis and treatment of anxiety and depressive disorders. In recent years, new chemical entities targeting the 5-HT1A receptor (alone or in combination with other molecular targets) have been proposed for novel therapeutic uses in neuroprotection, cognitive impairment, Parkinson’s disease, pain treatment, malignant carcinoid syndrome, and prostate cancer. This Perspective compares existing data on expression and signaling activity of the 5-HT1A receptor to a ligand with an intrinsic agonist or antagonist profile. Our purpose is also to make a complete overview, useful for underlining the features needed to select a specific pharmacological profile rather than another one. This aspect could be really interesting to consider and justify the 5-HT1A receptor as a new attractive target for drug discovery&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400533t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400533t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400533t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400533t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400533t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400533t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400533t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400533t&amp;href=/doi/10.1021/jm400533t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400533t" /></input><a href="/doi/pdf/10.1021/jm400533t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400533t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400533t%26sid%3Dliteratum%253Aachs%26pmid%3D24295064%26genre%3Darticle%26aulast%3DFiorino%26date%3D2014%26atitle%3D5-HT1A%2BReceptor%253A%2BAn%2BOld%2BTarget%2Bas%2Ba%2BNew%2BAttractive%2BTool%2Bin%2BDrug%2BDiscovery%2Bfrom%2BCentral%2BNervous%2BSystem%2Bto%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D11%26spage%3D4407%26epage%3D4426%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jmcmar.2014.57.issue-11/production/jmcmar.2014.57.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0019.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The serotonin receptor subtype 5-HT<sub>1A</sub> was one of the first serotonin receptor subtypes pharmacologically characterized. This receptor subtype has long been object of intense research and is implicated in the pathogenesis and treatment of anxiety and depressive disorders. In recent years, new chemical entities targeting the 5-HT<sub>1A</sub> receptor (alone or in combination with other molecular targets) have been proposed for novel therapeutic uses in neuroprotection, cognitive impairment, Parkinson’s disease, pain treatment, malignant carcinoid syndrome, and prostate cancer. This Perspective compares existing data on expression and signaling activity of the 5-HT<sub>1A</sub> receptor to a ligand with an intrinsic agonist or antagonist profile. Our purpose is also to make a complete overview, useful for underlining the features needed to select a specific pharmacological profile rather than another one. This aspect could be really interesting to consider and justify the 5-HT<sub>1A</sub> receptor as a new attractive target for drug discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">5-Hydroxytryptamine (5-HT, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was purified, crystallized, and named serotonin in 1948, the name being derived from the fact that the substance was produced in the serum (“ser”) and was found to limit or increase tone (“tonin”) in blood vessels. Although 5-HT is one of the most ancient neurotransmitters and appeared very early in evolution, its functions have been conserved and even expanded through the various branches of the evolutionary tree within the central and peripheral nervous systems. It plays a number of very important roles in normal brain function including modulation of mood states, hunger, sex, sleep, memory, emotion, anxiety, endocrine effects, and many others.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Serotonin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Serotonin receptors are widely expressed throughout the brain and in many key structures responsible for cognition and basic brain functions. As a local hormone, serotonin is present in numerous other tissues including the gastrointestinal tract and the cardiovascular and immune systems. This multiplicity of functions indicates that 5-HT is involved in a vast array of physiological and pathophysiological processes. This plethora of roles has fostered evaluation of many compounds as therapeutic tools in various pathological conditions, including antidepressants and antipsychotic and antiemetic drugs.</div><div class="NLM_p">The effects of 5-HT are mediated by a distinctive class of the G-protein-coupled receptors (GPCRs) except for the 5-HT<sub>3</sub> receptor, which is a cation channel. The GPCR 5-HT receptor family has been classified as a class A rhodopsin-like receptor.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> There are six classes of GPCR 5-HT receptors, 5-HT<sub>1</sub>, 5-HT<sub>2</sub>, 5-HT<sub>4</sub>, 5-HT<sub>5</sub>, 5-HT<sub>6</sub>, and 5-HT<sub>7</sub>, with additional subclasses, amounting to fifteen receptors (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Functional dissimilarities between the 5-HT classes are based on the stimulatory and inhibitory effect of the second messengers mediated through G proteins. The familiar structural topology includes seven-transmembrane domains (7-TM) together with a conserved “DRY” motif present at the cytoplasmic end of TM3 and the “NPxxY” motif at the TM7. Among these, one of the most important and extensively studied is the 5-HT<sub>1A</sub> receptor.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overview of 5-HT receptor subtypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">5-HT<sub>1A</sub> Receptor: Characteristics, Distribution, and Biological Role</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 5-HT<sub>1A</sub> receptor was the first among all the types of serotonin receptors to be cloned as an intronless genomic clone (G-21) of the human genome, which cross-hybridized with a full length β-adrenergic receptor probe at reduced stringency.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Sequence analysis of this genomic clone (to be later identified as the 5-HT<sub>1A</sub> receptor gene) indicated 43% amino acid homology with the β<sub>2</sub>-adrenergic receptor in the transmembrane domain. Moreover, while the gene was shown to be localized in chromosome 5 of the human genome and was thought to code for a potential member of the GPCR superfamily,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> its identity as a serotonin receptor was discovered only later.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Membranes prepared from COS-1 cells transiently transfected with G-21 showed typical ligand binding characteristics of the 5-HT<sub>1A</sub> receptor. Subsequently, genes for the rat and mouse 5-HT<sub>1A</sub> receptors have been cloned and their amino acid sequences deduced.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> These developments facilitated stable expression and characterization of the receptor in a large number of neural and non-neural cell lines.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> Furthermore, it was the first serotonin receptor for which polyclonal antibodies were obtained<a onclick="showRef(event, 'ref4 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref11">(4, 11)</a> allowing their visualization at the subcellular level in various regions of the brain.</div><div class="NLM_p">The human gene for the 5-HT<sub>1A</sub> receptor encodes a protein of 422 amino acids with a core molecular weight of ∼46 000. Considering the presence of three consensus sequences for N-linked glycosylation on the amino terminus and the homology of the receptor with the β-adrenergic receptor, it is predicted that the receptor is oriented in the plasma membrane with an arrangement typical of the G-protein-coupled receptor superfamily.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Although the structure of the 5-HT<sub>1A</sub> receptor has not been experimentally determined yet, mutagenesis studies helped in identifying amino acid residues important for ligand binding and G-protein coupling.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">5-HT<sub>1A</sub> receptors are broadly distributed in the CNS, being found in the soma, in dendrites, in some cases in the axon hillock of neurons, and in the cell body and processes of astrocytes. This receptor is expressed by all serotonin neurons (as an autoreceptor) and by many nonserotoninergic neurons (as a heteroreceptor). Recently the role of the 5-HT<sub>1A</sub> receptor in neural development was further disclosed,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> indicating protection of stressed neuronal cells undergoing degeneration and apoptosis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Moreover, localization of the 5-HT<sub>1A</sub> receptors in brain regions associated with learning and memory such as hippocampus, frontal cortex, and entorhinal cortex allows for direct and indirect modulation of multiple neurotransmitter systems involved in cognitive impairment.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In fact, 8-hydroxy-2-(di-<i>N</i>-propylamino)tetralin <b>1</b> (8-OH-DPAT, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), a 5-HT<sub>1A</sub> receptor agonist, is capable of impairing learning and memory in a range of rodent models including water maze, passive avoidance, radial maze, and delayed nonmatching to position. Moreover, studies in human volunteers have shown that oral administration of tandospirone <b>2</b> (a 5-HT<sub>1A</sub> agonist, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) impairs verbal memory.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 5-HT<sub>1A</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 5-HT<sub>1A</sub> receptor not only contributes to the dynamic modulation of serotonergic activity affecting diverse functions such as cognition and emotion but also is thought to play a crucial role in the neuronal migration, neurite outgrowth, and synapse formation inherent to the neurodevelopmental process.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The 5-HT<sub>1A</sub> receptor represents a natural candidate crucial in an array of phenotypes. Among them, affective disorders and 5-HT<sub>1A</sub> receptor dysfunctions may play an important role in the genesis of major depressive disorder. Regarding the role of 5-HT<sub>1A</sub> receptor in anxiety, most of the knowledge comes from animal studies; mice with genetically inactivated 5-HT<sub>1A</sub> receptor gene develop an anxiety-like phenotype, reduced locomotor activity, and increased responsiveness to stress. Instead, mice with overexpressed 5-HT<sub>1A</sub> receptors display diminished anxiety when compared to the wild-type animals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Schizophrenia is a life long, complex psychotic disorder, and the introduction of antipsychotic drugs, identified as D<sub>2</sub> antagonists (i.e., chloropromazine <b>3</b>, thiethylperazine <b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), in the late 1950s was a major advance in the management of this pathology. Unfortunately, blockade of D<sub>2</sub> receptors accounts for severe side effects, in particular extrapyramidal symptoms (EPS) and hyperprolactinemia, that undermine compliance. It tooks nearly 3 decades to obtain drugs that cause no or minimal EPS at therapeutically relevant doses. These second-generation derivatives, characterized by combined D<sub>2</sub> and 5-HT<sub>2A</sub> antagonism (i.e., olanzapine <b>5</b>, clozapine <b>6</b>, quetiapine <b>7</b>, risperidone <b>8</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), were defined as atypical, in contrast to conventional D<sub>2</sub> blockers. Finally, another pharmacological approach, which has been steadily gaining approval, involves the combination of D<sub>2</sub> antagonism and 5-HT<sub>1A</sub> agonism in the same molecule<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (i.e., perospirone <b>9</b>, F-15063 <b>10</b>, SLV-313 <b>11</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of D<sub>2</sub> antagonists, D<sub>2</sub>/5-HT<sub>2A</sub> antagonists, and D<sub>2</sub> antagonists/5-HT<sub>1A</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Regarding the role of the 5-HT<sub>1A</sub> receptor in Parkinson’s disease, it has been demonstrated that, acting as presynaptic receptor, 5-HT<sub>1A</sub> can decrease the release of a range of neurotransmitters including glutamate and dopamine (DA). While acting as postsynaptic receptor, it exerts an inhibitory effect by hyperpolarizing neurons. In agreement with the proposed role, 5-HT<sub>1A</sub> agonists reduce L-DOPA-induced dyskinesia (LID), even if several questions regarding the mechanism of action of 5-HT<sub>1A</sub> agonists in reducing dyskinesia and potential worsening of parkinsonism are still open.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The 5-HT<sub>1A</sub> receptor subtype has also been reported to play a role in nociception, and currently, it is investigated as the target of an analgesic, befiradol <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), that has entered the clinical phase of development.<a onclick="showRef(event, 'ref11 ref21'); return false;" href="javascript:void(0);" class="ref ref11 ref21">(11, 21)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure of befiradol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These results are in agreement with data suggesting the presence of 5-HT<sub>1A</sub> receptors in peripheral terminals of primary sensory afferent fibers. Accordingly, several lines of electrophysiological, pharmacological, and biochemical evidence have shown that 5-HT<sub>1A</sub> receptors are present in primary afferent neurons.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> 5-HT<sub>1A</sub>, 5-HT<sub>1C</sub>, 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and 5-HT<sub>4</sub> receptors have also been identified in the gut, either in the enteric nervous system or on smooth muscle cells. The actions of 5-HT<sub>1A</sub> and 5-HT<sub>1C</sub> may include inhibition of release and contraction of smooth muscle.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> 5-HT acts as a cell growth factor and is capable of promoting the proliferation of LNCap, a prostate cancer cell line, in a dose-dependent manner and affords similar results on the PC-3 and DU145 cell lines.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Numerous studies suggest that the 5-HT<sub>1A</sub> receptor subtype in the medullary raphe (MR) mediates protective responses to stress. Systemic administration of <b>1</b> induces bradycardia and a decrease in blood pressure, suggesting that the 5-HT<sub>1A</sub> receptor has an inhibitory effect on sympathetic outflow. Similar sympatholytic effects were evident when <b>1</b> was administered via microinjection directly to select nuclei of the MR. The 5-HT<sub>1A</sub> receptor also mediates the cardiovascular responses to other stressors such as conditioned fear, fever induction, and psychological stress.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> These data suggest that the inhibitory action of 5-HT<sub>1A</sub> receptor in the MR reduces the activity of neurons, mediating the cardiovascular responses to various forms of stress. Recently the role of serotoninergic receptors in sexual function was confirmed. In fact, 5-HT<sub>1A</sub> receptors are able to decrease ejaculatory latency time and erection in male rats, while 5-HT<sub>2C</sub> receptors have opposite functions.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> Finally, other studies show possible connections between serotoninergic receptors and sexual hormones. Thus, in the presence of a sexually receptive female, the blood testosterone level increases in male mice; this effect is blocked by administering a 5-HT<sub>1A</sub> receptor agonist.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> The other antagonistic hormone, estradiol, was reported to induce a desensitization of the 5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">5-HT<sub>1A</sub> and the CNS</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As reported above, 5-HT<sub>1A</sub> receptors are distributed throughout the CNS with an enrichment of presynaptic 5-HT<sub>1A</sub> autoreceptors in the raphe nucleus and in several postsynaptic regions, such as the hippocampic and cortical areas. These receptors play a crucial role in the control of 5-HT release, and 5-HT<sub>1A</sub> agonists seem to be effective in treatment of anxiety and depression states and in the therapy of pain and schizophrenia. Their efficacy in neuroprotection and stroke treatment has recently been confirmed.</div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> 5-HT<sub>1A</sub> and Anxiety</h3><div class="NLM_p">In order to validate the correlation between 5-HT<sub>1A</sub> receptor and anxiety, azapirone derivatives (i.e., buspirone <b>13</b>, Buspar), acting as 5-HT<sub>1A</sub> receptor full and partial agonists, have been developed as novel anxiolytic agents that are not associated with the dependence and the side effect profile of benzodiazepines.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Compound <b>13</b>, discovered and approved as an anxiolytic in the 1980s, was initially investigated as a putative antipsychotic agent devoid of the typical side effects of that drug class. When it lacked therapeutic utility in schizophrenia, further study showed that <b>13</b>, administered in single dose, had a marked taming effect on aggressive monkeys, and its chronic administration reversed stress-induced behavior in several animal models of anxiety.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The launch of <b>13</b> led to the preparation of several <i>N</i>4-(2-pyrimidinyl)piperazines containing a <i>N</i>1-imidobutyl substituent, as a potential new generation of anxiolytic agents, such as <b>2</b> (Sediel marketed in China and Japan), gepirone <b>14</b>, and ipsapirone <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). In these derivatives, the 1-(2-pyrimidinyl)piperazine, the tail of the molecule, and the heterocyclic head are linked to an alkyl chain that hardly affects the 5-HT<sub>1A</sub> affinity. Functional assays have demonstrated that these compounds act as partial agonists. Successively, the replacement of the 1-(2-pyrimidinyl)piperazine moiety with a 1-(2-methoxyphenyl)piperazine moiety led to BMY-8227, <b>17</b>. High 5-HT<sub>1A</sub> affinity is maintained by replacement of the azaspirodecanedione nucleus of <b>17</b> with an <i>N</i>-phthalimido group that led to NAN-190 <b>18</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> This compound was found to be nonselective, and shortening the alkyl chain length to three or two units significantly decreases the affinity. On the basis of these results, N-1-substituted <i>N</i>-4-arylpiperazines (so-called “long-chain arylpiperazines”) have been extensively studied as a structural element useful in designing 5-HT<sub>1A</sub> receptor ligands. The general formula of these compounds presents a 1-arylpiperazine moiety linked via an alkyl chain of variable length to a terminal fragment (imides, amides, alkyl, arylalkyl, or heteroarylalkyl derivatives and tetralines). Moreover, the identification of these new ligands as 5-HT<sub>1A</sub> receptor agonists led to the definition of the generally accepted 5-HT<sub>1A</sub> agonist pharmacophore, in which an aromatic ring and a coplanar basic nitrogen atom are two of the structural features required for ligand recognition.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 1-(2-Pyrimidinyl)piperazine and 1-(2-methoxyphenyl)piperazine derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The distance between the aromatic center and the basic nitrogen is optimal at 5.2 Å, with the amino group 0.2 Å above the plane of the aromatic moiety. Finally, the electron lone pair is almost perpendicular to the plane of the aromatic ring (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. General structure of long-chain arylpiperazines (LCAPs) and pharmacophoric model of 5-HT<sub>1A</sub> agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thereafter, a number of 5-HT<sub>1A</sub> agonists have shown anxiolytic activities in various animal models, such as the Vogel or Gellar–Seifter conflict test, the elevated-plus maze, light–dark and conditioned-fear paradigms, and the anti-marble-burying behavior test. The involvement and crucial role of the postsynaptic 5-HT<sub>1A</sub> receptor in limbic areas in regulating anxiety have been supported by numerous studies. In recent years, some of the novel compounds acting at 5-HT<sub>1A</sub> receptors have entered phase II and phase III clinical trials or are already commercially available as anxiolytics (<b>14</b> and S-15535 <b>19</b>, MN-305 <b>20</b>, flesinoxan <b>21</b>, alnespirone <b>22</b>, lesopitron <b>23</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The structural feature characterizing most of these promising compounds is the arylpiperazine scaffold.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The influence of each part of the arylpiperazine group on the 5-HT<sub>1A</sub> receptor affinity, intrinsic activity, and selectivity has been the subject of many structure–activity relationship (SAR) studies . In particular, much effort has been devoted to understand the role of the terminal part in the ligand–receptor interaction, and in consequence, a great number of many different fragments have been used.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, a limitation of many 5-HT<sub>1A</sub> receptor ligands for their potential use as drugs or pharmacological tools is their undesired high affinity for other receptors. The dopaminergic D<sub>2</sub> receptor and α<sub>1</sub>-adrenoceptor are two examples of receptors for which several 5-HT<sub>1A</sub> ligands show high affinity. However, there has been an ongoing effort to develop more selective 5-HT<sub>1A</sub> ligands in order to have novel pharmacological tools that could improve our knowledge of the signal transduction mechanism and lead to compounds with high affinity and selectivity.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. 5-HT<sub>1A</sub> receptor agonists with anxiolytic and antidepressant properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> 5-HT<sub>1A</sub> and Depressive Disorder</h3><div class="NLM_p">5-HT<sub>1A</sub> agonists show significant antidepressant activity in various animal models such as tail suspension test and forced swimming test.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Although the precise mechanism responsible for the antidepressant action of 5-HT<sub>1A</sub> agonists is still uncertain, desensitization or down-regulation of presynaptic 5-HT<sub>1A</sub> receptors has been proposed to be implicated in this pharmacological effect.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Specifically, repeated treatment with a 5-HT<sub>1A</sub> agonist desensitizes presynaptic 5-HT<sub>1A</sub> receptors in the raphe nuclei, which disengages 5-HT neurons from autoreceptor-mediated inhibition.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39-41)</a> As a consequence, 5-HT neurons are activated by chronic treatment with 5-HT<sub>1A</sub> agonists, and this counteracts the 5-HT deficit in depression. It has been proposed that combination therapy with a 5-HT<sub>1A</sub> agonist or antagonist would be expected to speed up the effect of serotonin reuptake inhibitors (SSRIs), which represent the first-line treatment of depression. In particular, a 5-HT<sub>1A</sub> antagonist can improve the efficacy of SSRIs by blocking inhibitory 5-HT<sub>1A</sub> autoreceptors. Likewise, a 5-HT<sub>1A</sub> agonist could have antidepressant-like activity by triggering postsynaptic 5-HT<sub>1A</sub> receptors and/or producing a faster desensitization of 5-HT<sub>1A</sub> autoreceptors. There is also evidence that 5-HT<sub>1A</sub> partial agonism, combined with 5-HT reuptake inhibition, can produce antidepressant-like effects. As example, vilazodone <b>24</b>, the prototype of SSRI/5-HT<sub>1A</sub> partial agonist, was approved in 2011 by the FDA for use in the treatment of major depressive disorders.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Similarly flibanserin <b>25</b>, DU-125530 <b>26</b>, and OPC-14523 <b>27</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) have reached late stage clinical development as antidepressant drugs.</div><div class="NLM_p">The LCAPs BMY 7378 (compound <b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and <b>18</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) represent a generation of 5-HT<sub>1A</sub> receptor antagonists possessing postsynaptic antagonist character but also behaving as low-efficacy partial agonists.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Successively a second generation of 5-HT<sub>1A</sub> antagonists (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) have been developed which include WAY-100135 <b>28</b>, WAY-100635 <b>29</b>, and S(−)-UH-301 <b>30</b> (a compound related to <b>1</b>). These compounds act as 5-HT<sub>1A</sub> antagonists both at presynaptic and postsynaptic level and are also called “silent” 5-HT<sub>1A</sub> receptor antagonists.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Their development should provide interesting and promising improvements in 5-HT<sub>1A</sub> research. For example, pretreatment of patients with 5-HT<sub>1A</sub> antagonists accelerates the effects of selective SSRIs and enhances their clinical efficacy as antidepressants. A new LCAP, LY-426965 <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), more metabolically stable and with a better oral bioavailability than <b>29</b>, in combination with fluoxetine (Prozac), increases extracellular levels of 5-HT beyond that achievable by fluoxetine alone. This combination is being examined for the treatment of depression and as a smoking cessation agent.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a> The therapeutic potential of 5-HT<sub>1A</sub> antagonists is quite intriguing.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. 5-HT<sub>1A</sub> receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">By comparison of the structural features of several 5-HT<sub>1A</sub> antagonists, it is possible to derive a basic pharmacophore of the recognition site<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> that contains the same elements as the agonist pharmacophore, represented by an aromatic nucleus and a basic nitrogen atom (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). In this model the mean distance between the center of the aromatic ring and the nitrogen atom is 5.6 Å while this nitrogen is lying at 1.6 Å above the plane defined by the reference ring.</div></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> 5-HT<sub>1A</sub> and Schizophrenia</h3><div class="NLM_p">In the field of schizophrenia, 5-HT<sub>1A</sub> receptor could represent another important opportunity for the medicinal chemist. In fact, as mentioned above, its activation was found to reduce motor side effects induced by activation of D<sub>2</sub> receptors. Thus, the new approach can involve the combination of D<sub>2</sub> antagonism and 5-HT<sub>1A</sub> agonism in the same molecule. Compound <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and ziprasidone <b>32</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) are two valuable examples of this multitarget strategy that reached the market in 2001 and 2002, respectively. Among many other agents with a similar pharmacological profile, <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and bifeprunox <b>33</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) entered respectively phase I and phase III clinical trials.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> There is still clinical demand of newer antipsychotic drugs against positive and negative symptoms, cognitive impairments, and affective disorders. It has been proposed that 5-HT<sub>1A</sub> agonists can alleviate antipsychotic-induced EPS by stimulating postsynaptic 5-HT<sub>1A</sub> receptors in the striatum and cerebral cortex,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> probably through nondopaminergic mechanisms.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Molecule acting as antipsychotic by combination of D<sub>2</sub> antagonism and 5-HT<sub>1A</sub> agonism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Even in the field of 5-HT<sub>1A</sub> agonists employed in the therapy of schizophrenia, the long-chain arylpiperazines represent an important class of derivatives that are able to modulate dopamine and serotonin receptors. Aripiprazole <b>34</b> (Abilify, Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>), approved by the FDA in November 2002 for the treatment of schizophrenia, is one of the most representative compounds. Successively different series of 1-arylpiperazine derivatives, structurally related to <b>34</b>, were developed.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> These compounds were designed to improve resistance to CYP-oxidative metabolism or to afford metabolites devoid of CNS activity at D<sub>2</sub>, 5-HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors. The most representative compounds are characterized by a benzoxazine scaffold, and in particular the 3-oxo-3,4-dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine derivatives (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) showed nanomolar affinity for all the target receptors.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The development of some analogues of <b>34</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) by Pfizer Inc.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> led to interesting results. In particular, compound <b>35</b> displayed a pharmacological profile comparable to that of <b>34</b>. Another series of classical long-chain arylpiperazine (or homopiperazine) derivatives incorporates a quinolinylamide as the terminal fragment. The compounds belonging to this class were able to modulate dopamine and serotonin receptors (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The antipsychotic potential of these compounds was evaluated in the MK-801 (dizocilpine) hyperactivity model. The administration of MK-801 in rodents and humans elicits schizophrenia-like symptoms characterized by hyperlocomotion and stereotyped behavior, which are reverted by antipsychotic drugs. Selected compounds were able to significantly reduce MK-801-induced hyperactivity at a minimal effective dose (MED) of 10 mg/kg.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Aripiprazole and some LCAP structural related derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another interesting class of LCAPs, represented by indolizine compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>), was reported as a new series of atypical antipsychotics. The compounds were screened at D<sub>2</sub>, 5-HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors, and the data disclosed indicated that the derivatives embodying a 1-(2,3-dichlorophenyl)piperazine group had better affinity profiles toward all the target receptors (especially for the 5-HT<sub>2A</sub> receptor) than those of the other substituted arylpiperazine derivatives. Moreover, the different position of the alkyl chain on the distal indolizine nucleus showed a limited influence on dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> and serotonin 5-HT<sub>1A</sub> receptor affinities whereas it had a more marked influence on 5-HT<sub>2A</sub> affinity. The intrinsic activity at D<sub>2</sub> receptors was assessed for selected compounds that behaved as full antagonists or partial agonists.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. LCAP derivatives based on indolizine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> 5-HT<sub>1A</sub> and Pain</h3><div class="NLM_p">5-HT<sub>1A</sub> receptors are also targeted by new analgesic substances. In fact, the possible correlation of the peripheral 5-HT<sub>1</sub> receptors producing antinociception in the formalin test with the 5-HT<sub>1A</sub> receptor subtype is established, in the first instance, by the use of <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), a highly potent and selective 5-HT<sub>1A</sub> antagonist (pIC<sub>50</sub> = 8.87 ± 0.14; p<i>A</i><sub>2</sub> = 9.71).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> At doses devoid of any effects on formalin-induced nociceptive behavior, this compound significantly blocked the antinociceptive effect of the 5-HT<sub>1A</sub> receptor agonist R(+)-UH-301 <b>36</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structure of <b>36</b> a 5-HT<sub>1A</sub> receptor agonist with antinociceptive effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Recent studies in knockout mice showed that 5-HT<sub>1A</sub> receptors mediate an endogenous inhibitory control of heat-evoked nociception.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Currently <b>12</b>, a highly selective and efficient 5-HT<sub>1A</sub> agonist (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) that (as already reported) has entered phase III clinical development,<a onclick="showRef(event, 'ref11 ref21'); return false;" href="javascript:void(0);" class="ref ref11 ref21">(11, 21)</a> is being studied as an analgesic. Therefore, the correlation between 5-HT<sub>1A</sub> receptors and 5-HT<sub>1A</sub> agonists as antinociceptive could represent another important opportunity for the medicinal chemist that could stimulate new efforts to develop 5-HT<sub>1A</sub> agonists possessing analgesic properties, including efficacy in neuropathic pain models.</div></div><div id="sec2_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> 5-HT<sub>1A</sub> and Neuroprotection</h3><div class="NLM_p last">Neuroprotection and stroke treatment could represent another interesting opportunity for 5-HT<sub>1A</sub> ligands. Activation of 5-HT<sub>1A</sub> receptors exerts a neuroprotective effect in different animal models of ischemia. The potential of 5-HT<sub>1A</sub> agonists for the treatment of ischemic brain disorders was revealed by several studies started in 1990. In particular, <b>1</b>, <b>13</b>, <b>14</b>, and <b>15</b> were tested in rat and mouse after induction of focal cerebral ischemia, demonstrating their efficacy in decreasing the area of cerebral damage. In gerbils <b>1</b> reduced hippocampal cell damage induced by transient global ischemia. This was found to correlate with a reduced phosphorylation of the NMDA receptor NR1 subunit and with prevention of the marked reduction of hippocampal brain-derived neurotrophic factor (BDNF) levels elicited by global ischemia. 5-HT<sub>1A</sub> receptor activation by <b>1</b> has been also associated with neuroprotection against NMDA-induced apoptotic cell death in cell cultures.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Other studies have shown that 5-HT<sub>1A</sub> receptor stimulation protects against ischemic neuronal cell death.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The cellular mechanisms underlying the neuroprotective effect of 5-HT<sub>1A</sub> receptor activation remain unclear. One of the proposed mechanisms is the hyperpolarization of pyramidal neurons that inhibits the excitotoxicity of glutamate after cerebral ischemia. Previous studies have shown that 5-HT<sub>1A</sub> receptor stimulation can modulate NMDA receptor-induced Ca<sup>2+</sup> influx, and other reports have provided evidence for functional interactions between NMDA channels and 5-HT<sub>1A</sub> receptors. These results suggest that 5-HT<sub>1A</sub> receptors may serve as mediators of autoprotective mechanisms of the brain against the effects of excitatory amino acid overstimulation.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In fact, the 5-HT<sub>1A</sub> receptors are coupled to G<sub>i</sub>/G<sub>o</sub> proteins to mediate a range of biological effects, especially negative modulation of adenylate cyclase and cAMP formation, which subsequently reduces the phosphorylation of ion channels and thereby neuronal excitation.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It should be noted that <b>1</b> prevents the ischemia-induced increase in NR1 subunit phosphorylation, but total levels of the NR1 subunit remain unchanged, indicating that the increase in phosphorylated NR1 subunit was not a consequence of an increase in total NR1 levels. Administration of the agonist <b>1</b> prevented a decrease in BDNF levels, and this might play a crucial role in the protection against ischemia-induced delayed pyramidal neuronal death in the CA1 subfield of hippocampus. It is known that global ischemia induces expression of activated caspase-3 which activates a host of downstream events leading to fragmentation of genomic DNA, a hallmark of apoptotic cell death.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> It was found that NMDA-induced caspase-3 activity and DNA fragmentation were almost completely blocked by <b>1</b> in cell cultures.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> These protective effects were reversed by pretreatment with the antagonist <b>29</b>. The antiapoptotic properties of 5-HT<sub>1A</sub> receptor stimulation against excitotoxic insult as well as the protective effect of <b>1</b> on ischemia-induced hippocampal cell damage might be related, among others, to a facilitated antiapoptotic effect of neurotrophin BDNF. It is known that 5-HT and BDNF often function in a cooperative manner to regulate neuronal plasticity and survival. Activation of 5-HT receptors coupled to cAMP production and CREB (cAMP response element-binding protein) activation can induce transcription of the BDNF gene, but interestingly, it was also found that serotonin acting on 5-HT<sub>1A</sub> autoreceptors increases BDNF expression.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> It was definitely demonstrated that 5-HT<sub>1A</sub> receptor stimulation could represent a useful therapeutic approach for modulating apoptotic events in neurodegenerative processes. The development of selective 5-HT<sub>1A</sub> agonists could lead to useful neuroprotective agents able to interfere with excitotoxic and apoptotic cell death processes in the postischemic brain.</div></div><div id="sec2_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 5-HT<sub>1A</sub> and Parkinson’s Disease</h3><div class="NLM_p">Treatment with <span class="smallcaps smallerCapital">l</span>-3,4-dihydroxyphenylalanine (L-DOPA) is currently the main therapy for Parkinson’s disease (PD).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> However, patients receiving long treatments may develop motor complications, such as dyskinesia. The underlying mechanism of L-DOPA-induced dyskinesia (LID) is complex, and several pathways are involved in the development of this side effect.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">Among these there is an abnormal 5-HT-mediated neurotransmission, since 5-HT<sub>1A</sub> receptors are localized both pre- and postsynaptically. Presynaptic 5-HT<sub>1A</sub> receptors reduce the release of several neurotransmitters, such as glutamate and dopamine. Postsynaptic 5-HT<sub>1A</sub> receptors hyperpolarize neurons exerting an inhibitory effect.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> Treatment with <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) reduces dyskinesia in both the 6-hydroxydopamine (6-OHDA) lesioned rat and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) lesioned primate, confirming the involvement of 5-HT<sub>1A</sub> receptors in LID. However, in the MPTP-lesioned primate, <i>R</i>-(+)-8-OH-DPAT <b>37</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) also reduces the antiparkinsonian benefit of L-DOPA.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The same effect is obtained following treatment with the 5-HT<sub>1A</sub> partial agonist <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Sarizotan <b>38</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), a 5-HT<sub>1A</sub> receptor agonist, reduces dyskinesia in parkinsonian rats and monkeys.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> In phase II studies, <b>38</b> reduced LID but increased duration of off-time, i.e., exacerbated parkinsonism, at high doses. However, <b>38</b> did not show an antidyskinetic effect in phase III trials.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p">Several studies have focused on elucidation of the mechanism by which 5-HT<sub>1A</sub> agonists reduce dyskinesia and worsen parkinsonism. Some of the reported evidence suggests that typical 5-HT<sub>1A</sub> agonists also act as antagonists toward D<sub>2</sub> receptors,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and some 5-HT<sub>1A</sub> ligands, described as full agonists, are actually partial 5-HT<sub>1A</sub> agonists. It is thus not clear whether the antidyskinetic properties are truly related to 5-HT<sub>1A</sub> stimulation or whether the potential to reduce antiparkinsonian benefit comes from another mechanism because D<sub>2</sub> receptor antagonists will alleviate dyskinesia, albeit at the expense of worsening parkinsonism. Understanding the pathophysiology of dyskinesia could be very important for the development of novel and useful therapeutics. The relevant role played by the 5-HT<sub>1A</sub> receptors in developing dyskinesia was confirmed by a recent study that has shown how parkinsonian animals treated chronically with L-DOPA have increased levels of 5-HT<sub>1A</sub> receptors in the striatal matrix. 5-HT<sub>1A</sub> agonists are potentially able to reduce dyskinesia. The challenge in developing such compounds appears to be to deliver this potential antidyskinetic effect without compromising the antiparkinsonian benefit. This might be obtained by stimulating striatal 5-HT<sub>1A</sub> receptors and/or those in middle layers of cortex without involving the 5-HT<sub>1A</sub> receptors in external cortical layers. This selective effect might be achieved within a specific therapeutic window, using compounds with partial agonist efficacy, or with 5-HT<sub>1A</sub> agonists exhibiting a specific anatomical selectivity. It is noteworthy that this kind of selectivity has already been described for the 5-HT<sub>1A</sub> agonist F15599 <b>39</b>, (p<i>K</i><sub>i</sub> = 8.65 ± 0.11; pEC<sub>50</sub> = 6.41 ± 0.06; Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), which shows selectivity of action for one brain region over another.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">Eltoprazine <b>40</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), a mixed 5-HT<sub>1A</sub>/<sub>1B</sub> receptor agonist, was found to be highly effective in reducing LID in rat and monkey models of PD. Also in this case, the antidyskinetic effect is associated with a partial loss of the therapeutic effect of <span class="smallcaps smallerCapital">l</span>-DOPA. Moreover, it was also demonstrated that <b>40</b>, given at a low dose, can be used to potentiate the antidyskinetic effect of amantadine <b>41</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>). Compound <b>40</b>, in contrast to <b>38</b>, can be used at lower doses because the simultaneous activation of both the 5-HT<sub>1A</sub> and the 5-HT<sub>1B</sub> receptors causes a synergistic effect on silencing of serotonin neurons induced by activation of both autoreceptor subtypes.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a> In addition, <b>38</b> is known to antagonize D<sub>2</sub> receptors, which may also contribute to the side effects observed in patients. In contrast, <b>40</b> has no antidopaminergic activity as demonstrated by the fact that the drug was not significantly effective against dyskinesia induced by apomorphine. On this basis, <b>40</b>, which is currently in clinical trials, may have a significantly better chance to become a drug. The ongoing clinical trials will help to verify whether the reduction of serotonin neuron activity obtained by treatment with 5-HT<sub>1A</sub> receptor agonists may lead not only to a reduction of dyskinesia but also to a partial loss of the therapeutic efficacy of L-DOPA. In this scenario, a combination of low doses of <b>40</b> with <b>41</b> may offer an alternative approach to improve antidyskinetic efficacy while reducing the side effects of the treatment. Thus, patients under <b>41</b> treatment may be ideal candidates for recruitment into clinical studies investigating the antidyskinetic efficacy of <b>40</b>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">The BMY-14802 <b>42</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), another 5-HT<sub>1A</sub> receptor agonist at an effective, antidyskinetic dose, did not alter L-DOPA’s efficacy in improving stepping in lesioned animals. Moreover, <b>42</b> was found to attenuate dyskinesia produced by direct D<sub>1</sub> and D<sub>2</sub> receptor agonists, thereby indicating antidyskinetic efficacy against a broad spectrum of DA replacement therapies. Finally, antidyskinetic effects of <b>42</b>, against L-DOPA but not direct toward DA receptor agonists, were reversed by the 5-HT<sub>1A</sub> antagonist <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). These results represent an extension of previous studies<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> that showed the antidyskinetic potential of <b>42</b> against LID at a dose range that is effective in reducing LID and contralateral rotations. More importantly, an antidyskinetic efficacy for <b>42</b> in attenuating dyskinesia produced by the direct DA receptor agonists SKF81297 <b>43</b> and quinpirole <b>44</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) was demonstrated.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In agreement with these considerations, the antidyskinetic profile of <b>42</b> is similar to that of 5-HT<sub>1A</sub> agonists, like <b>13</b>, <b>1</b>, <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), and piclozotan <b>45</b> (IC<sub>50</sub> = 0.47nM; Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) that have been shown to be effective in reducing dyskinesia both in humans and in animal models. Despite the early success of several 5-HT<sub>1A</sub> agonists, this class of compounds was not always successful in PD patients because their use was associated with increased extrapyramidal PD symptoms.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> However, it has been firmly established that <b>42</b> does not bind with high affinity to the D<sub>1</sub> and D<sub>2</sub> receptors (IC<sub>50</sub> values of >1000 and 6430 nM, respectively) and at the tested dose provides antidyskinetic relief without reducing antiparkinsonian efficacy.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of some 5-HT<sub>1A</sub> receptor agonists and other molecules useful in Parkinson’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">5-HT<sub>1A</sub> and Sexual Function</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anatomically, sexual reflexes are mixed (somatic–autonomic) circuits represented by emission (sympathetic center and somatic afferents), expulsion (parasympathetic center and somatic efferents), and erection (parasympathetic center and somatic afferents). Physiologically, ejaculation has a dual autonomic mediation consisting of two distinct and opposite autonomic centers (emission and expulsion), both of them with a positive contribution to the respective function.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Experimentally, 5-HT has two distinct, opposite, and positive effects on sexual function; via 5-HT<sub>1A</sub> receptors (5-HT<sub>1A</sub> agonists) it decreases intravaginal ejaculatory latency and erection, and via 5-HT<sub>2C</sub> receptors (5-HT<sub>2C</sub> agonists) it increases both erection and ejaculatory latency.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Consequently it appears clear that one type of serotonin receptor would have a stimulating effect on sexual function while the other one would have an inhibitory sexual effect. Another possibility is that both types of serotonin receptors could positively modulate sexual function. The 5-HT<sub>1A</sub> receptors could directly promote the sympathetic emission (shortening intravaginal ejaculatory latency times (IELT), as in premature emission after spinal cord injury) and could also indirectly decrease the opposite parasympathetic expulsion/erection centers (a decreased participation of erection and expulsion).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The 5-HT<sub>2C</sub> agonists would directly favor parasympathetic expulsion and erection (an increased erection) and consequently (indirectly) would inhibit the sympathetic (emission) center that starts ejaculation (increased IELT).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">A correlation between 5-HT<sub>1A</sub> and 5-HT<sub>2C</sub> receptors has been demonstrated by recent studies. Administration of a 5-HT<sub>2C</sub> agonist induces bursts of rhythmic activity in sympathetic nerves to the vas deferens in male rats, while 5-HT<sub>1A</sub> receptor agonists do not show such a response. The coadministration of a 5-HT<sub>1A</sub> agonist with a 5-HT<sub>2C</sub> agonist induces an enhancement of the vas deferens response.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Thus, the two agonists act in the lumbosacral spinal cord and the 5-HT<sub>2C</sub> receptors play a central role in ejaculation. In humans, the administration of drugs targeting the 5-HT<sub>2C</sub> receptors (e.g., paroxetine, which indirectly stimulates 5-HT<sub>2C</sub> activity by increasing levels of serotonin in the synapse) delays ejaculation, and this effect was reversed by drugs which stimulate the 5-HT<sub>1A</sub> receptors (e.g., <b>13</b>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">In the mating behavior test in rats, a significant reduction of intromission frequency, IELT, and interval after ejaculation can be achieved by the administration of <b>1</b>. By use of the mounting test with genital anesthesia, no effect of this drug was reported. In the ex copula test, <b>1</b> dramatically inhibits ejaculation and the display of penile erection.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> These complex results might be the consequence of the fact that libido and sexual arousal (cerebral ejaculation) could be induced by the action of complex afferents, represented by an association of genital somatic afferents with psychic/sensorial impulses. The administration of <b>1</b> followed by evaluation of sexual responses in male dogs (ejaculation, penile erection, and pelvic thrusting behavior) showed a dose-dependent decrease in the amount of ejaculated semen, possibly through indirect inhibition of parasympathetic expulsion/erection center (in fact this drug also exhibits an adverse effect on erectile response). However, at the highest doses, <b>1</b> produces an increase in IELT in dogs and a decrease in IELT in rats.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Explanations for these opposite responses are required. Hypoactive sexual desire disorder (HSDD) represents a persistent or recurrent deficiency or absence of sexual fantasies and desire, and it causes marked distress or interpersonal difficulty. This dysfunction should not be exclusively correlated to other psychiatric disorders (except another sexual dysfunction) or to the physiological effects of a single endogenous substance or to general pathological conditions. A cross-sectional, demographically representative U.S. population-based survey, conducted in 2006, found that approximately 1 in 10 premenopausal women reported low sexual desire with associated distress, typical of HSDD.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> HSDD is believed to be the most common form of female sexual dysfunction but remains underdiagnosed and undertreated. Recently, <b>25</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), a well-known serotonergic agent, has been reported to be efficacious in premenopausal women with HSDD and has an ongoing clinical development program in this population.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> The positive actions of <b>25</b> on sexual functioning were first discovered serendipitously while studying this agent in patients with major depressive disorder. Compound <b>25</b> was ineffective as an antidepressant, but it increased scores in women on the Arizona sexual experiences scale,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> thus leading to further formal clinical evaluations in HSDD. Compound <b>25</b> has multifunctional actions unlike most other therapeutic agents in clinical practice. It shows the highest affinity for 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, where it acts as agonist and antagonist, respectively.<a onclick="showRef(event, 'ref87 ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89 ref90">(87-90)</a> Compound <b>25</b> binds to additional receptors with affinities within 1 order of magnitude of that for 5-HT<sub>1A</sub> receptors. These include 5-HT<sub>2C</sub> receptors (antagonistic action), 5-HT<sub>2B</sub> receptors (antagonistic action), and D<sub>4</sub> receptors where it acts as either an antagonist or a weak agonist, depending on the model system used for testing.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Compound <b>25</b> shows a pharmacologic profile of 5-HT<sub>1A</sub> agonism/5-HT<sub>2A</sub> antagonism with consequent synergistic actions on pyramidal neurons in the prefrontal cortex (PFC). Through these receptors, 5-HT can profoundly influence the release of glutamate from the PFC pyramidal neurons innervating monoamine brainstem centers downstream and thus change the amount of 5-HT, norepinephrine (NE), and DA being released by these monoamine centers. As already demonstrated by neuroimaging studies of patients with HSDD, changes in PFC neuronal functioning are correlated to altered neuronal firing rates of certain pyramidal neurons and probably are responsible for HSDD. According to these studies, low desire may be expressed in women as an inability to attend to sexual cues.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Consequently the symptoms of HSDD may be balanced by increasing DA and NE levels and improving the efficiency of information processing of these pyramidal neurons.</div><div class="NLM_p last">In conclusion, <b>25</b> is a postsynaptic 5-HT<sub>1A</sub> agonist/5-HT<sub>2A</sub> antagonist that enhances DA and NE activity and reduces 5-HT activity in certain brain regions.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It has been hypothesized that the drug acts by redressing neurotransmitter imbalances thought to contribute to the low sexual desire of women with HSDD.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Unfortunately at the end of 2010, <b>25</b> received a negative report by the U.S. Food and Drug Administration, and consequently its development could be stopped. Finally GSK-958108 (structure not disclosed)<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> represents a novel 5-HT<sub>1A</sub> antagonist, which is being investigated by GlaxoSmithKline for the treatment of primary premature ejaculation.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">5-HT<sub>1A</sub> and Cardiovascular Response</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Numerous studies suggest that the 5-HT<sub>1A</sub> receptor subtype in the MR mediates protective responses to stress.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a> Systemic administration of <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) leads to bradycardia and a decrease in blood pressure suggesting that the 5-HT<sub>1A</sub> receptor has an inhibitory effect on sympathetic outflow. Moreover <b>1</b> reduces the cutaneous vasoconstriction evoked by physical stressors such as cold exposure or fever, conditioned fear,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> and psychological stress.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> To assess the role of 5-HT<sub>1A</sub> receptor subtype on these effects, microinjection of <b>29</b> (5-HT<sub>1A</sub> antagonist, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) in the MR reverses the inhibition of cold-evoked cutaneous vasoconstriction induced by <b>1</b>.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Thus, the MR is proved to be the site where 5-HT<sub>1A</sub> receptors can mediate stress-evoked cardiac or cutaneous vasoconstrictor responses.<a onclick="showRef(event, 'ref97 ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99">(97-99)</a> At the same time, activation of 5-HT<sub>1A</sub> receptors located in higher brain regions, such as limbic ones, may also reduce stress-evoked cardiovascular responses via an anxiolytic effect rather than via a direct effect on brainstem cardiovascular neurons.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> In addition to the inhibition mediated by activation of central 5-HT<sub>1A</sub> receptors, cardiovascular responses evoked by acute psychological stress, cold exposure, or fever could also be mediated by neurons within the dorsomedial hypothalamus (DMH), a region implicated in limbic and thermoregulatory functions.<a onclick="showRef(event, 'ref101 ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref101 ref102 ref103">(101-103)</a> Furthermore, the cardiovascular responses evoked by disinhibition of neurons in the DMH of anesthetized rats are also powerfully inhibited by systemic administration of <b>1</b>, and these effects are completely reversed by subsequent administration of <b>29</b>.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In transgenic 5-HT<sub>1A</sub> knockout models of mice it was found that the cardiovascular responses are exacerbated when the animals are exposed to stressful stimuli. These data suggested that the inhibitory effect of 5-HT<sub>1A</sub> receptor in the MR reduces the activity of neurons that help mediate the cardiovascular responses to various forms of stress.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> In addition, the possible role of the raphe pallidus nuclei (NRP) in mediating the same cardiovascular responses to several types of stress in conscious rats was explored. It was hypothesized that pharmacological inhibition of the NRP and selective activation of the inhibitory 5-HT<sub>1A</sub> receptor would block the sympatho-excitation associated with the cardiovascular response to various forms of environmental stress.</div><div class="NLM_p">Quite independently, studies in the central control of the autonomic nervous system showed that systemic 5-HT<sub>1A</sub> receptor stimulation can give rise to sympathetic inhibition that does not affect the baroreflex or chemoreflex,<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> but it does suppress responses evoked from the DMH.<a onclick="showRef(event, 'ref104 ref106'); return false;" href="javascript:void(0);" class="ref ref104 ref106">(104, 106)</a> Since sympathetic responses to all of these challenges can be attenuated at the level of the MR through 5-HT<sub>1A</sub> stimulation and since systemic 5-HT<sub>1A</sub> activation can also reduce sympathetic responses to physical and psychological stressors (i.e., cold exposure, inflammatory, air jet, open field, restraint, and social stress),<a onclick="showRef(event, 'ref97 ref98 ref99 ref107'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99 ref107">(97-99, 107)</a> it has been widely assumed that the 5-HT<sub>1A</sub> agonists could represent useful therapeutic agents for reducing all those sympathetic responses that occur in some forms of hypertension and heart failure.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> There is the possibility that systemic doses that are just sufficient to produce anxiolytic effects may reduce the sympathetic drive indirectly by an action at more rostral, purely limbic sites. In fact, doses that are sufficient to decrease the sympathetic responses to psychological stress are not enough to perturbate physical nature stress responses. Indeed it was demonstrated that at 0.25 mg/kg dose, <b>1</b> reduces the sympathetic responses to all emotional stressors but not to cold exposure. Definitely, the abolition of the cardiovascular responses to stress by administration of <b>1</b> into the NRP suggested that these responses were largely mediated by serotonergic neurotransmission and that NRP is responsible for mediation of protective cardiovascular responses to exogenous stress, most likely via the 5-HT<sub>1A</sub> receptor subtype.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_p last">Another correlation between 5-HT<sub>1A</sub> receptors and cardiovascular responses could be represented by treatment of hyperphagia and obesity with coadministration of a 5-HT<sub>1A</sub> agonist (<b>21</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) and an inhibitor of noradrenalin uptake (sibutramine). The reduction in food intake produced by sibutramine is largely due to increased noradrenergic activity through the central α<sub>1</sub>-adrenoceptors that can also cause an increased cardiovascular activity. A report suggests that when a 5-HT<sub>1A</sub> agonist (<b>21</b>) is combined with sibutramine, sibutramine-induced hypertension and tachycardia are attenuated. Surprisingly, the administration of <b>21</b> alone and at its maximally effective oral dose (2.5 mg/kg) does not produce significant effects on blood pressure or heart rate. Furthermore, coadministration of <b>21</b> (at the maximally effective dose of 2.5 mg/kg) does not significantly alter sibutramine’s ability to reduce food intake. Consequently, combining 5-HT<sub>1A</sub> activation with NA transport inhibition has two important attributes. First of all, it has the potential of preventing an increased sympathetic activity resulting from central increases in noradrenergic transmission produced by dual NA/5-HT reuptake inhibitors such as sibutramine. Second, the 5-HT<sub>1A</sub> activation may also contribute to hypophagia efficacy in combination with NA transporter blockade, through postsynaptic 5-HT<sub>1A</sub> receptor activity. Moreover it is additionally able to reduce food intake through the removal of tonic inhibition on spontaneous noradrenergic cell firing mediated by presynaptic 5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">5-HT<sub>1A</sub> and Urogenital Response</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Bladder dysfunction is characterized by impaired bladder sensation, increased bladder capacity, decreased bladder contractility, and increased residual urine. In several animal species, 5-HT is an important neurotransmitter that is also involved in the regulation of the micturition reflex and urinary incontinence. In addition to the central role of 5-HT, it also has a peripheral role with regard to bladder function.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> In humans and in animals 5-HT exhibits excitatory effects in both nonstimulated and electrically stimulated detrusor strips.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> While regulation of serotonergic receptors is considered a promising strategy for treating lower urinary tract symptoms, clinically available drugs have not been developed yet.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> The lumbosacral autonomic and the sphincter motor nuclei (Onuf’s nuclei) receive a dense serotonergic input, and the descending bulbospinal pathway to the urinary bladder is essentially an inhibitory circuit, where serotonin represents a key neurotransmitter. Ligands acting at 5-HT<sub>1A</sub> receptors are able to modify lower urinary tract function and have effects on both the external urethral sphincter (EUS) and external anal sphincter.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Intravenous (iv) or intracerebroventricular (icv) injection of <b>1</b> is able to activate the micturition reflex, inducing an increase in the frequency of isovolumic bladder contractions. Conversely it was shown that <b>1</b> induces periodic EUS relaxation during voiding in urethane-anesthetized chronic spinal cord injured rats and that this causes an increase in micturition volume, a decrease in bladder capacity, and an increase in voiding efficiency. All these actions were mediated via 5-HT<sub>1A</sub> receptors as demonstrated by the observation that they were reversed by <b>29</b>, suggesting the possibility that phasic relaxation depends upon descending serotonergic stimulation of 5-HT<sub>1A</sub> receptors. However, a direct excitatory effect of <b>1</b> on the bladder cannot be excluded because this agent can enhance spontaneous contractions of isolated bladder strips prepared from rats with chronic bladder outlet obstruction.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Developing 5-HT<sub>1A</sub> agonists with a preferential action on micturition reflex could provide a therapeutic tool for studying bladder dysfunction.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">5-HT<sub>1A</sub> and Cancer</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17027" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17027" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Serotonin exhibits multiple non-neural functions involved in essential hypertension, early embryogenesis, and follicle maturation and behavior.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It also acts as a growth factor on several types of nontumoral cells, and recently it was found to be related to oncogenes.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Depending on the tumor type, either 5-HT<sub>2</sub> (carcinoid tumors) or 5-HT<sub>1</sub> receptor antagonists are able to inhibit the 5-HT-induced increase in tumor growth. Growth-stimulatory activity of 5-HT in carcinoid valve disease and pancreatic carcinoid cells has been reported. Serotonin has also been proposed to take part in the autocrine loops of growth factors contributing to cell proliferation in tumors such as small cell lung carcinoma (SCLC).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> SCLC is a very aggressive and metastatic tumor often associated with tobacco smoking; SCLC cells express neuronal proteins like voltage-dependent Ca<sup>2+</sup> channels and nicotinic receptors. They also produce and release peptides like bombesin and insulin-like growth factor 1 which can establish an autocrine mitogenic loop. Moreover, it was shown that 5-HT is contained in and released from the SCLC cell lines NCI-N-592 and GLC-8. It is also mitogenic for SCLC cells and may therefore behave as an autocrine factor. Since this mitogenic effect of 5-HT appears to be important in controlling tumor growth, the 5-HT receptor subtype(s) present in SCLC cells were characterized and the involvement of 5-HT<sub>1D</sub> receptors into the mitogenic effects on SCLC cells was demonstrated.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">Serotonin also may be involved in prostate cancer (PC), the most frequently diagnosed invasive cancer and the leading cause of cancer-related death among males in a number of countries.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Mounting evidence indicates that neuroendocrine cells play a role in prostatic disease. Neuroendocrine cells populate both normal and malignant prostate tissues and can synthesize, store, and release growth factors, as well as biogenic amines, 5-HT, DA, and other neurotransmitter-related substances.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> An increase in the number of neuroendocrine cells is related to tumor progression.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Whether an increase in neuroendocrine cell secretory products as well as their synthesis and metabolism contribute to tumor progression remains to be determined. On the basis of these observations as well as the role of 5-HT as a growth factor for several types of nontumor and tumor cells, the expression of 5-HT receptor subtypes in PC-3 cells and in human hormone refractory prostate cancer tissue was investigated using immunohistochemical and Western blot techniques. Moreover, the effect of several 5-HTRs antagonists on PC-3 cells was evaluated.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> It was also verified that the 5-HT<sub>1A</sub> receptor is involved in the proliferation of human tumor cells, but while the functional role of 5-HT<sub>1A</sub> receptor is well characterized in neural cells, it remains still poorly understood elsewhere.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p">In particular, signal transduction of 5-HT<sub>1A</sub> receptor is complex and the exact mechanism of action is yet to be determined. However, this receptor subtype differs significantly from most other 5-HT receptors and exhibits a substantial similarity to adrenergic receptors (α 1,2 and β 1,2); this may explain why a number of adrenergic agents, including propranolol and pindolol, bind to the 5-HT<sub>1A</sub> receptor with high affinity. Previously, 5-HT<sub>1A</sub> antagonists and serotonin-uptake inhibitors were reported to inhibit the growth of three different prostatic tumor cell lines, PC-3, DU-145, and LNCaP, in vitro. The same agents inhibited proliferation of PC-3 xenografted subcutaneously in athymic nude mice.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> These results once again prove the implication of 5-HT in the growth of prostate carcinoma cells and indicate the 5-HT<sub>1A</sub> receptor as a potential therapeutic target for the treatment of PC. Identification of new therapeutic strategies is very important in particular for treating hormone-refractory PC. The localization and mRNA expression in (i) primary PC with clinical progression, (ii) PC metastases, and (iii) PC cell lines have been identified. Furthermore, the effects of serotonin and different 5-HT<sub>1A</sub> antagonists on proliferation of the PC cell lines in vitro were also examined together for the characterization and expression at the cellular level of 5-HT<sub>1A</sub> receptors in PC tissue, PC cell lines, and PC metastases. As demonstrated in experiments performed on Chinese hamster ovary (CHO) cells expressing 5-HT<sub>1A</sub> receptors, the activation of the receptor-stimulated ERK1/2 occurred via G<sub>i</sub>. By use of the same model system, it was also shown that the signaling downstream of the 5-HT<sub>1A</sub> receptor efficiently activates the PI3K/Akt signal transduction pathway promoting cell survival.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> This finding suggested that this heterologous expression system closely resembles the physiological function of this receptor in other systems. In order to improve the current knowledge of the mechanistic involvement of 5-HT in cell survival, it was shown that the PI3K/Akt pathway activates NF-κB downstream of 5-HT<sub>1A</sub> receptor stimulation by degradation of the inhibitory subunit IκBa. This event allows NF-κB nuclear translocation, leading to inhibition of caspase-3 activity. The functional antagonism between PI3K/Akt and ERK signaling on NF-κB activation has already been described in studies reporting the effects of platelet-derived growth factor on cell survival. Platelet-derived growth factor receptor-stimulated NF-κB exerted both pro- and antiapoptotic roles; apoptosis is induced by the Raf/MAPK pathway, while antiapoptosis is dependent on the PI3K/Akt pathway.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">Starting from these data, the antiproliferative activity of 1-naphthylpiperazine derivatives acting as selective 5-HT<sub>1A</sub> ligands was investigated. 1-Naphthylpiperazines were already described as able to block skin cancer induction likely because of an apoptotic mechanism.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><div class="NLM_p">Two of the newly synthesized derivatives (<b>46</b> and <b>47</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>) were selected in order to elucidate the mechanism responsible for the observed antiproliferative effect. Compounds <b>46</b> and <b>47</b> did not induce any apoptotic effect in PC-3 cells when compared with the same cell line treated with topotecan, a topoisomerase I inhibitor employed as positive control.</div><div class="NLM_p">Similar to <b>18</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), two compounds that did not induce any growth inhibition or apoptotic effects in PC-3 cells, no significant perturbation of cell cycle was observed when cells were treated with either <b>46</b> or <b>47</b>. On the other hand, the treatment with topotecan for 24 h induced an increase of cells in G2-M phase and the appearance of a sub-G1 peak, thus indicating a subpopulation of apoptotic cells. Moreover, a complete disruption of cell cycle kinetics with many cells in sub-G1 was observed after 48 and 72 h of treatment.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><div class="NLM_p">MAPK and Akt are apparently the most relevant pathways among the quite complex intracellular signaling by which serotonin induces mitogenesis. Furthermore, MAPK and Akt are directly connected to the signaling pathways of 5-HT<sub>1A</sub> receptors. On this basis, the effects of <b>1</b>, <b>18</b>, <b>46</b>, <b>47</b>, and topotecan on the activation of MAPK and Akt were evaluated in PC-3 cells by Western blotting. Treatment with compounds <b>46</b>, <b>47</b>, and topotecan did not reduce basal MAPK phosphorylation; on the contrary all three compounds induced a complete inhibition of Akt phosphorylation. The lack of effect on the phosphorylation of MAPK could be explained considering that in the PC-3 cells the MAPK signal is constitutively activated because of a KRAS mutation.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Moreover, recent studies about the role of α<sub>1</sub> and 5-HT<sub>1A</sub> receptors in prostate cancer seem to validate this target.</div><div class="NLM_p">Some 1,4-dioxane derivatives (compounds <b>48</b>–<b>50</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>), characterized by full or partial agonism at 5-HT<sub>1A</sub> receptor and associated with an antagonist profile toward all three α<sub>1</sub> receptor subtypes, when tested in human PC-3 prostate cancer cells showed antiproliferative and cytotoxic activities that were not affected by administration of the 5-HT<sub>1A</sub> antagonist <b>28</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). This indicates that their potent 5-HT<sub>1A</sub> agonist activity was not in contrast to their anticancer activity.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div><div class="NLM_p">Finally, this latter evidence as well as the inhibitory effect on Akt activity (associated with prosurvival signaling in cancer cells) shown by compounds <b>46</b> and <b>47</b> can explain the anticancer activity of 5-HT<sub>1A</sub> ligands. Further studies could be really useful to shed more light on the mechanism of action of the analyzed compounds that could represent new interesting leads as antiproliferative agents in prostatic cancer.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of 5-HT<sub>1A</sub> ligands as antiproliferative agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is clear that because of the multiplicity of functions, the 5-HT<sub>1A</sub> receptor is involved in a vast array of physiological and pathophysiological processes. Recent research advances have shown that many effects mediated by the 5-HT<sub>1A</sub> receptor remain largely unknown, and serotonergic modulation through this receptor appears promising for the development of novel therapeutic approaches for the treatment of many functional disorders from CNS to cancer. The intense research by medicinal chemists has allowed the identification of various classes of 5-HT<sub>1A</sub> receptor ligands, and there has been an ongoing effort to develop more selective 5-HT<sub>1A</sub> serotoninergic ligands<a onclick="showRef(event, 'ref123 ref124 ref125 ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125 ref126 ref127">(123-127)</a> in order to have novel pharmacological tools that could improve our knowledge of the signal transduction mechanisms. A limitation of many 5-HT<sub>1A</sub> ligands is their undesired high affinity for other receptor subtypes such as the dopaminergic D<sub>2</sub> receptor and α<sub>1</sub>-adrenoceptor.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Furthermore the use of some prototypical 5-HT<sub>1A</sub> agonists and antagonists has led to meaningful insight into the pathophysiological role of 5-HT<sub>1A</sub> receptor. It soon became clear that the 5-HT<sub>1A</sub> receptor is involved in many diseases and also that activation of this receptor would have beneficial effects on some unwanted side effects of antipsychotic drugs. As reported in this perspective, the identification of some potent and selective 5-HT<sub>1A</sub> receptor ligands led to the definition of newer therapeutic areas. In fact among the selective agonists, repinotan and <b>45</b> demonstrated anti-ischemic properties, whereas <b>12</b> showed remarkable analgesic properties. The 5-HT<sub>1A</sub> agonist component of <b>38</b> and pardoprunox has been shown to exert beneficial effects on levodopa-induced dyskinesia. A really interesting and emerging aspect could be represented by in-depth characterization of agonist intrinsic activity. In fact, many 5-HT<sub>1A</sub> agonists have been characterized only in comparison with <b>1</b> which also shows, in some biological systems, partial agonism compared to the native agonist 5-HT. Therefore, the evaluation in different in vitro and in vivo models of 5-HT<sub>1A</sub> receptor activation will give an accurate characterization of agonistic properties. It is important to note that regarding the involvement of 5-HT<sub>1A</sub> receptors in different pathologic conditions, the therapeutic role of 5-HT<sub>1A</sub> full or partial agonists seems to be more relevant than that of 5-HT<sub>1A</sub> antagonists, which in many cases are used as a tool to verify the efficacy of 5-HT<sub>1A</sub> agonists. Although some of the discussed agents will not reach the market as new drugs, they were shown to be powerful tools for elucidation of molecular mechanisms in which the 5-HT<sub>1A</sub> receptor is involved (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 5-HT<sub>1A</sub> Ligands in Pharmacological Development</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0017.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0018.gif" alt="" id="GRAPHIC-d2813e2342-autogenerated" /></img><div></div></div><div class="NLM_p">Several chemical classes are already known for their high affinity toward these receptors, and from a chemical point of view, they can be subdivided into different classes (i.e., aminotetralins, indolylalkylamines, ergolines, aporphines, arylpiperazines). Among them, one of the most studied and recurring chemical motifs present in many molecules, also reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> as new therapeutic tools acting on 5-HT<sub>1A</sub> receptor, is the long-chain arylpiperazines (LCAPs) one.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In these derivatives, the arylpiperazine moiety as tail of the molecule and the heterocyclic head are separated by a (CH<sub>2</sub>)<i><sub>n</sub></i> spacer attached to N-4 of the piperazine moiety. In the aryl position a substituted phenyl is typically located while the heterocyclic nucleus is an amide or imide. The chain length (<i>n</i>) can influence affinity and selectivity. When <i>n</i> = 4, optimal affinity is associated with a terminus that contains a heteroarylamide; when <i>n</i> = 2, alkylamides seem optimal.<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135, 136)</a> Although long-chain arylpiperazines typically possess an amide or imide moiety at or near the chain terminus, neither the amide nor the imide moiety is required for binding; that is, the terminus may be a phenyl or some other aromatic group.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Moreover the aromatic ring of the arylpiperazine scaffold is typically a substituted phenyl or heteroaromatic moiety (e.g., 2-pyrimidinyl). It is interesting to underline, however, that the presence of an oxygen atom at the phenyl 2-position (e.g., 2-methoxyphenyl) usually, but not always, imparts antagonist character. 2-Methoxyphenylpiperazine derivatives with structural similarity to <b>13</b>, such as <b>16</b> and <b>18</b>, were the first novel agents shown to possess 5-HT1A antagonist activity.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Compound <b>40</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) is another arylpiperazine derivative that has been successfully used as a 5-HT1A ligand. Structurally related agents such as <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), <b>21</b>, and <b>26</b><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) have been developed, and some of these are currently in clinical trials (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) in order to explore their therapeutic potential.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Hundreds of arylpiperazine derivatives have been synthesized, but many are nonselective and bind other 5-HT, dopamine, and adrenergic receptors. The significance of the respective parts of the LCAP structures on the 5-HT<sub>1A</sub> receptor affinity, intrinsic activity, and selectivity has been the subject of many structure–activity relationship (SAR) studies involving variation of the aromatic systems at the “head” and “tail” of the structure with the length of the methylene linker and with the replacement of the amide bond with other functions.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> A large number of SAR studies revealed the role of individual fragments, essential for high affinity for 5-HT<sub>1A</sub> sites and selectivity for other receptors.</div><div class="NLM_p last">In conclusion, it is evident that this old target is currently an interesting challenge for medicinal chemists, and continuing research could yield new therapeutic agents and shed more light on the molecular mechanisms that involve this receptor. At the same time, the development of new molecules that act as selective 5-HT<sub>1A</sub> agents could be useful to validate this therapeutic target in many pathologic conditions where its therapeutic role is still unclear. Finally, the long-chain arylpiperazines (LCAPs) motif could be explored further in order to obtain more selective and efficient 5-HT<sub>1A</sub> agents. In addition, it would be highly desirable to develop new chemical scaffolds that can act selectively on the 5-HT<sub>1A</sub> receptor subtype.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm400533t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01766" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01766" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferdinando Fiorino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#791f1c1f10160b1017390c1710171857100d"><span class="__cf_email__" data-cfemail="caacafaca3a5b8a3a48abfa4a3a4abe4a3be">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrice Severino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Magli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Ciano</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Caliendo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Santagada</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Frecentese</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Perissutti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Farmacia, Università
degli Studi di Napoli “Federico
II”, Via D. Montesano,
49, 80131, Napoli, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Ferdinando Fiorino</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2434-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ferdinando Fiorino</b> graduated in Pharmacy in 1995 from University of Naples “Federico II”, Italy. Then he started his career in medicinal chemistry at the Department of Pharmaceutical and Toxycological Chemistry with a Ph.D. in Pharmaceutical Sciences completed in 1999. In 2005 he held the position of Assistant Professor in Medicinal Chemistry at Faculty of Pharmacy, University of Naples “Federico II”, where he serves as full-time researcher. His research has focused on the synthesis and structure–activity relationships of heterocyclic compounds with serotonergic activity in order to obtain ligands with greater potency and selectivity on 5-HT<sub>1A</sub> receptors. More recently he has devoted his attention to the synthesis and structural characterization of peptide fragments of prion protein in order to clarify the mechanism by which the physiological form is converted to the pathological. He is author of 54 publications in international journals.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Beatrice Severino</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2442-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Beatrice Severino</b> obtained her Bachelor’s degree in Medicinal Chemistry in 1997 from University of Naples “Federico II”, Italy. In 2003 she earned a Ph.D. in Pharmaceutical Sciences working on a project focused on the design and synthesis of peptidomimetic derivatives acting on protease-activated receptors (PARs). In 2006 she held the position of Assistant Professor in Medicinal Chemistry, at Faculty of Pharmacy, University of Naples “Federico II”, where she serves as full-time researcher. Her scientific interest is mainly on the development of peptidomimetic derivatives acting on several pharmacological targets such as PARs, kallikreins, and more recently, sphingosine kinases. Such activity is documented by 49 publications in international journals.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Elisa Magli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2447-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elisa Magli</b> graduated in Pharmacy in 2008 from University of Naples “Federico II”, Italy. Then she received her Ph.D in Pharmaceutical Science in 2011, working on a project concerning the synthesis of novel serotoninergic ligands and evaluation of their antitumor activity. She is currently a postdoc at Department of Pharmacy of University of Naples “Federico II”, and her interest is in the design, synthesis, and characterization of heterocyclic molecules active on several pharmacological targets with a focused interest on the serotoninergic receptors. Such activity is documented by six publications in international journals.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Antonio Ciano</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2452-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Antonio Ciano</b> attended the Faculty of Pharmacy at the University of Naples “Federico II”, Italy, and graduated in 2010, with a MPharm thesis on novel 2,6-diaminoanthraquinone derivatives as anticancer agents. Currently, he is a Ph.D. student at the Department of Pharmacy, University of Naples “Federico II”, and he is working on the synthesis and the pharmacologic evaluation of novel 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>2C</sub> ligands. Currently, he is coauthor of two scientific articles in international journals.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Giuseppe Caliendo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2466-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Giuseppe Caliendo</b> received his B.Sc. in Pharmacy from University of Naples “Federico II”, Italy, in 1981. Currently, he is Full Professor of Medicinal Chemistry at the Faculty of Pharmacy of Naples. He has published over 120 peer-reviewed papers and some scientific books in the field of peptidomimetics and synthesis by microwave of biologically active compounds. His research is focused on identification and characterization of heterocyclic derivatives acting on some of the most attractive targets for medicinal chemists such as serotonin receptors, protease activated receptors, and kallikreins. In recent years, he has been interested in the development of hybrid structures containing H<sub>2</sub>S-releasing moiety in order to produce novel pharmacological tools able to highlight the therapeutic potential of modulation of the H<sub>2</sub>S pathway.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Vincenzo Santagada</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2477-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vincenzo Santagada</b> received his B.Sc. in Pharmacy from University of Naples “Federico II”, Italy, in 1982 and his Ph.D. in Medicinal Chemistry in 1987. Currently, he is Full Professor of Medicinal Chemistry at the Faculty of Pharmacy of Naples. He has published over 120 peer-reviewed papers and some scientific books in the field of peptidomimetics and synthesis by microwave. His scientific interests cover design and synthesis of pharmacologically active peptides and peptidomimetics that have been evaluated for their antitumoral, anti-inflammatory, antiviral, or analgesic properties. Recent years have seen a deep interest in the application of microwave technology to medicinal chemistry and in the development of H<sub>2</sub>S-releasing molecules.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Francesco Frecentese</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2485-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Francesco Frecentese</b> graduated in Pharmacy in 2003 from University of Naples “Federico II”, Italy. Then he received his Ph.D. in Pharmaceutical Sciences in 2006, working on a project concerning the application of microwaves in the synthesis of pharmacologically active heterocyclic, peptidic, and peptidomimetic molecules. He is currently a full-time researcher at Faculty of Biotechnology, and his interest is focused on development of PARs ligands and agents acting as H<sub>2</sub>S releasing molecules and/or inhibitors of enzymes involved in H<sub>2</sub>S production pathway. His scientific activity is reported in 25 articles in international journals.</p></figure></div><div class="bio" rid="ath8"><figure id="ath8" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Elisa Perissutti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=BIO-d2813e2496-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elisa Perissutti</b> obtained her B.Sc. in Pharmacy from University of Naples “Federico II”, Italy, in 1984 followed by a Ph.D. in Pharmaceutical Sciences in 1989. Currently she attends the Department of Pharmaceutical and Toxicological Chemistry and is Associate Professor of Medicinal Chemistry at the Faculty of Pharmacy. She has published over 70 full articles in international journals. Her main scientific interests include structure–activity relationship studies on heterocyclic derivatives acting as serotoninergic ligands, identification and characterization of PAR ligands, and application of novel technological tools to drug discovery. She is also coauthor of a book on the applications of microwave on peptide and organic synthesis.</p></figure></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">This paper was published ASAP on December 10, 2013. The structure for compound <b>34</b> in Figure 11 and Table 1 was replaced and the revised version was reposted on December 12, 2013.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbreviations Used</h2><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">CA1</td><td class="NLM_def"><p class="first last">area of hippocampus filled with densely packed pyramidal cells</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">COS-1</td><td class="NLM_def"><p class="first last">fibroblast-like cells derived from kidney of the African green monkey</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cAMP response element-binding protein</p></td></tr><tr><td class="NLM_term">DMH</td><td class="NLM_def"><p class="first last">dorsomedial hypothalamus</p></td></tr><tr><td class="NLM_term">DU145</td><td class="NLM_def"><p class="first last">human prostate cancer cell line</p></td></tr><tr><td class="NLM_term">EPS</td><td class="NLM_def"><p class="first last">extrapyramidal symptoms</p></td></tr><tr><td class="NLM_term">EUS</td><td class="NLM_def"><p class="first last">external urethral sphincter</p></td></tr><tr><td class="NLM_term">HSDD</td><td class="NLM_def"><p class="first last">hypoactive sexual desire disorder</p></td></tr><tr><td class="NLM_term">IELT</td><td class="NLM_def"><p class="first last">intravaginal ejaculatory latency time</p></td></tr><tr><td class="NLM_term">LCAP</td><td class="NLM_def"><p class="first last">long-chain arylpiperazine</p></td></tr><tr><td class="NLM_term">LID</td><td class="NLM_def"><p class="first last">L-DOPA-induced dyskinesia</p></td></tr><tr><td class="NLM_term">LNCaP</td><td class="NLM_def"><p class="first last">androgen-sensitive human prostate adenocarcinoma cell line</p></td></tr><tr><td class="NLM_term">MR</td><td class="NLM_def"><p class="first last">medullary raphe</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">NRP</td><td class="NLM_def"><p class="first last">raphe pallidus nuclei</p></td></tr><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">prostate cancer</p></td></tr><tr><td class="NLM_term">PC-3</td><td class="NLM_def"><p class="first last">human prostate cancer cell line</p></td></tr><tr><td class="NLM_term">PFC</td><td class="NLM_def"><p class="first last">prefrontal cortex</p></td></tr><tr><td class="NLM_term">SCLC</td><td class="NLM_def"><p class="first last">small cell lung carcinoma</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">serotonin reuptake inhibitor</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 138 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. D.</span><span> </span><span class="NLM_article-title">Serotonin receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr078224o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1614-1641&author=D.+E.+Nicholsauthor=C.+D.+Nichols&title=Serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin Receptors</span></div><div class="casAuthors">Nichols, David E.; Nichols, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1614-1641</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on phylogeny, structural features, oligomerization, classification and functions of serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnlR5CHbuX7Vg90H21EOLACvtfcHk0lgj4swyTVTZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D&md5=55b70829f6be71cbfe4de05c5ef665d8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcr078224o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr078224o%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DNichols%26aufirst%3DC.%2BD.%26atitle%3DSerotonin%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1614%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Fredriksson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerström, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundin, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiöth, H. B.</span><span> </span><span class="NLM_article-title">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fmol.63.6.1256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12761335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1256-1272&issue=6&author=R.+Fredrikssonauthor=M.+C.+Lagerstr%C3%B6mauthor=L.+G.+Lundinauthor=H.+B.+Schi%C3%B6th&title=The+G-protein-coupled+receptors+in+the+human+genome+form+five+main+families.+Phylogenetic+analysis%2C+paralogon+groups%2C+and+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span></div><div class="casAuthors">Fredriksson, Robert; Lagerstrom, Malin C.; Lundin, Lars-Gustav; Schioth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-1272</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The superfamily of G-protein-coupled receptors (GPCRs) is very diverse in structure and function and its members are among the most pursued targets for drug development.  We identified more than 800 human GPCR sequences and simultaneously analyzed 342 unique functional nonolfactory human GPCR sequences with phylogenetic analyses.  Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system.  The rhodopsin family is the largest and forms four main groups with 13 subbranches.  Positions of the GPCRs in chromosomal paralogons regions indicate the importance of tetraploidizations or local gene duplication events for their creation.  We also searched for "fingerprint" motifs using Hidden Markov Models delineating the putative inter-relationship of the GRAFS families.  We show several common structural features indicating that the human GPCRs in the GRAFS families share a common ancestor.  This study represents the first overall map of the GPCRs in a single mammalian genome.  Our novel approach of analyzing such large and diverse sequence sets may be useful for studies on GPCRs in other genomes and divergent protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX4VhTsaDzrVg90H21EOLACvtfcHk0lhJ0M104aR4ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D&md5=504ea873ee8469cd0b6016bc94943836</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1256%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DLagerstr%25C3%25B6m%26aufirst%3DM.%2BC.%26aulast%3DLundin%26aufirst%3DL.%2BG.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DThe%2520G-protein-coupled%2520receptors%2520in%2520the%2520human%2520genome%2520form%2520five%2520main%2520families.%2520Phylogenetic%2520analysis%252C%2520paralogon%2520groups%252C%2520and%2520fingerprints%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26issue%3D6%26spage%3D1256%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frielle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang-Feng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2F329075a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=3041227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaL1cXmvFyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=75-79&author=B.+K.+Kobilkaauthor=T.+Frielleauthor=S.+Collinsauthor=T.+Yang-Fengauthor=T.+S.+Kobilkaauthor=U.+Franckeauthor=R.+J.+Lefkowitzauthor=M.+G.+Caron&title=An+intronless+gene+encoding+a+potential+member+of+the+family+of+receptors+coupled+to+guanine+nucleotide+regulatory+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins</span></div><div class="casAuthors">Kobilka, Brian K.; Frielle, Thomas; Collins, Sheila; Yang-Feng, Theresa; Kobilka, Tong Sun; Francke, Uta; Lefkowitz, Robert J.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">6134</span>),
    <span class="NLM_cas:pages">75-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A DNA fragment from a human genomic library was isolated, cloned, and sequenced.  The fragment (G-21) cross-hybridizes with a full-length B2-adrenergic probe at reduced stringency.  The gene is intronless, and contains an uninterrupted long open reading frame which encodes a putative protein in the expected structural features of a G-protein-coupled receptor.  The G-21 locus was localized to chromosome 5.  The corresponding mRNA of 6000 nucleotides was most abundant in lymphatic tissues including lymph node, spleen, and thymus.  This mRNA was also expressed in gut, muscle, and kidney but not in lung, heart, adrenal gland, and placenta.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJGLNLxFcT6bVg90H21EOLACvtfcHk0lhJ0M104aR4ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmvFyktA%253D%253D&md5=d2ad5e28f45bc40ece0fd9aaa96ad61b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F329075a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329075a0%26sid%3Dliteratum%253Aachs%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DFrielle%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DYang-Feng%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAn%2520intronless%2520gene%2520encoding%2520a%2520potential%2520member%2520of%2520the%2520family%2520of%2520receptors%2520coupled%2520to%2520guanine%2520nucleotide%2520regulatory%2520proteins%26jtitle%3DNature%26date%3D1987%26volume%3D329%26spage%3D75%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fargin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1988&pages=358-360&author=A.+Farginauthor=J.+R.+Raymondauthor=M.+J.+Lohseauthor=B.+K.+Kobilkaauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=The+genomic+clone+G-21+which+resembles+a+%CE%B2-adrenergic+receptor+sequence+encodes+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFargin%26aufirst%3DA.%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520genomic%2520clone%2520G-21%2520which%2520resembles%2520a%2520%25CE%25B2-adrenergic%2520receptor%2520sequence%2520encodes%2520the%25205-HT1A%2520receptor%26jtitle%3DNature%26date%3D1988%26volume%3D335%26spage%3D358%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Albert, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tol, H. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">5825</span><span class="NLM_x">–</span> <span class="NLM_lpage">5832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=5825-5832&issue=10&author=P.+R.+Albertauthor=Q.+Y.+Zhouauthor=H.+H.+M.+Van+Tolauthor=J.+R.+Bunzowauthor=O.+Civelli&title=Cloning%2C+functional+expression%2C+and+mRNA+tissue+distribution+of+the+rat+5-hydroxytryptamine1A+receptor+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DP.%2BR.%26aulast%3DZhou%26aufirst%3DQ.%2BY.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%252C%2520functional%2520expression%252C%2520and%2520mRNA%2520tissue%2520distribution%2520of%2520the%2520rat%25205-hydroxytryptamine1A%2520receptor%2520gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26issue%3D10%26spage%3D5825%26epage%3D5832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Charest, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainer, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, P. R.</span><span> </span><span class="NLM_article-title">Cloning and differentiation-induced expression of a murine serotonin<sub>1A</sub> receptor in a septal cell line</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5164</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2cXht1Gls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=5164-5171&author=A.+Charestauthor=B.+H.+Wainerauthor=P.+R.+Albert&title=Cloning+and+differentiation-induced+expression+of+a+murine+serotonin1A+receptor+in+a+septal+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line</span></div><div class="casAuthors">Charest, Alain; Wainer, Bruce H.; Albert, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5164-71</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">A neuronal cell model endogenously expressing the 5-HT1A receptor, in which to study the function and regulation of this gene, has yet to be identified.  The authors examd. murine SN-48 cells, a septum x neuroblastoma fusion cell line that proliferates in a nondifferentiated state but can be induced to differentiate into neurofilament-pos. cells following 24-96 h treatment with 10 μM retinoic acid in low serum.  Northern blot anal. demonstrated the presence of a single 10.9 kilobase (kb) 5-HT1A receptor RNA species in differentiated SN-48 cells, which was not detected in undifferentiated SN-48 cells.  The presence of receptor RNA in differentiated SN-48 cells correlated with the appearance of functional responses (i.e., pertussis toxin-sensitive inhibition of cAMP accumulation) to 5-HT1A agonists in differentiated but not in undifferentiated cells.  To verify that the large 10.9 kb RNA species in SN-48 cells truly corresponded to the mouse 5-HT1A receptor RNA, a cDNA fragment from differentiated SN-48 cells was used to clone the corresponding mouse brain cDNA.  The 2.4 kb cDNA contained a single open reading frame that displayed high (>85% predicted amino acid identity) homol. to the human and rat 5-HT1A receptor genes.  When transfected into receptor-neg. Ltk- cells, this cDNA was found to direct expression of a murine 5-HT1A receptor.  Thus, the authors conclude that upon differentiation SN-48 cells express RNA encoding functional 5-HT1A receptors.  The SN-48 septal cells will provide a useful cellular model system for investigating aspects of neuronal differentiation leading to the development of sensitivity to serotonergic input.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7jtec-7H8_rVg90H21EOLACvtfcHk0lhJ0M104aR4ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1Gls78%253D&md5=57ee14b593f0901acb39a2e14230cbbc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharest%26aufirst%3DA.%26aulast%3DWainer%26aufirst%3DB.%2BH.%26aulast%3DAlbert%26aufirst%3DP.%2BR.%26atitle%3DCloning%2520and%2520differentiation-induced%2520expression%2520of%2520a%2520murine%2520serotonin1A%2520receptor%2520in%2520a%2520septal%2520cell%2520line%26jtitle%3DJ.%2520Neurosci.%26date%3D1993%26volume%3D13%26spage%3D5164%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Banerjee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buse, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, G.</span><span> </span><span class="NLM_article-title">Differential solubilization of lipids along with membrane proteins by different classes of detergents</span> <span class="citation_source-journal">Chem. Phys. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1995&pages=65-78&author=P.+Banerjeeauthor=J.+B.+Jooauthor=J.+T.+Buseauthor=G.+Dawson&title=Differential+solubilization+of+lipids+along+with+membrane+proteins+by+different+classes+of+detergents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DP.%26aulast%3DJoo%26aufirst%3DJ.%2BB.%26aulast%3DBuse%26aufirst%3DJ.%2BT.%26aulast%3DDawson%26aufirst%3DG.%26atitle%3DDifferential%2520solubilization%2520of%2520lipids%2520along%2520with%2520membrane%2520proteins%2520by%2520different%2520classes%2520of%2520detergents%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D1995%26volume%3D77%26spage%3D65%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaput, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrièle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT<sub>1A</sub> receptors as a function of receptor: G-protein stoichiometry</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=451-459&author=A.+Newman-Tancrediauthor=C.+Conteauthor=C.+Chaputauthor=L.+Verri%C3%A8leauthor=M.+J.+Millan&title=Agonist+and+inverse+agonist+efficacy+at+human+recombinant+serotonin+5-HT1A+receptors+as+a+function+of+receptor%3A+G-protein+stoichiometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DConte%26aufirst%3DC.%26aulast%3DChaput%26aufirst%3DC.%26aulast%3DVerri%25C3%25A8le%26aufirst%3DL.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DAgonist%2520and%2520inverse%2520agonist%2520efficacy%2520at%2520human%2520recombinant%2520serotonin%25205-HT1A%2520receptors%2520as%2520a%2520function%2520of%2520receptor%253A%2520G-protein%2520stoichiometry%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D451%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kalipatnapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">A GFP fluorescence-based approach to determine detergent insolubility of the human serotonin<sub>1A</sub> receptor</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=2004&pages=455-460&author=S.+Kalipatnapuauthor=A.+Chattopadhyay&title=A+GFP+fluorescence-based+approach+to+determine+detergent+insolubility+of+the+human+serotonin1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalipatnapu%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DA%2520GFP%2520fluorescence-based%2520approach%2520to%2520determine%2520detergent%2520insolubility%2520of%2520the%2520human%2520serotonin1A%2520receptor%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D576%26spage%3D455%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Paila, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">The human serotonin<sub>1A</sub> receptor expressed in neuronal cells: toward a native environment for neuronal receptors</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2Fs10571-006-9098-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=17120164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtleksb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=925-942&author=Y.+D.+Pailaauthor=A.+Chattopadhyay&title=The+human+serotonin1A+receptor+expressed+in+neuronal+cells%3A+toward+a+native+environment+for+neuronal+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Serotonin1A Receptor Expressed in Neuronal Cells: Toward a Native Environment for Neuronal Receptors</span></div><div class="casAuthors">Paila, Yamuna Devi; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">925-942</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The serotonin1A (5-HT1A) receptor is an important representative of G-protein coupled family of receptors.  It is the most extensively studied among the serotonin receptors, and appears to be involved in various behavioral and cognitive functions.  We report here the pharmacol. and functional characterization of the human serotonin1A receptor stably expressed in HN2 cell line, which is a hybrid cell line between hippocampal cells and mouse neuroblastoma.  Our results show that serotonin1A receptors in HN2-5-HT1AR cells display ligand-binding properties that closely mimic binding properties obsd. with native receptors.  We further demonstrate that the differential discrimination of G-protein coupling by the specific agonist and antagonist, a hallmark of the native receptor, is maintained for the receptor in HN2-5-HT1AR cells.  Importantly, the serotonin1A receptor in HN2-5-HT1AR cells shows efficient downstream signalling by reducing cellular cAMP levels.  We conclude that serotonin1A receptors expressed in HN2-5-HT1AR cells represent a useful model system to study serotonin1A receptor biol., and is a potential system for solubilization and purifn. of the receptor in native-like membrane environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr9u9LxEfCHLVg90H21EOLACvtfcHk0liAe5cC72r5Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtleksb3I&md5=7f0691bdb52e26100e616eff5e3cd316</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10571-006-9098-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-006-9098-9%26sid%3Dliteratum%253Aachs%26aulast%3DPaila%26aufirst%3DY.%2BD.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DThe%2520human%2520serotonin1A%2520receptor%2520expressed%2520in%2520neuronal%2520cells%253A%2520toward%2520a%2520native%2520environment%2520for%2520neuronal%2520receptors%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2006%26volume%3D26%26spage%3D925%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pucadyil, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalipatnapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">The serotonin<sub>1A</sub> receptor: a representative member of the serotonin receptor family</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2Fs10571-005-3969-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16075379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnslyrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=553-580&author=T.+J.+Pucadyilauthor=S.+Kalipatnapuauthor=A.+Chattopadhyay&title=The+serotonin1A+receptor%3A+a+representative+member+of+the+serotonin+receptor+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin1A receptor: a representative member of the serotonin receptor family</span></div><div class="casAuthors">Pucadyil, Thomas J.; Kalipatnapu, Shanti; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">553-580</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Serotonin is an intrinsically fluorescent biogenic amine that acts as a neurotransmitter and is found in a wide variety of sites in the central and peripheral nervous system.  Serotonergic signaling appears to play a key role in the generation and modulation of various cognitive and behavioral functions.  Serotonin exerts its diverse actions by binding to distinct cell surface receptors which have been classified into many groups.  The serotonin1A (5-HT1A) receptor is the most extensively studied of the serotonin receptors and belongs to the large family of 7-transmembrane domain G-protein coupled receptors.  The tissue and sub-cellular distribution, structural characteristics, signaling of the serotonin1A receptor and its interaction with G-proteins are discussed.  The pharmacol. of serotonin1A receptors is reviewed in terms of binding of agonists and antagonists and sensitivity of their binding to guanine nucleotides.  Membrane biol. of 5-HT1A receptors is presented using the bovine hippocampal serotonin1A receptor as a model system.  The ligand binding activity and G-protein coupling of the receptor is modulated by membrane cholesterol thereby indicating the requirement of cholesterol in maintaining the receptor organization and function.  This, along with the reported detergent resistance characteristics of the receptor, raises important questions on the role of membrane lipids and domains in the function of this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvzwhksrHu17Vg90H21EOLACvtfcHk0liAe5cC72r5Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnslyrurw%253D&md5=4bf849e2150b81a4525ec381130b70f3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10571-005-3969-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-005-3969-3%26sid%3Dliteratum%253Aachs%26aulast%3DPucadyil%26aufirst%3DT.%2BJ.%26aulast%3DKalipatnapu%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DThe%2520serotonin1A%2520receptor%253A%2520a%2520representative%2520member%2520of%2520the%2520serotonin%2520receptor%2520family%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2005%26volume%3D25%26spage%3D553%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">G protein-coupled receptors. II. Mechanism of agonist activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">17979</span><span class="NLM_x">–</span> <span class="NLM_lpage">17982</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=17979-17982&author=U.+Getherauthor=B.+K.+Kobilka&title=G+protein-coupled+receptors.+II.+Mechanism+of+agonist+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGether%26aufirst%3DU.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DG%2520protein-coupled%2520receptors.%2520II.%2520Mechanism%2520of%2520agonist%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D17979%26epage%3D17982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kalipatnapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">Membrane organization and function of the serotonin<sub>1A</sub> receptor</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2Fs10571-007-9189-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1097-1116&issue=8&author=S.+Kalipatnapuauthor=A.+Chattopadhyay&title=Membrane+organization+and+function+of+the+serotonin1A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Organization and Function of the Serotonin1A Receptor</span></div><div class="casAuthors">Kalipatnapu, Shanti; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1097-1116</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  (1) The serotonin1A receptor is a G-protein coupled receptor involved in several cognitive, behavioral, and developmental functions.  It binds the neurotransmitter serotonin and signals across the membrane through its interactions with heterotrimeric G-proteins.  (2) Lipid-protein interactions in membranes play an important role in the assembly, stability, and function of membrane proteins.  The role of membrane environment in serotonin1A receptor function is beginning to be addressed by exploring the consequences of lipid manipulations on the ligand binding and G-protein coupling of serotonin1A receptors, the ability to functionally solubilize the serotonin1A receptor, and the factors influencing the membrane organization of the serotonin1A receptor.  (3) Recent developments involving the application of detergent-based and detergent-free approaches to understand the membrane organization of the serotonin1A receptor under conditions of ligand activation and modulation of membrane lipid content, with an emphasis on membrane cholesterol, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpef7HfbClvTLVg90H21EOLACvtfcHk0lgY7d7vUt-ZqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWluro%253D&md5=6ed5e145c5474a3f6ce12ba293495318</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs10571-007-9189-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-007-9189-2%26sid%3Dliteratum%253Aachs%26aulast%3DKalipatnapu%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DMembrane%2520organization%2520and%2520function%2520of%2520the%2520serotonin1A%2520receptor%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2007%26volume%3D27%26issue%3D8%26spage%3D1097%26epage%3D1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">del Olmo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Giménez, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaró, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengod, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, A.</span><span> </span><span class="NLM_article-title">Early localization of mRNA coding for 5-HT<sub>1A</sub> receptors in human brain during development</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0169-328X%2898%2900149-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=9748536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXlvFeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1998&pages=123-126&author=E.+del+Olmoauthor=J.+F.+L%C3%B3pez-Gim%C3%A9nezauthor=M.+T.+Vilar%C3%B3author=G.+Mengodauthor=J.+M.+Palaciosauthor=A.+Pazos&title=Early+localization+of+mRNA+coding+for+5-HT1A+receptors+in+human+brain+during+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Early localization of mRNA coding for 5-HT1A receptors in human brain during development</span></div><div class="casAuthors">del Olmo, Elena; Lopez-Gimenez, Juan F.; Vilaro, M. Teresa; Mengod, Guadalupe; Palacios, Jose M.; Pazos, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-126</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The distribution of 5-HT1A receptor mRNA in the human brain was studied in neonatal, children and adult cases by in situ hybridization histochem., using an oligonucleotide derived from the coding region of the human receptor.  A prenatal pattern of development was obsd.  The hippocampus, raphe nuclei and neocortex presented high levels of hybridization already at the fetal/neonatal stage, fully comparable to the adult.  A high and transient hybridization signal was found in cerebellum.  These results support a role for 5-HT1A receptors in the regulation of neural development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUli9S7e40CbVg90H21EOLACvtfcHk0lgY7d7vUt-ZqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvFeqtrY%253D&md5=3779e8bce67f280c4231da3d92e999e1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2898%2900149-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252898%252900149-1%26sid%3Dliteratum%253Aachs%26aulast%3Ddel%2BOlmo%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez-Gim%25C3%25A9nez%26aufirst%3DJ.%2BF.%26aulast%3DVilar%25C3%25B3%26aufirst%3DM.%2BT.%26aulast%3DMengod%26aufirst%3DG.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26aulast%3DPazos%26aufirst%3DA.%26atitle%3DEarly%2520localization%2520of%2520mRNA%2520coding%2520for%25205-HT1A%2520receptors%2520in%2520human%2520brain%2520during%2520development%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1998%26volume%3D60%26spage%3D123%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Singh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chromy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, P.</span><span> </span><span class="NLM_article-title">Induction of the serotonin<sub>1A</sub> receptor in neuronal cells during prolonged stress and degeneration</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2361</span><span class="NLM_x">–</span> <span class="NLM_lpage">2372</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1046%2Fj.1471-4159.1996.66062361.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK28XjtFCktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=2361-2372&author=J.+K.+Singhauthor=B.+A.+Chromyauthor=M.+J.+Boyersauthor=G.+Dawsonauthor=P.+Banerjee&title=Induction+of+the+serotonin1A+receptor+in+neuronal+cells+during+prolonged+stress+and+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of the serotonin1A receptor in neuronal cells during prolonged stress and degeneration</span></div><div class="casAuthors">Singh, Jyoti K.; Chromy, Brett A.; Boyers, Michael J.; Dawson, Glyn; Banerjee, Probal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2361</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Neuronal migration in brain is followed by differentiation of committed neurons and simultaneous apoptosis of uncommitted preneuronal cells due to a limiting supply of trophic factors and nutrients.  The authors have dissected differentiation and apoptosis by designing a simple in vitro model for this nutrient deprivation using engineered neuronal cell lines stably transfected with a promoterless segment (G-21) of the intronless human serotonin1A receptor (G-21) of the intronless human serotonin1A receptor (5-HT1A-R) gene.  Despite the use of widely different heterologous promoters (cytomegalovirus and Rous sarcoma virus) for the stable expression of G-21, a dramatic increase in expression of the 5-HT1A-R (five- to 15-fold) and its mRNA was always obsd. during degeneration and apoptosis of nutrient-deprived neuronal cells.  Involvement in this induction of a 170-bp 5'-end untranslated sequence (5'-UT) (tail end of the 500-bp natural promoter) of G-21 was confirmed by stable transfection of neuronal cells with an SV-40 promoter-driven construct harboring the 5'-UT and the reporter chloramphenicol acetyltransferase (CAT) cDNA.  Presence of the 5'-UT resulted in a threefold increase in CAT expression during nutrient deprivation in randomly chosen clones.  The induction was also obsd. in the endogenous 5-HT1A-R, expressed by embryonic day 16 mouse hippocampal neurons, subsequent to nutrient deprivation and onset of degeneration.  A trophic role of the 5-HT1A-R has been suggested in early studies.  Considering the example of protective heat shock proteins, which are induced during various types of stress, the results suggest that stressed neuronal cells undergoing degeneration and apoptosis synthesize increased levels of 5-HT1A-R as a final attempt to survive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszVsE0dHwvLVg90H21EOLACvtfcHk0lgY7d7vUt-ZqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFCktbs%253D&md5=f302ba94a7ed5b92d8a4299a92e03f10</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.66062361.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.66062361.x%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BK.%26aulast%3DChromy%26aufirst%3DB.%2BA.%26aulast%3DBoyers%26aufirst%3DM.%2BJ.%26aulast%3DDawson%26aufirst%3DG.%26aulast%3DBanerjee%26aufirst%3DP.%26atitle%3DInduction%2520of%2520the%2520serotonin1A%2520receptor%2520in%2520neuronal%2520cells%2520during%2520prolonged%2520stress%2520and%2520degeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D66%26spage%3D2361%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feingold, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (<i>R</i>)-<i>N</i>-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-<i>N</i>-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.107.133082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=18182558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=134-145&author=W.+D.+Hirstauthor=T.+H.+Andreeauthor=S.+Aschmiesauthor=W.+E.+Childersauthor=T.+A.+Comeryauthor=L.+A.+Dawsonauthor=M.+Dayauthor=I.+B.+Feingoldauthor=S.+M.+Grauerauthor=B.+L.+Harrisonauthor=Z.+A.+Hughesauthor=J.+Kaoauthor=M.+G.+Kellyauthor=H.+van+der+Leeauthor=S.+Rosenzweig-Lipsonauthor=A.+L.+Saabauthor=D.+L.+Smithauthor=K.+Sullivanauthor=S.+J.+Sukoff+Rizzoauthor=C.+Tioauthor=M.+Y.+Zhangauthor=L.+E.+Schechter&title=Correlating+efficacy+in+rodent+cognition+models+with+in+vivo+5-hydroxytryptamine1A+receptor+occupancy+by+a+novel+antagonist%2C+%28R%29-N-%282-methyl-%284-indolyl-1-piperazinyl%29ethyl%29-N-%282-pyridinyl%29-cyclohexane+carboxamide+%28WAY-101405%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span></div><div class="casAuthors">Hirst, Warren D.; Andree, Terrance H.; Aschmies, Suzan; Childers, Wayne E.; Comery, Thomas A.; Dawson, Lee A.; Day, Mark; Feingold, Irene B.; Grauer, Steven M.; Harrison, Boyd L.; Hughes, Zoe A.; Kao, John; Kelly, Michael G.; van der Lee, Heidi; Rosenzweig-Lipson, Sharon; Saab, Annmarie L.; Smith, Deborah L.; Sullivan, Kelly; Rizzo, Stacey J. Sukoff; Tio, Cesario; Zhang, Mei-Yi; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-145</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)1A receptors play an important role in multiple cognitive processes, and compelling evidence suggests that 5-HT1A antagonists can reverse cognitive impairment.  We have examd. the therapeutic potential of a potent (Ki = 1.1 nM), selective (>100-fold), orally bioavailable, silent 5-HT1A receptor antagonist (KB = 1.3 nM) (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)-ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).  Oral administration of WAY-101405 was shown to be effective in multiple rodent models of learning and memory.  In a novel object recognition paradigm, 1 mg/kg enhanced retention (memory) for previously learned information, and it was able to reverse the memory deficits induced by scopolamine.  WAY-101405 (1 mg/kg) was also able to reverse scopolamine-induced deficits in a rat contextual fear conditioning model.  In the Morris water maze, WAY-101405 (3 mg/kg) significantly improved learning in a paradigm of increasing task difficulty.  In vivo microdialysis studies in the dorsal hippocampus of freely moving adult rats demonstrated that acute administration of WAY-101405 (10 mg/kg) increased extracellular acetylcholine levels.  The selective radioligand [3H]WAY-100635, administered i.v., was used for in vivo receptor occupancy studies, where WAY-101405 occupied 50HT1A receptors in the rat cortex, with an ED50 value of 0.1 mg/kg p.o.  Taken together, these studies demonstrate that WAY-101405 is a potent and selective, brain penetrant, orally bioavailable 5-HT1A receptor "silent" antagonist that is effective in preclin. memory paradigms at doses where approx. 90% of the postsynaptic 5-HT1A receptors are occupied.  These results further support the rationale for use of this compd. class in the treatment of cognitive dysfunction assocd. with psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHA4lNdFCubVg90H21EOLACvtfcHk0ljCial44CGkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D&md5=32bf330b68ae1b11a2013e4563b8f686</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133082%26sid%3Dliteratum%253Aachs%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DFeingold%26aufirst%3DI.%2BB.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3Dvan%2Bder%2BLee%26aufirst%3DH.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSaab%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DTio%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DCorrelating%2520efficacy%2520in%2520rodent%2520cognition%2520models%2520with%2520in%2520vivo%25205-hydroxytryptamine1A%2520receptor%2520occupancy%2520by%2520a%2520novel%2520antagonist%252C%2520%2528R%2529-N-%25282-methyl-%25284-indolyl-1-piperazinyl%2529ethyl%2529-N-%25282-pyridinyl%2529-cyclohexane%2520carboxamide%2520%2528WAY-101405%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D134%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Whitaker-Azmitia, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauder, J. M.</span><span> </span><span class="NLM_article-title">Serotonin as a developmental signal</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=19-29&author=P.+M.+Whitaker-Azmitiaauthor=M.+Druseauthor=P.+Walkerauthor=J.+M.+Lauder&title=Serotonin+as+a+developmental+signal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitaker-Azmitia%26aufirst%3DP.%2BM.%26aulast%3DDruse%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DP.%26aulast%3DLauder%26aufirst%3DJ.%2BM.%26atitle%3DSerotonin%2520as%2520a%2520developmental%2520signal%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1996%26volume%3D73%26spage%3D19%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bordukalo-Niksic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrovic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefulj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernej, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicin-Sain, L.</span><span> </span><span class="NLM_article-title">5HT<sub>1A</sub> receptors and anxiety-like behaviours: studies in rats with constitutionally upregulated/downregulated serotonin transporter</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2010&pages=238-245&issue=2&author=T.+Bordukalo-Niksicauthor=G.+Mokrovicauthor=J.+Stefuljauthor=M.+Zivinauthor=B.+Jernejauthor=L.+Cicin-Sain&title=5HT1A+receptors+and+anxiety-like+behaviours%3A+studies+in+rats+with+constitutionally+upregulated%2Fdownregulated+serotonin+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBordukalo-Niksic%26aufirst%3DT.%26aulast%3DMokrovic%26aufirst%3DG.%26aulast%3DStefulj%26aufirst%3DJ.%26aulast%3DZivin%26aufirst%3DM.%26aulast%3DJernej%26aufirst%3DB.%26aulast%3DCicin-Sain%26aufirst%3DL.%26atitle%3D5HT1A%2520receptors%2520and%2520anxiety-like%2520behaviours%253A%2520studies%2520in%2520rats%2520with%2520constitutionally%2520upregulated%252Fdownregulated%2520serotonin%2520transporter%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D213%26issue%3D2%26spage%3D238%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Cuisiat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdiol, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacharme, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span> </span><span class="NLM_article-title">Towards a new generation of potential antipsychotic agents combining D<sub>2</sub> and 5-HT<sub>1A</sub> receptor activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061180b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=865-876&issue=4&author=S.+Cuisiatauthor=N.+Bourdiolauthor=V.+Lacharmeauthor=A.+Newman-Tancrediauthor=F.+Colpaertauthor=B.+Vacher&title=Towards+a+new+generation+of+potential+antipsychotic+agents+combining+D2+and+5-HT1A+receptor+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm061180b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061180b%26sid%3Dliteratum%253Aachs%26aulast%3DCuisiat%26aufirst%3DS.%26aulast%3DBourdiol%26aufirst%3DN.%26aulast%3DLacharme%26aufirst%3DV.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DVacher%26aufirst%3DB.%26atitle%3DTowards%2520a%2520new%2520generation%2520of%2520potential%2520antipsychotic%2520agents%2520combining%2520D2%2520and%25205-HT1A%2520receptor%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D4%26spage%3D865%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Huot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprich, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkelmolen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span> </span><span class="NLM_article-title">Regulation of cortical and striatal 5-HT<sub>1A</sub> receptors in the MPTP-lesioned macaque</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">207.e9</span><span class="NLM_x">–</span> <span class="NLM_lpage">207.e19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=207.e9-207.e19&author=P.+Huotauthor=T.+H.+Johnstonauthor=J.+B.+Koprichauthor=L.+Winkelmolenauthor=S.+H.+Foxauthor=J.+M.+Brotchie&title=Regulation+of+cortical+and+striatal+5-HT1A+receptors+in+the+MPTP-lesioned+macaque"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuot%26aufirst%3DP.%26aulast%3DJohnston%26aufirst%3DT.%2BH.%26aulast%3DKoprich%26aufirst%3DJ.%2BB.%26aulast%3DWinkelmolen%26aufirst%3DL.%26aulast%3DFox%26aufirst%3DS.%2BH.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26atitle%3DRegulation%2520of%2520cortical%2520and%2520striatal%25205-HT1A%2520receptors%2520in%2520the%2520MPTP-lesioned%2520macaque%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D207.e9%26epage%3D207.e19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Nadeson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodchild, C. S.</span><span> </span><span class="NLM_article-title">Antinociceptive role of 5-HT<sub>1A</sub> receptors in rat spinal cord</span> <span class="citation_source-journal">Br. J. Anaesth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1093%2Fbja%2F88.5.679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlSjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2002&pages=679-684&author=R.+Nadesonauthor=C.+S.+Goodchild&title=Antinociceptive+role+of+5-HT1A+receptors+in+rat+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive role of 5-HT1A receptors in rat spinal cord</span></div><div class="casAuthors">Nadeson, R.; Goodchild, C. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">679-684</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">0007-0912</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Intrathecal administration of 5-hydroxytryptamine (5-HT) is antinociceptive to noxious heat and elec. stimuli.  The contributions of different receptor subtypes to the antinociceptive effects of 5-HT are controversial.  The main reasons for this are the poor receptor subtype selectivity of some agonist drugs and the difficulty of restricting drug action to the spinal cord in some exptl. paradigms.  This study investigated the roles of different 5-HT receptor subtypes involved in the spinal cord control of the nociception produced by these two nociceptive testing paradigms.  Tail-flick latency and elec. current threshold for nociception were measured in an acute pain model that allowed the study of the antinociceptive effects of intrathecally administered drugs that were due to actions of these drugs at spinal cord receptors.  Expts. were performed in male Wistar rats with chronically implanted lumbar subarachnoid catheters.  Dose-response curves for spinally mediated antinociceptive effects of agonists selective for 5-HT receptor subtypes were constructed.  The 5-HT1 agonist 1-(3-chlorophenyl)-piperazine dihydrochloride caused a dose-dependent antinociceptive effect, measured by both nociceptive tests.  However, 8-hydroxy-DPAT (selective 5-HT1A agonist) produced antinociception assessed by elec. current but not tail flick.  A 5-HT1A-selective antagonist, 4-[3-(benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)-piperazine, reversed the antinociception in the elec. test produced by both of these agonists but the tail-flick latency effects after intrathecal 1-(3-chlorophenyl)-piperazine were not suppressed by this antagonist.  We conclude that 5-HT1A receptors in the spinal cord are involved in the nociceptive mechanisms assessed by noxious elec. stimuli.  Other 5-HT1 receptors (non 5-HT1A receptors) are involved in the spinally mediated antinociception assessed by thermal noxious stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPyW-6tsoRSbVg90H21EOLACvtfcHk0ljCial44CGkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlSjtb0%253D&md5=55ee82893851a55544cd0b0efecff7ea</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fbja%2F88.5.679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252F88.5.679%26sid%3Dliteratum%253Aachs%26aulast%3DNadeson%26aufirst%3DR.%26aulast%3DGoodchild%26aufirst%3DC.%2BS.%26atitle%3DAntinociceptive%2520role%2520of%25205-HT1A%2520receptors%2520in%2520rat%2520spinal%2520cord%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2002%26volume%3D88%26spage%3D679%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zhang, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. Q.</span><span> </span><span class="NLM_article-title">Expression of 5-HT<sub>1A</sub> receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2002&pages=287-295&author=Y.+Q.+Zhangauthor=X.+Gaoauthor=G.+C.+Jiauthor=Y.+L.+Huangauthor=G.+C.+Wuauthor=Z.+Q.+Zhao&title=Expression+of+5-HT1A+receptor+mRNA+in+rat+lumbar+spinal+dorsal+horn+neurons+after+peripheral+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DG.%2BC.%26aulast%3DHuang%26aufirst%3DY.%2BL.%26aulast%3DWu%26aufirst%3DG.%2BC.%26aulast%3DZhao%26aufirst%3DZ.%2BQ.%26atitle%3DExpression%2520of%25205-HT1A%2520receptor%2520mRNA%2520in%2520rat%2520lumbar%2520spinal%2520dorsal%2520horn%2520neurons%2520after%2520peripheral%2520inflammation%26jtitle%3DPain%26date%3D2002%26volume%3D98%26spage%3D287%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Pithadiaa, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine receptor subtypes and their modulators with therapeutic potentials</span> <span class="citation_source-journal">J. Clin. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=72-80&issue=2&author=A.+B.+Pithadiaaauthor=S.+M.+Jain&title=5-Hydroxytryptamine+receptor+subtypes+and+their+modulators+with+therapeutic+potentials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPithadiaa%26aufirst%3DA.%2BB.%26aulast%3DJain%26aufirst%3DS.%2BM.%26atitle%3D5-Hydroxytryptamine%2520receptor%2520subtypes%2520and%2520their%2520modulators%2520with%2520therapeutic%2520potentials%26jtitle%3DJ.%2520Clin.%2520Med.%2520Res.%26date%3D2009%26volume%3D1%26issue%3D2%26spage%3D72%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Shinka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onodera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, T.</span><span> </span><span class="NLM_article-title">Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line</span> <span class="citation_source-journal">Oncol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=211-215&issue=2&author=T.+Shinkaauthor=D.+Onoderaauthor=T.+Tanakaauthor=N.+Shojiauthor=T.+Miyazakiauthor=T.+Moriuchiauthor=T.+Fukumoto&title=Serotonin+synthesis+and+metabolism-related+molecules+in+a+human+prostate+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line</span></div><div class="casAuthors">Shinka, Toshiaki; Onodera, Dai; Tanaka, Tetsuji; Shoji, Noriaki; Miyazaki, Tadaaki; Moriuchi, Tetsuya; Fukumoto, Takahiro</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-215</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most common tumors in males and its incidence is steadily increasing worldwide.  Serotonin or 5-hydroxytryptamine (5-HT) is a well-known neurotransmitter that mediates a wide variety of physiol. effects.  An increase in the no. of 5-HT-releasing neuroendocrine (NE) cells has been correlated with tumor progression.  However, it is particularly unclear whether released 5-HT or the release of 5-HT has a role in tumor cell growth.  We hypothesized that 5-HT synthesis and metab. in NE cells regulate the growth of prostate cancer cells.  In the present study, 5-HT was found to play a role as a cell growth factor in prostate cancer cells.  Moreover, the pharmacol. inhibition of 5-HT synthesis and metab. interrupted the growth of prostate cancer cells.  To confirm the existence of 5-HT in prostate cancer cells, we performed ELISA, HPLC, RT-PCR and immunohistochem. analyses.  A high expression of tryptophan hydroxylase (TPH-1), dopa decarboxylase (DDC) and monoamine oxidase A (MAO-A) was noted in the prostate cancer cells when compared with normal prostate cells.  Previous studies showed that 5-HT stimulated the proliferation of prostate cancer cells mediated by 5-HT receptors 5-HTR1A and R1B.  However, cell proliferation was significantly inhibited when siRNA for both DDC and TPH-1 was transfected to the cells.  Consequently, we propose that the secretion system of prostate NE cells capable of 5-HT synthesis and metab. plays a significant role in prostate tumor generation and progression.  These findings provide crucial clues for the development of potential pharmacotherapeutics to slow prostate tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJqJqWdseDrVg90H21EOLACvtfcHk0ljmYYHubgdihg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSht7c%253D&md5=df3bf2023889085c2cea0a9d4c63e205</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShinka%26aufirst%3DT.%26aulast%3DOnodera%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DMoriuchi%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DT.%26atitle%3DSerotonin%2520synthesis%2520and%2520metabolism-related%2520molecules%2520in%2520a%2520human%2520prostate%2520cancer%2520cell%2520line%26jtitle%3DOncol.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D2%26spage%3D211%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pham-Le, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span> </span><span class="NLM_article-title">Activation of GABA<sub>A</sub> or 5HT<sub>1A</sub> receptors in the raphe pallidus abolish the cardiovascular responses to exogenous stress in conscious rats</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.brainresbull.2011.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOhurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2011&pages=360-366&author=N.+M.+Pham-Leauthor=C.+Cockburnauthor=K.+Nowellauthor=J.+Brown&title=Activation+of+GABAA+or+5HT1A+receptors+in+the+raphe+pallidus+abolish+the+cardiovascular+responses+to+exogenous+stress+in+conscious+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of GABAA or 5HT1A receptors in the raphe pallidus abolish the cardiovascular responses to exogenous stress in conscious rats</span></div><div class="casAuthors">Pham-Le, Nhut Minh; Cockburn, Chelsea; Nowell, Katherine; Brown, Justin</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">360-366</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysfunction in serotonin (5HT) neurotransmission in the brainstem of infants may disrupt protective responses to stress and increase the risk for Sudden Infant Death Syndrome (SIDS).  The raphe pallidus (NRP) and other brainstem nuclei are rich in 5HT and are thought to mediate stress responses, including increases in blood pressure (BP) and heart rate (HR).  Detg. how 5HT neurotransmission in the brainstem mediates responses to stress will help to explain how dysfunction in neurotransmission could increase the risk of SIDS.  It was hypothesized that alterations in neurotransmission in the NRP, specifically activation of the 5HT1A receptor subtype, would block cardiovascular responses to various types of exogenous stress.  Using aseptic techniques, male Sprague-Dawley rats were instrumented with radiotelemetry probes which enabled non-invasive measurement of BP and HR.  An indwelling microinjection cannula was also stereotaxically implanted into the NRP for injection of drugs that altered local 5HT neurotransmission.  Following a one week recovery period, rats were microinjected with either muscimol (GABAA receptor agonist), 8-OH-DPAT (agonist to the inhibitory 5HT1A receptor), or a vehicle control (artificial cerebral spinal fluid; ACSF) immediately prior to exposure to one of three stressors: handling, air jet, or restraint.  Phys. handling and restraint of the animal were designed to elicit a mild and a maximal stress response resp.; while an air jet directed at the rat's face was used to provoke a psychol. stress that did not require phys. contact.  All three stressors elicited similar and significant elevations in HR and BP following ACSF that persisted for at least 15 min with BP and HR elevated by ∼14.0 mmHg and ∼56.3 bpm resp.  The similarity in the stress responses suggest even mild handling of a rat elicits a maximal sympathoexcitatory response.  The stress response was abolished following 8-OH-DPAT or muscimol microinjection suggesting the cardiovascular responses to stress are mediated by the NRP and likely involve the 5HT1A receptor.  Impairment in 5HT1A receptor function in the NRP likely impairs the normal cardioprotective responses to stress and may contribute to the etiol. of SIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmVRD6gJYo97Vg90H21EOLACvtfcHk0ljmYYHubgdihg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOhurbK&md5=91f48ced5bcdc19a122bd663ca6cf4f9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2011.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2011.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DPham-Le%26aufirst%3DN.%2BM.%26aulast%3DCockburn%26aufirst%3DC.%26aulast%3DNowell%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520GABAA%2520or%25205HT1A%2520receptors%2520in%2520the%2520raphe%2520pallidus%2520abolish%2520the%2520cardiovascular%2520responses%2520to%2520exogenous%2520stress%2520in%2520conscious%2520rats%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2011%26volume%3D86%26spage%3D360%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ahlenius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, K.</span><span> </span><span class="NLM_article-title">Specific involvement of central 5-HT<sub>1A</sub> receptors in the mediation of male rat ejaculatory behavior</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1023%2FA%3A1022443413745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2sXkslyjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=1065-1070&author=S.+Ahleniusauthor=K.+Larsson&title=Specific+involvement+of+central+5-HT1A+receptors+in+the+mediation+of+male+rat+ejaculatory+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior</span></div><div class="casAuthors">Ahlenius, Sven; Larsson, Knut</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1065-1070</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A review, with 34 refs.  The aminotetralin 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), pharmacol. characterized as a 5-HT1A receptor agonist, produces a pronounced decrease in ejaculation latency in the male rat.  Stimulation of 5-HT receptors by a pharmacol. induced increase in the synaptic availability of 5-HT has been shown to produce the opposite effect.  The 8-OH-DPAT-induced decrease in ejaculation latency is specific for this compd., and some chem. related ergot derivs.  In this paper the authors review the evidence in support for stimulation of serotonergic autoreceptors of the 5-HT1A receptor subtype as a mechanism of action for effects by 8-OH-DPAT on male rat ejaculatory behavior.  The authors also present the questions posed by the fact that quinpirole and lisuride both produce 8-OH-DPAT-like effects on male rat ejaculatory behavior.  The effects by quinpirole, lisuride or 8-OH-DPAT are not sensitive to pretreatment with the DA D2/3 receptor antagonist raclopride.  Continued studies will show whether the effects of quinpirole and lisuride can be related to stimulation of 5-HT1A receptors, or if all these compds. have as yet undefined common properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF47hHBWDOAbVg90H21EOLACvtfcHk0ljmYYHubgdihg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslyjsbo%253D&md5=1a9b2576476368323dc078bf240febbe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022443413745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022443413745%26sid%3Dliteratum%253Aachs%26aulast%3DAhlenius%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DK.%26atitle%3DSpecific%2520involvement%2520of%2520central%25205-HT1A%2520receptors%2520in%2520the%2520mediation%2520of%2520male%2520rat%2520ejaculatory%2520behavior%26jtitle%3DNeurochem.%2520Res.%26date%3D1997%26volume%3D22%26spage%3D1065%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ahlenius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, P.</span><span> </span><span class="NLM_article-title">Effects of a new type of 5-HT receptor agonist on male rat sexual behaviour</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1981&pages=785-788&author=S.+Ahleniusauthor=K.+Larssonauthor=L.+Svenssonauthor=S.+Hjorthauthor=A.+Carlssonauthor=P.+Lindberg&title=Effects+of+a+new+type+of+5-HT+receptor+agonist+on+male+rat+sexual+behaviour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhlenius%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DK.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindberg%26aufirst%3DP.%26atitle%3DEffects%2520of%2520a%2520new%2520type%2520of%25205-HT%2520receptor%2520agonist%2520on%2520male%2520rat%2520sexual%2520behaviour%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1981%26volume%3D15%26spage%3D785%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Stafford, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coote, J. H.</span><span> </span><span class="NLM_article-title">Activation of lumbosacral 5-HT (2C) receptors induces bursts of rhythmic activity in sympathetic nerves to the vas deferens in male rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0706814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=1083-1090&author=S.+A.+Staffordauthor=K.+Tangauthor=J.+H.+Coote&title=Activation+of+lumbosacral+5-HT+%282C%29+receptors+induces+bursts+of+rhythmic+activity+in+sympathetic+nerves+to+the+vas+deferens+in+male+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of lumbosacral 5-HT2C receptors induces bursts of rhythmic activity in sympathetic nerves to the vas deferens in male rats</span></div><div class="casAuthors">Stafford, Stuart A.; Tang, Kim; Coote, John H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-1090</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We previously demonstrated that p-chloroamphetamine (PCA) i.v. evokes a specific patterned bursting response in the vas deferens nerve (VDN) of anesthetized male rats that is assocd. with contraction of the vas deferens, and ejaculation and contraction of the bulbospongiosus muscles.  The present study used selective 5-HT agonists to induce similar rhythmic bursting responses in the VDN in order to reveal the 5-HT receptor subtypes involved.  The 5-HT2C receptor agonist (1.0 mg kg-1 Ro600175 i.v.) evoked the characteristic bursting pattern responses in the VDN.  The 5-HT1A receptor agonist (1.0 mg kg-1 8-OH-DPAT i.v.) failed to elicit any responses.  However, 8-OH-DPAT coadministered in combination with Ro600175 induced a potentiation of the responses.  Responses were also evoked in rats with a mid-thoracic spinalization, with a more predictable response being obsd. following the combination of agonists.  This suggests an action of both agonists in the lumbosacral spinal cord.  Responses were blocked by 0.5 mg kg-1 SB206553 i.v. (5-HT2B/C receptor antagonist) or 0.5 mg kg-1 WAY100635 i.v. (5-HT1A receptor antagonist), but not 0.1 or 1.0 mg kg-1 SB269970 i.v. (5-HT7 receptor antagonist).  We suggest that activation of 5-HT2C and 5-HT1A receptor subtypes synergistically elicits contraction of the vas deferens through the activation of sympathetic preganglionic neurons in the spinal cord.  These data support the idea of a proejaculatory action of 5-HT2C receptors in the lumbosacral spinal cord, suggesting a descending 5-HT excitatory pathway in addn. to a 5-HT inhibitory pathway.  An excitatory action of 8-OH-DPAT at lumbosacral sites is also evident.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofM5qm2FbkZ7Vg90H21EOLACvtfcHk0ljJc1gep1ifLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVylsL4%253D&md5=8a5bfcbf24ffb474fafa87e7f2d93ca5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706814%26sid%3Dliteratum%253Aachs%26aulast%3DStafford%26aufirst%3DS.%2BA.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DCoote%26aufirst%3DJ.%2BH.%26atitle%3DActivation%2520of%2520lumbosacral%25205-HT%2520%25282C%2529%2520receptors%2520induces%2520bursts%2520of%2520rhythmic%2520activity%2520in%2520sympathetic%2520nerves%2520to%2520the%2520vas%2520deferens%2520in%2520male%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D1083%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yonezawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutsuwa, M.</span><span> </span><span class="NLM_article-title">Differential effects of yohimbine, naloxone and 8-OH-DPAT on ejaculatory response in male dogs</span> <span class="citation_source-journal">Methods Find. Exp. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1358%2Fmf.2004.26.1.793472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1WksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=47-51&author=A.+Yonezawaauthor=R.+Andoauthor=M.+Imaiauthor=C.+Watanabeauthor=S.+Furutaauthor=M.+Kutsuwa&title=Differential+effects+of+yohimbine%2C+naloxone+and+8-OH-DPAT+on+ejaculatory+response+in+male+dogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of yohimbine, naloxone and 8-OH-DPAT on ejaculatory response in male dogs</span></div><div class="casAuthors">Yonezawa, A.; Ando, R.; Imai, M.; Watanabe, C.; Furuta, S.; Kutsuwa, M.; Kimura, Y.; Sakurada, S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods and Findings in Experimental and Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-51</span>CODEN:
                <span class="NLM_cas:coden">MFEPDX</span>;
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">The aim of this study was to compare the effects of the α2-adrenergic-receptor antagonist yohimbine, the 5-HT1A-receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and the opioid-receptor antagonist naloxone (all of which have been shown to stimulate male sexual arousal/motivation in rats) on sexual responses in male dogs.  Sexual responses (i.e., ejaculation, penile erection and pelvic thrusting behavior) were elicited by manual penile stimulation.  Systemic administration of yohimbine (0.03-1.0 mg/kg) produced a biphasic dose response curve for the amt. of ejaculated semen collected during genital stimulation (for 5 min), whereas 8-OH-DPAT (0.03-0.3 mg/kg) dose-dependently decreased the amt. of ejaculated semen.  Thus, yohimbine increased the amt. of ejaculated semen at lower doses (0,03-0.3 mg/kg), but decreased it at the highest dose (1.0 mg/kg).  The highest dose of yohimbine (1.0 mg/kg) and 8-OH-DPAT (0.3 mg/kg) also produced a significant delay of onset in both ejaculation and penile erection latency (tune from starting the stimulation to the first ejaculation and full erection), and a decrease in the incidence of pelvic thrusting behavior.  In contrast, administration of naloxone (0.03-1.0 mg/kg) did not affect the sexual responses elicited by genital stimulation.  These results indicate that yohimbine and 8-OH-DPAT, but not naloxone, affect sexual responses, particularly ejaculation, and that the drugs which stimulate the mechanisms regulating sexual arousal/motivation in male rats do not show identical effects for sexual function in male dogs.  The present findings also confirm our previous observations that the ejaculatory capacity in dogs can be stimulated by lower doses of yohimbine, as evidenced by an increase in the amt. of ejaculated semen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkosd0jjoTtLVg90H21EOLACvtfcHk0ljJc1gep1ifLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1WksL4%253D&md5=85d35eeba81996d8244fbd05b75a0894</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1358%2Fmf.2004.26.1.793472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2004.26.1.793472%26sid%3Dliteratum%253Aachs%26aulast%3DYonezawa%26aufirst%3DA.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DC.%26aulast%3DFuruta%26aufirst%3DS.%26aulast%3DKutsuwa%26aufirst%3DM.%26atitle%3DDifferential%2520effects%2520of%2520yohimbine%252C%2520naloxone%2520and%25208-OH-DPAT%2520on%2520ejaculatory%2520response%2520in%2520male%2520dogs%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D26%26spage%3D47%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Amstislavskaya, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, N. K.</span><span> </span><span class="NLM_article-title">The roles of different types of serotonin receptors in activation of the hypophyseal-testicular complex induced in mice by the presence of a female</span> <span class="citation_source-journal">Neurosci. Behav. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=833-837&author=T.+G.+Amstislavskayaauthor=N.+K.+Popova&title=The+roles+of+different+types+of+serotonin+receptors+in+activation+of+the+hypophyseal-testicular+complex+induced+in+mice+by+the+presence+of+a+female"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmstislavskaya%26aufirst%3DT.%2BG.%26aulast%3DPopova%26aufirst%3DN.%2BK.%26atitle%3DThe%2520roles%2520of%2520different%2520types%2520of%2520serotonin%2520receptors%2520in%2520activation%2520of%2520the%2520hypophyseal-testicular%2520complex%2520induced%2520in%2520mice%2520by%2520the%2520presence%2520of%2520a%2520female%26jtitle%3DNeurosci.%2520Behav.%2520Physiol.%26date%3D2004%26volume%3D34%26spage%3D833%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Popova, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amstislavskaya, T. G.</span><span> </span><span class="NLM_article-title">Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=609-618&author=N.+K.+Popovaauthor=T.+G.+Amstislavskaya&title=Involvement+of+the+5-HT%281A%29+and+5-HT%281B%29+serotonergic+receptor+subtypes+in+sexual+arousal+in+male+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopova%26aufirst%3DN.%2BK.%26aulast%3DAmstislavskaya%26aufirst%3DT.%2BG.%26atitle%3DInvolvement%2520of%2520the%25205-HT%25281A%2529%2520and%25205-HT%25281B%2529%2520serotonergic%2520receptor%2520subtypes%2520in%2520sexual%2520arousal%2520in%2520male%2520mice%26jtitle%3DPsychoneuroendocrinology%26date%3D2002%26volume%3D27%26spage%3D609%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Motofei, I. G.</span><span> </span><span class="NLM_article-title">A dual physiological character for sexual function: the role of serotonergic receptors</span> <span class="citation_source-journal">BJU Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1464-410X.2007.07255.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=531-534&author=I.+G.+Motofei&title=A+dual+physiological+character+for+sexual+function%3A+the+role+of+serotonergic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-410X.2007.07255.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-410X.2007.07255.x%26sid%3Dliteratum%253Aachs%26aulast%3DMotofei%26aufirst%3DI.%2BG.%26atitle%3DA%2520dual%2520physiological%2520character%2520for%2520sexual%2520function%253A%2520the%2520role%2520of%2520serotonergic%2520receptors%26jtitle%3DBJU%2520Int.%26date%3D2007%26volume%3D101%26spage%3D531%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Riblet, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eison, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, H. C.</span><span> </span><span class="NLM_article-title">Pharmacology and neurochemistry of buspirone</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaL3sXhtFyqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1982&pages=11-18&issue=12&author=L.+A.+Ribletauthor=D.+P.+Taylorauthor=M.+S.+Eisonauthor=H.+C.+Stanton&title=Pharmacology+and+neurochemistry+of+buspirone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and neurochemistry of buspirone</span></div><div class="casAuthors">Riblet, Leslie A.; Taylor, Duncan P.; Eison, Michael S.; Stanton, Hubert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12, Sec. 2</span>),
    <span class="NLM_cas:pages">11-18</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    </div><div class="casAbstract">A review with 18 refs. of the pharmacol. and neurochem. of buspirone (I)  [36505-84-7].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-focGUKC6Z7Vg90H21EOLACvtfcHk0lgbwi0IjeDw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhtFyqsLw%253D&md5=e88e75fce78ee4d1f2573dc4d09e7f31</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiblet%26aufirst%3DL.%2BA.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26aulast%3DEison%26aufirst%3DM.%2BS.%26aulast%3DStanton%26aufirst%3DH.%2BC.%26atitle%3DPharmacology%2520and%2520neurochemistry%2520of%2520buspirone%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1982%26volume%3D43%26issue%3D12%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span> </span><span class="NLM_article-title">Derivatives as 5-HT<sub>1A</sub> receptor ligands—past and present</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.2174%2F0929867054367220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16029144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1721-1753&author=G.+Caliendoauthor=V.+Santagadaauthor=E.+Perissuttiauthor=F.+Fiorino&title=Derivatives+as+5-HT1A+receptor+ligands%E2%80%94past+and+present"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives as 5HT1A receptor ligands-past and present</span></div><div class="casAuthors">Caliendo, G.; Santagada, V.; Perissutti, E.; Fiorino, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1721-1753</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, depression and, insomnia as well as in normal human function such as sleep, sexual activity and appetite.  In this way, serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists and pharmaceutical companies.  Among 5-HTRs, the 5-HT1A subtype is the best studied, and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1A receptor sites such as aminotetralins, ergolines, arylpiperazines, indolylalkylamines, aporphines and aryloxyalkylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNq1YopI8Ho7Vg90H21EOLACvtfcHk0lgbwi0IjeDw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D&md5=42c78fb99de63e801880ae4577fe3583</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F0929867054367220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054367220%26sid%3Dliteratum%253Aachs%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26atitle%3DDerivatives%2520as%25205-HT1A%2520receptor%2520ligands%25E2%2580%2594past%2520and%2520present%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D1721%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viso, A.</span><span> </span><span class="NLM_article-title">Arylpiperazine derivatives acting at 5-HT<sub>1A</sub> receptors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.2174%2F0929867023371030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=11945120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=443-469&author=M.+L.+L%C3%B3pez-Rodr%C3%ADguezauthor=D.+Ayalaauthor=B.+Benham%C3%BAauthor=M.+J.+Morcilloauthor=A.+Viso&title=Arylpiperazine+derivatives+acting+at+5-HT1A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Arylpiperazine derivatives acting at 5-HT1A receptors</span></div><div class="casAuthors">Lopez-Rodriguez, M. L.; Ayala, D.; Benhamu, B.; Morcillo, M. J.; Viso, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists.  Among 5-HTRs, the 5-HT1A subtype is the best studied and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1AR sites.  Among these, arylpiperazine derivs. represent one of the most important classes of 5-HT1AR ligands.  This article will review the development of arylpiperazine derivs. acting at 5-HT1ARs with an emphasis on structure-affinity relationships of agonists and antagonists, ligand-receptor interactions and pharmacol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp08_YI2jco87Vg90H21EOLACvtfcHk0lgbwi0IjeDw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D&md5=88125d9e44708938260bdadeb73c6efb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F0929867023371030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023371030%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26aulast%3DAyala%26aufirst%3DD.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DViso%26aufirst%3DA.%26atitle%3DArylpiperazine%2520derivatives%2520acting%2520at%25205-HT1A%2520receptors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D443%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">5-HT<sub>1A</sub> receptor, an old target for new therapeutic agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.2174%2F156802608785161385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=18691130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1024-1034&author=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Berardiauthor=R.+Perrone&title=5-HT1A+receptor%2C+an+old+target+for+new+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A receptor, an old target for new therapeutic agents</span></div><div class="casAuthors">Lacivita, Enza; Leopoldo, Marcello; Berardi, Francesco; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1024-1034</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacol. characterized.  Over the last twenty years the 5-HT1A receptor has been the object of intense research efforts as witnessed by the 5-HT1A acting drugs marketed as anxiolytics.  In recent years, several new chem. entities targeting the 5-HT1A receptor (alone or in combination with other mol. targets) have been proposed for novel therapeutic indications (neuroprotection, cognitive impairment, Parkinson Disease and related disorders, pain treatment).  The present review will focus on those 5-HT1A receptor agents that entered preclin. trials starting from 2000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquGiFKFKnqLrVg90H21EOLACvtfcHk0ljcCni5BgzY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D&md5=cd19fc17c1edcfec3977fffe3920480d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156802608785161385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161385%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D5-HT1A%2520receptor%252C%2520an%2520old%2520target%2520for%2520new%2520therapeutic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1024%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Pessoa-Mahana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araya-Maturana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitz, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessoa-Mahana, C. D.</span><span> </span><span class="NLM_article-title">A synthetic overview of new molecules with 5-HT<sub>1A</sub> binding affinities</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=77-93&author=H.+Pessoa-Mahanaauthor=R.+Araya-Maturanaauthor=C.+B.+Saitzauthor=C.+D.+Pessoa-Mahana&title=A+synthetic+overview+of+new+molecules+with+5-HT1A+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPessoa-Mahana%26aufirst%3DH.%26aulast%3DAraya-Maturana%26aufirst%3DR.%26aulast%3DSaitz%26aufirst%3DC.%2BB.%26aulast%3DPessoa-Mahana%26aufirst%3DC.%2BD.%26atitle%3DA%2520synthetic%2520overview%2520of%2520new%2520molecules%2520with%25205-HT1A%2520binding%2520affinities%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D77%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wieland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Antidepressant-like activity of 5-HT<sub>1A</sub> agonists measured with the forced swim test</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2FBF02244228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1990&pages=497-504&author=S.+Wielandauthor=I.+Lucki&title=Antidepressant-like+activity+of+5-HT1A+agonists+measured+with+the+forced+swim+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test</span></div><div class="casAuthors">Wieland, Scott; Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-304</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">This study examd. the abilities of 5-hydroxytryptamine (5-HT) agonists with varying selectivity for different subtypes of 5-HT receptors to produce antidepressant-like behavioral effects in the forced swim test in rats.  The 5-HT1A agonists 8-OH-DPAT (0.125-1.0 mg/kg, s.c.) and tandospirone (SM-3997) (5-20 mg/kg, s.c.) both produced dose-related decreases in immobility time following subchronic treatment in rats.  These effects were similar to those of the tricyclic antidepressants imipramine (5-15 mg/kg) and desipramine (5-15 mg/kg).  In addn., the 5-HT1A agonists, buspirone (20 mg/kg), gepirone (20 mg/kg) and ipsapirone (10 and 20 mg/kg) demonstrated antidepressant-like effects.  Other groups of rats treated subchronically with each of the 5-HT1A agonists or antidepressants showed no increase in locomotor activity, so that general changes in activity could not account for the redn. of immobility time in the forced swim test.  5-HT agonists selective for other receptor subtypes, such as the 5-HT1B/1C agonist m-CPP (5 mg/kg) and the 5-HT2/1C agonist DOB (1 mg/kg), were not effective in this behavioral test.  The benzodiazepine diazepam (5 mg/kg) also failed to reduce immobility time, suggesting that anxiolytic properties of 5-HT1A agonists did not mediate this behavioral effect.  A common metabolite of some of the 5-HT1A agonists, 1-PP, was ineffective in reducing immobility time.  The stimulant d-amphetamine (2 mg/kg) significantly reduced immobility time but also significantly increased locomotor activity.  Pretreatment with the 5-HT synthesis inhibitor PCPA alone did not alter immobility time, and did not alter the antidepressant-like effects of 8-OH-DPAT or tandospirone, suggesting that the 5-HT1A agonists are producing their antidepressant-like effects through postsynaptic 5-HT1A receptors.  These results suggest that 5-HT1A agonists may have antidepressant efficacy and act as a novel class of antidepressant drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKxkymPp89XLVg90H21EOLACvtfcHk0ljcCni5BgzY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVCmtLo%253D&md5=853b6bffc0150426eed355f715947168</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF02244228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02244228%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DS.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAntidepressant-like%2520activity%2520of%25205-HT1A%2520agonists%2520measured%2520with%2520the%2520forced%2520swim%2520test%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D1990%26volume%3D101%26spage%3D497%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, N. M.</span><span> </span><span class="NLM_article-title">Is there a role for 5-HT<sub>1A</sub> agonists in the treatment of depression?</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0006-3223%2802%2901643-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12559651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=193-203&author=P.+Blierauthor=N.+M.+Ward&title=Is+there+a+role+for+5-HT1A+agonists+in+the+treatment+of+depression%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a role for 5-HT1A agonists in the treatment of depression?</span></div><div class="casAuthors">Blier, Pierre; Ward, Nick M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The role of serotonin (5-hydroxytryptamine; 5-HT) in the treatment of depressive and anxiety disorders is underscored by the therapeutic action of selective 5-HT reuptake inhibitors acting to enhance the degree of activation of various 5-HT receptor subtypes.  The 5-HT1A receptors are particularly relevant to the antidepressant and anxiolytic responses in human beings.  They are located presynaptically in the raphe nuclei, where they act as cell body autoreceptors to inhibit the firing rate of 5-HT neurons, and are located postsynaptically in limbic and cortical regions, where they also attenuate firing activity.  The azapirones are full agonists at 5-HT1A autoreceptors and are generally, but not exclusively, partial agonists at postsynaptic 5-HT1A receptors.  Some of these drugs, including gepirone and other 5-HT1A agonists such as buspirone, have been reported to exert anxiolytic and antidepressive activity in double-blind, placebo-controlled, and comparative trials.  Their delayed therapeutic activity is believed to result from increased activation of postsynaptic 5-HT1A receptors occurring only after 5-HT neurons regain their normal firing activity.  The recovery of this parameter, which is attributable to 5-HT1A autoreceptor desensitization, also restores 5-HT release.  At this point, the summed effects of a normalized level of synaptic 5-HT and the exogenous 5-HT1A agonist can be exerted on postsynaptic 5-HT1A receptors.  The widespread recognition of the clin. efficacy of such agents has largely been hampered by their undesirable pharmacokinetic properties.  Most 5-HT1A agonists are indeed readily absorbed but are also rapidly eliminated, thereby often producing either suboptimal therapeutic responses at low doses, or cumbersome adverse effects at higher doses.  Extended-release formulations allow once-daily dosing regimens, thus avoiding sharp peak plasma concns.  This improves compliance and permits the use of higher dosages, which may be assocd. with enhanced efficacy and better tolerability relative to the immediate-release formulations.  In sum, 5-HT1A receptor agonism represents a valuable and efficacious therapeutic approach to major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqave4phsEojLVg90H21EOLACvtfcHk0ljcCni5BgzY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D&md5=94f64a33cbc40a67fc0a4ae347dc36bd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2802%2901643-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252802%252901643-8%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DN.%2BM.%26atitle%3DIs%2520there%2520a%2520role%2520for%25205-HT1A%2520agonists%2520in%2520the%2520treatment%2520of%2520depression%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D2003%26volume%3D53%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Montigny, C.</span><span> </span><span class="NLM_article-title">Modification of 5-HT neuron properties by sustained administration of the 5-HT<sub>1A</sub> agonist gepirone: electrophysiological studies in the rat brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1987&pages=470-480&author=P.+Blierauthor=C.+de+Montigny&title=Modification+of+5-HT+neuron+properties+by+sustained+administration+of+the+5-HT1A+agonist+gepirone%3A+electrophysiological+studies+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3Dde%2BMontigny%26aufirst%3DC.%26atitle%3DModification%2520of%25205-HT%2520neuron%2520properties%2520by%2520sustained%2520administration%2520of%2520the%25205-HT1A%2520agonist%2520gepirone%253A%2520electrophysiological%2520studies%2520in%2520the%2520rat%2520brain%26jtitle%3DSynapse%26date%3D1987%26volume%3D1%26spage%3D470%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozlan, H.</span><span> </span><span class="NLM_article-title">Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK3MXnsFGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1990&pages=1335-1347&author=L.+E.+Schechterauthor=F.+J.+Bolanosauthor=H.+Gozlan&title=Alterations+of+central+serotoninergic+and+dopaminergic+neurotransmission+in+rats+chronically+treated+with+ipsapirone%3A+biochemical+and+electrophysiological+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone:  biochemical and electrophysiological studies</span></div><div class="casAuthors">Schechter, L. E.; Bolanos, F. J.; Gozlan, H.; Lanfumey, L.; Haj-Dahmane, S.; Laporte, A. M.; Fattaccini, C. M.; Hamon, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1335-47</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Inasmuch as sustained treatment with the 5-HT1A agonist, ipsapirone, is necessary for inducing anxiolytic and antidepressant effects in the clinic, investigations were performed for assessing the possible changes in serotoninergic and dopaminergic neurotransmission in the brain of rats 24 h after a 2-wk treatment with this drug.  Receptor binding assays with membranes and quant. autoradiog. indicated that the twice-daily administration of ipsapirone (5 mg/kg, i.p.) for 14 days did not alter the characteristics of 5-HT1A sites in the hippocampus, septum and dorsal raphe nucleus.  In contrast, decreases in the Bmax values for 5-HT2 sites (-24%) and 5-HT3 sites (-19%) were found in the frontal and posterior cortex, resp.  As expected from unchanged postsynaptic 5-HT1A receptors, inhibition of forskolin-stimulated adenylate cyclase by 5-HT1A agonists (8-hydroxy-2-(dipropylamino)tetralin, ipsapirone) exhibited the same characteristics in hippocampal homogenates from both control and ipsapirone-treated animals.  An acute administration of 8-hydroxy-2-(dipropylamino)tetralin (0.5 mg/kg i.p.) or ipsapirone (1 or 5 mg/kg i.p.) 24 h after the last injection for the chronic treatment produced a similar decrease in the rate of 5-HT turnover in various brain areas in rats treated for 2 wk with saline or ipsapirone.  At the highest dose (5 mg/kg i.p.), acute ipsapirone also increased the rate of dopamine turnover in the striatum and cerebral cortex approx. to the same extent in both treatment groups.  In vitro recording of the firing of serotoninergic neurons in brain stem slices revealed a desensitization of the somatodendritic 5-HT1A receptors, which might be responsible for the increased 5-HT turnover in the brain stem and striatum of rats chronically treated with ipsapirone as compared with controls.  Thus, chronically administered ipsapirone produces adaptive changes in central serotoninergic neurotransmission which might account for the anxiolytic and antidepressant properties of this drug after sustained treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9OkZF1loZN7Vg90H21EOLACvtfcHk0ljGXy68mo_v0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXnsFGkug%253D%253D&md5=249e10fa3e6b5a1967aaa0f70a4fd873</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DBolanos%26aufirst%3DF.%2BJ.%26aulast%3DGozlan%26aufirst%3DH.%26atitle%3DAlterations%2520of%2520central%2520serotoninergic%2520and%2520dopaminergic%2520neurotransmission%2520in%2520rats%2520chronically%2520treated%2520with%2520ipsapirone%253A%2520biochemical%2520and%2520electrophysiological%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1990%26volume%3D255%26spage%3D1335%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Citrome, L.</span><span> </span><span class="NLM_article-title">Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant—What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1742-1241.2011.02885.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=22284853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=356-368&author=L.+Citrome&title=Vilazodone+for+major+depressive+disorder%3A+a+systematic+review+of+the+efficacy+and+safety+profile+for+this+newly+approved+antidepressant%E2%80%94What+is+the+number+needed+to+treat%2C+number+needed+to+harm+and+likelihood+to+be+helped+or+harmed%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?</span></div><div class="casAuthors">Citrome, L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-368</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1742-1241</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Objective: To describe the efficacy and safety of vilazodone for the treatment of major depressive disorder (MDD).  Data sources: The pivotal registration trials were accessed by querying http://www.ncbi.nlm.nih.gov/pubmed/, http://www.fda.gov and http://www.clinicaltrials.gov for the search term "vilazodone".  Product labeling provided addnl. information.  Study selection: All available clin. reports of studies were identified.  Data extn.: Descriptions of the principal results and calcn. of no. needed to treat (NNT) and no. needed to harm (NNH) for relevant dichotomous outcomes were extd. from the available study reports and other sources of information.  Data synthesis: Vilazodone is a specific serotonin reuptake inhibitor and serotonin 5HT1A receptor partial agonist.  In needs to be administered with food to ensure adequate bioavailability.  Approval for the treatment of MDD was based on a clin. development program that included two 8-wk placebo-controlled randomised clin. trials in outpatients with MDD where vilazodone was titrated to a target dose of 40 mg/d over the first 2 wk.  Both trials evidenced efficacy for vilazodone as measured by the Montgomery Asberg Depression Rating Scale.  NNT for response vs. placebo was 8 (95% CI 6-16) and for remission was 14 (95% CI 8-55).  NNH vs. placebo for discontinuation because of an adverse event (AE) was 27 (95% CI 15-104).  The most commonly encountered AEs (incidence ≥ 5% and at least twice the rate of placebo) were diarrhoea, nausea, vomiting and insomnia, with NNH values vs. placebo of 6 (95% CI 5-8), 6 (95% CI 5-8), 30 (95% CI 18-82) and 26 (95% CI 16-78), resp.  NNH vs. placebo for any sexual AB was 12 (95% CI 9-18), but systematically collected data using rating scales of sexual function did not reveal treatment assocd. effects.  Vilazodone was not assocd. with clin. relevant wt. change in the short-term trials.  In an open-label 1-yr study of vilazodone, mean wt. increased by 1.7 kg among the obsd. cases.  Conclusions: Vilazodone represents another option for the treatment of MDD.  Vilazodone appears to have a favorable wt.-gain profile based on short-term studies.  Sexual side-effects were not consistently demonstrated when assessed using clin. rating scales but spontaneously reported AEs related to sexual functioning were obsd.  Addnl. controlled data regarding long-term efficacy and effectiveness will help characterize this new agent when used in maintenance treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-IWZwfNBy7LVg90H21EOLACvtfcHk0ljGXy68mo_v0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKhsrw%253D&md5=13f82826149cf353ff2e218096d8fed3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2011.02885.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2011.02885.x%26sid%3Dliteratum%253Aachs%26aulast%3DCitrome%26aufirst%3DL.%26atitle%3DVilazodone%2520for%2520major%2520depressive%2520disorder%253A%2520a%2520systematic%2520review%2520of%2520the%2520efficacy%2520and%2520safety%2520profile%2520for%2520this%2520newly%2520approved%2520antidepressant%25E2%2580%2594What%2520is%2520the%2520number%2520needed%2520to%2520treat%252C%2520number%2520needed%2520to%2520harm%2520and%2520likelihood%2520to%2520be%2520helped%2520or%2520harmed%253F%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2012%26volume%3D66%26spage%3D356%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span> </span><span class="NLM_article-title">Silent 5-HT<sub>1A</sub> receptor antagonists: utility as research tools and therapeutic agents</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1993&pages=441-448&author=A.+Fletcherauthor=I.+Cliffeauthor=C.+T.+Dourish&title=Silent+5-HT1A+receptor+antagonists%3A+utility+as+research+tools+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DCliffe%26aufirst%3DI.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26atitle%3DSilent%25205-HT1A%2520receptor%2520antagonists%253A%2520utility%2520as%2520research%2520tools%2520and%2520therapeutic%2520agents%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1993%26volume%3D14%26spage%3D441%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Assie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koek, W.</span><span> </span><span class="NLM_article-title">Effects of 5-HT<sub>1A</sub> receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=1996&pages=15-21&author=M.+B.+Assieauthor=W.+Koek&title=Effects+of+5-HT1A+receptor+antagonists+on+hippocampal+5-hydroxytryptamine+levels%3A+%28S%29-WAY100135%2C+but+not+WAY100635%2C+has+partial+agonist+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssie%26aufirst%3DM.%2BB.%26aulast%3DKoek%26aufirst%3DW.%26atitle%3DEffects%2520of%25205-HT1A%2520receptor%2520antagonists%2520on%2520hippocampal%25205-hydroxytryptamine%2520levels%253A%2520%2528S%2529-WAY100135%252C%2520but%2520not%2520WAY100635%252C%2520has%2520partial%2520agonist%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D304%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Arborelius, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomikos, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hook, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, T. H.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>1A</sub> receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2FBF00167182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=8738296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK28XjtlChsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1996&pages=630-640&author=L.+Arboreliusauthor=G.+G.+Nomikosauthor=P.+Hertelauthor=P.+Salmiauthor=P.+Grillnerauthor=B.+B.+Hookauthor=U.+Hacksellauthor=T.+H.+Svensson&title=The+5-HT1A+receptor+antagonist+%28S%29-UH-301+augments+the+increase+in+extracellular+concentrations+of+5-HT+in+the+frontal+cortex+produced+by+both+acute+and+chronic+treatment+with+citalopram"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram</span></div><div class="casAuthors">Arborelius, Lotta; Nomikos, George G.; Hertel, Peter; Salmi, Peter; Grillner, Pernilla; Hoeoek, Berit Backlund; Hacksell, Uli; Svensson, Torgny H.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">630-640</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In a recent study, utilizing single cell recording technique, we have shown that administration of 5-HT1A receptor antagonists, e.g. (S)-UH-301, to rats concomitantly treated, acute or chronically, with the selective serotonin reuptake inhibitor (SSRI) citalopram significantly increases the activity of 5-hydroxytryptamine (5-HT) contg. neurons in the dorsal raphe nucleus (DRN).  Here we report correlative expts. using microdialysis in freely moving animals to measure extracellular levels of 5-HT and its metabolite 5-hydroxyindole acetic acid (5-HIAA) in the frontal cortex, a major projection area for DRN-5-HT neurons.  Acute administration of (S)-UH-301 (2.5 mg/kg s.c.) or citalopram (2.0 mg/kg s.c.) increased 5-HT concns. with a max. of about 70% and 185%, resp., above baseline.  However, when (S)-UH-301 was administered 30 min before citalopram the maximal increase in 5-HT levels was approx. 400%.  In rats chronically treated with citalopram (20 mg/kg/day i.p. for 14 days) basal 5-HT concns. in the frontal cortex were significantly increased and 5-HIAA concns. were decreased when measured 10-12 h, but not 18-20 h, after the last injection of citalopram, as compared to basal 5-HT and 5-HIAA concns. in chronic saline-treated rats.  When (S)-UH-301 (2.5 mg/kg s.c.) was administered 12 h, but not 20 h, after the last dose of citalopram it produced a significantly larger increase in extracellular concns. of 5-HT than in control rats.  However, in rats pretreated with a single, very high dose of citalopram, 20 mg/kg i.p., administration of (S)-UH-301 at 12 h after citalopram did not increase 5-HT levels.  The augmentation by (S)-UH-301 of the increase in brain 5-HT output produced by acute administration of citalopram is probably by acute administration of citalopram is probably due to antagonism of the citalopram induced feedback inhibition of 5-HT cells in the DRN, as previously suggested.  However, the capacity of (S)-UH-301 to further increase the already elevated extracellular concns. of 5-HT in brain in animals maintained on a chronic citalopram regimen, in which significant tolerance to the initial feedback inhibition of DRN-5-HT cells had developed, represents a novel finding.  Generally, the reduced feedback inhibition of DRN-5-HT cells had developed, represents a novel finding.  Generally, the reduced feedback inhibition of 5-HT neurons obtained with chronic citalopram treatment, and the assocd. elevation of brain 5-HT concns., may be related to functional desensitization of somatodendritic 5-HT1A autoreceptors in the DRN.  This phenomenon may also largely explain the larger increase in 5-HT output produced by (S)-UH-301 in chronic citalopram treated animals as compared to its effect in control animals.  Yet, a contributory factor may be a slight, remaining feedback inhibition of the 5-HT cells caused by residual citalopram at 12, but not 20 h after its last administration.  Previous clin. studies suggest that addn. of a 5-HT1A receptor antagonist to an SSRI in the treatment of depression may accelerate the onset of clin. effects.  Moreover, in therapy-resistant cases maintained on SSRI treatment, addn. of a 5-HT1A receptor antagonist may improve clin. efficacy.  Since the therapeutic effect of SSRIs in depression has been found to be critically linked to the availability of 5-HT in brain, our exptl. results support, in principle, both of the above clin. based notions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnXgeuYpoK8rVg90H21EOLACvtfcHk0lj03dE6cHsxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtlChsLY%253D&md5=a2f277e5dc827cc08ed82335e7be960c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2FBF00167182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00167182%26sid%3Dliteratum%253Aachs%26aulast%3DArborelius%26aufirst%3DL.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26aulast%3DHertel%26aufirst%3DP.%26aulast%3DSalmi%26aufirst%3DP.%26aulast%3DGrillner%26aufirst%3DP.%26aulast%3DHook%26aufirst%3DB.%2BB.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DSvensson%26aufirst%3DT.%2BH.%26atitle%3DThe%25205-HT1A%2520receptor%2520antagonist%2520%2528S%2529-UH-301%2520augments%2520the%2520increase%2520in%2520extracellular%2520concentrations%2520of%25205-HT%2520in%2520the%2520frontal%2520cortex%2520produced%2520by%2520both%2520acute%2520and%2520chronic%2520treatment%2520with%2520citalopram%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1996%26volume%3D353%26spage%3D630%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Grignaschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Invernizzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fracasso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanin, R.</span><span> </span><span class="NLM_article-title">Citalopram-induced hypophagia is enhanced by blockade of 5-HT<sub>1A</sub> receptors: role of 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0702028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=9756397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXlslKnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=1781-1787&author=G.+Grignaschiauthor=R.+Invernizziauthor=R.+Fanelliauthor=C.+Fracassoauthor=S.+Cacciaauthor=R.+Samanin&title=Citalopram-induced+hypophagia+is+enhanced+by+blockade+of+5-HT1A+receptors%3A+role+of+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Citalopram-induced hypophagia is enhanced by blockade of 5-HT1A receptors: role of 5-HT2C receptors</span></div><div class="casAuthors">Grignaschi, G.; Invernizzi, R. W.; Fanelli, E.; Fracasso, C.; Caccia, S.; Samanin, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1781-1787</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The selective 5-hydroxytryptamine reuptake inhibitor citalopram (10 and 20 mg kg-1, i.p.) significantly reduced food intake in male rats (CD-COBS) habituated to eat their daily food during a 4-h period.  The 5-HT1A receptor antagonist WAY100635 (0.3 mg kg-1) administered systemically did not modify feeding but significantly potentiated the redn. in food intake caused by 10 mg kg-1 i.p. citalopram.  The dose of 5 mg kg-1 i.p. citalopram was not active in animals pretreated with vehicle but significantly reduced feeding in animals pretreated with WAY100635.  WAY100635 (0.1 μg 0.5 μL-1) injected into the dorsal raphe significantly potentiated the hypophagic effect of 10 mg kg-1 citalopram.  WAY100635 (1.0 μg 0.5 μL-1) injected into the median raphe did not modify feeding or the hypophagic effect of 10 mg kg-1 citalopram.  The 5-HT2B/2C receptor antagonist SB206553 (10 mg kg-1, p.o.) slightly reduced feeding by itself but partially antagonized the effect of WAY100635 administered systemically (0.3 mg kg-1, s.c.) or into the dorsal raphe (0.1 μg 0.5 μL-1) in combination with 10 mg kg-1 i.p. citalopram.  The hypophagic effect of 10 mg kg-1 i.p. citalopram alone was not significantly modified by SB206553.  Brain concns. of citalopram and its metabolite desmethylcitalopram in rats pretreated with SB206553, WAY100635 and their combination were comparable to those of vehicle-pretreated rats, 90 min after citalopram injection.  The hypophagic effect of citalopram was potentiated by blocking 5-HT1A receptors.  Only the effect of the WAY100635/citalopram combination seemed to be partially mediated by central 5-HT2C receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobRKhurUe8MLVg90H21EOLACvtfcHk0lj03dE6cHsxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslKnt78%253D&md5=63b5e4d37a720d5f15e2553cb33f63d6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702028%26sid%3Dliteratum%253Aachs%26aulast%3DGrignaschi%26aufirst%3DG.%26aulast%3DInvernizzi%26aufirst%3DR.%26aulast%3DFanelli%26aufirst%3DR.%26aulast%3DFracasso%26aufirst%3DC.%26aulast%3DCaccia%26aufirst%3DS.%26aulast%3DSamanin%26aufirst%3DR.%26atitle%3DCitalopram-induced%2520hypophagia%2520is%2520enhanced%2520by%2520blockade%2520of%25205-HT1A%2520receptors%253A%2520role%2520of%25205-HT2C%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D124%26spage%3D1781%26epage%3D1787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czachura, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreshfield-Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemrick-Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zgombick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. C.</span><span> </span><span class="NLM_article-title">The novel 5-hydroxytryptamine 1A antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=10900249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2000&pages=688-700&author=K.+Rasmussenauthor=D.+O.+Calligaroauthor=J.+F.+Czachuraauthor=L.+J.+Dreshfield-Ahmadauthor=D.+C.+Evansauthor=S.+K.+Hemrick-Lueckeauthor=M.+J.+Kallmanauthor=W.+T.+Kendrickauthor=J.+D.+Leanderauthor=D.+L.+Nelsonauthor=C.+D.+Overshinerauthor=D.+B.+Wainscottauthor=M.+C.+Wolffauthor=D.+T.+Wongauthor=T.+A.+Branchekauthor=J.+M.+Zgombickauthor=Y.+C.+Xu&title=The+novel+5-hydroxytryptamine+1A+antagonist+LY426965%3A+effects+on+nicotine+withdrawal+and+interactions+with+fluoxetine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The novel 5-hydroxytryptamine1A antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine</span></div><div class="casAuthors">Rasmussen, Kurt; Calligaro, David O.; Czachura, Janet F.; Dreshfield-Ahmad, Laura J.; Evans, David C.; Hemrick-Luecke, Susan K.; Kallman, Mary Jeanne; Kendrick, William T.; Leander, J. David; Nelson, David L.; Overshiner, Carl D.; Wainscott, David B.; Wolff, Mary C.; Wong, David T.; Branchek, Theresa A.; Zgombick, John M.; Xu, Yao-Chang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">688-700</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">LY426965 [(2S)-(+)-1-cyclohexyl-4-[4-(2-methoxyphenyl)-1-piperazinyl]2-methyl-2-phenyl-1-butanone monohydrochloride] is a novel compd. with high affinity for the cloned human 5-hydroxytryptamine (HT)1A receptor (Ki = 4.66 nM) and 20-fold or greater selectivity over other serotonin and nonserotonin receptor subtypes.  Both in vitro and in vivo studies indicate that LY426965 is a full antagonist and has no partial agonist properties.  LY426965 did not stimulate [35S]guanosine-5'-O-(3-thio) triphosphate (GTPγS) binding to homogenates of cells expressing the cloned human 5-HT1A receptor in vitro but did inhibit 300 nM 5-HT-stimulated [35S]GTPγS binding with a Ki value of 3.07 nM.  After both p.o. and s.c. administration, LY426965 blocked the lower lip retraction, flat body posture, hypothermia, and increase in rat serum corticosterone induced by the 5-HT1A agonist 8-OH-DPAT (8-hydroxy-2-dipropylaminotetralin).  In pigeons, LY426965 dose-dependently blocked the stimulus cue induced by 8-OH-DPAT but had no 8-OH-DPAT-like discriminative properties.  LY426965 completely reversed the effects of nicotine withdrawal on the auditory startle reflex in rats.  In microdialysis expts., LY426965 administered together with fluoxetine significantly increased extracellular levels of serotonin above those achievable with fluoxetine alone.  In electrophysiol. studies, the administration of LY426965 produced a slight elevation of the firing rate of 5-HT neurons in the dorsal raphe nucleus of anesthetized rats and both blocked and reversed the effects of fluoxetine on 5-HT neuronal activity.  These preclin. results indicate that LY426965 is a selective, full 5-HT1A antagonist that may have clin. use as pharmacotherapy for smoking cessation and depression and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnUG4icAtQrVg90H21EOLACvtfcHk0lj03dE6cHsxhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKgtro%253D&md5=c88befd68b6102f11fb3a543fbb4d0ec</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCzachura%26aufirst%3DJ.%2BF.%26aulast%3DDreshfield-Ahmad%26aufirst%3DL.%2BJ.%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DHemrick-Luecke%26aufirst%3DS.%2BK.%26aulast%3DKallman%26aufirst%3DM.%2BJ.%26aulast%3DKendrick%26aufirst%3DW.%2BT.%26aulast%3DLeander%26aufirst%3DJ.%2BD.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DWolff%26aufirst%3DM.%2BC.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DZgombick%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DY.%2BC.%26atitle%3DThe%2520novel%25205-hydroxytryptamine%25201A%2520antagonist%2520LY426965%253A%2520effects%2520on%2520nicotine%2520withdrawal%2520and%2520interactions%2520with%2520fluoxetine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D294%26spage%3D688%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hibert, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gittos, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00401a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hibert%2C+M.+F.%3B+Gittos%2C+M.+W.%3B+Middlemiss%2C+D.+N.%3B+Mir%2C+A.+K.%3B+Fozard%2C+J.+R.J.+Med.+Chem.+1988%2C+31%2C+1087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm00401a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00401a007%26sid%3Dliteratum%253Aachs%26aulast%3DHibert%26aufirst%3DM.%2BF.%26aulast%3DGittos%26aufirst%3DM.%2BW.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DMir%26aufirst%3DA.%2BK.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, Y.</span><span> </span><span class="NLM_article-title">Role of cortical and striatal 5-HT<sub>1A</sub> receptors in alleviating antipsychotic-induced extrapyramidal disorders</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.pnpbp.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=20398719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1KrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=877-881&author=S.+Shimizuauthor=A.+Tataraauthor=J.+Imakiauthor=Y.+Ohno&title=Role+of+cortical+and+striatal+5-HT1A+receptors+in+alleviating+antipsychotic-induced+extrapyramidal+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders</span></div><div class="casAuthors">Shimizu, Saki; Tatara, Ayaka; Imaki, Junta; Ohno, Yukihiro</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">877-881</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have revealed that 5-HT1A agonists ameliorate antipsychotic-induced extrapyramidal symptoms (EPS) through postsynaptic 5-HT1A receptors.  Here, we conducted an intracerebral microinjection study of (±)-8-hydroxy-2-(di-n-propylamino)-tetralin ((±)8-OH-DPAT) to det. the action site of the 5-HT1A agonist in alleviating EPS.  Bilateral microinjection of(±)8-OH-DPAT (5 μg/1 μL per side) either into the primary motor cortex (MC) or the dorsolateral striatum (dlST) significantly attenuated haloperidol-induced catalepsy in rats.  The anticataleptic action of (±)8-OH-DPAT was more prominent with the MC injection than with the dlST injection.  WAY-100135 (a selective 5-HT1A antagonist) completely antagonized the reversal of haloperidol-induced catalepsy both by intracortical and intrastriatal (±)8-OH-DPAT.  Furthermore, lesioning of dopamine neurons with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (30 mg/kg/day, i.p., for 4 days) did not alter the anti-EPS actions of (±)8-OH-DPAT in a mouse pole test.  The present results strongly suggest that 5-HT1A agonist alleviates antipsychotic-induced EPS by activating postsynaptic 5-HT1A receptors in the MC and dlST, probably through non-dopaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPAjyUQFCgNLVg90H21EOLACvtfcHk0lhYz65oWNs-BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1KrsbY%253D&md5=87f7b69d93c44b1d9d4dc10a92309493</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DTatara%26aufirst%3DA.%26aulast%3DImaki%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DY.%26atitle%3DRole%2520of%2520cortical%2520and%2520striatal%25205-HT1A%2520receptors%2520in%2520alleviating%2520antipsychotic-induced%2520extrapyramidal%2520disorders%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2010%26volume%3D34%26spage%3D877%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Madjid, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottie, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttgen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzmin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiedl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ögren, S. O.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.105.092262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=581-591&author=N.+Madjidauthor=E.+E.+Tottieauthor=M.+Luttgenauthor=B.+Meisterauthor=J.+Sandinauthor=A.+Kuzminauthor=O.+Stiedlauthor=S.+O.+%C3%96gren&title=5-Hydroxytryptamine1A+receptor+blockade+facilitates+aversive+learning+in+mice%3A+interactions+with+cholinergic+and+glutamatergic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms</span></div><div class="casAuthors">Madjid, Nather; Tottie, Elin Elvander; Luttgen, Maria; Meister, Bjoern; Sandin, Johan; Kuzmin, Alexander; Stiedl, Oliver; Oegren, Sven Ove</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">581-591</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of 5-hydroxytryptamine 1A (5-HT1A) receptor ligands on aversive learning were examd. in the passive avoidance (PA) task in mice.  Anxiety and autonomic functions were investigated using the elevated plus-maze and heart rate measurements.  The main findings from this study are as follows.  Pretraining administration of the 5-HT1A receptor agonist 8-OH-DPAT [8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide] facilitated PA retention at low doses (0.01 and 0.03 mg/kg) but impaired PA retention at higher doses (0.1-1.0 mg/kg), consistent with previous findings in the rat.  Similar to the acetylcholinesterase inhibitor physostigmine, pretraining administration of the 5-HT1A receptor antagonists NAD-299 (0.1-2 mg/kg) and WAY-100635 (0.3-3 mg/kg) enhanced PA retention.  The impairment (1 mg/kg) but not the facilitation (0.03 mg/kg) induced by 8-OH-DPAT was fully blocked by NAD-299 (0.3 mg/kg).  5-HT1A receptor ligands given immediate post-training failed to alter PA retention.  NAD-299 (0.3-1 mg/kg) blocked the impairment of PA retention caused by (a) the nonselective muscarinic receptor antagonist scopolamine and (b) the non-competitive N-methyl-D-aspartate receptor antagonist MK-801.  A subthreshold dose of scopolamine completely blocked the facilitatory effect of NAD-299 on PA retention.  Anxiety-related behaviors and autonomic function were unchanged by NAD-299.  In situ hybridization showed that septal neurons expressing 5-HT1A receptor mRNA were codistributed with markers for cholinergic, GABAergic, and glutamatergic neurons.  These results indicate that systemic administration of 5-HT1A receptor antagonists can facilitate cognitive performance, most likely by enhancing hippocampal/cortical cholinergic and glutamatergic neurotransmissions.  Selective 5-HT1A receptor antagonists may be useful in the treatment of cognitive deficits such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1uEd4tiUMZbVg90H21EOLACvtfcHk0lhYz65oWNs-BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLg%253D&md5=b3af2af582c8bd5ae5f1501d9f0e7c14</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092262%26sid%3Dliteratum%253Aachs%26aulast%3DMadjid%26aufirst%3DN.%26aulast%3DTottie%26aufirst%3DE.%2BE.%26aulast%3DLuttgen%26aufirst%3DM.%26aulast%3DMeister%26aufirst%3DB.%26aulast%3DSandin%26aufirst%3DJ.%26aulast%3DKuzmin%26aufirst%3DA.%26aulast%3DStiedl%26aufirst%3DO.%26aulast%3D%25C3%2596gren%26aufirst%3DS.%2BO.%26atitle%3D5-Hydroxytryptamine1A%2520receptor%2520blockade%2520facilitates%2520aversive%2520learning%2520in%2520mice%253A%2520interactions%2520with%2520cholinergic%2520and%2520glutamatergic%2520mechanisms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D581%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bhat, L.; Mohapatra, P. P.; Adiey, K.</span><span> </span><span class="NLM_article-title">Composition, Synthesis, and Methods of Utilizing Arylpiperazine Derivatives</span>.WO/2010/099502,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Reviva Pharmaceuticals, Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+Bhat&author=P.+P.+Mohapatra&author=K.+Adiey&title=Composition%2C+Synthesis%2C+and+Methods+of+Utilizing+Arylpiperazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DL.%26atitle%3DComposition%252C%2520Synthesis%252C%2520and%2520Methods%2520of%2520Utilizing%2520Arylpiperazine%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Bhat, L.; Mohapatra, P. P.; Adiey, K.</span><span> </span><span class="NLM_article-title">Compositions, Synthesis, and Methods of Using Piperazine Based Antipsychotic Agents</span>. US 20090298819,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Reviva Pharmaceuticals, Inc</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Bhat&author=P.+P.+Mohapatra&author=K.+Adiey&title=Compositions%2C+Synthesis%2C+and+Methods+of+Using+Piperazine+Based+Antipsychotic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DL.%26atitle%3DCompositions%252C%2520Synthesis%252C%2520and%2520Methods%2520of%2520Using%2520Piperazine%2520Based%2520Antipsychotic%2520Agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Favor, D. A.; Repine, J. T.</span><span> </span><span class="NLM_article-title">7-(4-(4-[3-Chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-naphthyridin-2(1H)-one</span>. US 20080167319,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Pfizer, Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+A.+Favor&author=J.+T.+Repine&title=7-%284-%284-%5B3-Chloro-2-%28trifluoromethyl%29phenyl%5Dpiperazin-1-yl%29butoxy%29-%5B1%2C8%5D-naphthyridin-2%281H%29-one"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFavor%26aufirst%3DD.%2BA.%26atitle%3D7-%25284-%25284-%255B3-Chloro-2-%2528trifluoromethyl%2529phenyl%255Dpiperazin-1-yl%2529butoxy%2529-%255B1%252C8%255D-naphthyridin-2%25281H%2529-one%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Peters, D.; Rønn, L. C.; Nielsen, K. S.; Scheel-Krüger, J.</span><span> </span><span class="NLM_article-title">Novel Quinolinylamide Derivatives Useful As Modulators of Dopamine and Serotonin Receptors</span>.WO/2009/112568,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>NeuroSearch A/S.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Peters&author=L.+C.+R%C3%B8nn&author=K.+S.+Nielsen&author=J.+Scheel-Kr%C3%BCger&title=Novel+Quinolinylamide+Derivatives+Useful+As+Modulators+of+Dopamine+and+Serotonin+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DD.%26atitle%3DNovel%2520Quinolinylamide%2520Derivatives%2520Useful%2520As%2520Modulators%2520of%2520Dopamine%2520and%2520Serotonin%2520Receptors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Gmeiner, P.; Huebner, H.; Skultety, M.</span><span> </span><span class="NLM_article-title">Indolizines and Aza-Analog Derivatives Thereof as CNS Active Compounds</span>. WO/2008/113559,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Schwarz Pharma AG.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Gmeiner&author=H.+Huebner&author=M.+Skultety&title=Indolizines+and+Aza-Analog+Derivatives+Thereof+as+CNS+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DIndolizines%2520and%2520Aza-Analog%2520Derivatives%2520Thereof%2520as%2520CNS%2520Active%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Forster, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bill, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dover, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span> </span><span class="NLM_article-title">A pharmacological profile of the selective silent 5-HT<sub>1A</sub> receptor antagonist, WAY-100635</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2F0014-2999%2895%2900234-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=8566121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2MXntFCktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1995&pages=81-88&author=E.+A.+Forsterauthor=I.+A.+Cliffeauthor=D.+J.+Billauthor=G.+M.+Doverauthor=D.+Jonesauthor=Y.+Reillyauthor=A.+Fletcher&title=A+pharmacological+profile+of+the+selective+silent+5-HT1A+receptor+antagonist%2C+WAY-100635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635</span></div><div class="casAuthors">Forster, Elaine A.; Cliffe, Ian A.; Bill, David J.; Dover, Gillian M.; Jones, Deborah; Reilly, Yvonne; Fletcher, Allan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">WAY-100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohex anecarboxamide trihydrochloride) is an achiral phenylpiperazine deriv. that binds with high affinity and selectivity to the 5-HT1A receptor.  WAY-100635 displaced specific binding of the 5-HT1A radioligand, [3H]8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin), to rat hippocampal membranes with a pIC50 of 8.87.  This represented a greater than 100-fold selectivity relative to binding at other 5-HT receptor subtypes and major neurotransmitter receptor, reuptake and ion channel sites.  In functional assays, WAY-100635 was a potent 5-HT1A receptor antagonist, with no evidence of any 5-HT1A receptor agonist or partial agonist activity.  In the isolated guinea-pig ileum WAY-100635 was a potent and, at high concns., an insurmountable antagonist of the 5-HT1A receptor agonist action of 5-carboxamidotryptamine, with an apparent pA2 value (at 0.3 nM) of 9.71.  WAY-100635 blocked the inhibitory action of 8-OH-DPAT on dorsal raphe neuronal firing in the anesthetized rat at doses which had no inhibitory action per se.  In behavioral models, WAY-100635 itself induced no overt behavioral changes but potently antagonized the behavioral syndrome induced by 8-OH-DPAT in the rat and guinea-pig (min. ED = 0.003 mg/kg s.c. and ID50 = 0.01 mg/kg s.c., resp.).  WAY-100635 also blocked the hypothermia induced by 8-OH-DPAT in the mouse and rat with ID50 values of 0.01 mg/kg s.c.  These data indicate that WAY-100635 will be used as a std. antagonist in further studies of 5-HT1A receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgPJI4KdQUp7Vg90H21EOLACvtfcHk0lifNdA7qtpaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFCktbg%253D&md5=6b28ceb6b6f1ae1d7ff44dc14c56d42f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900234-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900234-C%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DE.%2BA.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DBill%26aufirst%3DD.%2BJ.%26aulast%3DDover%26aufirst%3DG.%2BM.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DReilly%26aufirst%3DY.%26aulast%3DFletcher%26aufirst%3DA.%26atitle%3DA%2520pharmacological%2520profile%2520of%2520the%2520selective%2520silent%25205-HT1A%2520receptor%2520antagonist%252C%2520WAY-100635%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D281%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Björk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewander, T.</span><span> </span><span class="NLM_article-title">Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2F0924-977X%2892%2990024-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=1385999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADyaK38zjvVKrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=141-147&author=L.+Bj%C3%B6rkauthor=A.+Fredrikssonauthor=U.+Hacksellauthor=T.+Lewander&title=Effects+of+%28R%29-8-OH-DPAT+and+the+enantiomers+of+UH-301+on+motor+activities+in+the+rat%3A+antagonism+of+%28R%29-8-OH-DPAT-induced+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects</span></div><div class="casAuthors">Bjork L; Fredriksson A; Hacksell U; Lewander T</div><div class="citationInfo"><span class="NLM_cas:title">European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-7</span>
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    </div><div class="casAbstract">The effects of the enantiomers of 5-fluoro-8-hydroxy-2-(dipropylamino)tetralin, UH-301 and the potent 5-HT1A-receptor agonist (R)-8-hydroxy-2-(dipropylamino)tetralin, (R)-8-OH-DPAT, on locomotion, rearing and total activity were studied in rats.  The experiments were performed as tests either of exploratory activity in non-habituated rats or of motor activity of rats habituated to the environment for 2 h before drug injection. (R)-8-OH-DPAT increased locomotion and total activity and decreased rearing in both conditions. (R)-UH-301 increased locomotion and slightly also total activity in habituated rats and decreased rearing in both conditions. (S)-UH-301 decreased locomotion and rearing in both conditions but only in doses of 10 mumol/kg and above.  Lower doses of (S)-UH-301 (10 mumol/kg) antagonized (R)-8-OH-DPAT-induced increases of locomotion and total activity.  As (S)-UH-301 decreased rearing, per se, it was not able to antagonize the (R)-8-OH-DPAT induced decrease.  These results further support previous data that (S)-UH-301 is a 5-HT1A antagonist while (R)-UH-301 is a 5-HT1A agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTA-SBGiRSYuCXXDYhVZBdlfW6udTcc2eZAXPBEuV3Dxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zjvVKrsw%253D%253D&md5=ff6897f48e48677c49934fe3277692fb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0924-977X%2892%2990024-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0924-977X%252892%252990024-3%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B6rk%26aufirst%3DL.%26aulast%3DFredriksson%26aufirst%3DA.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DLewander%26aufirst%3DT.%26atitle%3DEffects%2520of%2520%2528R%2529-8-OH-DPAT%2520and%2520the%2520enantiomers%2520of%2520UH-301%2520on%2520motor%2520activities%2520in%2520the%2520rat%253A%2520antagonism%2520of%2520%2528R%2529-8-OH-DPAT-induced%2520effects%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D1992%26volume%3D2%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kayser, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elfassi, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melfort, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgoin, S.</span><span> </span><span class="NLM_article-title">Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT<sub>1A</sub>–/–, 5-HT<sub>1B</sub>–/–, 5-HT<sub>2A</sub>–/–, 5-HT<sub>3A</sub>–/– and 5-HTT–/– knock-out male mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=235-248&author=V.+Kayserauthor=I.+E.+Elfassiauthor=B.+Aubelauthor=M.+Melfortauthor=D.+Juliusauthor=J.+A.+Gingrichauthor=M.+Hamonauthor=S.+Bourgoin&title=Mechanical%2C+thermal+and+formalin-induced+nociception+is+differentially+altered+in+5-HT1A%E2%80%93%2F%E2%80%93%2C+5-HT1B%E2%80%93%2F%E2%80%93%2C+5-HT2A%E2%80%93%2F%E2%80%93%2C+5-HT3A%E2%80%93%2F%E2%80%93+and+5-HTT%E2%80%93%2F%E2%80%93+knock-out+male+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKayser%26aufirst%3DV.%26aulast%3DElfassi%26aufirst%3DI.%2BE.%26aulast%3DAubel%26aufirst%3DB.%26aulast%3DMelfort%26aufirst%3DM.%26aulast%3DJulius%26aufirst%3DD.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DBourgoin%26aufirst%3DS.%26atitle%3DMechanical%252C%2520thermal%2520and%2520formalin-induced%2520nociception%2520is%2520differentially%2520altered%2520in%25205-HT1A%25E2%2580%2593%252F%25E2%2580%2593%252C%25205-HT1B%25E2%2580%2593%252F%25E2%2580%2593%252C%25205-HT2A%25E2%2580%2593%252F%25E2%2580%2593%252C%25205-HT3A%25E2%2580%2593%252F%25E2%2580%2593%2520and%25205-HTT%25E2%2580%2593%252F%25E2%2580%2593%2520knock-out%2520male%2520mice%26jtitle%3DPain%26date%3D2007%26volume%3D130%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Madhavan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anantharam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthasamy, A. G.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine 1A receptor activation protects against <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.102.044370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12604665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1ejurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=913-923&author=L.+Madhavanauthor=W.+J.+Freedauthor=V.+Anantharamauthor=A.+G.+Kanthasamy&title=5-Hydroxytryptamine+1A+receptor+activation+protects+against+N-methyl-d-aspartate-induced+apoptotic+cell+death+in+striatal+and+mesencephalic+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures</span></div><div class="casAuthors">Madhavan, Lalitha; Freed, William J.; Anantharam, Vellareddy; Kanthasamy, Anumantha G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913-923</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Apoptosis and glutamate-mediated excitotoxicity may play a role in the pathogenesis of many neurodegenerative disorders, including Parkinson's disease (PD).  In the present study, we investigated whether stimulation of the 5-hydroxytryptamine 1A (5-HT1A) receptor attenuates N-methyl-D-asparate- (NMDA) and 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in cell culture models.  A brief exposure (20 min) of M213-20 striatal cells to NMDA and glutamate produced a delayed increase in caspase-3 activity and DNA fragmentation in a dose- and time-dependent manner.  NMDA-induced caspase-3 activity and DNA fragmentation were almost completely blocked by the 5-HT1A agonists 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and (R)-5-fluoro-8 hydroxy-2-(dipropylamino)-tetralin (R-UH-301).  Addnl., the protective effects of 8-OH-DPAT and R-UH-301 on NMDA-induced caspase-3 activation and apoptosis were reversed by pretreatment with the 5-HT1A antagonists N-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) and S-UH-301, resp.  Similarly, dose- and time-dependent increases in caspase-3 activity and DNA fragmentation were obsd. in rat primary mesencephalic neurons after a brief exposure to NMDA and glutamate.  Caspase-3 activation and DNA fragmentation in primary mesencephalic neurons were almost completely inhibited by 8-OH-DPAT.  This neuroprotective effect of 8-OH-DPAT was reversed by WAY 100635.  Addnl., 8-OH-DPAT blocked tyrosine hydroxylase (TH)-pos. cell death after NMDA exposure and also almost completely attenuated the NMDA-induced Ca2+ influx in primary mesencephalic cultures.  Furthermore, 8-OH-DPAT and R-UH-301 blocked apoptotic cell death in the primary mesencephalic neurons that were exposed to the Parkinsonian toxin MPP+.  Together, these results suggest that 5-HT1A receptor stimulation may be a promising pharmacol. approach in the development of neuroprotective agents for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCFc3hc_8NbVg90H21EOLACvtfcHk0lifNdA7qtpaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1ejurs%253D&md5=18d463de2d78fbbcde2ce0cc014e6d9d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.044370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.044370%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavan%26aufirst%3DL.%26aulast%3DFreed%26aufirst%3DW.%2BJ.%26aulast%3DAnantharam%26aufirst%3DV.%26aulast%3DKanthasamy%26aufirst%3DA.%2BG.%26atitle%3D5-Hydroxytryptamine%25201A%2520receptor%2520activation%2520protects%2520against%2520N-methyl-d-aspartate-induced%2520apoptotic%2520cell%2520death%2520in%2520striatal%2520and%2520mesencephalic%2520cultures%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D913%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Nakata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogure, K.</span><span> </span><span class="NLM_article-title">Role of hippocampal serotonergic neurons in ischemic neuronal death</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1997&pages=217-220&author=N.+Nakataauthor=H.+Sudaauthor=J.+Izumiauthor=Y.+Tanakaauthor=Y.+Ikedaauthor=H.+Katoauthor=Y.+Itoyamaauthor=K.+Kogure&title=Role+of+hippocampal+serotonergic+neurons+in+ischemic+neuronal+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakata%26aufirst%3DN.%26aulast%3DSuda%26aufirst%3DH.%26aulast%3DIzumi%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DItoyama%26aufirst%3DY.%26aulast%3DKogure%26aufirst%3DK.%26atitle%3DRole%2520of%2520hippocampal%2520serotonergic%2520neurons%2520in%2520ischemic%2520neuronal%2520death%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1997%26volume%3D83%26spage%3D217%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Oosterink, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korte, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luiten, P. G.</span><span> </span><span class="NLM_article-title">Neuroprotection against <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT<sub>1A</sub> receptor agonist 8-OH-DPAT</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0014-2999%2898%2900614-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=9808263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1emtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1998&pages=147-152&author=B.+J.+Oosterinkauthor=S.+M.+Korteauthor=C.+Nyakasauthor=J.+Korfauthor=P.+G.+Luiten&title=Neuroprotection+against+N-methyl-d-aspartate-induced+excitotoxicity+in+rat+magnocellular+nucleus+basalis+by+the+5-HT1A+receptor+agonist+8-OH-DPAT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection against N-methyl-D-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT1A receptor agonist 8-OH-DPAT</span></div><div class="casAuthors">Oosterink, Bart J.; Mechiel Korte, S.; Nyakas, Csaba; Korf, Jakob; Luiten, Paul G. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study reports the neuroprotective efficacy of the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone against in vivo excitotoxic neuronal injury.  Excitotoxic cell death was induced by injections of N-methyl-D-aspartate (NMDA) in the rat magnocellular nucleus basalis.  The neurodegenerative effects were quantified by image anal. of the axonal d. of the nucleus basalis projection to the somatosensory cortex visualized with acetylcholinesterase histochem.  Pretreatment with 8-OH-DPAT, but not ipsapirone, 1 h prior to NMDA infusion showed significant preservation of cortical cholinergic innervation in all doses tested.  Furthermore, 8-OH-DPAT exhibited sustained efficacy under homeothermic conditions in which the body temp. was maintained at 36.8±0.1. These data indicate that selective 5-HT1A receptor activation by 8-OH-DPAT protects against NMDA-induced excitotoxic neuronal damage, probably as a result of 5-HT1A receptor-mediated neuronal hyperpolarization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2JhhIbSjGLVg90H21EOLACvtfcHk0ljLBuHYnVStsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1emtrg%253D&md5=965e32db1705c4fe91f1f0c26aebf4fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900614-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900614-1%26sid%3Dliteratum%253Aachs%26aulast%3DOosterink%26aufirst%3DB.%2BJ.%26aulast%3DKorte%26aufirst%3DS.%2BM.%26aulast%3DNyakas%26aufirst%3DC.%26aulast%3DKorf%26aufirst%3DJ.%26aulast%3DLuiten%26aufirst%3DP.%2BG.%26atitle%3DNeuroprotection%2520against%2520N-methyl-d-aspartate-induced%2520excitotoxicity%2520in%2520rat%2520magnocellular%2520nucleus%2520basalis%2520by%2520the%25205-HT1A%2520receptor%2520agonist%25208-OH-DPAT%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D358%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Carr, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spruston, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span> </span><span class="NLM_article-title">Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6846</span><span class="NLM_x">–</span> <span class="NLM_lpage">6855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1523%2FJNEUROSCI.22-16-06846.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12177182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2gsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=6846-6855&author=D.+B.+Carrauthor=D.+C.+Cooperauthor=S.+L.+Ulrichauthor=N.+Sprustonauthor=D.+J.+Surmeier&title=Serotonin+receptor+activation+inhibits+sodium+current+and+dendritic+excitability+in+prefrontal+cortex+via+a+protein+kinase+C-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism</span></div><div class="casAuthors">Carr, David B.; Cooper, Donald C.; Ulrich, Sasha L.; Spruston, Nelson; Surmeier, D. James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6846-6855</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The serotonin (5-HT) innervation of the prefrontal cortex (PFC) exerts a powerful modulatory influence on neuronal activity in this cortical region, although the mechanisms through which 5-HT modulates cellular activity are unclear.  Voltage-dependent Na+ channels are one potential target of 5-HT receptor signaling that have wide-ranging effects on activity.  Mol. and electrophysiol. studies were used to test this potential linkage.  Single cell RT-PCR profiling revealed that the vast majority of pyramidal neurons expressed detectable levels of 5-HT2a and/or 5-HT2c receptor mRNA with half of the cells expressing both mRNAs.  Whole-cell voltage-clamp recordings of dissocd. pyramidal neurons showed that 5-HT2a/c receptor activation reduced rapidly inactivating Na+ currents by reducing maximal current amplitude and shifting fast inactivation voltage dependence.  These effects were mediated by Gq activation of phospholipase C, leading to activation of protein kinase C (PKC).  5-HT2a/c receptor stimulation also reduced the amplitude of persistent Na+ current without altering its activation voltage dependence.  This modulation was also mediated by PKC.  Although 5-HT2a,c receptor activation did not affect somatic action potentials of layer V pyramidal neurons in PFC slices, it did reduce the amplitude of action potentials back-propagating into the apical dendrite.  These findings show that 5-HT2a,c receptor activation reduces dendritic excitability and may neg. modulate activity-dependent dendritic synaptic plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIXRSDdUhvObVg90H21EOLACvtfcHk0ljLBuHYnVStsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2gsrw%253D&md5=37cb9f88335aa780a3973ed92d87fe88</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-16-06846.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-16-06846.2002%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DD.%2BB.%26aulast%3DCooper%26aufirst%3DD.%2BC.%26aulast%3DUlrich%26aufirst%3DS.%2BL.%26aulast%3DSpruston%26aufirst%3DN.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26atitle%3DSerotonin%2520receptor%2520activation%2520inhibits%2520sodium%2520current%2520and%2520dendritic%2520excitability%2520in%2520prefrontal%2520cortex%2520via%2520a%2520protein%2520kinase%2520C-dependent%2520mechanism%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D6846%26epage%3D6855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Namura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, M. A.</span><span> </span><span class="NLM_article-title">Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3659</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVWltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=3659-3668&author=S.+Namuraauthor=J.+Zhuauthor=K.+Finkauthor=M.+Endresauthor=A.+Srinivasanauthor=K.+J.+Tomaselliauthor=J.+Yuanauthor=M.+A.+Moskowitz&title=Activation+and+cleavage+of+caspase-3+in+apoptosis+induced+by+experimental+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia</span></div><div class="casAuthors">Namura, Shobu; Zhu, Jinmin; Fink, Klaus; Endres, Matthias; Srinivasan, Anu; Tomaselli, Kevin J.; Yuan, Junying; Moskowitz, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3659-3668</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We examd. the expression, activation, and cellular localization of caspase-3 (CPP32) using immunohistochem., immunoblots, and cleavage of the fluorogenic substrate N-benzyloxycarbonyl-Asp-Glu-Val-Asp-7-amino-4-trifluoro-Me coumarin (zDEVD-afc) in adult mouse brain after temporary (2 h) middle cerebral artery occlusion produced by filament insertion into the carotid artery.  Immunoreactive caspase-3p32 but not its cleavage product caspase-3p20 was constitutively expressed in neurons throughout brain and was most prominent in neuronal perikarya within piriform cortex.  Caspase-like enzyme activity was elevated in brain homogenate 0-3 h after reperfusion and reached a peak within 30 to 60 min.  Caspase-3p20 immunoreactivity became prominent in neuronal perikarya within the middle cerebral artery territory at the time of reperfusion and on immunoblots 1-12 h later.  DNA laddering (agarose gels) and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL)- stained cells were detected 6-24 h after reperfusion.  At 12-24 h, immunoreactive p20 was visualized in TUNEL-pos. cells, a finding also obsd. in apoptotic mouse cerebellar granule cells on postnatal day 5.  These observations suggest the existence of a time-dependent evolution of ischemic injury characterized by the close correspondence between caspase-like enzyme activation and an assocd. increase in immunoreactive product (caspase-3p20) beginning at or before reperfusion and followed several hours later by morphol. and biochem. features of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFqzDjk4dQQLVg90H21EOLACvtfcHk0ljLBuHYnVStsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVWltL8%253D&md5=1369145597dc93720b24bd2e3215ae1e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNamura%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DK.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26atitle%3DActivation%2520and%2520cleavage%2520of%2520caspase-3%2520in%2520apoptosis%2520induced%2520by%2520experimental%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D3659%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Galter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unsicker, K.</span><span> </span><span class="NLM_article-title">Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1006%2Fmcne.2000.0841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs12gsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=446-455&author=D.+Galterauthor=K.+Unsicker&title=Sequential+activation+of+the+5-HT1%28A%29+serotonin+receptor+and+TrkB+induces+the+serotonergic+neuronal+phenotype"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential Activation of the 5-HT1A Serotonin Receptor and TrkB Induces the Serotonergic Neuronal Phenotype</span></div><div class="casAuthors">Galter, Dagmar; Unsicker, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-455</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Serotonin (5-HT) is an important factor controlling survival, differentiation, and plasticity of neurons in serotonergic target regions of the brain and has been implicated in major psychiatric and autonomic disorders.  Relatively little is known, however, of factors controlling differentiation and plasticity of developing and adult 5-HT neurons.  We show now that 5-HT, the 5-HT1A receptor, brain-derived neurotrophic factor (BDNF), and its receptor, trkB, form an auto/paracrine loop for the regulation of the serotonergic phenotype.  Serotonin applied to cultures from E14 rat raphe increased nos. of neurons expressing serotonergic markers in a dose-dependent manner.  Agonists of the 5-HT1A receptor, BP-554 and 8-OH-DPAT, but not agonists of the 5-HT1B and 5-HT1D receptors, mimicked this effect, while the specific 5-HT1A antagonist, WAY-100635, inhibited it.  Serotonin also increased BDNF mRNA and protein in embryonic raphe cultures.  Induction of serotonergic markers by serotonin was suppressed by a trkB-IgG fusion protein but not by trkC-IgG.  Taken together, our data indicate that serotonin acts on 5-HT1A autoreceptors, causing up-regulation of BDNF, which activates trkB to promote serotonergic phenotype-specific markers.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX6KmFBoWodLVg90H21EOLACvtfcHk0lgDAohzmq7RBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs12gsr0%253D&md5=99ce48798ee363b60a28b5a8986ee070</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1006%2Fmcne.2000.0841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.2000.0841%26sid%3Dliteratum%253Aachs%26aulast%3DGalter%26aufirst%3DD.%26aulast%3DUnsicker%26aufirst%3DK.%26atitle%3DSequential%2520activation%2520of%2520the%25205-HT1%2528A%2529%2520serotonin%2520receptor%2520and%2520TrkB%2520induces%2520the%2520serotonergic%2520neuronal%2520phenotype%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2000%26volume%3D15%26spage%3D446%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Fahn, S.</span><span> </span><span class="NLM_article-title">The history of dopamine and levodopa in the treatment of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">S497</span><span class="NLM_x">–</span> <span class="NLM_lpage">S508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=S497-S508&author=S.+Fahn&title=The+history+of+dopamine+and+levodopa+in+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFahn%26aufirst%3DS.%26atitle%3DThe%2520history%2520of%2520dopamine%2520and%2520levodopa%2520in%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3DS497%26epage%3DS508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiglieri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picconi, B.</span><span> </span><span class="NLM_article-title">Molecular mechanisms underlying levodopa-induced dyskinesia</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">S570</span><span class="NLM_x">–</span> <span class="NLM_lpage">S579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=S570-S579&author=P.+Calabresiauthor=M.+Di+Filippoauthor=V.+Ghiglieriauthor=B.+Picconi&title=Molecular+mechanisms+underlying+levodopa-induced+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DGhiglieri%26aufirst%3DV.%26aulast%3DPicconi%26aufirst%3DB.%26atitle%3DMolecular%2520mechanisms%2520underlying%2520levodopa-induced%2520dyskinesia%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3DS570%26epage%3DS579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Calcagno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Invernizzi, R. W.</span><span> </span><span class="NLM_article-title">The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1471-4159.2005.03600.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16405507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=853-860&author=E.+Calcagnoauthor=M.+Carliauthor=R.+W.+Invernizzi&title=The+5-HT%281A%29+receptor+agonist+8-OH-DPAT+prevents+prefrontocortical+glutamate+and+serotonin+release+in+response+to+blockade+of+cortical+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT1A receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors</span></div><div class="casAuthors">Calcagno, E.; Carli, M.; Invernizzi, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">853-860</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">We studied the role of 5-HT1A receptors in controlling the release of glutamate (GLU) in the medial prefrontal cortex (mPFC) of conscious rats with the in vivo microdialysis technique.  The effect of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin infused in the prefrontal cortex was examd. under basal conditions and on the rise of extracellular GLU (+106%) induced by co-infusion of the competitive N-methyl-D-aspartate receptor antagonist 3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP).  8-OH-DPAT (0.3 and 3 μM) had no effect on basal extracellular GLU, but the higher concn. completely abolished the rise of extracellular GLU induced by CPP.  CPP also increased extracellular serotonin (5-HT) in the mPFC (+50%) and this effect was antagonized by 3 μM 8-OH-DPAT which, by itself, had no effect on basal 5-HT release.  The effects of 8-OH-DPAT on extracellular GLU and 5-HT were reversed by the 5-HT1A receptor antagonist WAY 100635 (100 μM), indicating a selective involvement of 5-HT1A receptors.  WAY 100635 had no effect by itself.  These results show that the stimulation of cortical 5-HT1A receptors prevents the CPP-evoked rise of extracellular GLU and 5-HT and suggest that these effects may contribute to the ability of intracortical 8-OH-DPAT to counteract cognitive deficits caused by the blockade of NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkcOIp3b72pbVg90H21EOLACvtfcHk0lgDAohzmq7RBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCnu7c%253D&md5=09601c189b2d9b0609929627e04819e7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03600.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03600.x%26sid%3Dliteratum%253Aachs%26aulast%3DCalcagno%26aufirst%3DE.%26aulast%3DCarli%26aufirst%3DM.%26aulast%3DInvernizzi%26aufirst%3DR.%2BW.%26atitle%3DThe%25205-HT%25281A%2529%2520receptor%2520agonist%25208-OH-DPAT%2520prevents%2520prefrontocortical%2520glutamate%2520and%2520serotonin%2520release%2520in%2520response%2520to%2520blockade%2520of%2520cortical%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D96%26spage%3D853%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Carta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span> </span><span class="NLM_article-title">Serotonin–dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0079-6123%2808%2900922-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=18772046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2isbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2008&pages=465-478&author=M.+Cartaauthor=T.+Carlssonauthor=A.+Munozauthor=D.+Kirikauthor=A.+Bjorklund&title=Serotonin%E2%80%93dopamine+interaction+in+the+induction+and+maintenance+of+L-DOPA-induced+dyskinesias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias</span></div><div class="casAuthors">Carta, Manolo; Carlsson, Thomas; Munoz, Ana; Kirik, Deniz; Bjoerklund, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">Serotonin-Dopamine Interaction</span>),
    <span class="NLM_cas:pages">465-478</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Appearance of dyskinesia is a common problem of long-term Levodopa (L-DOPA) treatment in Parkinson's disease (PD) patients and represents a major limitation for the pharmacol. management of the motor symptoms in the advanced stages of disease.  An increasing body of evidence points to dopamine released as a false neurotransmitter from the striatal serotonin terminals as the main pre-synaptic determinant of L-DOPA-induced dyskinesia.  Here we review the animal exptl. and human clin. data in support of this view, which point to the serotonin system as a promising target for anti-dyskinetic therapy in PD patients under L-DOPA medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMSuUVOwFKIrVg90H21EOLACvtfcHk0lgDAohzmq7RBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2isbjJ&md5=550e213a75ccfd9650431d48c7533cf5</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900922-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900922-9%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DM.%26aulast%3DCarlsson%26aufirst%3DT.%26aulast%3DMunoz%26aufirst%3DA.%26aulast%3DKirik%26aufirst%3DD.%26aulast%3DBjorklund%26aufirst%3DA.%26atitle%3DSerotonin%25E2%2580%2593dopamine%2520interaction%2520in%2520the%2520induction%2520and%2520maintenance%2520of%2520L-DOPA-induced%2520dyskinesias%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D172%26spage%3D465%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Iravani, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayarani-Binazir, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1A agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.106.110429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16959959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1225-1234&author=M.+M.+Iravaniauthor=K.+Tayarani-Binazirauthor=W.+B.+Chuauthor=M.+J.+Jacksonauthor=P.+Jenner&title=In+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-treated+primates%2C+the+selective+5-hydroxytryptamine+1A+agonist+%28R%29-%28%2B%29-8-OHDPAT+inhibits+levodopa-induced+dyskinesia+but+only+with%5C+increased+motor+disability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with increased motor disability</span></div><div class="casAuthors">Iravani, Mahmoud M.; Tayarani-Binazir, Kayhan; Chu, Wing B.; Jackson, Michael J.; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1234</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine 1a (5-HT1a) receptor agonists, such as sarizotan and tandospirone, are reported to reduce levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaques and in Parkinson's disease without worsening motor disability.  However, these compds. are not specific for 5-HT1a receptors and also possess dopamine antagonist actions.  We now report on the effects of (2R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin [(R)-(+)-8-OHDPAT], a selective 5-HT1a agonist lacking dopaminergic activity, on motor disability and dyskinesia (chorea and dystonia) in levodopa-primed MPTP-treated common marmosets.  Administration of (R)-(+)-8-OHDPAT (0.2, 0.6, and 2.0 mg/kg s.c), in conjunction with levodopa/carbidopa (12.5 mg/kg each p.o.) to levodopa-primed animals, dose-dependently reduced levodopa-induced chorea but did not affect dystonic movements.  However, (R)-(+)-8-OHDPAT treatment also reduced locomotor activity and the reversal of motor disability.  Administration of (R)-(+)-8-OHDPAT alone had no effects of motor behaviors.  The effects of (R)-(+)-8-OHDPAT on levodopa-induced motor behaviors were antagonized by the 5-HT1a receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide maleate (WAY-100635) (1.0 mg/kg s.c.).  Administration of (R)-(+)-8-OHDPAT (0.6 mg/kg s.c.) also reduced chorea produced by the administration of the D2/D3 dopamine receptor agonist pramipexole (0.06 mg/kg p.o.) to levodopa-primed MPTP-treated animals.  However, again the increase in locomotor activity and reversal of motor disability produced by pramipexole were also inhibited.  These data suggest that selective 5-HT1a agonists do not provide an effective means of suppressing levodopa-induced dyskinesia, except with worsening of parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp6G1H1kUDUbVg90H21EOLACvtfcHk0ljDS4TzCZbfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltLzL&md5=bee8d68da27e297314db4142acdc0acb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110429%26sid%3Dliteratum%253Aachs%26aulast%3DIravani%26aufirst%3DM.%2BM.%26aulast%3DTayarani-Binazir%26aufirst%3DK.%26aulast%3DChu%26aufirst%3DW.%2BB.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DIn%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-treated%2520primates%252C%2520the%2520selective%25205-hydroxytryptamine%25201A%2520agonist%2520%2528R%2529-%2528%252B%2529-8-OHDPAT%2520inhibits%2520levodopa-induced%2520dyskinesia%2520but%2520only%2520with%255C%2520increased%2520motor%2520disability%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1225%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Gregoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paolo, T.</span><span> </span><span class="NLM_article-title">Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.parkreldis.2008.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=19196540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BD1MvktlCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=445-452&author=L.+Gregoireauthor=P.+Samadiauthor=J.+Grahamauthor=P.+J.+Bedardauthor=G.+D.+Bartoszykauthor=T.+Di+Paolo&title=Low+doses+of+sarizotan+reduce+dyskinesias+and+maintain+antiparkinsonian+efficacy+of+L-Dopa+in+parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys</span></div><div class="casAuthors">Gregoire Laurent; Samadi Pershia; Graham Julie; Bedard Paul J; Bartoszyk Gerd D; Di Paolo Therese</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyskinesia is an important complication of treatment in Parkinson's disease (PD).  Sarizotan, a 5-HT(1A) agonist with high affinity for D3 and D4 receptors was investigated on L-Dopa-induced dyskinesia (LID) in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model of PD.  Five MPTP female cynomolgus monkeys (Macaca fascicularis) with a moderate to severe parkinsonian syndrome and LID were used.  Sarizotan 0.2, 1, and 2 mg/kg administered alone did not worsen parkinsonian symptoms; there were no effect on locomotor counts or on normal behavior of the monkeys.  Sarizotan 0.2, 1, and 2 mg/kg administered 30 min before a fixed dose of L-Dopa (25-30 mg/kg s.c.) + benserazide (50 mg) did not affect the antiparkinsonian response to L-Dopa.  However, mean dyskinetic scores were significantly reduced with sarizotan 1 and 2 mg/kg but not at 0.2 mg/kg.  Higher doses of sarizotan (4 and 8 mg/kg, administered immediately before L-Dopa) reduced L-Dopa-induced locomotor response in all monkeys.  A pharmacokinetic investigation in these monkeys showed a dose-dependent increase in mean plasma sarizotan concentrations with similar mean plasma concentrations for sarizotan 1 mg/kg alone or with L-Dopa, indicating a lack of sarizotan/L-Dopa interaction.  The time course of plasma sarizotan concentrations was associated with time of maximal reduction of dyskinesias.  When administered daily for two weeks in combination with L-Dopa in the same MPTP monkeys, sarizotan 1 mg/kg had a sustained antidyskinetic effect while maintaining the antiparkinsonian and locomotor effect of L-Dopa.  This detailed sarizotan investigation in MPTP monkeys supports the antidyskinetic activity of this drug and for 5-HT(1A) agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvhMMzFaaX52Zyxfu64m4ffW6udTcc2ea3nxe9R-NbgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvktlCgsw%253D%253D&md5=970beb3ee233df876b1bc52b1ccfa558</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.parkreldis.2008.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parkreldis.2008.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DGregoire%26aufirst%3DL.%26aulast%3DSamadi%26aufirst%3DP.%26aulast%3DGraham%26aufirst%3DJ.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26atitle%3DLow%2520doses%2520of%2520sarizotan%2520reduce%2520dyskinesias%2520and%2520maintain%2520antiparkinsonian%2520efficacy%2520of%2520L-Dopa%2520in%2520parkinsonian%2520monkeys%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2009%26volume%3D15%26spage%3D445%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Goetz, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoulson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurgans, S.</span><span> </span><span class="NLM_article-title">Placebo response in Parkinson’s disease: comparisons among 11 trials covering medical and surgical interventions</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=690-699&author=C.+G.+Goetzauthor=J.+Wuuauthor=M.+P.+McDermottauthor=C.+H.+Adlerauthor=S.+Fahnauthor=C.+R.+Freedauthor=R.+A.+Hauserauthor=W.+C.+Olanowauthor=I.+Shoulsonauthor=P.+K.+Tandonauthor=S.+Leurgans&title=Placebo+response+in+Parkinson%E2%80%99s+disease%3A+comparisons+among+11+trials+covering+medical+and+surgical+interventions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DWuu%26aufirst%3DJ.%26aulast%3DMcDermott%26aufirst%3DM.%2BP.%26aulast%3DAdler%26aufirst%3DC.%2BH.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DFreed%26aufirst%3DC.%2BR.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DOlanow%26aufirst%3DW.%2BC.%26aulast%3DShoulson%26aufirst%3DI.%26aulast%3DTandon%26aufirst%3DP.%2BK.%26aulast%3DLeurgans%26aufirst%3DS.%26atitle%3DPlacebo%2520response%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520comparisons%2520among%252011%2520trials%2520covering%2520medical%2520and%2520surgical%2520interventions%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3D690%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Kuzhikandathil, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span> </span><span class="NLM_article-title">The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2006&pages=873-884&author=E.+V.+Kuzhikandathilauthor=G.+D.+Bartoszyk&title=The+novel+antidyskinetic+drug+sarizotan+elicits+different+functional+responses+at+human+D2-like+dopamine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuzhikandathil%26aufirst%3DE.%2BV.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26atitle%3DThe%2520novel%2520antidyskinetic%2520drug%2520sarizotan%2520elicits%2520different%2520functional%2520responses%2520at%2520human%2520D2-like%2520dopamine%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2006%26volume%3D51%26spage%3D873%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Assie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carilla-Durand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depoortere, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleven, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1-14&author=M.+B.+Assieauthor=L.+Bardinauthor=A.+L.+Auclairauthor=E.+Carilla-Durandauthor=R.+Depoortereauthor=W.+Koekauthor=M.+S.+Klevenauthor=F.+Colpaertauthor=B.+Vacherauthor=A.+Newman-Tancredi&title=F15599%2C+a+highly+selective+post-synaptic+5-HT1A+receptor+agonist%3A+in-vivo+profile+in+behavioural+models+of+antidepressant+and+serotonergic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssie%26aufirst%3DM.%2BB.%26aulast%3DBardin%26aufirst%3DL.%26aulast%3DAuclair%26aufirst%3DA.%2BL.%26aulast%3DCarilla-Durand%26aufirst%3DE.%26aulast%3DDepoortere%26aufirst%3DR.%26aulast%3DKoek%26aufirst%3DW.%26aulast%3DKleven%26aufirst%3DM.%2BS.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DVacher%26aufirst%3DB.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DF15599%252C%2520a%2520highly%2520selective%2520post-synaptic%25205-HT1A%2520receptor%2520agonist%253A%2520in-vivo%2520profile%2520in%2520behavioural%2520models%2520of%2520antidepressant%2520and%2520serotonergic%2520activity%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2010%26volume%3D11%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Carta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span> </span><span class="NLM_article-title">Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1819</span><span class="NLM_x">–</span> <span class="NLM_lpage">1833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=1819-1833&author=M.+Cartaauthor=T.+Carlssonauthor=D.+Kirikauthor=A.+Bjorklund&title=Dopamine+released+from+5-HT+terminals+is+the+cause+of+L-DOPA-induced+dyskinesia+in+parkinsonian+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DM.%26aulast%3DCarlsson%26aufirst%3DT.%26aulast%3DKirik%26aufirst%3DD.%26aulast%3DBjorklund%26aufirst%3DA.%26atitle%3DDopamine%2520released%2520from%25205-HT%2520terminals%2520is%2520the%2520cause%2520of%2520L-DOPA-induced%2520dyskinesia%2520in%2520parkinsonian%2520rats%26jtitle%3DBrain%26date%3D2007%26volume%3D130%26spage%3D1819%26epage%3D1833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Munoz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Luca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, M.</span><span> </span><span class="NLM_article-title">Combined 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor agonists for the treatment of L-DOPA-induced dyskinesia</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3380</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2008&pages=3380-3394&author=A.+Munozauthor=Q.+Liauthor=F.+Gardoniauthor=E.+Marcelloauthor=C.+Qinauthor=T.+Carlssonauthor=D.+Kirikauthor=M.+Di+Lucaauthor=A.+Bjorklundauthor=E.+Bezardauthor=M.+Carta&title=Combined+5-HT1A+and+5-HT1B+receptor+agonists+for+the+treatment+of+L-DOPA-induced+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DGardoni%26aufirst%3DF.%26aulast%3DMarcello%26aufirst%3DE.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DCarlsson%26aufirst%3DT.%26aulast%3DKirik%26aufirst%3DD.%26aulast%3DDi%2BLuca%26aufirst%3DM.%26aulast%3DBjorklund%26aufirst%3DA.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DCarta%26aufirst%3DM.%26atitle%3DCombined%25205-HT1A%2520and%25205-HT1B%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520L-DOPA-induced%2520dyskinesia%26jtitle%3DBrain%26date%3D2008%26volume%3D131%26spage%3D3380%26epage%3D3394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tronci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pioli, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, M.</span><span> </span><span class="NLM_article-title">Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=1088-1096&author=E.+Bezardauthor=E.+Tronciauthor=E.+Y.+Pioliauthor=Q.+Liauthor=G.+Porrasauthor=A.+Bj%C3%B6rklundauthor=M.+Carta&title=Study+of+the+antidyskinetic+effect+of+eltoprazine+in+animal+models+of+levodopa-induced+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DTronci%26aufirst%3DE.%26aulast%3DPioli%26aufirst%3DE.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DPorras%26aufirst%3DG.%26aulast%3DBj%25C3%25B6rklund%26aufirst%3DA.%26aulast%3DCarta%26aufirst%3DM.%26atitle%3DStudy%2520of%2520the%2520antidyskinetic%2520effect%2520of%2520eltoprazine%2520in%2520animal%2520models%2520of%2520levodopa-induced%2520dyskinesia%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D1088%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Paquette, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brudney, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshul, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. P.</span><span> </span><span class="NLM_article-title">The sigma-1 antagonist BMY-14802 inhibits L-DOPAinduced abnormal involuntary movements by a WAY-100635-sensitive mechanism</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2009&pages=743-754&author=M.+A.+Paquetteauthor=K.+Foleyauthor=E.+G.+Brudneyauthor=C.+K.+Meshulauthor=S.+W.+Johnsonauthor=S.+P.+Berger&title=The+sigma-1+antagonist+BMY-14802+inhibits+L-DOPAinduced+abnormal+involuntary+movements+by+a+WAY-100635-sensitive+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaquette%26aufirst%3DM.%2BA.%26aulast%3DFoley%26aufirst%3DK.%26aulast%3DBrudney%26aufirst%3DE.%2BG.%26aulast%3DMeshul%26aufirst%3DC.%2BK.%26aulast%3DJohnson%26aufirst%3DS.%2BW.%26aulast%3DBerger%26aufirst%3DS.%2BP.%26atitle%3DThe%2520sigma-1%2520antagonist%2520BMY-14802%2520inhibits%2520L-DOPAinduced%2520abnormal%2520involuntary%2520movements%2520by%2520a%2520WAY-100635-sensitive%2520mechanism%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D204%26spage%3D743%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Bhide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindenbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surrena, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, M. A.</span><span> </span><span class="NLM_article-title">The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2013&pages=533-544&issue=3&author=N.+Bhideauthor=D.+Lindenbachauthor=M.+A.+Surrenaauthor=A.+A.+Goldenbergauthor=C.+Bishopauthor=S.+P.+Bergerauthor=M.+A.+Paquette&title=The+effects+of+BMY-14802+against+L-DOPA-+and+dopamine+agonist-induced+dyskinesia+in+the+hemiparkinsonian+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DN.%26aulast%3DLindenbach%26aufirst%3DD.%26aulast%3DSurrena%26aufirst%3DM.%2BA.%26aulast%3DGoldenberg%26aufirst%3DA.%2BA.%26aulast%3DBishop%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DS.%2BP.%26aulast%3DPaquette%26aufirst%3DM.%2BA.%26atitle%3DThe%2520effects%2520of%2520BMY-14802%2520against%2520L-DOPA-%2520and%2520dopamine%2520agonist-induced%2520dyskinesia%2520in%2520the%2520hemiparkinsonian%2520rat%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D227%26issue%3D3%26spage%3D533%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Goetz, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicking, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rascol, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russ, H.</span><span> </span><span class="NLM_article-title">Sarizotan as a treatment for dyskinesias in Parkinson’s disease: a double-blind placebo-controlled trial</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=179-186&author=C.+G.+Goetzauthor=P.+Damierauthor=C.+Hickingauthor=E.+Laskaauthor=T.+Mullerauthor=C.+W.+Olanowauthor=O.+Rascolauthor=H.+Russ&title=Sarizotan+as+a+treatment+for+dyskinesias+in+Parkinson%E2%80%99s+disease%3A+a+double-blind+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DDamier%26aufirst%3DP.%26aulast%3DHicking%26aufirst%3DC.%26aulast%3DLaska%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DRuss%26aufirst%3DH.%26atitle%3DSarizotan%2520as%2520a%2520treatment%2520for%2520dyskinesias%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520double-blind%2520placebo-controlled%2520trial%26jtitle%3DMov.%2520Disord.%26date%3D2007%26volume%3D22%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Hillegaart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlenius, S.</span><span> </span><span class="NLM_article-title">Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1733</span><span class="NLM_x">–</span> <span class="NLM_lpage">1743</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0702239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Kiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1998&pages=1733-1743&author=V.+Hillegaartauthor=S.+Ahlenius&title=Facilitation+and+inhibition+of+male+rat+ejaculatory+behaviour+by+the+respective+5-HT1A+and+5-HT1B+receptor+agonists+8-OH-DPAT+and+anpirtoline%2C+as+evidenced+by+use+of+the+corresponding+new+and+selective+receptor+antagonists+NAD-299+and+NAS-181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Facilitation and inhibition of male rat ejaculatory behavior by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181</span></div><div class="casAuthors">Hillegaart, Viveka; Ahlenius, Sven</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1733-1743</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Ejaculatory problems and anorgasmia are well-known side-effects of the SSRI (selective serotonin reuptake inhibitor) antidepressants, and a pharmacol. induced increase in serotonergic neurotransmission inhibits ejaculatory behavior in the rat.  In the present study the role of 5-HT1A and 5-HT1B receptors in the mediation of male rat ejaculatory behavior was examd. by use of selective agonists and antagonists acting at these 5-HT receptor subtypes.  The 5-HT1A receptor agonist 8-OH-DPAT (0.25-4.00 μmol kg-1 s.c.) produced an expected facilitation of the male rat ejaculatory behavior, and this effect was fully antagonized by pretreatment with the new selective 5-HT1A receptor antagonist (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R) tartrate monohydrate (NAD-299) (1.0 μmol kg-1 s.c.).  NAD-299 by itself (0.75-3.00 μmol kg-1 s.c.) did not affect the male rat ejaculatory behavior.  The 5-HT1B receptor agonist anpirtoline (0.25-4.00 μmol kg-1 s.c.) produced a dose-dependent inhibition of the male rat ejaculatory behavior, and this effect was fully antagonized by pretreatment with the 5-HT1B receptor antagonist isamoltane (16 μmol kg-1 s.c.) as well as by the new and selective antagonist (R)-(+)-2-(3-morpholinomethyl-2H-chromene-8-yl)oxymethylmorpholino methanesulfonate (NAS-181) (16 μmol kg-1 s.c.).  Isamoltane (1.0-16.0 μmol kg-1 s.c.) and NAD-181 (1.0-16.0 μmol kg-1 s.c.) had no, or weakly facilitatory effects on the male rat ejaculatory behavior.  The non-selective 5-HT1 receptor antagonist (-)-pindolol (8 μmol kg-1 s.c.), did not antagonize the inhibition produced by anpirtoline.  The present results demonstrate opposite effects, facilitation and inhibition, of male rat ejaculatory behavior by stimulation of 5-HT1A and 5-HT1B receptors, resp., suggesting that the SSRI-induced inhibition of male ejaculatory dysfunction is due to 5-HT1B receptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMNI5gg-0YSLVg90H21EOLACvtfcHk0lgN2MwojOKerQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Kiug%253D%253D&md5=a5866ffaa97c37cb6412b6146268e81b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702239%26sid%3Dliteratum%253Aachs%26aulast%3DHillegaart%26aufirst%3DV.%26aulast%3DAhlenius%26aufirst%3DS.%26atitle%3DFacilitation%2520and%2520inhibition%2520of%2520male%2520rat%2520ejaculatory%2520behaviour%2520by%2520the%2520respective%25205-HT1A%2520and%25205-HT1B%2520receptor%2520agonists%25208-OH-DPAT%2520and%2520anpirtoline%252C%2520as%2520evidenced%2520by%2520use%2520of%2520the%2520corresponding%2520new%2520and%2520selective%2520receptor%2520antagonists%2520NAD-299%2520and%2520NAS-181%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D125%26spage%3D1733%26epage%3D1743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Waldinger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengeveld, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwinderman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span> </span><span class="NLM_article-title">Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebocontrolled study with fluoxetine, fluvoxamine, paroxetine, and sertraline</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=291-297&author=M.+D.+Waldingerauthor=M.+W.+Hengeveldauthor=A.+H.+Zwindermanauthor=B.+Olivier&title=Effect+of+SSRI+antidepressants+on+ejaculation%3A+a+double-blind%2C+randomized%2C+placebocontrolled+study+with+fluoxetine%2C+fluvoxamine%2C+paroxetine%2C+and+sertraline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldinger%26aufirst%3DM.%2BD.%26aulast%3DHengeveld%26aufirst%3DM.%2BW.%26aulast%3DZwinderman%26aufirst%3DA.%2BH.%26aulast%3DOlivier%26aufirst%3DB.%26atitle%3DEffect%2520of%2520SSRI%2520antidepressants%2520on%2520ejaculation%253A%2520a%2520double-blind%252C%2520randomized%252C%2520placebocontrolled%2520study%2520with%2520fluoxetine%252C%2520fluvoxamine%252C%2520paroxetine%252C%2520and%2520sertraline%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2001%26volume%3D21%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Schnur, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, J. M.</span><span> </span><span class="NLM_article-title">A component analysis of the effects of DPAT on male rat sexual behavior</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=897-901&author=S.+L.+Schnurauthor=E.+R.+Smithauthor=R.+L.+Leeauthor=M.+Masauthor=J.+M.+Davidson&title=A+component+analysis+of+the+effects+of+DPAT+on+male+rat+sexual+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchnur%26aufirst%3DS.%2BL.%26aulast%3DSmith%26aufirst%3DE.%2BR.%26aulast%3DLee%26aufirst%3DR.%2BL.%26aulast%3DMas%26aufirst%3DM.%26aulast%3DDavidson%26aufirst%3DJ.%2BM.%26atitle%3DA%2520component%2520analysis%2520of%2520the%2520effects%2520of%2520DPAT%2520on%2520male%2520rat%2520sexual%2520behavior%26jtitle%3DPhysiol.%2520Behav.%26date%3D1989%26volume%3D45%26spage%3D897%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Rosen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shifren, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monz, B. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odom, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannes, C. B.</span><span> </span><span class="NLM_article-title">Correlates of sexually related personal distress in women with low sexual desire</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1743-6109.2009.01252.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BD1MvjtFSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1549-1560&author=R.+C.+Rosenauthor=J.+L.+Shifrenauthor=B.+U.+Monzauthor=D.+M.+Odomauthor=P.+A.+Russoauthor=C.+B.+Johannes&title=Correlates+of+sexually+related+personal+distress+in+women+with+low+sexual+desire"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Correlates of sexually related personal distress in women with low sexual desire</span></div><div class="casAuthors">Rosen Raymond C; Shifren Jan L; Monz Brigitta U; Odom Dawn M; Russo Patricia A; Johannes Catherine B</div><div class="citationInfo"><span class="NLM_cas:title">The journal of sexual medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1549-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Sexual distress is an important component of diagnostic criteria for sexual dysfunctions, but little is known about the factors associated with sexual distress in women with low sexual desire.  AIM:  To investigate the correlates of sexual distress in women with self-reported low sexual desire.  METHODS:  The Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking study was a cross-sectional, nationally representative, mailed survey of U.S. adult women.  There were 31,581 respondents (response rate 63.2%) to the 42-item questionnaire that measured sexual function, sexual distress, demographic, and health-related factors.  Multivariable logistic regression was used to explore the correlates of distress.  MAIN OUTCOME MEASURES:  Low sexual desire was defined as a response of "never" or "rarely" to the question, "How often do you desire to engage in sexual activity?" Sexual distress was measured with the Female Sexual Distress Scale (range 0-48), with a score of 15 or higher indicating presence of distress.  RESULTS:  Of 10,429 women with low desire, 2,868 (27.5%) had sexual distress (mean age 48.6 years, 81% with a current partner).  Women without distress were 10 years older on average, and 44% had a current partner.  Having a partner was strongly related to distress (odds ratio 4.6, 95% confidence interval 4.1-5.2).  Other correlates were age, race, current depression, anxiety, lower social functioning, hormonal medication use, urinary incontinence, and concurrent sexual problems (arousal or orgasm).  Dissatisfaction with sex life was more common in women with low desire and distress (65%) than in those without distress (20%).  CONCLUSIONS:  Age has a curvilinear relationship with distress, and the strongest correlate of sexual distress was having a current partner.  Sexual distress and dissatisfaction with sex life are strongly correlated.  Distress is higher in women with low sexual desire in a partner relationship; further research on this factor is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNU9oC2uYrlrGbPKh4T9eAfW6udTcc2eYUmVJrPO72Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvjtFSisA%253D%253D&md5=0795da66f4251a9c958d0fa27d6d40d2</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2009.01252.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2009.01252.x%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DR.%2BC.%26aulast%3DShifren%26aufirst%3DJ.%2BL.%26aulast%3DMonz%26aufirst%3DB.%2BU.%26aulast%3DOdom%26aufirst%3DD.%2BM.%26aulast%3DRusso%26aufirst%3DP.%2BA.%26aulast%3DJohannes%26aufirst%3DC.%2BB.%26atitle%3DCorrelates%2520of%2520sexually%2520related%2520personal%2520distress%2520in%2520women%2520with%2520low%2520sexual%2520desire%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2009%26volume%3D6%26spage%3D1549%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Rosen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maserejian, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krychman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, I.</span><span> </span><span class="NLM_article-title">Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the hypoactive sexual desire disorder registry for women</span> <span class="citation_source-journal">Menopause</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1097%2Fgme.0b013e318230e286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BC38zntlOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=396-405&author=R.+C.+Rosenauthor=N.+N.+Maserejianauthor=M.+K.+Connorauthor=M.+L.+Krychmanauthor=C.+S.+Brownauthor=I.+Goldstein&title=Characteristics+of+premenopausal+and+postmenopausal+women+with+acquired%2C+generalized+hypoactive+sexual+desire+disorder%3A+the+hypoactive+sexual+desire+disorder+registry+for+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder:  the Hypoactive Sexual Desire Disorder Registry for women</span></div><div class="casAuthors">Rosen Raymond C; Maserejian Nancy N; Connor Megan K; Krychman Michael L; Brown Candace S; Goldstein Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Menopause (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">396-405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Little is known about the natural history of hypoactive sexual desire disorder (HSDD).  We examined the sociodemographic, relationship, help seeking, sexual function, and medical characteristics of women with a clinical diagnosis of generalized, acquired HSDD by menopause status.  METHODS:  This study was a cross-sectional baseline data analysis from the HSDD Registry for Women (N = 1,574, from 33 US clinical sites).  HSDD was clinically diagnosed and confirmed.  Validated measures of sexual function, relationship factors, and health, as well as newly developed questions on help seeking were assessed using the questionnaire.  RESULTS:  Participants were predominantly married or living with a partner (81.7%) and represented a range of race/ethnic backgrounds and ages (mean ± SD, 42.9 ± 11.9 y).  Most (56.8%) described their HSDD severity as "moderate to severe," with 26.5% rating the problem severe.  Nonetheless, most women (69.8%) reported being happy in their relationship, and 61.8% were satisfied with their partner communication.  Postmenopausal women had lower Female Sexual Function Index total scores, indicating worse sexual function (14.0 ± 7.5) than premenopausal women (16.7 ± 6.8, P < 0.001), although both groups had similarly low scores on the sexual desire domain (3.4 ± 1.3 vs 3.3 ± 1.4).  Less than half of the overall sample had sought professional help, among whom hormonal treatments had been used by 23.7% of postmenopausal women and by 7.6% of premenopausal women.  CONCLUSIONS:  Most women with HSDD were in long-term partner relationships with high levels of overall relationship satisfaction.  Postmenopausal women were more likely to seek help for their disorder, despite similarly high levels of distress associated with HSDD.  Further research is needed to examine treatment outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5EvAbyjoY9TEC-75aqa5AfW6udTcc2eYUmVJrPO72Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zntlOisg%253D%253D&md5=57d2696345f0661e59b34610542f9d7b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1097%2Fgme.0b013e318230e286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fgme.0b013e318230e286%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DR.%2BC.%26aulast%3DMaserejian%26aufirst%3DN.%2BN.%26aulast%3DConnor%26aufirst%3DM.%2BK.%26aulast%3DKrychman%26aufirst%3DM.%2BL.%26aulast%3DBrown%26aufirst%3DC.%2BS.%26aulast%3DGoldstein%26aufirst%3DI.%26atitle%3DCharacteristics%2520of%2520premenopausal%2520and%2520postmenopausal%2520women%2520with%2520acquired%252C%2520generalized%2520hypoactive%2520sexual%2520desire%2520disorder%253A%2520the%2520hypoactive%2520sexual%2520desire%2520disorder%2520registry%2520for%2520women%26jtitle%3DMenopause%26date%3D2012%26volume%3D19%26spage%3D396%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Allers, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dremencov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cremers, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span> </span><span class="NLM_article-title">Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1743-6109.2010.01763.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=20163532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1aku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1757-1767&author=K.+A.+Allersauthor=E.+Dremencovauthor=A.+Ceciauthor=G.+Flikauthor=B.+Fergerauthor=T.+I.+Cremersauthor=C.+Ittrichauthor=B.+Sommer&title=Acute+and+repeated+flibanserin+administration+in+female+rats+modulates+monoamines+differentially+across+brain+areas%3A+a+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study</span></div><div class="casAuthors">Allers, Kelly A.; Dremencov, Eliyahu; Ceci, Angelo; Flik, Gunnar; Ferger, Boris; Cremers, Thomas I. F. H.; Ittrich, Carina; Sommer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Sexual Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1757-1767</span>CODEN:
                <span class="NLM_cas:coden">JSMOAN</span>;
        ISSN:<span class="NLM_cas:issn">1743-6095</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Introduction: Hypoactive sexual desire disorder (HSDD) is defined as persistent lack of sexual fantasies or desire marked by distress.  With a prevalence of 10% it is the most common form of female sexual dysfunction.  Recently, the serotonin-1A (5-HT1A) receptor agonist and the serotonin-2A (5-HT2A) receptor antagonist flibanserin were shown to be safe and efficacious in premenopausal women suffering from HSDD in phase III clin. trials.  Aim: The current study aims to assess the effect of flibanserin on neurotransmitters serotonin (5-HT), norepinephrine (NE), dopamine (DA), glutamate, and γ-aminobutyric acid (GABA) in brain areas assocd. with sexual behavior.  Methods: Flibanserin was administered to female Wistar rats (280-350 g).  Microdialysis probes were stereotactically inserted into the mPFC, NAC, or MPOA, under isoflurane anesthesia.  The extracellular levels of neurotransmitters were assessed in freely moving animals, 24 h after the surgery.  Main Outcome Measures: Dialyzate levels of DA, NE, and serotonin from medial prefrontal cortex (mPFC), nucleus accumbens (NAC), and hypothalamic medial preoptic area (MPOA) from female rats.  Results: Acute flibanserin administration decreased 5-HT and increased NE levels in all tested areas.  DA was increased in mPFC and MPOA, but not in the NAC.  Basal levels of NE in mPFC and NAC and of DA in mPFC were increased upon repeated flibanserin administration, when compared to vehicle-treated animals.  The basal levels of 5-HT were not altered by repeated flibanserin administration, but basal DA and NE levels were increased in the mPFC.  Glutamate and GABA levels remained unchanged following either repeated or acute flibanserin treatment.  Conclusions: Systemic administration of flibanserin to female rats differentially affects the monoamine systems of the brain.  This may be the mechanistic underpinning of flibanserin's therapeutic efficacy in HSDD, as sexual behavior is controlled by an intricate interplay between stimulatory (catecholaminergic) and inhibitory (serotonergic) systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9NN2p_MmISbVg90H21EOLACvtfcHk0lgMuPryqACaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1aku7s%253D&md5=bd81ec60f65adb6749cc8250071351cf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2010.01763.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2010.01763.x%26sid%3Dliteratum%253Aachs%26aulast%3DAllers%26aufirst%3DK.%2BA.%26aulast%3DDremencov%26aufirst%3DE.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DFlik%26aufirst%3DG.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DCremers%26aufirst%3DT.%2BI.%26aulast%3DIttrich%26aufirst%3DC.%26aulast%3DSommer%26aufirst%3DB.%26atitle%3DAcute%2520and%2520repeated%2520flibanserin%2520administration%2520in%2520female%2520rats%2520modulates%2520monoamines%2520differentially%2520across%2520brain%2520areas%253A%2520a%2520microdialysis%2520study%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2010%26volume%3D7%26spage%3D1757%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollentier, S.</span><span> </span><span class="NLM_article-title">Pharmacology of flibanserin</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=117-142&author=F.+Borsiniauthor=K.+Evansauthor=K.+Jasonauthor=F.+Rohdeauthor=B.+Alexanderauthor=S.+Pollentier&title=Pharmacology+of+flibanserin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DK.%26aulast%3DJason%26aufirst%3DK.%26aulast%3DRohde%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DB.%26aulast%3DPollentier%26aufirst%3DS.%26atitle%3DPharmacology%2520of%2520flibanserin%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2002%26volume%3D8%26spage%3D117%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladinsky, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monferini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turconi, M.</span><span> </span><span class="NLM_article-title">Flibanserin: antidepressant, 5-HT<sub>1A</sub> receptor agonist, 5-HT<sub>2</sub> receptor antagonist</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1358%2Fdof.1998.023.01.439435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXit1SntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=9-16&author=F.+Borsiniauthor=A.+Brambillaauthor=A.+Ceciauthor=R.+Cesanaauthor=E.+Giraldoauthor=H.+Ladinskyauthor=E.+Monferiniauthor=M.+Turconi&title=Flibanserin%3A+antidepressant%2C+5-HT1A+receptor+agonist%2C+5-HT2+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Flibanserin: antidepressant 5-HT1A receptor agonist 5-HT2 receptor agonist</span></div><div class="casAuthors">Borsini, Franco; Brambilla, Alessandro; Ceci, Angelo; Cesana, Raffaele; Giraldo, Ettore; Ladinsky, Herbert; Monferini, Eugenia; Turconi, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">J. R. Prous, S.A.</span>)
        </div><div class="casAbstract">Review with 36 refs. of the synthesis and inhibitory effects of flibanserin are given.  Flibanserin not only mimics antidepressant-like action but also induces after a single dose some of the effects exerted by antidepressants after repeated administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcKFLYu4kjZbVg90H21EOLACvtfcHk0lgMuPryqACaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1SntL0%253D&md5=4932ae08e81ed5e862d5f2a81d55df47</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1358%2Fdof.1998.023.01.439435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.1998.023.01.439435%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DBrambilla%26aufirst%3DA.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DCesana%26aufirst%3DR.%26aulast%3DGiraldo%26aufirst%3DE.%26aulast%3DLadinsky%26aufirst%3DH.%26aulast%3DMonferini%26aufirst%3DE.%26aulast%3DTurconi%26aufirst%3DM.%26atitle%3DFlibanserin%253A%2520antidepressant%252C%25205-HT1A%2520receptor%2520agonist%252C%25205-HT2%2520receptor%2520antagonist%26jtitle%3DDrugs%2520Future%26date%3D1998%26volume%3D23%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesana, R.</span><span> </span><span class="NLM_article-title">Mechanism of action of flibanserin in the learned helplessness paradigm in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">433</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0014-2999%2801%2901495-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2001&pages=81-89&author=F.+Borsiniauthor=R.+Cesana&title=Mechanism+of+action+of+flibanserin+in+the+learned+helplessness+paradigm+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of flibanserin in the learned helplessness paradigm in rats</span></div><div class="casAuthors">Borsini, Franco; Cesana, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">433</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The mechanism of action of flibanserin, a 5-HT1A receptor agonist and a 5-HT2A receptor antagonist, was investigated in learned helplessness in rats.  The effect of flibanserin (32 mg/kg, i.p. 30 min before testing) on learned helplessness was not antagonized by the (a) 5-HT synthesis inhibitor parachlorophenylalanine (pCPA; 150 mg/kg p.o. ×3 times), which reduced brain 5-HT by 89%; (b) 5-HT1A receptor antagonists ()-N-tert-butyl-3-4-(2-ethoxyphenyl)piperazin-1yl-2-Ph propionamide [WAY100135; 10 mg/kg, i.p. 30 min before flibanserin, or 40 mg/kg, s.c. 15 min before flibanserin] and tertatolol (2.5 and 5 mg/kg, i.p. 30 min before flibanserin); and (c) 5-HT receptor agonist ()-2,5-dimethoxy-4-iodoamphetamine (DOI; 3 mg/kg, s.c. simultaneously with flibanserin).  The effect of flibanserin on learned helplessness was antagonized by the dopamine D1 receptor antagonist [R]-3-methyl-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390; 0.1 mg/kg, i.p. 30 min before flibanserin) and by the opioid receptor antagonist naloxone (3 mg/kg, s.c. 15 min before flibanserin).  Flibanserin (32 and 64 mg/kg) did not induce conditioned place preference.  In conclusion, flibanserin improved rats' performance in the learned helplessness paradigm, by stimulating dopamine D1 and opioid receptors, probably indirectly, since flibanserin has a low affinity for these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGtnvEybcNybVg90H21EOLACvtfcHk0lgMuPryqACaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVei&md5=9cc3e131089f9c542ec45b9d9d5a559d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901495-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901495-9%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DCesana%26aufirst%3DR.%26atitle%3DMechanism%2520of%2520action%2520of%2520flibanserin%2520in%2520the%2520learned%2520helplessness%2520paradigm%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D433%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Invernizzi, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acconcia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanin, R.</span><span> </span><span class="NLM_article-title">Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0705341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2003&pages=1281-1288&author=R.+W.+Invernizziauthor=G.+Sacchettiauthor=S.+Pariniauthor=S.+Acconciaauthor=R.+Samanin&title=Flibanserin%2C+a+potential+antidepressant+drug%2C+lowers+5-HT+and+raises+dopamine+and+noradrenaline+in+the+rat+prefrontal+cortex+dialysate%3A+role+of+5-HT%281A%29+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: Role of 5-HT1A receptors</span></div><div class="casAuthors">Invernizzi, Roberto William; Sacchetti, Giuseppina; Parini, Stefania; Acconcia, Sabrina; Samanin, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1281-1288</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using in vivo intracerebral microdialysis in conscious, freely moving rats, we examd. the effect of flibanserin, a potential antidepressant drug with high affinity for human 5-HT1A receptors and four-50-fold lower affinity for 5-HT2A and D4 receptors, on basal extracellular concns. of serotonin (5-hydroxytryptamine, 5-HT), dopamine (DA) and noradrenaline (NA) in selected regions of the rat brain.  Flibanserin at 3 and 10 mg kg-1 significantly reduced extracellular 5-HT in the prefrontal cortex (by 30 and 45%) and dorsal raphe (35 and 44%), but had no effect on extracellular 5-HT in the ventral hippocampus.  The 3 and 10 mg kg-1 doses raised extracellular NA to a similar extent in the prefrontal cortex (47 and 50%).  In all, 10 mg kg-1 raised extracellular DA in the prefrontal cortex (63%) whereas 3 mg kg-1 had no significant effect.  Pretreatment with the selective 5-HT1A receptor antagonist WAY100,635 (0.3 mg kg-1) 30 min before 10 mg kg-1 flibanserin completely antagonized the latter's effects on extracellular 5-HT, DA and NA in the prefrontal cortex.  WAY100,635 by itself had no effect on cortical extracellular monoamines.  The results show that the stimulation of 5-HT1A receptors plays a major role in the effect of flibanserin on brain extracellular 5-HT, DA and NA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPOldOt5xkzLVg90H21EOLACvtfcHk0ljlDubn2y-Srw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVCisro%253D&md5=e8efcdc38f53f5deefc61a7678b99ab1</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705341%26sid%3Dliteratum%253Aachs%26aulast%3DInvernizzi%26aufirst%3DR.%2BW.%26aulast%3DSacchetti%26aufirst%3DG.%26aulast%3DParini%26aufirst%3DS.%26aulast%3DAcconcia%26aufirst%3DS.%26aulast%3DSamanin%26aufirst%3DR.%26atitle%3DFlibanserin%252C%2520a%2520potential%2520antidepressant%2520drug%252C%2520lowers%25205-HT%2520and%2520raises%2520dopamine%2520and%2520noradrenaline%2520in%2520the%2520rat%2520prefrontal%2520cortex%2520dialysate%253A%2520role%2520of%25205-HT%25281A%2529%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D139%26spage%3D1281%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Scandroglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monferini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span> </span><span class="NLM_article-title">Ex vivo binding of flibanserin to serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1006%2Fphrs.2000.0762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsl2jt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2001&pages=179-183&author=A.+Scandroglioauthor=E.+Monferiniauthor=F.+Borsini&title=Ex+vivo+binding+of+flibanserin+to+serotonin+5-HT1A+and+5-HT2A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors</span></div><div class="casAuthors">Scandroglio, Alessandro; Monferini, Eugenia; Borsini, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-183</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Flibanserin was reported to be an agonist at 5-HT1A-receptors and an antagonist at 5-HT2A-receptors, with higher affinity for 5-HT1A receptors.  Despite the fact that less receptor occupation is required by full agonists than by antagonists to exert their effects, flibanserin was shown to exert 5-HT2A antagonism at doses (4-5 mg kg-1) that are lower or equal to those required to stimulate 5-HT1A receptors.  To understand this phenomenon, the interaction of flibanserin with 5-HT1A and 5-HT2A receptors was evaluated in ex vivo binding studies.  This interaction was evaluated in the prefrontal cortex, hippocampus, and midbrain by [3H]8-OH-DPAT and [3H]ketanserin to label 5-HT1A and 5-HT2A receptors, resp.  Flibanserin was given at 1, 10, and 30 mg kg-1 i.p.  The dose of 1 mg kg-1 displaced both radioligands preferentially in the frontal cortex.  The doses of 10 and 30 mg kg-1 reduced the binding of both radioligands in all the 3 brain regions non-selectively by about 50 and 70%, resp.  The displacement was maximal after 0.5 h and was reduced or not evident after 3 h.  The authors conclude that 5-HT2 antagonism brought about by low doses of flibanserin may reflect functional mechanisms more than receptor-mediated effects.  (c) 2001 The Italian Pharmacological Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeG3QC8I1t8bVg90H21EOLACvtfcHk0ljlDubn2y-Srw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsl2jt7o%253D&md5=b4538108e5b28d18a19d5dd177a8affe</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1006%2Fphrs.2000.0762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fphrs.2000.0762%26sid%3Dliteratum%253Aachs%26aulast%3DScandroglio%26aufirst%3DA.%26aulast%3DMonferini%26aufirst%3DE.%26aulast%3DBorsini%26aufirst%3DF.%26atitle%3DEx%2520vivo%2520binding%2520of%2520flibanserin%2520to%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%26jtitle%3DPharmacol.%2520Res.%26date%3D2001%26volume%3D43%26spage%3D179%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Arnow, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millheiser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightbody, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, J. E.</span><span> </span><span class="NLM_article-title">Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=484-502&author=B.+A.+Arnowauthor=L.+Millheiserauthor=A.+Garrettauthor=P.+M.+Lakeauthor=G.+H.+Gloverauthor=K.+R.+Hillauthor=A.+Lightbodyauthor=C.+Watsonauthor=L.+Bannerauthor=T.+Smartauthor=T.+Buchananauthor=J.+E.+Desmond&title=Women+with+hypoactive+sexual+desire+disorder+compared+to+normal+females%3A+a+functional+magnetic+resonance+imaging+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnow%26aufirst%3DB.%2BA.%26aulast%3DMillheiser%26aufirst%3DL.%26aulast%3DGarrett%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DP.%2BM.%26aulast%3DGlover%26aufirst%3DG.%2BH.%26aulast%3DHill%26aufirst%3DK.%2BR.%26aulast%3DLightbody%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DBanner%26aufirst%3DL.%26aulast%3DSmart%26aufirst%3DT.%26aulast%3DBuchanan%26aufirst%3DT.%26aulast%3DDesmond%26aufirst%3DJ.%2BE.%26atitle%3DWomen%2520with%2520hypoactive%2520sexual%2520desire%2520disorder%2520compared%2520to%2520normal%2520females%253A%2520a%2520functional%2520magnetic%2520resonance%2520imaging%2520study%26jtitle%3DNeuroscience%26date%3D2009%26volume%3D158%26spage%3D484%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allers, K. A.</span><span> </span><span class="NLM_article-title">Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1743-6109.2010.02032.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFajtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=15-27&author=S.+M.+Stahlauthor=B.+Sommerauthor=K.+A.+Allers&title=Multifunctional+pharmacology+of+flibanserin%3A+possible+mechanism+of+therapeutic+action+in+hypoactive+sexual+desire+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder</span></div><div class="casAuthors">Stahl, Stephen M.; Sommer, Bernd; Allers, Kelly A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Sexual Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JSMOAN</span>;
        ISSN:<span class="NLM_cas:issn">1743-6095</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Introduction. Flibanserin is a novel pharmacol. agent in late-stage clin. testing for hypoactive sexual desire disorder (HSDD) in premenopausal women.  Aim. The aim of this article is to review the hypothetical mechanism of action of flibanserin in HSDD.  Methods. A literature review was conducted of all published works on flibanserin and on related studies of serotonin (5-HT)1A receptors and 5-HT2A receptors, including their actions on monoamines and on sexual function.  Main Outcome Measures. The main outcome measures are preclin. pharmacol. actions, esp. changes in regional monoamines following treatment with flibanserin.  Results. At clin. relevant doses, flibanserin acts predominantly at 5-HT1A receptors as an agonist and secondarily at 5-HT2A receptors as an antagonist.  Addnl. binding actions within an order of magnitude of its 5-HT1A affinity, which are not likely to be clin. relevant, include weaker antagonist actions at 5-HT2C and 5-HT2B receptors, and less defined activity at dopamine (DA) D4 receptors.  The 5-HT1A actions of flibanserin are only seen postsynaptically, which is unlike other agents such as buspirone that act at presynaptic 5-HT1A receptors.  Furthermore, the postsynaptic actions of chronic flibanserin administration appear to demonstrate a preference for some populations of postsynaptic 5-HT receptors, particularly those that are located on the prefrontal cortex (PFC) pyramidal neurons, which regulate monoamine release in certain selective brain regions.  Conclusions. The regional selectivity of flibanserin results in a unique pattern of monoamine modulation.  Sustained increases in baseline of DA and norepinephrine (NE) are obsd. in the PFC, and flibanserin dosing increases DA and NE levels above the basal changes.  Conversely, flibanserin induces transient decreases in 5-HT levels in some brain areas such as the PFC, nucleus accumbens, and hypothalamus, but not in other brain areas such as the hippocampus.  Therefore, since DA and NE are excitatory and 5-HT is inhibitory to sexual desire and arousal, it is tempting to postulate that the actions of flibanserin on serotonin receptors at the PFC pyramidal neurons, resulting in increased DA and NE yet reduced 5-HT in the PFC, are the mechanistic underpinnings of enhancing sexual desire in HSDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol4qKWeNXtjLVg90H21EOLACvtfcHk0ljlDubn2y-Srw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFajtbc%253D&md5=5bbf7d2ba38e2d28c7c32ed6033e59ae</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2010.02032.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2010.02032.x%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DSommer%26aufirst%3DB.%26aulast%3DAllers%26aufirst%3DK.%2BA.%26atitle%3DMultifunctional%2520pharmacology%2520of%2520flibanserin%253A%2520possible%2520mechanism%2520of%2520therapeutic%2520action%2520in%2520hypoactive%2520sexual%2520desire%2520disorder%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2011%26volume%3D8%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pilato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span> </span><span class="NLM_article-title">The therapeutic potential of 5-HT<sub>1A</sub> receptors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1517%2F13543776.2012.703654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=887-902&issue=8&author=E.+Lacivitaauthor=P.+Di+Pilatoauthor=P.+De+Giorgioauthor=N.+A.+Colabufoauthor=F.+Berardiauthor=R.+Perroneauthor=M.+Leopoldo&title=The+therapeutic+potential+of+5-HT1A+receptors%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of 5-HT1A receptors: a patent review</span></div><div class="casAuthors">Lacivita, Enza; Di Pilato, Pantaleo; De Giorgio, Paola; Colabufo, Nicola A.; Berardi, Francesco; Perrone, Roberto; Leopoldo, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">887-902</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The 5-HT1A receptors are implicated in mood disorders (anxiety, depression), in cognition, and in modulation of pain.  Nearly 30 years of research in this field, there is still interest in developing new chem. entities capable of 5-HT1A receptor activation or blockade.Areas covered: This review article will highlight and review the research advances published in the patent literature between Jan. 2007 and Dec. 2011, giving emphasis to the medicinal chemist's standpoint.  Literature search methodol. included search in Scifinder and PubMed Databases and browsing clin. trials.gov website.Expert opinion: Almost no new therapeutic applications have been proposed for mols. targeting the 5-HT1A receptor, during the years covered by the present review.  The discovery that stimulation of 5-HT1A receptor can promote neurogenesis will likely renew the interest for selective 5-HT1A receptor agonists as therapeutics to replace neural populations damaged by disease or injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBIFI285-n_7Vg90H21EOLACvtfcHk0ljlDubn2y-Srw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLfF&md5=ceb93bd2bc5c6b22924a15dc32732f76</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.703654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.703654%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DDi%2BPilato%26aufirst%3DP.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DLeopoldo%26aufirst%3DM.%26atitle%3DThe%2520therapeutic%2520potential%2520of%25205-HT1A%2520receptors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D887%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Brown, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirlin, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnall, R. A.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors in medullary raphe disrupts sleep and decreases shivering during cooling in the conscious piglet</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00655.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=884-894&issue=3&author=J.+W.+Brownauthor=E.+A.+Sirlinauthor=A.+M.+Benoitauthor=J.+M.+Hoffmanauthor=R.+A.+Darnall&title=Activation+of+5-HT1A+receptors+in+medullary+raphe+disrupts+sleep+and+decreases+shivering+during+cooling+in+the+conscious+piglet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00655.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00655.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BW.%26aulast%3DSirlin%26aufirst%3DE.%2BA.%26aulast%3DBenoit%26aufirst%3DA.%2BM.%26aulast%3DHoffman%26aufirst%3DJ.%2BM.%26aulast%3DDarnall%26aufirst%3DR.%2BA.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520in%2520medullary%2520raphe%2520disrupts%2520sleep%2520and%2520decreases%2520shivering%2520during%2520cooling%2520in%2520the%2520conscious%2520piglet%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2008%26volume%3D294%26issue%3D3%26spage%3D884%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Vianna, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrive, P.</span><span> </span><span class="NLM_article-title">Cardiovascular and behavioral responses to conditioned fear after medullary raphe neuronal blockade</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=1344-1353&issue=4&author=D.+M.+Viannaauthor=C.+Allenauthor=P.+Carrive&title=Cardiovascular+and+behavioral+responses+to+conditioned+fear+after+medullary+raphe+neuronal+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVianna%26aufirst%3DD.%2BM.%26aulast%3DAllen%26aufirst%3DC.%26aulast%3DCarrive%26aufirst%3DP.%26atitle%3DCardiovascular%2520and%2520behavioral%2520responses%2520to%2520conditioned%2520fear%2520after%2520medullary%2520raphe%2520neuronal%2520blockade%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D153%26issue%3D4%26spage%3D1344%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">van den Buuse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegener, N.</span><span> </span><span class="NLM_article-title">Involvement of serotonin<sub>1A</sub> receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">507</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.ejphar.2004.11.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVChsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2005&pages=187-198&issue=1%E2%80%933&author=M.+van+den+Buuseauthor=N.+Wegener&title=Involvement+of+serotonin1A+receptors+in+cardiovascular+responses+to+stress%3A+a+radio-telemetry+study+in+four+rat+strains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of serotonin1A receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains</span></div><div class="casAuthors">van den Buuse, Maarten; Wegener, Nico</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">187-198</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We studied the effect of treatment with the serotonin-1A (5-HT1A) receptor ligands buspirone, 8-hydroxy-di-propyl-aminotetralin (8-OH-DPAT), and (8-[2-(2,3-dihydro-1,4-benzodioxin-2-yl-methylamino)ethyl]-8-azaspiro[4,5]decane-7,9-dione Me sulfonate) (MDL73,005EF) on blood pressure and heart rate increases to open field stress.  We compared Spontaneously Hypertensive Rats (SHR), Fawn-Hooded (FH) rats, Wistar-Kyoto (WKY) rats, and Sprague-Dawley (SD) rats instrumented with radio-telemetry probes.  Buspirone treatment reduced the blood pressure increase in SHR, FH rats, and WKY rats and heart rate increase in FH rats and WKY rats. 8-OH-DPAT treatment reduced the blood pressure increase in FH rats and WKY rats, but had no effect in SHR and enhanced the pressor response in SD rats.  This treatment reduced the heart rate increase in FH rats and WKY rats only.  Similarly, MDL73,005EF treatment reduced the blood pressure increase in FH rats and WKY rats, but had no effect in SHR and enhanced this response in SD rats.  Little effect of this treatment was seen on heart rate changes.  For comparison, diazepam treatment abolished the pressor response in SD rats and reduced it in FH rats and WKY rats, but not SHR.  Differential effects of the treatments were also seen between strains for locomotor activity in the open field, although behavioral changes could not explain the effects of the drugs on cardiovascular responses.  These data suggest that 5-HT1A receptors are involved in cardiovascular stress responses; however, the extent of this involvement differs between rat strains and the drugs used.  These results could be important for our understanding of possible anxiolytic properties of antipsychotic drugs with affinity for the 5-HT1A receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoozDCIWn5x_LVg90H21EOLACvtfcHk0li4IgnT69zJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVChsw%253D%253D&md5=246e52fff9e1b5efd9c6fe3259a5ccc3</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.11.048%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BBuuse%26aufirst%3DM.%26aulast%3DWegener%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520serotonin1A%2520receptors%2520in%2520cardiovascular%2520responses%2520to%2520stress%253A%2520a%2520radio-telemetry%2520study%2520in%2520four%2520rat%2520strains%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D507%26issue%3D1%25E2%2580%25933%26spage%3D187%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Ootsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing, W. W.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1073–1074</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.brainres.2005.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1073%E2%80%931074&publication_year=2006&pages=252-261&author=Y.+Ootsukaauthor=W.+W.+Blessing&title=Activation+of+5-HT1A+receptors+in+rostral+medullary+raph%C3%A9+inhibits+cutaneous+vasoconstriction+elicited+by+cold+exposure+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT1A receptors in rostral medullary raphe inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits</span></div><div class="casAuthors">Ootsuka, Youichirou; Blessing, William W.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1073-1074</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In both conscious and anesthetized rabbits, we detd. whether microinjection of a 5-hydroxytryptamine (5-HT) 1A receptor agonist 8-hydroxy-2-(di-n-propylaminio) tetralin (8-OH-DPAT) into the medullary raphe/parapyramidal region inhibits thermoregulatory vasoconstriction and whether microinjection of a 5-HT1A receptor antagonist N-2-4-(2-methoxyphenyl)-(1-piperazinylethyl)-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY-100635) into the raphe reverses the cutaneous vasomotor changes induced by i.v. administration of 8-OH-DPAT.  In conscious rabbits with measuring ear pinna blood flow, after microinjection of 8-OH-DPAT (3-5 nmol in 300-500 nl) into the raphe, transferring the animal from a warm cage (25-28°) to a cold cage (5-10°) did not reduce the ear pinna flow (from 57±7 cm/s to 59±3 cm/s, P > 0.05, n = 5), unlike Ringer-treated animals.  Microinjection of WAY-100635 (5 nmol in 500 nl) into the raphe reversed ear pinna flow changes induced by i.v. administration of 8-OH-DPAT (0.1 mg/kg, i.v.).  In anesthetized rabbits with measuring postganglionic ear pinna sympathetic nerve activity, microinjection of 8-OH-DPAT (1-2 nmol in 100-200 nl) into the raphe reduced resting ear pinna sympathetic nerve activity to 14±4% of pre-injection level (P < 0.01, n = 12) and attenuated increases in ear pinna sympathetic nerve activity normally elicited by cooling the animal's trunk.  WAY-100635 (2 nmol into 200 nl) into the raphe reversed inhibition of ear pinna sympathetic nerve activity elicited by 8-OH-DPAT (0.1 mg/kg, i.v.).  The activation of 5-HT1A receptors expressed on the medullary raphe neurons results in reversal of cold-elicited cutaneous vasoconstriction possibly through inhibition of sympathetic premotor neurons that innervate sympathetic preganglionic neurons controlling cutaneous vasomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqtFzFwQchTLVg90H21EOLACvtfcHk0li4IgnT69zJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7k%253D&md5=105e1b6bfaf1de2b8f42004498030ba3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DOotsuka%26aufirst%3DY.%26aulast%3DBlessing%26aufirst%3DW.%2BW.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520in%2520rostral%2520medullary%2520raph%25C3%25A9%2520inhibits%2520cutaneous%2520vasoconstriction%2520elicited%2520by%2520cold%2520exposure%2520in%2520rabbits%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1073%25E2%2580%25931074%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Nalivaiko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ootsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing, W. W.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors in the medullary raphé reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00845.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2005&pages=596-604&author=E.+Nalivaikoauthor=Y.+Ootsukaauthor=W.+W.+Blessing&title=Activation+of+5-HT1A+receptors+in+the+medullary+raph%C3%A9+reduces+cardiovascular+changes+elicited+by+acute+psychological+and+inflammatory+stresses+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00845.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00845.2004%26sid%3Dliteratum%253Aachs%26aulast%3DNalivaiko%26aufirst%3DE.%26aulast%3DOotsuka%26aufirst%3DY.%26aulast%3DBlessing%26aufirst%3DW.%2BW.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520in%2520the%2520medullary%2520raph%25C3%25A9%2520reduces%2520cardiovascular%2520changes%2520elicited%2520by%2520acute%2520psychological%2520and%2520inflammatory%2520stresses%2520in%2520rabbits%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2005%26volume%3D289%26spage%3D596%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Ngampramuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beig, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotchabhakdi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalivaiko, E.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors attenuates tachycardia induced by restraint stress in rats</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00464.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=132-141&author=S.+Ngampramuanauthor=M.+Baumertauthor=M.+I.+Beigauthor=N.+Kotchabhakdiauthor=E.+Nalivaiko&title=Activation+of+5-HT1A+receptors+attenuates+tachycardia+induced+by+restraint+stress+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00464.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00464.2007%26sid%3Dliteratum%253Aachs%26aulast%3DNgampramuan%26aufirst%3DS.%26aulast%3DBaumert%26aufirst%3DM.%26aulast%3DBeig%26aufirst%3DM.%2BI.%26aulast%3DKotchabhakdi%26aufirst%3DN.%26aulast%3DNalivaiko%26aufirst%3DE.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520attenuates%2520tachycardia%2520induced%2520by%2520restraint%2520stress%2520in%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3D132%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Vianna, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrive, P.</span><span> </span><span class="NLM_article-title">Inhibition of the cardiovascular response to stress by systemic 5-HT<sub>1A</sub> activation: sympathoinhibition or anxiolysis?</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00232.2009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=495-501&author=D.+M.+Viannaauthor=P.+Carrive&title=Inhibition+of+the+cardiovascular+response+to+stress+by+systemic+5-HT1A+activation%3A+sympathoinhibition+or+anxiolysis%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00232.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00232.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVianna%26aufirst%3DD.%2BM.%26aulast%3DCarrive%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520the%2520cardiovascular%2520response%2520to%2520stress%2520by%2520systemic%25205-HT1A%2520activation%253A%2520sympathoinhibition%2520or%2520anxiolysis%253F%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3D495%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Di Micco, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretskaia, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretsky, D. V.</span><span> </span><span class="NLM_article-title">The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=469-480&author=J.+A.+Di+Miccoauthor=B.+C.+Samuelsauthor=M.+V.+Zaretskaiaauthor=D.+V.+Zaretsky&title=The+dorsomedial+hypothalamus+and+the+response+to+stress%3A+part+renaissance%2C+part+revolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DJ.%2BA.%26aulast%3DSamuels%26aufirst%3DB.%2BC.%26aulast%3DZaretskaia%26aufirst%3DM.%2BV.%26aulast%3DZaretsky%26aufirst%3DD.%2BV.%26atitle%3DThe%2520dorsomedial%2520hypothalamus%2520and%2520the%2520response%2520to%2520stress%253A%2520part%2520renaissance%252C%2520part%2520revolution%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D71%26spage%3D469%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Di Micco, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretskaia, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretsky, D. V.</span><span> </span><span class="NLM_article-title">Stress-induced cardiac stimulation and fever: common hypothalamic origins and brainstem mechanisms</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126–127</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.autneu.2006.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126%E2%80%93127&publication_year=2006&pages=106-119&author=J.+A.+Di+Miccoauthor=S.+Sarkarauthor=M.+V.+Zaretskaiaauthor=D.+V.+Zaretsky&title=Stress-induced+cardiac+stimulation+and+fever%3A+common+hypothalamic+origins+and+brainstem+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2006.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2006.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DJ.%2BA.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DZaretskaia%26aufirst%3DM.%2BV.%26aulast%3DZaretsky%26aufirst%3DD.%2BV.%26atitle%3DStress-induced%2520cardiac%2520stimulation%2520and%2520fever%253A%2520common%2520hypothalamic%2520origins%2520and%2520brainstem%2520mechanisms%26jtitle%3DAuton.%2520Neurosci.%26date%3D2006%26volume%3D126%25E2%2580%2593127%26spage%3D106%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Di Micco, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretsky, D. V.</span><span> </span><span class="NLM_article-title">The dorsomedial hypothalamus: a new player in thermoregulation</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00498.2006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=47-63&author=J.+A.+Di+Miccoauthor=D.+V.+Zaretsky&title=The+dorsomedial+hypothalamus%3A+a+new+player+in+thermoregulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00498.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00498.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DJ.%2BA.%26aulast%3DZaretsky%26aufirst%3DD.%2BV.%26atitle%3DThe%2520dorsomedial%2520hypothalamus%253A%2520a%2520new%2520player%2520in%2520thermoregulation%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3D47%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Horiuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dampney, R. A. L.</span><span> </span><span class="NLM_article-title">Activation of 5-hydroxytryptamine<sub>1A</sub> receptors suppresses the cardiovascular response evoked from the dorsomedial hypothalamic nucleus</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=173-179&author=J.+Horiuchiauthor=S.+Wakabayashiauthor=R.+A.+L.+Dampney&title=Activation+of+5-hydroxytryptamine1A+receptors+suppresses+the+cardiovascular+response+evoked+from+the+dorsomedial+hypothalamic+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DJ.%26aulast%3DWakabayashi%26aufirst%3DS.%26aulast%3DDampney%26aufirst%3DR.%2BA.%2BL.%26atitle%3DActivation%2520of%25205-hydroxytryptamine1A%2520receptors%2520suppresses%2520the%2520cardiovascular%2520response%2520evoked%2520from%2520the%2520dorsomedial%2520hypothalamic%2520nucleus%26jtitle%3DHypertension%26date%3D2005%26volume%3D46%26spage%3D173%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Pattij, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenink, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijzen, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosting, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Gugten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span> </span><span class="NLM_article-title">Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=380-390&issue=3&author=T.+Pattijauthor=L.+Groeninkauthor=T.+H.+Hijzenauthor=R.+S.+Oostingauthor=R.+A.+Maesauthor=J.+van+der+Gugtenauthor=B.+Olivier&title=Autonomic+changes+associated+with+enhanced+anxiety+in+5-HT%281A%29+receptor+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPattij%26aufirst%3DT.%26aulast%3DGroenink%26aufirst%3DL.%26aulast%3DHijzen%26aufirst%3DT.%2BH.%26aulast%3DOosting%26aufirst%3DR.%2BS.%26aulast%3DMaes%26aufirst%3DR.%2BA.%26aulast%3Dvan%2Bder%2BGugten%26aufirst%3DJ.%26aulast%3DOlivier%26aufirst%3DB.%26atitle%3DAutonomic%2520changes%2520associated%2520with%2520enhanced%2520anxiety%2520in%25205-HT%25281A%2529%2520receptor%2520knockout%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2002%26volume%3D27%26issue%3D3%26spage%3D380%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Horiuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dampney, R. A.</span><span> </span><span class="NLM_article-title">Role of 5-HT<sub>1A</sub> receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.autneu.2008.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ejtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2008&pages=71-76&author=J.+Horiuchiauthor=L.+M.+McDowallauthor=R.+A.+Dampney&title=Role+of+5-HT1A+receptors+in+the+lower+brainstem+on+the+cardiovascular+response+to+dorsomedial+hypothalamus+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of 5-HT1A receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation</span></div><div class="casAuthors">Horiuchi, Jouji; McDowall, Lachlan M.; Dampney, Roger A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Autonomic Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">71-76</span>CODEN:
                <span class="NLM_cas:coden">ANUEB2</span>;
        ISSN:<span class="NLM_cas:issn">1566-0702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dorsomedial hypothalamus (DMH) is an essential brain region for the integration of the physiol. response to psychol. stressors.  The cardiovascular components of the response include increases in blood pressure, heart rate and the activity of sympathetic nerves to the kidney, skin, brown adipose tissue, and heart.  Neurons in the rostral ventrolateral medulla (RVLM) and in the region of the medullary raphe are important components of the descending pathways that mediate the cardiovascular response to the DMH activation.  Activation of 5-hydroxytryptamine 1A (5-HT1A) receptors in the brain leads to a suppression of the cardiac and sympathetic vasomotor components of the DMH-evoked response and of the response to acute psychol. stress.  In this study we showed that intracisternal injection of a low dose (1 μg/kg) of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), significantly reduced the increases in heart rate and renal sympathetic nerve activity evoked by disinhibition of the DMH, but had no effect on these responses when injected i.v.  Subsequent intracisternal administration of the 5-HT1A receptor antagonist WAY-100635 restored the DMH-evoked cardiovascular responses to levels obsd. before 8-OH-DPAT administration.  Bilateral microinjections of 8-OH-DPAT (200pmol on each side) into the RVLM, however, did not significantly affect the cardiovascular response to disinhibition of the DMH.  These observations demonstrate that activation of 5-HT1A receptors within the lower brainstem, but not in the RVLM, can powerfully suppress the cardiovascular response evoked from the DMH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt5lhaP1gvxLVg90H21EOLACvtfcHk0lh_hDv3EezdUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ejtb%252FN&md5=5d57b0661c80416fdebf82b000f38f74</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2008.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2008.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DJ.%26aulast%3DMcDowall%26aufirst%3DL.%2BM.%26aulast%3DDampney%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%25205-HT1A%2520receptors%2520in%2520the%2520lower%2520brainstem%2520on%2520the%2520cardiovascular%2520response%2520to%2520dorsomedial%2520hypothalamus%2520activation%26jtitle%3DAuton.%2520Neurosci.%26date%3D2008%26volume%3D142%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Ootsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing, W. W.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine<sub>1A</sub> receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">552</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1113%2Fjphysiol.2003.048041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2003&pages=303-314&author=Y.+Ootsukaauthor=W.+W.+Blessing&title=5-Hydroxytryptamine1A+receptors+inhibit+cold-induced+sympathetically+mediated+cutaneous+vasoconstriction+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits</span></div><div class="casAuthors">Ootsuka, Y.; Blessing, W. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">303-314</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">5-HT1A receptor agonists lower body temp.  The authors have investigated whether activation of 5-HT1A receptors inhibits cutaneous sympathetic discharge so that dilatation of the cutaneous vascular bed lowers body temp. by increasing heat transfer to the environment.  The authors measured ear pinna blood flow in conscious rabbits (with chronically implanted Doppler ultrasound flow probes), and postganglionic sympathetic vasomotor nerve activity in anesthetized rabbits.  Recordings from conscious rabbits were made in a cage at 26°C and the rabbit was then transferred to a cage at 10°C.  The ear pinna Doppler signal fell from 56±4 cm s-1 in the 26°C cage to 4±1 cm s-1 (P < 0.0001, n = 24) after 30 min in the 10°C cage, and body temp. increased from 38.8±0.2 to 39.0±0.2°C (P < 0.01, n = 24).  The 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT;0.1 mg kg-1 I.V.) reversed the cold-induced fall in ear pinna blood flow (Doppler signal increased from 5±1 to 55±8 cm s-1, P < 0.001, n = 7) within 5 min when administered 30 min after transfer to the 10°C cage, and prevented the fall in ear pinna blood flow when administered before the rabbit was transferred to the 10°C cage.  Body temp. decreased after administration of 8-OH-DPAT.  These changes were abolished by the specific 5-HT1A antagonist WAY-100635 (0.1 mg kg-1 I.V.).  In anesthetized rabbits, 8-OH-DPAT (0.1 mg kg-1 I.V.) reduced resting postganglionic cutaneous sympathetic vasomotor discharge, and prevented the increase normally elicited by cooling the trunk.  The authors' expts. constitute the first demonstration that activation of 5-HT1A receptors powerfully inhibits cold-induced increases in cutaneous sympathetic vasomotor discharge, thereby dilating the cutaneous vascular bed and increasing transfer of heat to the environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozevnbZqNkRLVg90H21EOLACvtfcHk0lh_hDv3EezdUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCns7g%253D&md5=e89636925d64dbdf2fbdc594e5010855</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2003.048041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2003.048041%26sid%3Dliteratum%253Aachs%26aulast%3DOotsuka%26aufirst%3DY.%26aulast%3DBlessing%26aufirst%3DW.%2BW.%26atitle%3D5-Hydroxytryptamine1A%2520receptors%2520inhibit%2520cold-induced%2520sympathetically%2520mediated%2520cutaneous%2520vasoconstriction%2520in%2520rabbits%26jtitle%3DJ.%2520Physiol.%26date%3D2003%26volume%3D552%26spage%3D303%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Thomas, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatfield, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krülle, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, J. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>1A</sub> activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Foby.2008.550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=467-473&issue=3&author=G.+H.+Thomasauthor=A.+J.+Babbsauthor=R.+E.+Chatfieldauthor=T.+M.+Kr%C3%BClleauthor=P.+S.+Widdowsonauthor=D.+Provostauthor=J.+G.+McCormack&title=5-HT1A+activation+counteracts+cardiovascular+but+not+hypophagic+effects+of+sibutramine+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A Activation Counteracts Cardiovascular But Not Hypophagic Effects of Sibutramine in Rats</span></div><div class="casAuthors">Thomas, Gerard H.; Babbs, Adam J.; Chatfield, Rosemary E.; Kruelle, Thomas M.; Widdowson, Peter S.; Provost, Daniel; McCormack, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-473</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The noradrenaline (NA) and serotonin reuptake inhibitor, sibutramine, gives effective wt. loss, but full efficacy cannot be attained at approved doses due to cardiovascular side effects.  We assessed in rats the contributions of NA and serotonin transporters to sibutramine's hypophagic and cardiovascular effects, and whether selective 5-hydroxytryptamine (5-HT1A) receptor activation could counteract the latter without affecting the former.  Food intake was assessed in freely feeding rats and cardiovascular parameters in conscious telemetered rats.  Ex vivo radioligand binding was used to est. brain monoamine transporter occupancy.  Sibutramine (1-10 mg/kg p.o.) dose-dependently reduced food intake; however, 10 mg/kg p.o. markedly elevated blood pressure and heart rate.  Sibutramine gave greater occupancy of NA than serotonin reuptake sites.  Coadministration of the selective 5-HT1A agonist F-11440 (2.5 mg/kg p.o.) attenuated sibutramine-induced hypertension and tachycardia without altering its food intake effects.  The selective NA reuptake inhibitors, nisoxetine or reboxetine, did not alter food intake alone, but each reduced food intake when combined with F-11440.  These results suggest that sibutramine-induced hypophagic and cardiovascular effects are largely due to increased brain synaptic NA via NA reuptake inhibition, and that 5-HT1A activation can counter the undesirable cardiovascular effects resulting from increased sympathetic activity.  Selective NA reuptake inhibitors did not reduce food intake alone but did when combined with 5-HT1A activation.  Hence increased synaptic serotonin, via serotonin reuptake inhibition or 5-HT1A activation, together with increased NA, would appear to produce hypophagia.  Thus wt. loss with minimal cardiovascular risk could be achieved by 5-HT1A activation combined with NA transporter blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohNXqUyviRwrVg90H21EOLACvtfcHk0liKqjtlRCHXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7o%253D&md5=699f2b3ad9fb8bdfeb6202c882f140b3</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Foby.2008.550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2008.550%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DG.%2BH.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DChatfield%26aufirst%3DR.%2BE.%26aulast%3DKr%25C3%25BClle%26aufirst%3DT.%2BM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DProvost%26aufirst%3DD.%26aulast%3DMcCormack%26aufirst%3DJ.%2BG.%26atitle%3D5-HT1A%2520activation%2520counteracts%2520cardiovascular%2520but%2520not%2520hypophagic%2520effects%2520of%2520sibutramine%2520in%2520rats%26jtitle%3DObesity%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Ramage, A. G.</span><span> </span><span class="NLM_article-title">The role of central 5-hydtroxytryrptamine (5-HT, serotonin) receptors in the control of micturition</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0706504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=120-131&author=A.+G.+Ramage&title=The+role+of+central+5-hydtroxytryrptamine+%285-HT%2C+serotonin%29+receptors+in+the+control+of+micturition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition</span></div><div class="casAuthors">Ramage, Andrew G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S120-S131</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  At present the most investigated 5-HT receptor that has been shown to play a role in the control of micturition is the 5-HT1A receptor followed by 5-HT7, 5-HT2 and 5-HT3 receptors.  Most expts. focus on the control these receptors have on the parasympathetic outflow to the bladder and the somatic outflow to the external urethral sphincter (EUS) in the rat.  Furthermore, 5-HT1A and 5-HT7 receptors have been identified as having an excitatory physiol. role in the control of bladder function. 5-HT1A receptors act, at least in the rat, at both a spinal (probably a heteroreceptor) and supraspinal (probably an autoreceptor) level, while 5-HT7 receptors only act at a supraspinal level.  Addnl., in the rat, 5-HT administered at a spinal or supraspinal site has an excitatory action, although earlier expts. have shown that activating 5-HT-contg. brain areas causes inhibition of the bladder.  Recent expts. have also indicated that blockade of the 5-HT1A receptor pathway shows rapid tolerance.  However, no data exist for the development of tolerance for the 5-HT7 receptor pathway.  Neither receptor seems to play a role in the control of the urethra.  Regarding 5-HT2 receptors, activation of this receptor subtype inhibits micturition, and this inhibitory action may occur at a spinal, supraspinal or both levels.  Although no physiol. role for 5-HT2C receptors can yet be identified, 5-HT2C receptors have been implicated in the proposed supraspinal tonically active 5-HT1A autoreceptor (neg. feedback) pathway.  This proposition reconciles the data that central 5-HT-contg. pathways are inhibitory to micturition, while 5-HT1A receptors, although inhibitory to adenylyl cyclase, have an excitatory function.  This is because activation of 5-HT1A autoreceptors reduces the release of 5-HT thus reducing the activation of the 5-HT2C receptors, which are inhibitory in the control of micturition (disinhibition).  Furthermore, 5-HT2A receptors in the rat and 5-HT2C receptors in the guinea pig cause activation of the EUS.  In this respect, 5-ht5A receptors have also been identified in Onuf's nucleus, the site of somatic motoneurons controlling this sphincter.  In the cat there is very little evidence to indicate that 5-HT receptors are involved in micturition except under pathol. conditions in which activation of 5-HT1A receptors causes inhibition of micturition.  Interestingly, under such conditions 5-HT1A receptors cause excitation of the EUS.  Nevertheless, spinal 5HT3 receptors have been implicated in the physiol. control of micturition in the cat, but not yet in the rat.  Overall, the data support the view that 5-HT receptors are important in the control of micturition.  However, many more studies are required to fully understand these roles and why there are such species differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZsLw-jq6iNLVg90H21EOLACvtfcHk0liKqjtlRCHXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGqsLo%253D&md5=61bda5e1c99af5ddd9f35998f2fac710</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706504%26sid%3Dliteratum%253Aachs%26aulast%3DRamage%26aufirst%3DA.%2BG.%26atitle%3DThe%2520role%2520of%2520central%25205-hydtroxytryrptamine%2520%25285-HT%252C%2520serotonin%2529%2520receptors%2520in%2520the%2520control%2520of%2520micturition%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3D120%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, H.</span><span> </span><span class="NLM_article-title">Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">700</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.ejphar.2012.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislyntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=700&publication_year=2013&pages=194-200&author=T.+Sakaiauthor=K.+Kasaharaauthor=K.+Tomitaauthor=I.+Ikegakiauthor=H.+Kuriyama&title=Naftopidil+inhibits+5-hydroxytryptamine-induced+bladder+contraction+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats</span></div><div class="casAuthors">Sakai, Takumi; Kasahara, Ken-ichi; Tomita, Ken-ichi; Ikegaki, Ichiro; Kuriyama, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">700</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">194-200</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Naftopidil is an α1D and α1A subtype-selective α1-adrenoceptor antagonist that has been used to treat lower urinary tract symptoms of benign prostatic hyperplasia.  In this study, we investigated the effects of naftopidil on 5-hydroxytryptamine (5-HT)-induced rat bladder contraction (10-8-10-4 M).  Naftopidil (0.3, 1, and 3 μM) inhibited 5-HT-induced bladder contraction in a concn.-dependent manner.  On the other hand, other α1-adrenoceptor antagonists, tamsulosin, silodosin or prazosin, did not inhibit 5-HT-induced bladder contraction.  The 5-HT-induced bladder contraction was inhibited by both ketanserin and 4-(4-fluoronaphthalen-1-yl)-6-propan-2-ylpyrimidin-2-amine (RS127445), serotonin 5-HT2A and 5-HT2B receptor antagonists, resp.  In addn., 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and α-methyl-5-HT, 5-HT2A and 5-HT2 receptor agonists, resp., induced bladder contraction.  The 5-HT-induced bladder contraction was not inhibited by N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-yl-cyclohexanecarboxamide (WAY-100635), [1-[2[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl-1-methyl-1H-indole-3-carboxylate (GR113808) or (R)-3-[2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol (SB269970), 5-HT1A, 5-HT4 and 5-HT7 receptor antagonists, resp.  Naftopidil inhibited both the 5-HT2A and 5-HT2 receptor agonists-induced bladder contractions.  Naftopidil binds to the human 5-HT2A and 5-HT2B receptors with pKi values of 6.55 and 7.82, resp.  These results suggest that naftopidil inhibits 5-HT-induced bladder contraction via blockade of the 5-HT2A and 5-HT2B receptors in rats.  Furthermore, 5-HT-induced bladder contraction was enhanced in bladder strips obtained from bladder outlet obstructed rats, with this contraction inhibited by naftopidil.  The beneficial effects of naftopidil on storage symptoms such as urinary frequency and nocturia in patients with benign prostatic hyperplasia may be due, in part, to the blockade of the 5-HT2A and 5-HT2B receptors in the bladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBrhpwW3ri7Vg90H21EOLACvtfcHk0liKqjtlRCHXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislyntLY%253D&md5=79984b8d7fdd80f9c965a6cb153eafa6</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DKasahara%26aufirst%3DK.%26aulast%3DTomita%26aufirst%3DK.%26aulast%3DIkegaki%26aufirst%3DI.%26aulast%3DKuriyama%26aufirst%3DH.%26atitle%3DNaftopidil%2520inhibits%25205-hydroxytryptamine-induced%2520bladder%2520contraction%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D700%26spage%3D194%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Sorbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tait, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasili, L.</span><span> </span><span class="NLM_article-title">1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure–affinity/activity relationships at α<sub>1</sub> and 5-HT<sub>1A</sub> receptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=393-399&author=C.+Sorbiauthor=S.+Franchiniauthor=A.+Taitauthor=A.+Prandiauthor=R.+Gallesiauthor=P.+Angeliauthor=G.+Marucciauthor=L.+Pironaauthor=E.+Poggesiauthor=L.+Brasili&title=1%2C3-Dioxolane-based+ligands+as+rigid+analogues+of+naftopidil%3A+structure%E2%80%93affinity%2Factivity+relationships+at+%CE%B11+and+5-HT1A+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorbi%26aufirst%3DC.%26aulast%3DFranchini%26aufirst%3DS.%26aulast%3DTait%26aufirst%3DA.%26aulast%3DPrandi%26aufirst%3DA.%26aulast%3DGallesi%26aufirst%3DR.%26aulast%3DAngeli%26aufirst%3DP.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DPirona%26aufirst%3DL.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DBrasili%26aufirst%3DL.%26atitle%3D1%252C3-Dioxolane-based%2520ligands%2520as%2520rigid%2520analogues%2520of%2520naftopidil%253A%2520structure%25E2%2580%2593affinity%252Factivity%2520relationships%2520at%2520%25CE%25B11%2520and%25205-HT1A%2520receptors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D393%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">de Groat, W. C.</span><span> </span><span class="NLM_article-title">Influence of central serotonergic mechanisms on lower urinary tract function</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=30-36&author=W.+C.+de+Groat&title=Influence+of+central+serotonergic+mechanisms+on+lower+urinary+tract+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGroat%26aufirst%3DW.%2BC.%26atitle%3DInfluence%2520of%2520central%2520serotonergic%2520mechanisms%2520on%2520lower%2520urinary%2520tract%2520function%26jtitle%3DUrology%26date%3D2002%26volume%3D59%26spage%3D30%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Gu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K. E.</span><span> </span><span class="NLM_article-title">Improving voiding efficiency in the diabetic rat by a 5-HT<sub>1A</sub> serotonin receptor agonist</span> <span class="citation_source-journal">Neurourol. Urodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1002%2Fnau.21182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=168-173&author=B.+Guauthor=G.+Wuauthor=J.+Siauthor=Y.+Xuauthor=K.+E.+Andersson&title=Improving+voiding+efficiency+in+the+diabetic+rat+by+a+5-HT1A+serotonin+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist</span></div><div class="casAuthors">Gu, Baojun; Wu, Gang; Si, Jieming; Xu, Yuemin; Andersson, Karl-Erik</div><div class="citationInfo"><span class="NLM_cas:title">Neurourology and Urodynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-173</span>CODEN:
                <span class="NLM_cas:coden">NEUREM</span>;
        ISSN:<span class="NLM_cas:issn">0733-2467</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Serotonin affects micturition in the normal rat through actions not only on ascending and descending spinal pathways and supraspinal centers but also on the lumbosacral spinal cord level.  The selective 5-HT1A receptor agonist, 8-OH-DPAT((R)-(+)-8-hydroxy-2-(di-n-propylamino) tetralin), reversed detrusor-sphincter dyssynergia (DSD) in the spinal cord injury (SCI) rat.  Rats with exptl. diabetes mellitus (DM) have been shown to have both bladder and urethral dysfunction during reflex voiding.  We therefore examd. the effects of 8-OH-DPAT on micturition in DM rats.  Female Sprague-Dawley rats were used.  DM was induced by an i.p. injection of streptozotocin (STZ, 65 mg/kg) and a cystometric study was performed 8 wk post-injection.  External urethral sphincter electromyog. (EUS-EMG) was also measured.  The 5-HT1A antagonist WAY-100635(N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide) was administered after each 8-OH-DPAT dose-response.  Compared to controls, DM rats had a higher bladder capacity, residual vol., and a lower voiding efficiency.  In DM rats, 8-OH-DPAT (3-1,000 μg/kg, i.v.) induced significant dose-dependent increases in micturition vol., and decreases in residual vol., resulting in increases in voiding efficiency.  During the micturition, there was a dose-dependent increased phasic EUS activity correlated with the improved voiding efficiency.  WAY-100635 (300 μg/kg, i.v.) reversed the 8-OH-DPAT-induced changes.  Both the bladder voiding efficiency and the periodic EUS activity were decreased in DM rats.  5-HT1A receptor agonism promoted periodic EUS activity, thereby improving voiding efficiency.  Whether or not these results may have implications for the future treatment of voiding dysfunction in DM patients remains to be studied.  Neurourol. Urodynam. 31:168-173, 2012. © 2011 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4swchT9qxBLVg90H21EOLACvtfcHk0lhAXkNKk3KoJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSju7o%253D&md5=9423022d75874f7c218831b83fe0b5ab</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fnau.21182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fnau.21182%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DSi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DAndersson%26aufirst%3DK.%2BE.%26atitle%3DImproving%2520voiding%2520efficiency%2520in%2520the%2520diabetic%2520rat%2520by%2520a%25205-HT1A%2520serotonin%2520receptor%2520agonist%26jtitle%3DNeurourol.%2520Urodyn.%26date%3D2012%26volume%3D31%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Dizeyi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjartell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleanu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span> </span><span class="NLM_article-title">Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=328-336&author=N.+Dizeyiauthor=A.+Bjartellauthor=E.+Nilssonauthor=J.+Hanssonauthor=V.+Gadaleanuauthor=N.+Crossauthor=P.+A.+Abrahamsson&title=Expression+of+serotonin+receptors+and+role+of+serotonin+in+human+prostate+cancer+tissue+and+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDizeyi%26aufirst%3DN.%26aulast%3DBjartell%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DE.%26aulast%3DHansson%26aufirst%3DJ.%26aulast%3DGadaleanu%26aufirst%3DV.%26aulast%3DCross%26aufirst%3DN.%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520serotonin%2520receptors%2520and%2520role%2520of%2520serotonin%2520in%2520human%2520prostate%2520cancer%2520tissue%2520and%2520cell%2520lines%26jtitle%3DProstate%26date%3D2004%26volume%3D59%26spage%3D328%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Cattaneo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicentini, L. M.</span><span> </span><span class="NLM_article-title">Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT<sub>1A</sub> and 5-HT<sub>1D</sub> receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol., Mol. Pharmacol. Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2F0922-4106%2895%2990145-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2MXovVygtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1995&pages=209-211&author=M.+G.+Cattaneoauthor=R.+Fesceauthor=L.+M.+Vicentini&title=Mitogenic+effect+of+serotonin+in+human+small+cell+lung+carcinoma+cells+via+both+5-HT1A+and+5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors</span></div><div class="casAuthors">Cattaneo, Maria G.; Fesce, Riccardo; Vicentini, Lucia M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-11</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The authors have recently shown that the mitogenic effect of serotonin (5-hydroxytryptamine, 5-HT) on human small cell lung carcinoma (SCLC) cells is at least partly due to stimulation of a 5-HT1D receptor type.  The authors now report that the 5-HT1A receptor agonist R(+)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) is also capable of stimulating [3H]thymidine incorporation into SCLC GLC-8 cells, although with lower efficacy than 5-HT.  The simultaneous administration of maximal doses of 8-OH-DPAT and the 5-HT1D receptor agonist sumatriptan reproduced the maximal [3H]thymidine incorporation obsd. with 5-HT alone.  The 5-HT1A receptor antagonists spiperone and SDZ 216-525 completely abolished the effect of 8-OH-DPAT (IC50 30 nM for both drugs) behaving as pure antagonists.  Accordingly, the two drugs partially inhibited the mitogenic effect of 5-HT.  These data indicate that the mitogenic effect of 5-HT in SCLC cells involves both 5-HT1A and 5-HT1D receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokjO1J7SmRWLVg90H21EOLACvtfcHk0lhAXkNKk3KoJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovVygtbw%253D&md5=84bae9da43b08974186e7b3d702c22ff</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2895%2990145-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252895%252990145-0%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DM.%2BG.%26aulast%3DFesce%26aufirst%3DR.%26aulast%3DVicentini%26aufirst%3DL.%2BM.%26atitle%3DMitogenic%2520effect%2520of%2520serotonin%2520in%2520human%2520small%2520cell%2520lung%2520carcinoma%2520cells%2520via%2520both%25205-HT1A%2520and%25205-HT1D%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1995%26volume%3D291%26spage%3D209%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Chin, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, S. S.</span><span> </span><span class="NLM_article-title">A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BC3c3nsVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=24-29&author=S.+N.+Chinauthor=L.+Wangauthor=M.+Mooreauthor=S.+S.+Sridhar&title=A+review+of+the+patterns+of+docetaxel+use+for+hormone-resistant+prostate+cancer+at+the+Princess+Margaret+Hospital"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital</span></div><div class="casAuthors">Chin S N; Wang L; Moore M; Sridhar S S</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology (Toronto, Ont.)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">24-9</span>
        ISSN:<span class="NLM_cas:issn">1198-0052</span>.
    </div><div class="casAbstract">BACKGROUND:  Based on the TAX 327 phase III trial, docetaxel-based chemotherapy is the standard first-line treatment for hormone-resistant prostate cancer (HRPC); however, there is some heterogeneity in the use of this agent in routine clinical practice.  The aim of the present study was to examine the patterns of docetaxel use in routine clinical practice at our institution and to compare them with docetaxel use in the TAX 327 clinical trial.  METHODS:  We conducted a retrospective chart review of HRPC patients treated with first-line docetaxel between 2005 and 2007 at the Princess Margaret Hospital.  RESULTS:  In the first-line setting, 88 patients with HRPC received docetaxel.  The main reasons for initiating docetaxel were rising prostate-specific antigen (PSA, 98%) and progressive symptoms (77%).  The PSA response rate was 67%; median time to response was 1.5 months, and duration of response was 6.8 months.  Median survival was 15.9 months (95% confidence interval: 12.4 to 20.5 months).  Patients received a median of 7 cycles of treatment, and the main toxicities were fatigue (35%) and neuropathy (24%).  Post docetaxel, 36 patients received second-line treatment with a 22% response rate.  CONCLUSIONS:  In routine clinical practice, HRPC patients received docetaxel mainly because of symptomatic disease progression.  Overall response rates and toxicities were comparable to those in the TAX 327 trial.  However, our patients received a median of only 7 cycles of treatment versus the 9.5 administered on trial, and survival was slightly shorter in our single-institution study.  A larger prospective multicentre analysis, including performance status and quality-of-life parameters, may be warranted to determine if docetaxel performs as well in routine clinical practice as it does in the clinical trial setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZq5iNynRg0LZpSb_XWfMrfW6udTcc2eYastUWJBoE7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3nsVKrsA%253D%253D&md5=5dd45f26f4938b4c32375ded3126a9ff</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DS.%2BN.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSridhar%26aufirst%3DS.%2BS.%26atitle%3DA%2520review%2520of%2520the%2520patterns%2520of%2520docetaxel%2520use%2520for%2520hormone-resistant%2520prostate%2520cancer%2520at%2520the%2520Princess%2520Margaret%2520Hospital%26jtitle%3DCurr.%2520Oncol.%26date%3D2010%26volume%3D17%26spage%3D24%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span> </span><span class="NLM_article-title">Prostate cancer and active surveillance</span> <span class="citation_source-journal">Front. Radiat. Ther. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1159%2F000139867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BD1czns1yitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1-6&author=P.+A.+Abrahamsson&title=Prostate+cancer+and+active+surveillance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate cancer and active surveillance</span></div><div class="casAuthors">Abrahamsson Per-Anders</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers of radiation therapy and oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>
        ISSN:<span class="NLM_cas:issn">0071-9676</span>.
    </div><div class="casAbstract">This review outlines the different treatment options in localized prostate cancer.  This information can be considered alongside other important factors, such as the individual patient's values and situation as well as the potential impact of treatment on his quality of life, in the treatment decision-making process.  Taking all these factors into consideration, the data support active surveillance as an appropriate choice in patients with well or moderately differentiated, low-volume prostate cancer who have a life expectancy of less than 10 years.  Men with higher-grade tumors and longer life expectancy may be at excess risk of death from prostate cancer managed with active surveillance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRw9cirtAUkpbxanA7vODO6fW6udTcc2ebErEZ-j9pzDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czns1yitA%253D%253D&md5=760dff61d21224051ba199d790e3ab0f</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1159%2F000139867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000139867%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26atitle%3DProstate%2520cancer%2520and%2520active%2520surveillance%26jtitle%3DFront.%2520Radiat.%2520Ther.%2520Oncol.%26date%3D2008%26volume%3D41%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Waguespack, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Ramirez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, C.</span><span> </span><span class="NLM_article-title">A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1210%2Fjc.2009-2830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFegtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=2023-2037&author=S.+G.+Waguespackauthor=T.+Richauthor=E.+Grubbsauthor=A.+K.+Yingauthor=N.+D.+Perrierauthor=M.+Ayala-Ramirezauthor=C.+Jimenez&title=A+current+review+of+the+etiology%2C+diagnosis%2C+and+treatment+of+pediatric+pheochromocytoma+and+paraganglioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma</span></div><div class="casAuthors">Waguespack, S. G.; Rich, T.; Grubbs, E.; Ying, A. K.; Perrier, N. D.; Ayala-Ramirez, M.; Jimenez, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2023-2037</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Pheochromocytomas and paragangliomas (PHEO/PGL) are neuroendocrine tumors that arise from sympathetic and parasympathetic paraganglia.  Diagnosed rarely during childhood, PHEO/PGL are nonetheless important clin. entities, particularly given our evolving understanding of their pathophysiol.  Evidence Acquisition: We identified articles through the U.S. National Library of Medicine by using the search terms pheochromocytoma and paraganglioma.  Results were narrowed to manuscripts that included children and studies related to the genetics of PHEO/PGL.  Web-based resources for genetic disorders were also used.  For all articles, we performed subsequent ref. searches and verification of source data.  Evidence Synthesis: Up to 20% of PHEO/PGL are diagnosed in children.  Most are functional tumors, and clin. presentation includes symptoms related to catecholamine hypersecretion and/or tumor mass effect.  Increasingly, PHEO/PGL are identified during presymptomatic screening in children with genetic syndromes assocd. with PHEO/PGL (multiple endocrine neoplasia type 2, von Hippel-Lindau disease, and the paraganglioma syndromes).  Plasma and/or urine metanephrines are the best diagnostic test for a functional tumor, and the management of pediatric patients is similar to adults.  Genetic counseling should be undertaken in all cases.  Although most pediatric PHEO/PGL are benign, these tumors can occasionally metastasize, a condition for which no curative treatment exists.  Conclusions: Although PHEO/PGL are rarely diagnosed during childhood, the pediatric provider should be able to recognize and screen for such tumors, particularly in the context of a known genetic predisposition.  Optimal care of these children includes a multidisciplinary team approach at centers experienced in the evaluation and treatment of these uncommon yet fascinating endocrine neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNz5hXqE3A2LVg90H21EOLACvtfcHk0ljsF6xMJRd9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFegtLc%253D&md5=56052358436a554319d04da9f8cbc54a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1210%2Fjc.2009-2830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2009-2830%26sid%3Dliteratum%253Aachs%26aulast%3DWaguespack%26aufirst%3DS.%2BG.%26aulast%3DRich%26aufirst%3DT.%26aulast%3DGrubbs%26aufirst%3DE.%26aulast%3DYing%26aufirst%3DA.%2BK.%26aulast%3DPerrier%26aufirst%3DN.%2BD.%26aulast%3DAyala-Ramirez%26aufirst%3DM.%26aulast%3DJimenez%26aufirst%3DC.%26atitle%3DA%2520current%2520review%2520of%2520the%2520etiology%252C%2520diagnosis%252C%2520and%2520treatment%2520of%2520pediatric%2520pheochromocytoma%2520and%2520paraganglioma%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26spage%3D2023%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Siddiqui, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikhailidis, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumtaz, F. H.</span><span> </span><span class="NLM_article-title">The role of serotonin (5-hydroxytryptamine<sub>1A</sub> and <sub>1B</sub>) receptors in prostate cancer cell proliferation</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">1648</span><span class="NLM_x">–</span> <span class="NLM_lpage">1653</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.juro.2006.06.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCht7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1648-1653&author=E.+J.+Siddiquiauthor=M.+Shabbirauthor=D.+P.+Mikhailidisauthor=C.+S.+Thompsonauthor=F.+H.+Mumtaz&title=The+role+of+serotonin+%285-hydroxytryptamine1A+and+1B%29+receptors+in+prostate+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation</span></div><div class="casAuthors">Siddiqui, Emad J.; Shabbir, Majid; Mikhailidis, Dimitri P.; Thompson, Cecil S.; Mumtaz, Faiz H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">4, Pt. 1</span>),
    <span class="NLM_cas:pages">1648-1653</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine), a monoamine neurotransmitter released by prostate neuroendocrine cells, has a fundamental role in tumor growth, differentiation and gene expression.  We investigated the effect of 5-hydroxytryptamine and 5-hydroxytryptamine antagonists on the growth of prostate cancer cells and we identified 5-hydroxytryptamine receptor expression in PC3 cells and in human hormone refractory prostate cancer tissue.  A total of 12 prepns. of hormone refractory PC3 human prostate cancer cells were incubated with 5-hydroxytryptamine or the 5-hydroxytryptamine receptor antagonists 5-hydroxytryptamine1A, 1B, 1D, 2, 3 or 4.  After 72 h cell viability was assessed using the crystal violet assay.  PC3 cells treated with 5-hydroxytryptamine1A and 1B antagonists were investigated for apoptosis using flow cytometry.  PC3 cells and sections of hormone refractory human prostate cancer tissue were studied by immunohistochem. and Western blot anal.  In PC3 cells 5-hydroxytryptamine caused dose dependent proliferation with a max. increase of 15% in 12 prepns. at a concn. of 10-8 M at 72 h compared to controls (p < 0.0001).  At a concn. of 10-4 M at 72 h the 5HT1A antagonist NAN-190 and the 5-hydroxytryptamine1B antagonist SB224289 (Tocris Labs., Bristol, United Kingdom) induced a 20% and 78% inhibitory effect, resp., on PC3 cell growth compared to that in controls (p < 0.0001).  In PC3 cells 5-hydroxytryptamine1A and 1B antagonists demonstrated apoptosis after 24 and 48 h of incubation.  Immunostaining for 5-hydroxytryptamine1A and 1B receptors was seen in PC3 cells and prostate cancer tissue.  Western blot anal. demonstrated 5-hydroxytryptamine1A and 1B receptor proteins with 46 and 43 kDa bands, resp.  In PC3 prostate cancer cells 5-hydroxytryptamine1A and to a greater extent 5-hydroxytryptamine1B antagonists significantly inhibit growth and induce apoptosis.  To our knowledge growth inhibition caused by the 5-hydroxytryptamine1B antagonist SB224289 is a novel finding, as is apoptosis caused by the 2 antagonists 5-hydroxytryptamine1A and 1B.  This effect is most likely mediated via 5-hydroxytryptamine1A and 1B receptors.  Therefore, our results imply that 5-hydroxytryptamine1A and in particular 5-hydroxytryptamine1B receptor antagonists warrant further investigations as potential anti-neoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDpkrkMuG7rLVg90H21EOLACvtfcHk0ljsF6xMJRd9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCht7fK&md5=5f3cce17e4a13b77c4259586d1189081</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.06.087%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DE.%2BJ.%26aulast%3DShabbir%26aufirst%3DM.%26aulast%3DMikhailidis%26aufirst%3DD.%2BP.%26aulast%3DThompson%26aufirst%3DC.%2BS.%26aulast%3DMumtaz%26aufirst%3DF.%2BH.%26atitle%3DThe%2520role%2520of%2520serotonin%2520%25285-hydroxytryptamine1A%2520and%25201B%2529%2520receptors%2520in%2520prostate%2520cancer%2520cell%2520proliferation%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D1648%26epage%3D1653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Hsiung, S-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.-p.</span><span> </span><span class="NLM_article-title">Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-κB-dependent cell survival after serotonin 1A receptor activation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1471-4159.2005.03496.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=1653-1666&issue=6&author=S-c.+Hsiungauthor=H.+Tamirauthor=T.+F.+Frankeauthor=K.-p.+Liu&title=Roles+of+extracellular+signal-regulated+kinase+and+Akt+signaling+in+coordinating+nuclear+transcription+factor-%CE%BAB-dependent+cell+survival+after+serotonin+1A+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-κB-dependent cell survival after serotonin 1A receptor activation</span></div><div class="casAuthors">Hsiung, Shu-chi; Tamir, Hadassah; Franke, Thomas F.; Liu, Kuo-peing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1653-1666</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">To investigate the functional consequences of cross-talk between multiple effectors of serotonin (5-HT) 1A receptor, the authors employed transfected Chinese hamster ovary cells.  Activation of 5-HT1A receptor stimulated extracellular signal-regulated kinase (ERK)1/2, Akt and nuclear transcription factor-κB (NF-κB).  Stimulation of cells with 5-HT1A receptor agonist induced a rapid but transient ERK1/2 phosphorylation followed by increased phosphorylation of Akt.  Elevated Akt activity in turn suppressed Raf activity and induced a decline in ERK activation.  The activation of ERK and Akt downstream of 5-HT1A receptor was sensitive to inhibitors of Ras, Raf and phosphatidylinositol 3-kinase (PI3K).  Stimulation of 5-HT1A receptor also resulted in activation of NF-κB through a decrease in inhibitor of nuclear transcription factor-κB.  In support of the importance of 5-HT1A receptor signaling for cell survival, inhibition of NF-κB facilitated caspase 3 activation and cleavage of poly (ADP-ribose) polymerase, while treatment of cells with agonist inhibited caspase 3, DNA fragmentation and cell death.  Both agonist-dependent NF-κB activation and cell survival were decreased by Akt Inhibitor II or by overexpression of dominant-neg. Akt.  These findings suggest a role for 5-HT1A receptor signaling in the Ras/Raf-dependent regulation of multiple intracellular signaling pathways that include ERK and PI3K/Akt.  Of these, only PI3K/Akt and NF-κB activation were required for 5-HT1A receptor-dependent cell survival, implying that the relative distribution of signals between competing transduction pathways dets. the functional outcome of 5-HT1A receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrGjOJ846-SLVg90H21EOLACvtfcHk0ljsF6xMJRd9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVKitQ%253D%253D&md5=c29e7f16d848b1e29e587475cb880bf0</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03496.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03496.x%26sid%3Dliteratum%253Aachs%26aulast%3DHsiung%26aufirst%3DS-c.%26aulast%3DTamir%26aufirst%3DH.%26aulast%3DFranke%26aufirst%3DT.%2BF.%26aulast%3DLiu%26aufirst%3DK.-p.%26atitle%3DRoles%2520of%2520extracellular%2520signal-regulated%2520kinase%2520and%2520Akt%2520signaling%2520in%2520coordinating%2520nuclear%2520transcription%2520factor-%25CE%25BAB-dependent%2520cell%2520survival%2520after%2520serotonin%25201A%2520receptor%2520activation%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26issue%3D6%26spage%3D1653%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incisivo, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Gennaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cintio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2206-2216&issue=6&author=F.+Fiorinoauthor=E.+Magliauthor=E.+Perissuttiauthor=B.+Severinoauthor=F.+Frecenteseauthor=A.+Espositoauthor=F.+De+Angelisauthor=G.+M.+Incisivoauthor=P.+Massarelliauthor=C.+Nenciniauthor=E.+Di+Gennaroauthor=A.+Budillonauthor=A.+Di+Cintioauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+of+1-naphtylpiperazine+derivatives+as+serotoninergic+ligands+and+their+evaluation+as+antiproliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DMagli%26aufirst%3DE.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DA.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DIncisivo%26aufirst%3DG.%2BM.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DNencini%26aufirst%3DC.%26aulast%3DDi%2BGennaro%26aufirst%3DE.%26aulast%3DBudillon%26aufirst%3DA.%26aulast%3DDi%2BCintio%26aufirst%3DA.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25201-naphtylpiperazine%2520derivatives%2520as%2520serotoninergic%2520ligands%2520and%2520their%2520evaluation%2520as%2520antiproliferative%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2206%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Bonifazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piergentili, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Bello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farande, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pigini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amantini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabissi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farfariello, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menegon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quaglia, W.</span><span> </span><span class="NLM_article-title">Structure–activity relationships in 1,4-benzodioxan-related compounds. 11. Reversed enantioselectivity of 1,4-dioxane derivatives in α<sub>1</sub>-adrenergic and 5-HT<sub>1A</sub> receptor binding sites recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301525w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=584-588&author=A.+Bonifaziauthor=A.+Piergentiliauthor=F.+Del+Belloauthor=Y.+Farandeauthor=M.+Giannellaauthor=M.+Piginiauthor=C.+Amantiniauthor=M.+Nabissiauthor=V.+Farfarielloauthor=G.+Santoniauthor=E.+Poggesiauthor=A.+Leonardiauthor=S.+Menegonauthor=W.+Quaglia&title=Structure%E2%80%93activity+relationships+in+1%2C4-benzodioxan-related+compounds.+11.+Reversed+enantioselectivity+of+1%2C4-dioxane+derivatives+in+%CE%B11-adrenergic+and+5-HT1A+receptor+binding+sites+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm301525w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301525w%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DY.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DFarfariello%26aufirst%3DV.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DA.%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520in%25201%252C4-benzodioxan-related%2520compounds.%252011.%2520Reversed%2520enantioselectivity%2520of%25201%252C4-dioxane%2520derivatives%2520in%2520%25CE%25B11-adrenergic%2520and%25205-HT1A%2520receptor%2520binding%2520sites%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D584%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collavoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5495</span><span class="NLM_x">–</span> <span class="NLM_lpage">5503</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050246k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5495-5503&author=F.+Fiorinoauthor=E.+Perissuttiauthor=B.+Severinoauthor=V.+Santagadaauthor=D.+Cirilloauthor=S.+Terraccianoauthor=P.+Massarelliauthor=G.+Bruniauthor=E.+Collavoliauthor=C.+Rennerauthor=G.+Caliendo&title=New+5-hydroxytryptamine%281A%29+receptor+ligands+containing+a+norbornene+nucleus%3A+synthesis+and+in+vitro+pharmacological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm050246k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050246k%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCirillo%26aufirst%3DD.%26aulast%3DTerracciano%26aufirst%3DS.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DBruni%26aufirst%3DG.%26aulast%3DCollavoli%26aufirst%3DE.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DNew%25205-hydroxytryptamine%25281A%2529%2520receptor%2520ligands%2520containing%2520a%2520norbornene%2520nucleus%253A%2520synthesis%2520and%2520in%2520vitro%2520pharmacological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5495%26epage%3D5503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collavoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis and in-vitro pharmacological evaluation of new 5-HT<sub>1A</sub> receptor ligands containing a benzotriazinone nucleus</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1002%2Fardp.200700151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2rtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=20-27&author=F.+Fiorinoauthor=B.+Severinoauthor=F.+De+Angelisauthor=E.+Perissuttiauthor=F.+Frecenteseauthor=P.+Massarelliauthor=G.+Bruniauthor=E.+Collavoliauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+and+in-vitro+pharmacological+evaluation+of+new+5-HT1A+receptor+ligands+containing+a+benzotriazinone+nucleus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus</span></div><div class="casAuthors">Fiorino, Ferdinando; Severino, Beatrice; De Angelis, Francesca; Perissutti, Elisa; Frecentese, Francesco; Massarelli, Paola; Bruni, Giancarlo; Collavoli, Elga; Santagada, Vincenzo; Caliendo, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-27</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In order to identify selective ligands for the 5-HT1A subtype receptor, the microwave-assisted synthesis and the binding assays on the 5-HT1A, 5-HT2A and 5-HT2C receptors of new benzotriazinone derivs. were reported.  Conventional and microwave heating of the reactions were compared.  Good yields and short reaction times were the main advantages of our synthetic route.  More active compds. were selected and further evaluated for their binding affinities on D1, D2 dopaminergic and α1, α2 adrenergic receptors.  The 3-(2-(4-(naphthalen-1-yl)piperazin-1-yl)ethyl)benzo[d][1,2,3]triazin-4(3H)-one I with Ki = 0.000178 nM was the most active and selective deriv. for the 5-HT1A receptor with respect to other serotonin receptors and the most selective deriv. compared to dopaminergic and adrenergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmvaxBNh5msbVg90H21EOLACvtfcHk0liy9IXqdPBevg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2rtr8%253D&md5=8f92c8c9ed2c1633e40e444ba6ebaaae</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700151%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DBruni%26aufirst%3DG.%26aulast%3DCollavoli%26aufirst%3DE.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520in-vitro%2520pharmacological%2520evaluation%2520of%2520new%25205-HT1A%2520receptor%2520ligands%2520containing%2520a%2520benzotriazinone%2520nucleus%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2008%26volume%3D341%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">New 5-HT<sub>1A</sub> receptor ligands containing a <i>N</i>′-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2978</span><span class="NLM_x">–</span> <span class="NLM_lpage">2982</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2978-2982&issue=9&author=F.+Fiorinoauthor=B.+Severinoauthor=F.+De+Angelisauthor=E.+Perissuttiauthor=E.+Magliauthor=F.+Frecenteseauthor=A.+Espositoauthor=P.+Massarelliauthor=C.+Nenciniauthor=V.+Santagadaauthor=G.+Caliendo&title=New+5-HT1A+receptor+ligands+containing+a+N%E2%80%B2-cyanoisonicotinamidine+nucleus%3A+synthesis+and+in+vitro+pharmacological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DMagli%26aufirst%3DE.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DA.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DNencini%26aufirst%3DC.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DNew%25205-HT1A%2520receptor%2520ligands%2520containing%2520a%2520N%25E2%2580%25B2-cyanoisonicotinamidine%2520nucleus%253A%2520synthesis%2520and%2520in%2520vitro%2520pharmacological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D9%26spage%3D2978%26epage%3D2982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Czopek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrtus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko1aczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paw1owski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatarczynska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacka-Wojcik, E.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT<sub>1A</sub> receptor agonist with potential antidepressant and anxiolytic activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1295-1303&author=A.+Czopekauthor=H.+Byrtusauthor=M.+Ko1aczkowskiauthor=M.+Paw1owskiauthor=M.+Dybalaauthor=G.+Nowakauthor=E.+Tatarczynskaauthor=A.+Wesolowskaauthor=E.+Chojnacka-Wojcik&title=Synthesis+and+pharmacological+evaluation+of+new+5-%28cyclo%29alkyl-5-phenyl-+and+5-spiroimidazolidine-2%2C4-dione+derivatives.+Novel+5-HT1A+receptor+agonist+with+potential+antidepressant+and+anxiolytic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzopek%26aufirst%3DA.%26aulast%3DByrtus%26aufirst%3DH.%26aulast%3DKo1aczkowski%26aufirst%3DM.%26aulast%3DPaw1owski%26aufirst%3DM.%26aulast%3DDybala%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DG.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DWesolowska%26aufirst%3DA.%26aulast%3DChojnacka-Wojcik%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520new%25205-%2528cyclo%2529alkyl-5-phenyl-%2520and%25205-spiroimidazolidine-2%252C4-dione%2520derivatives.%2520Novel%25205-HT1A%2520receptor%2520agonist%2520with%2520potential%2520antidepressant%2520and%2520anxiolytic%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1295%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Prandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova Manasieva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasili, L.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α<sub>1</sub>- and serotonine 5-HT<sub>1A</sub> Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200421e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=23-36&author=A.+Prandiauthor=S.+Franchiniauthor=L.+Ivanova+Manasievaauthor=P.+Fossaauthor=E.+Cicheroauthor=G.+Marucciauthor=M.+Buccioniauthor=A.+Ciliaauthor=L.+Pironaauthor=L.+Brasili&title=Synthesis%2C+biological+evaluation%2C+and+docking+studies+of+tetrahydrofuran-+cyclopentanone-+and+cyclopentanol-based+ligands+acting+at+adrenergic+%CE%B11-+and+serotonine+5-HT1A+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm200421e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200421e%26sid%3Dliteratum%253Aachs%26aulast%3DPrandi%26aufirst%3DA.%26aulast%3DFranchini%26aufirst%3DS.%26aulast%3DIvanova%2BManasieva%26aufirst%3DL.%26aulast%3DFossa%26aufirst%3DP.%26aulast%3DCichero%26aufirst%3DE.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DCilia%26aufirst%3DA.%26aulast%3DPirona%26aufirst%3DL.%26aulast%3DBrasili%26aufirst%3DL.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520docking%2520studies%2520of%2520tetrahydrofuran-%2520cyclopentanone-%2520and%2520cyclopentanol-based%2520ligands%2520acting%2520at%2520adrenergic%2520%25CE%25B11-%2520and%2520serotonine%25205-HT1A%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D23%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span>IUPHAR Database. <a href="http://www.iuphar-db.org" class="extLink">http://www.iuphar-db.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IUPHAR+Database.+http%3A%2F%2Fwww.iuphar-db.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Van Aar, M. P. M.; Van Amsterdam, P. H.; Barf, G. A.; Bakker, J. A.; Den Besten, C.; Herremans, A. H. J.; Zorgdrager, J.</span><span> </span><span class="NLM_article-title"><i>N</i>-Oxides of Pyridylmethylpiperazine and -piperidine Derivatives</span>. WO2007128694,<span class="NLM_x"> </span><span class="NLM_year">2007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+P.+M.+Van+Aar&author=P.+H.+Van+Amsterdam&author=G.+A.+Barf&author=J.+A.+Bakker&author=C.+Den+Besten&author=A.+H.+J.+Herremans&author=J.+Zorgdrager&title=N-Oxides+of+Pyridylmethylpiperazine+and+-piperidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BAar%26aufirst%3DM.%2BP.%2BM.%26atitle%3DN-Oxides%2520of%2520Pyridylmethylpiperazine%2520and%2520-piperidine%2520Derivatives%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkheimer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udo de Haes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl] butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a [11C] [O-methyl-3H]-n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.301.3.1144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1144-1150&issue=3&author=E.+A.+Rabinerauthor=M.+R.+Wilkinsauthor=F.+Turkheimerauthor=R.+N.+Gunnauthor=J.+Udo+de+Haesauthor=M.+De+Vriesauthor=P.+M.+Grasby&title=5-Hydroxytryptamine1A+receptor+occupancy+by+novel+full+antagonist+2-%5B4-%5B4-%287-chloro-2%2C3-dihydro-1%2C4-benzdioxyn-5-yl%29-1-piperazinyl%5D+butyl%5D-1%2C2-benzisothiazol-3-%282H%29-one-1%2C1-dioxide%3A+a+%5B11C%5D+%5BO-methyl-3H%5D-n-%282-%284-%282-methoxyphenyl%29-1-piperazinyl%29ethyl%29-N-%282pyridinyl%29cyclohexanecarboxamide+trihydrochloride+%28WAY-100635%29+positron+emission+tomography+study+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl] -1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: A [11C][O-methyl-3H]-n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl) -N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans</span></div><div class="casAuthors">Rabiner, Eugenii A.; Wilkins, Martin R.; Turkheimer, Federico; Gunn, Roger N.; Udo de Haes, Joanna; De Vries, Michiel; Grasby, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1144-1150</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine1A (5-HT1A) receptors have been implicated in the pathophysiol. and treatment of anxiety and depression, and are a target for novel drug development.  This is the first study examg. the human brain in vivo occupancy by a novel, selective, silent 5-HT1A antagonist.  2-[4-[4-(7-Chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl] butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide (DU 125530), a compd. in clin. development, has potential applications in the treatment of anxiety and mood disorders.  Positron emission tomog. (PET) and [11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl) -N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635), were used to assess 5-HT1A autoreceptor and postsynaptic receptor occupancy in 12 healthy male volunteers.  Over a 10- to 40-mg daily dose range, DU 125530 was well tolerated, and exhibited a dose-dependent occupancy from 0 to 72% at 2 h post the last dose.  Occupancy correlated significantly with plasma levels of DU 125530, and a fitting of the data to a std. single-site binding model gave a max. occupancy of ∼80%, and a half-satn. concn. (ED50) of ∼7 ng/mL.  At 24 h after the last dose 5-HT1A occupancy was ∼50% of that achieved at 2 h.  This study demonstrates that high occupancy of the human brain 5-HT1A receptor can be achieved at doses producing minimal acute side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnL-RXF0Mhi7Vg90H21EOLACvtfcHk0lgMAZDCqAU9Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrs%253D&md5=ab580b421d1a185f187fccc8dbdd4fa4</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1144%26sid%3Dliteratum%253Aachs%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DWilkins%26aufirst%3DM.%2BR.%26aulast%3DTurkheimer%26aufirst%3DF.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DUdo%2Bde%2BHaes%26aufirst%3DJ.%26aulast%3DDe%2BVries%26aufirst%3DM.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3D5-Hydroxytryptamine1A%2520receptor%2520occupancy%2520by%2520novel%2520full%2520antagonist%25202-%255B4-%255B4-%25287-chloro-2%252C3-dihydro-1%252C4-benzdioxyn-5-yl%2529-1-piperazinyl%255D%2520butyl%255D-1%252C2-benzisothiazol-3-%25282H%2529-one-1%252C1-dioxide%253A%2520a%2520%255B11C%255D%2520%255BO-methyl-3H%255D-n-%25282-%25284-%25282-methoxyphenyl%2529-1-piperazinyl%2529ethyl%2529-N-%25282pyridinyl%2529cyclohexanecarboxamide%2520trihydrochloride%2520%2528WAY-100635%2529%2520positron%2520emission%2520tomography%2520study%2520in%2520humans%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26issue%3D3%26spage%3D1144%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Vilazodone: a 5-HT<sub>1A</sub> receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1755-5949.2008.00067.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=107-117&issue=2&author=L.+A.+Dawsonauthor=J.+M.+Watson&title=Vilazodone%3A+a+5-HT1A+receptor+agonist%2Fserotonin+transporter+inhibitor+for+the+treatment+of+affective+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Vilazodone: A 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders</span></div><div class="casAuthors">Dawson, Lee A.; Watson, Jeannette M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Vilazodone (EMD 68843; 5-{4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide hydrochloride) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clin. evaluation for the treatment of major depression.  This mol. was designed based on the premise that neg. feedback circuitry, mediated via 5-HT1 receptors, limits the acute SSRI-induced enhancements in serotonergic neurotransmission.  If the hypothesis is correct, combination of SSRI with 5-HT1A partial agonism should temporally enhance the neuroplastic adaptation and subsequently hasten therapeutic efficacy compared to current treatments.  Preclin. in vitro evaluation has confirmed vilazodone's primary pharmacol. profile both in clonal and native systems, i.e., serotonin reuptake blockade and 5-HT1A partial agonism.  However, in vivo and in contrast to combination of 8-OH-DPAT and paroxetine, vilazodone selectively enhanced serotonergic output in the prefrontal cortex of rats.  Behavioral evaluations, in the ultrasonic vocalization model of anxiety in rats, demonstrated anxiolytic efficacy.  In the forced swim test (a putative model of depression), vilazodone also showed efficacy but at a single dose only.  In man, vilazodone abolished REM sleep and demonstrated clin. antidepressant efficacy equiv. to an SSRI.  Ongoing clin. evaluations will hopefully reveal whether the founding hypothesis was valid and if vilazodone will produce a more rapid onset of antidepressant efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCgrflmbxrcLVg90H21EOLACvtfcHk0ljbnyRq4dgJvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVyis7w%253D&md5=d08600166737197fc1114ff031bba81b</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2008.00067.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2008.00067.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DVilazodone%253A%2520a%25205-HT1A%2520receptor%2520agonist%252Fserotonin%2520transporter%2520inhibitor%2520for%2520the%2520treatment%2520of%2520affective%2520disorders%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2009%26volume%3D15%26issue%3D2%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Shiwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, N.</span><span> </span><span class="NLM_article-title">Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1254%2Fjphs.93.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVWntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=114-117&issue=1&author=T.+Shiwaauthor=T.+Amanoauthor=H.+Matsubayashiauthor=T.+Sekiauthor=M.+Sasaauthor=N.+Sakai&title=Perospirone%2C+a+novel+antipsychotic+agent%2C+hyperpolarizes+rat+dorsal+raphe+neurons+via+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor</span></div><div class="casAuthors">Shiwa, Tsuguka; Amano, Taku; Matsubayashi, Hiroaki; Seki, Takahiro; Sasa, Masashi; Sakai, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-117</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">To investigate the effect of cis-N-[4-[4-(1,2-benz-isozole-3-yl)-1-piperazinyl]butyl] cyclohexane-1,2-dicarboximide hydrochloride (perospirone), a novel antipsychotic agent with high affinities for D2/5-HT2 receptors, on the rat dorsal raphe (DR) neurons, an electrophysiol. study was performed using the tight-seal whole-cell patch-clamp technique.  Applications of perospirone at the concn. between 10-9 and 10-5 M hyperpolarized the membrane potential and inhibited spontaneous action potentials of the DR neurons in a concn.-dependent manner.  This effect of perospirone on DR neurons is similar to that of typical 5HT1A-receptor agonists, including 8-OH-DPAT or tandospirone.  In addn., WAY100635, a 5-HT1A-receptor antagonist, inhibited this perospirone-induced hyperpolarization of DR neurons, suggesting that perospirone physiol. acts on DR neurons as a 5HT1A-receptor agonist.  These results provide new profiles of perospirone as an antipsychotic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKXrv7SwNIELVg90H21EOLACvtfcHk0ljbnyRq4dgJvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVWntrg%253D&md5=4f69fa1798745ace5d9d0691bff5e297</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1254%2Fjphs.93.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.93.114%26sid%3Dliteratum%253Aachs%26aulast%3DShiwa%26aufirst%3DT.%26aulast%3DAmano%26aufirst%3DT.%26aulast%3DMatsubayashi%26aufirst%3DH.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DSasa%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DN.%26atitle%3DPerospirone%252C%2520a%2520novel%2520antipsychotic%2520agent%252C%2520hyperpolarizes%2520rat%2520dorsal%2520raphe%2520neurons%2520via%25205-HT1A%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D93%26issue%3D1%26spage%3D114%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Ishibashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span> </span><span class="NLM_article-title">Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT<sub>7</sub>) and 5-HT<sub>1A</sub> receptor activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.110.167346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1KltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=171-181&issue=1&author=T.+Ishibashiauthor=T.+Horisawaauthor=K.+Tokudaauthor=T.+Ishiyamaauthor=M.+Ogasaauthor=R.+Tagashiraauthor=K.+Matsumotoauthor=H.+Nishikawaauthor=Y.+Uedaauthor=S.+Tomaauthor=H.+Okiauthor=N.+Tannoauthor=I.+Sajiauthor=A.+Itoauthor=Y.+Ohnoauthor=M.+Nakamura&title=Pharmacological+profile+of+lurasidone%2C+a+novel+antipsychotic+agent+with+potent+5-hydroxytryptamine+7+%285-HT7%29+and+5-HT1A+receptor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity</span></div><div class="casAuthors">Ishibashi, Tadashi; Horisawa, Tomoko; Tokuda, Kumiko; Ishiyama, Takeo; Ogasa, Masaaki; Tagashira, Rie; Matsumoto, Kenji; Nishikawa, Hiroyuki; Ueda, Yoko; Toma, Satoko; Oki, Hitomi; Tanno, Norihiko; Saji, Ikutaro; Ito, Akira; Ohno, Yukihiro; Nakamura, Mitsutaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lurasidone [(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; SM-13496] is an azapirone deriv. and a novel antipsychotic candidate.  The objective of the current studies was to investigate the in vitro and in vivo pharmacol. properties of lurasidone.  Receptor binding affinities of lurasidone and several antipsychotic drugs were tested under comparable assay conditions using cloned human receptors or membrane fractions prepd. from animal tissue.  Lurasidone was found to have potent binding affinity for dopamine D2, 5-hydroxytryptamine 2A (5-HT2A), 5-HT7, 5-HT1A, and noradrenaline α2C receptors.  Affinity for noradrenaline α1, α2A, and 5-HT2C receptors was weak, whereas affinity for histamine H1 and muscarinic acetylcholine receptors was negligible.  In vitro functional assays demonstrated that lurasidone acts as an antagonist at D2 and 5-HT7 receptors and as a partial agonist at the 5-HT1A receptor subtype.  Lurasidone showed potent effects predictive of antipsychotic activity, such as inhibition of methamphetamine-induced hyperactivity and apomorphine-induced stereotyped behavior in rats, similar to other antipsychotics.  Furthermore, lurasidone had only weak extrapyramidal effects in rodent models.  In animal models of anxiety disorders and depression, treatment with lurasidone was assocd. with significant improvement.  Lurasidone showed a preferential effect on the frontal cortex (vs. striatum) in increasing dopamine turnover.  Anti-α1-noradrenergic, anticholinergic, and central nervous system (CNS) depressant actions of lurasidone were also very weak.  These results demonstrate that lurasidone possesses antipsychotic activity and antidepressant- or anxiolytic-like effects with potentially reduced liability for extrapyramidal and CNS depressant side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYVWqS8Us3N7Vg90H21EOLACvtfcHk0ljbnyRq4dgJvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1KltLo%253D&md5=3f589915df9e66cc86ee90924a509bc2</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167346%26sid%3Dliteratum%253Aachs%26aulast%3DIshibashi%26aufirst%3DT.%26aulast%3DHorisawa%26aufirst%3DT.%26aulast%3DTokuda%26aufirst%3DK.%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DOgasa%26aufirst%3DM.%26aulast%3DTagashira%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DToma%26aufirst%3DS.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DTanno%26aufirst%3DN.%26aulast%3DSaji%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DOhno%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DM.%26atitle%3DPharmacological%2520profile%2520of%2520lurasidone%252C%2520a%2520novel%2520antipsychotic%2520agent%2520with%2520potent%25205-hydroxytryptamine%25207%2520%25285-HT7%2529%2520and%25205-HT1A%2520receptor%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26issue%3D1%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horváth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Némethy, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugovics, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazekas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orosz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyán, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ágai-Csongor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domány, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a dopamine D<sub>3</sub> receptor preferring, D<sub>3</sub>/D<sub>2</sub> dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horv%C3%A1thauthor=Z.+N%C3%A9methyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyerty%C3%A1nauthor=E.+%C3%81gai-Csongorauthor=G.+Dom%C3%A1nyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+dopamine+D3+receptor+preferring%2C+D3%2FD2+dopamine+receptor+antagonist-partial+agonist+antipsychotic+candidate%3A+in+vitro+and+neurochemical+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0lgM3F5tY8UyQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorv%25C3%25A1th%26aufirst%3DA.%26aulast%3DN%25C3%25A9methy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyerty%25C3%25A1n%26aufirst%3DI.%26aulast%3D%25C3%2581gai-Csongor%26aufirst%3DE.%26aulast%3DDom%25C3%25A1ny%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520dopamine%2520D3%2520receptor%2520preferring%252C%2520D3%252FD2%2520dopamine%2520receptor%2520antagonist-partial%2520agonist%2520antipsychotic%2520candidate%253A%2520in%2520vitro%2520and%2520neurochemical%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Concepts for the design of 5-HT1A serotonin agonists and antagonists</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1992&pages=251-274&author=R.+A.+Glennon&title=Concepts+for+the+design+of+5-HT1A+serotonin+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DConcepts%2520for%2520the%2520design%2520of%25205-HT1A%2520serotonin%2520agonists%2520and%2520antagonists%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1992%26volume%3D26%26spage%3D251%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">5-HT receptor ligands—update 1992</span> <span class="citation_source-journal">Curr. Drugs Serotonin</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1993&pages=1-45&author=R.+A.+Glennonauthor=M.+Dukat&title=5-HT+receptor+ligands%E2%80%94update+1992"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3D5-HT%2520receptor%2520ligands%25E2%2580%2594update%25201992%26jtitle%3DCurr.%2520Drugs%2520Serotonin%26date%3D1993%26volume%3D1%26spage%3D1%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Scorza, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llado-Pelfort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puigdemont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portella, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Egea, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artigas, F.</span><span> </span><span class="NLM_article-title">Preclinical and clinical characterization of the selective 5-HT<sub>1A</sub> receptor antagonist DU-125530 for antidepressant treatment</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1476-5381.2011.01770.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1021-1034&issue=5&author=M.+C.+Scorzaauthor=L.+Llado-Pelfortauthor=S.+Ollerauthor=R.+Cortesauthor=D.+Puigdemontauthor=M.+J.+Portellaauthor=R.+Perez-Egeaauthor=E.+Alvarezauthor=P.+Celadaauthor=V.+Perezauthor=F.+Artigas&title=Preclinical+and+clinical+characterization+of+the+selective+5-HT1A+receptor+antagonist+DU-125530+for+antidepressant+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical characterization of the selective 5-HT1A receptor antagonist DU-125530 for antidepressant treatment</span></div><div class="casAuthors">Scorza, M. C.; Llado-Pelfort, L.; Oller, S.; Cortes, R.; Puigdemont, D.; Portella, M. J.; Perez-Egea, R.; Alvarez, E.; Celada, P.; Perez, V.; Artigas, F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antidepressant efficacy of selective 5-HT reuptake inhibitors (SSRI) and other 5-HT-enhancing drugs is compromised by a neg. feedback mechanism involving 5-HT1A autoreceptor activation by the excess 5-HT produced by these drugs in the somatodendritic region of 5-HT neurons.  5-HT1A receptor antagonists augment antidepressant-like effects in rodents by preventing this neg. feedback, and the mixed β-adrenoceptor/5-HT1A receptor antagonist pindolol improves clin. antidepressant effects by preferentially interacting with 5-HT1A autoreceptors.  However, it is unclear whether 5-HT1A receptor antagonists not discriminating between pre- and post-synaptic 5-HT1A receptors would be clin. effective.  We characterized the pharmacol. properties of the 5-HT1A receptor antagonist DU-125530 using receptor autoradiog., intracerebral microdialysis and electrophysiol. recordings.  Its capacity to accelerate/enhance the clin. effects of fluoxetine was assessed in a double-blind, randomized, 6 wk placebo-controlled trial in 50 patients with major depression.  DU-125530 showed equal (low nM) potency to displace agonist and antagonist binding to pre- and post-synaptic 5-HT1A receptors in rat and human brain.  It antagonized suppression of 5-hydroxytryptaminergic activity evoked by 8-OH-DPAT and SSRIs in vivo.  DU-125530 augmented SSRI-induced increases in extracellular 5-HT as effectively as in mice lacking 5-HT1A receptors, indicating a silent, maximal occupancy of pre-synaptic 5-HT1A receptors at the dose used.  However, DU-125530 addn. to fluoxetine did not accelerate nor augment its antidepressant effects.  DU-125530 is an excellent pre- and post-synaptic 5-HT1A receptor antagonist.  However, blockade of post-synaptic 5- HT1A receptors by DU-125530 cancels benefits obtained by enhancing pre-synaptic 5-hydroxytryptaminergic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop-FHgJ63zZbVg90H21EOLACvtfcHk0lgM3F5tY8UyQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bL&md5=19d3e3d51dcfdd92ac29a229cb9f8208</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01770.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01770.x%26sid%3Dliteratum%253Aachs%26aulast%3DScorza%26aufirst%3DM.%2BC.%26aulast%3DLlado-Pelfort%26aufirst%3DL.%26aulast%3DOller%26aufirst%3DS.%26aulast%3DCortes%26aufirst%3DR.%26aulast%3DPuigdemont%26aufirst%3DD.%26aulast%3DPortella%26aufirst%3DM.%2BJ.%26aulast%3DPerez-Egea%26aufirst%3DR.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DCelada%26aufirst%3DP.%26aulast%3DPerez%26aufirst%3DV.%26aulast%3DArtigas%26aufirst%3DF.%26atitle%3DPreclinical%2520and%2520clinical%2520characterization%2520of%2520the%2520selective%25205-HT1A%2520receptor%2520antagonist%2520DU-125530%2520for%2520antidepressant%2520treatment%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26issue%3D5%26spage%3D1021%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orteca, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandager-Nielsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheel-Kruger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D<sub>3</sub> and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4803</span><span class="NLM_x">–</span> <span class="NLM_lpage">4807</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100294b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4803-4807&author=S.+Butiniauthor=G.+Campianiauthor=S.+Franceschiniauthor=F.+Trottaauthor=V.+Kumarauthor=E.+Guarinoauthor=G.+Borrelliauthor=I.+Fioriniauthor=E.+Novellinoauthor=C.+Fattorussoauthor=M.+Persicoauthor=N.+Ortecaauthor=K.+Sandager-Nielsenauthor=T.+A.+Jacobsenauthor=K.+Madsenauthor=J.+Scheel-Krugerauthor=S.+Gemma&title=Discovery+of+bishomo%28hetero%29arylpiperazines+as+novel+multifunctional+ligands+targeting+dopamine+D3+and+serotonin+5-HT1A+and+5-HT2A+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm100294b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100294b%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DGuarino%26aufirst%3DE.%26aulast%3DBorrelli%26aufirst%3DG.%26aulast%3DFiorini%26aufirst%3DI.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DPersico%26aufirst%3DM.%26aulast%3DOrteca%26aufirst%3DN.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DJacobsen%26aufirst%3DT.%2BA.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520bishomo%2528hetero%2529arylpiperazines%2520as%2520novel%2520multifunctional%2520ligands%2520targeting%2520dopamine%2520D3%2520and%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4803%26epage%3D4807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 58 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Abhishek Kumar, Parijat Sarkar, <span class="NLM_string-name hlFld-ContribAuthor">Amitabha Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Depletion of Sphingolipids Reduces Cell Surface Population of the Human Serotonin1A Receptor due to Impaired Trafficking. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1189-1196. <a href="https://doi.org/10.1021/acschemneuro.1c00017" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00017%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMetabolic%252BDepletion%252Bof%252BSphingolipids%252BReduces%252BCell%252BSurface%252BPopulation%252Bof%252Bthe%252BHuman%252BSerotonin1A%252BReceptor%252Bdue%252Bto%252BImpaired%252BTrafficking%26aulast%3DKumar%26aufirst%3DAbhishek%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11012021%26date%3D17032021%26date%3D24032021%26volume%3D12%26issue%3D7%26spage%3D1189%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pasquale Linciano, Claudia Sorbi, Antonella Comitato, Anna Lesniak, Magdalena Bujalska-Zadrożny, Agata Pawłowska, Anna Bielenica, Jolanta Orzelska-Górka, Ewa Kędzierska, Grażyna Biała, Simone Ronsisvalle, Silvia Limoncella, Livio Casarini, Elena Cichero, Paola Fossa, Grzegorz Satała, Andrzej J. Bojarski, Livio Brasili, Rita Bardoni, <span class="NLM_string-name hlFld-ContribAuthor">Silvia Franchini</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent and Selective 5-HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (24)
                                     , 4111-4127. <a href="https://doi.org/10.1021/acschemneuro.0c00289" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00289%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Bof%252Ba%252BPotent%252Band%252BSelective%252B5-HT1A%252BReceptor%252BAgonist%252Bwith%252BIn%252BVitro%252Band%252BIn%252BVivo%252BAntinociceptive%252BActivity%26aulast%3DLinciano%26aufirst%3DPasquale%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13052020%26date%3D11112020%26date%3D02122020%26volume%3D11%26issue%3D24%26spage%3D4111%26epage%3D4127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Parijat Sarkar, Bhagyashree D. Rao, <span class="NLM_string-name hlFld-ContribAuthor">Amitabha Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Cell Cycle Dependent Modulation of Membrane Dipole Potential and Neurotransmitter Receptor Activity: Role of Membrane Cholesterol. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (18)
                                     , 2890-2899. <a href="https://doi.org/10.1021/acschemneuro.0c00499" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00499%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCell%252BCycle%252BDependent%252BModulation%252Bof%252BMembrane%252BDipole%252BPotential%252Band%252BNeurotransmitter%252BReceptor%252BActivity%25253A%252BRole%252Bof%252BMembrane%252BCholesterol%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31072020%26date%3D07082020%26date%3D25082020%26date%3D07082020%26volume%3D11%26issue%3D18%26spage%3D2890%26epage%3D2899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">G. Aditya Kumar, <span class="NLM_string-name hlFld-ContribAuthor">Amitabha Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Statin-Induced Chronic Cholesterol Depletion Switches GPCR Endocytosis and Trafficking: Insights from the Serotonin1A Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 453-465. <a href="https://doi.org/10.1021/acschemneuro.9b00659" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00659%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DStatin-Induced%252BChronic%252BCholesterol%252BDepletion%252BSwitches%252BGPCR%252BEndocytosis%252Band%252BTrafficking%25253A%252BInsights%252Bfrom%252Bthe%252BSerotonin1A%252BReceptor%26aulast%3DKumar%26aufirst%3DG.%2BAditya%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11122019%26date%3D27122019%26date%3D09012020%26date%3D27122019%26volume%3D11%26issue%3D3%26spage%3D453%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">G. Aditya Kumar, Parijat Sarkar, Md. Jafurulla, Shishu Pal Singh, Gunda Srinivas, Gopal Pande, <span class="NLM_string-name hlFld-ContribAuthor">Amitabha Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Endocytosis and Intracellular Trafficking of the Human Serotonin1A Receptor. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (22)
                                     , 2628-2641. <a href="https://doi.org/10.1021/acs.biochem.9b00033" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00033%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DExploring%252BEndocytosis%252Band%252BIntracellular%252BTrafficking%252Bof%252Bthe%252BHuman%252BSerotonin1A%252BReceptor%26aulast%3DKumar%26aufirst%3DG.%2BAditya%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14012019%26date%3D06032019%26date%3D28032019%26date%3D21032019%26volume%3D58%26issue%3D22%26spage%3D2628%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Durba Sengupta, Xavier Prasanna, Madhura Mohole, <span class="NLM_string-name hlFld-ContribAuthor">Amitabha Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring GPCR–Lipid Interactions by Molecular Dynamics Simulations: Excitements, Challenges, and the Way Forward. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2018,</strong> <em>122 </em>
                                    (22)
                                     , 5727-5737. <a href="https://doi.org/10.1021/acs.jpcb.8b01657" title="DOI URL">https://doi.org/10.1021/acs.jpcb.8b01657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.8b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.8b01657%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DExploring%252BGPCR%2525E2%252580%252593Lipid%252BInteractions%252Bby%252BMolecular%252BDynamics%252BSimulations%25253A%252BExcitements%25252C%252BChallenges%25252C%252Band%252Bthe%252BWay%252BForward%26aulast%3DSengupta%26aufirst%3DDurba%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16022018%26date%3D09042018%26date%3D06052018%26date%3D23042018%26volume%3D122%26issue%3D22%26spage%3D5727%26epage%3D5737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Dilly</span> and <span class="hlFld-ContribAuthor ">Jean-François  Liégeois</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Insights into 5-HT1A/D4 Selectivity of WAY-100635 Analogues: Molecular Modeling, Synthesis, and in Vitro Binding. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (7)
                                     , 1324-1331. <a href="https://doi.org/10.1021/acs.jcim.5b00753" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00753%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructural%252BInsights%252Binto%252B5-HT1A%25252FD4%252BSelectivity%252Bof%252BWAY-100635%252BAnalogues%25253A%252BMolecular%252BModeling%25252C%252BSynthesis%25252C%252Band%252Bin%252BVitro%252BBinding%26aulast%3DDilly%26aufirst%3DS%25C3%25A9bastien%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D28122015%26date%3D13072016%26date%3D25072016%26date%3D22062016%26volume%3D56%26issue%3D7%26spage%3D1324%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingzhu  Jia</span>, <span class="hlFld-ContribAuthor ">Xue  Cui</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Shuqian  Xia</span>, and <span class="hlFld-ContribAuthor ">Peisheng  Ma</span>  . </span><span class="cited-content_cbyCitation_article-title">Quantitative Structure–Activity Relationship for High Affinity 5-HT1A Receptor Ligands Based on Norm Indexes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2015,</strong> <em>119 </em>
                                    (51)
                                     , 15561-15567. <a href="https://doi.org/10.1021/acs.jpcb.5b08980" title="DOI URL">https://doi.org/10.1021/acs.jpcb.5b08980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.5b08980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.5b08980%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DQuantitative%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bfor%252BHigh%252BAffinity%252B5-HT1A%252BReceptor%252BLigands%252BBased%252Bon%252BNorm%252BIndexes%26aulast%3DJia%26aufirst%3DQingzhu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D15092015%26date%3D17112015%26date%3D10122015%26date%3D24122015%26date%3D25112015%26volume%3D119%26issue%3D51%26spage%3D15561%26epage%3D15567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Brosda</span>, <span class="hlFld-ContribAuthor ">Nadine  Müller</span>, <span class="hlFld-ContribAuthor ">Bettina  Bert</span>, and <span class="hlFld-ContribAuthor ">Heidrun  Fink</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulatory Role of Postsynaptic 5-Hydroxytryptamine Type 1A Receptors in (±)-8-Hydroxy-N,N-dipropyl-2-aminotetralin-Induced Hyperphagia in Mice. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (7)
                                     , 1176-1185. <a href="https://doi.org/10.1021/cn5003094" title="DOI URL">https://doi.org/10.1021/cn5003094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn5003094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn5003094%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DModulatory%252BRole%252Bof%252BPostsynaptic%252B5-Hydroxytryptamine%252BType%252B1A%252BReceptors%252Bin%252B%252528%2525C2%2525B1%252529-8-Hydroxy-N%25252CN-dipropyl-2-aminotetralin-Induced%252BHyperphagia%252Bin%252BMice%26aulast%3DBrosda%26aufirst%3DJan%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D28112014%26date%3D05032015%26date%3D17032015%26date%3D15072015%26volume%3D6%26issue%3D7%26spage%3D1176%26epage%3D1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhagyashree D.  Rao</span>, <span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of tertiary amine local anesthetics on G protein-coupled receptor lateral diffusion and actin cytoskeletal reorganization. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2021,</strong> <em>1863 </em>
                                    (9)
                                     , 183547. <a href="https://doi.org/10.1016/j.bbamem.2020.183547" title="DOI URL">https://doi.org/10.1016/j.bbamem.2020.183547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2020.183547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2020.183547%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3DEffect%252Bof%252Btertiary%252Bamine%252Blocal%252Banesthetics%252Bon%252BG%252Bprotein-coupled%252Breceptor%252Blateral%252Bdiffusion%252Band%252Bactin%252Bcytoskeletal%252Breorganization%26aulast%3DRao%26aufirst%3DBhagyashree%2BD.%26date%3D2021%26volume%3D1863%26issue%3D9%26spage%3D183547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Anna  Czopek</span>, <span class="hlFld-ContribAuthor ">Anna  Jaromin</span>, <span class="hlFld-ContribAuthor ">Magdalena  Mielczarek-Puta</span>, <span class="hlFld-ContribAuthor ">Marta  Struga</span>, <span class="hlFld-ContribAuthor ">Dorota  Stary</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Antiproliferative Activity of Hydantoin and Purine Derivatives with the 4-Acetylphenylpiperazinylalkyl Moiety. </span><span class="cited-content_cbyCitation_journal-name">Materials</span><span> <strong>2021,</strong> <em>14 </em>
                                    (15)
                                     , 4156. <a href="https://doi.org/10.3390/ma14154156" title="DOI URL">https://doi.org/10.3390/ma14154156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ma14154156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fma14154156%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BAntiproliferative%252BActivity%252Bof%252BHydantoin%252Band%252BPurine%252BDerivatives%252Bwith%252Bthe%252B4-Acetylphenylpiperazinylalkyl%252BMoiety%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D15%26spage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Kaleeckal G.  Harikumar</span>, <span class="hlFld-ContribAuthor ">Satinder S.  Rawat</span>, <span class="hlFld-ContribAuthor ">Sanjib  Das</span>, <span class="hlFld-ContribAuthor ">Tushar K.  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Environment-Sensitive Fluorescence of 7-Nitrobenz-2-oxa-1,3-Diazol-4-yl (NBD)-Labeled Ligands for Serotonin Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (13)
                                     , 3848. <a href="https://doi.org/10.3390/molecules26133848" title="DOI URL">https://doi.org/10.3390/molecules26133848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26133848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26133848%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEnvironment-Sensitive%252BFluorescence%252Bof%252B7-Nitrobenz-2-oxa-1%25252C3-Diazol-4-yl%252B%252528NBD%252529-Labeled%252BLigands%252Bfor%252BSerotonin%252BReceptors%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D13%26spage%3D3848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. Aditya  Kumar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Membrane cholesterol regulates endocytosis and trafficking of the serotonin1A receptor: Insights from acute cholesterol depletion. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2021,</strong> <em>1866 </em>
                                    (4)
                                     , 158882. <a href="https://doi.org/10.1016/j.bbalip.2021.158882" title="DOI URL">https://doi.org/10.1016/j.bbalip.2021.158882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2021.158882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2021.158882%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DMembrane%252Bcholesterol%252Bregulates%252Bendocytosis%252Band%252Btrafficking%252Bof%252Bthe%252Bserotonin1A%252Breceptor%25253A%252BInsights%252Bfrom%252Bacute%252Bcholesterol%252Bdepletion%26aulast%3DKumar%26aufirst%3DG.%2BAditya%26date%3D2021%26volume%3D1866%26issue%3D4%26spage%3D158882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into cellular signaling from membrane dynamics. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2021,</strong> <em>701 </em>, 108794. <a href="https://doi.org/10.1016/j.abb.2021.108794" title="DOI URL">https://doi.org/10.1016/j.abb.2021.108794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2021.108794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2021.108794%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DInsights%252Binto%252Bcellular%252Bsignaling%252Bfrom%252Bmembrane%252Bdynamics%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2021%26volume%3D701%26spage%3D108794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Sukanya  Mozumder</span>, <span class="hlFld-ContribAuthor ">Aritra  Bej</span>, <span class="hlFld-ContribAuthor ">Sujoy  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Jayati  Sengupta</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Structure, dynamics and lipid interactions of serotonin receptors: excitements and challenges. </span><span class="cited-content_cbyCitation_journal-name">Biophysical Reviews</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     , 101-122. <a href="https://doi.org/10.1007/s12551-020-00772-8" title="DOI URL">https://doi.org/10.1007/s12551-020-00772-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12551-020-00772-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12551-020-00772-8%26sid%3Dliteratum%253Aachs%26jtitle%3DBiophysical%2520Reviews%26atitle%3DStructure%25252C%252Bdynamics%252Band%252Blipid%252Binteractions%252Bof%252Bserotonin%252Breceptors%25253A%252Bexcitements%252Band%252Bchallenges%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2021%26date%3D2020%26volume%3D13%26issue%3D1%26spage%3D101%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gao‐Bo  Lv</span>, <span class="hlFld-ContribAuthor ">Ting‐Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Hai‐Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Hong‐Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Sun</span>, <span class="hlFld-ContribAuthor ">Li‐Feng  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine induces apoptosis and autophagy of gastric cancer AGS cells via the PI3K/AKT pathway. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 2157-2165. <a href="https://doi.org/10.1002/2211-5463.12944" title="DOI URL">https://doi.org/10.1002/2211-5463.12944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.12944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.12944%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DVortioxetine%252Binduces%252Bapoptosis%252Band%252Bautophagy%252Bof%252Bgastric%252Bcancer%252BAGS%252Bcells%252Bvia%252Bthe%252BPI3K%25252FAKT%252Bpathway%26aulast%3DLv%26aufirst%3DGao%25E2%2580%2590Bo%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D2157%26epage%3D2165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Md.  Jafurulla</span>, <span class="hlFld-ContribAuthor ">Sukanya  Bhowmick</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Stringency and Optimal Nature of Cholesterol Requirement in the Function of the Serotonin1A Receptor. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Membrane Biology</span><span> <strong>2020,</strong> <em>253 </em>
                                    (5)
                                     , 445-457. <a href="https://doi.org/10.1007/s00232-020-00138-x" title="DOI URL">https://doi.org/10.1007/s00232-020-00138-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00232-020-00138-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00232-020-00138-x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Membrane%2520Biology%26atitle%3DStructural%252BStringency%252Band%252BOptimal%252BNature%252Bof%252BCholesterol%252BRequirement%252Bin%252Bthe%252BFunction%252Bof%252Bthe%252BSerotonin1A%252BReceptor%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2020%26date%3D2020%26volume%3D253%26issue%3D5%26spage%3D445%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarosh N.  Fatakia</span>, <span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular evolution of a collage of cholesterol interaction motifs in transmembrane helix V of the serotonin1A receptor. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2020,</strong> <em>232 </em>, 104955. <a href="https://doi.org/10.1016/j.chemphyslip.2020.104955" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2020.104955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2020.104955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2020.104955%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DMolecular%252Bevolution%252Bof%252Ba%252Bcollage%252Bof%252Bcholesterol%252Binteraction%252Bmotifs%252Bin%252Btransmembrane%252Bhelix%252BV%252Bof%252Bthe%252Bserotonin1A%252Breceptor%26aulast%3DFatakia%26aufirst%3DSarosh%2BN.%26date%3D2020%26volume%3D232%26spage%3D104955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhagyashree D.  Rao</span>, <span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Selectivity in agonist and antagonist binding to Serotonin1A receptors via G-protein coupling. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2020,</strong> <em>1862 </em>
                                    (6)
                                     , 183265. <a href="https://doi.org/10.1016/j.bbamem.2020.183265" title="DOI URL">https://doi.org/10.1016/j.bbamem.2020.183265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2020.183265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2020.183265%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3DSelectivity%252Bin%252Bagonist%252Band%252Bantagonist%252Bbinding%252Bto%252BSerotonin1A%252Breceptors%252Bvia%252BG-protein%252Bcoupling%26aulast%3DRao%26aufirst%3DBhagyashree%2BD.%26date%3D2020%26volume%3D1862%26issue%3D6%26spage%3D183265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Magli</span>, <span class="hlFld-ContribAuthor ">Beatrice  Severino</span>, <span class="hlFld-ContribAuthor ">Angela  Corvino</span>, <span class="hlFld-ContribAuthor ">Elisa  Perissutti</span>, <span class="hlFld-ContribAuthor ">Francesco  Frecentese</span>, <span class="hlFld-ContribAuthor ">Irene  Saccone</span>, <span class="hlFld-ContribAuthor ">Flavia  Giordano</span>, <span class="hlFld-ContribAuthor ">Marián  Castro</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">María I.  Loza</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Santagada</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Caliendo</span>, <span class="hlFld-ContribAuthor ">Ferdinando  Fiorino</span>. </span><span class="cited-content_cbyCitation_article-title">New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and In Vitro Pharmacological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2020,</strong> <em>16 </em>
                                    (4)
                                     , 517-530. <a href="https://doi.org/10.2174/1573406415666190613153220" title="DOI URL">https://doi.org/10.2174/1573406415666190613153220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190613153220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190613153220%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DNew%252BSerotoninergic%252BLigands%252BContaining%252BIndolic%252Band%252BMethyl%252BIndolic%252BNuclei%25253A%252BSynthesis%252Band%252BIn%252BVitro%252BPharmacological%252BEvaluation%26aulast%3DMagli%26aufirst%3DElisa%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Pascal  Preira</span>, <span class="hlFld-ContribAuthor ">Laurence  Salomé</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Actin Cytoskeleton in Dynamics and Function of the Serotonin1A Receptor. </span><span class="cited-content_cbyCitation_journal-name">Biophysical Journal</span><span> <strong>2020,</strong> <em>118 </em>
                                    (4)
                                     , 944-956. <a href="https://doi.org/10.1016/j.bpj.2019.08.034" title="DOI URL">https://doi.org/10.1016/j.bpj.2019.08.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bpj.2019.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bpj.2019.08.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBiophysical%2520Journal%26atitle%3DRole%252Bof%252BActin%252BCytoskeleton%252Bin%252BDynamics%252Band%252BFunction%252Bof%252Bthe%252BSerotonin1A%252BReceptor%26aulast%3DShrivastava%26aufirst%3DSandeep%26date%3D2020%26volume%3D118%26issue%3D4%26spage%3D944%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Sniecikowska</span>, <span class="hlFld-ContribAuthor ">Adrian  Newman-Tancredi</span>, <span class="hlFld-ContribAuthor ">Marcin  Kolaczkowski</span>. </span><span class="cited-content_cbyCitation_article-title">From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (26)
                                     , 2393-2420. <a href="https://doi.org/10.2174/1568026619666190911122040" title="DOI URL">https://doi.org/10.2174/1568026619666190911122040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190911122040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190911122040%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BReceptor%252BSelectivity%252Bto%252BFunctional%252BSelectivity%25253A%252BThe%252BRise%252Bof%252BBiased%252BAgonism%252Bin%252B5-HT1A%252BReceptor%252BDrug%252BDiscovery%26aulast%3DSniecikowska%26aufirst%3DJoanna%26date%3D2019%26volume%3D19%26issue%3D26%26spage%3D2393%26epage%3D2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruna Maria Castro Salomão  Quaresma</span>, <span class="hlFld-ContribAuthor ">Amanda Reis  Pimenta</span>, <span class="hlFld-ContribAuthor ">Anne Caroline  Santos da Silva</span>, <span class="hlFld-ContribAuthor ">André Sampaio  Pupo</span>, <span class="hlFld-ContribAuthor ">Luiz Antonio S.  Romeiro</span>, <span class="hlFld-ContribAuthor ">Claudia Lucia Martins  Silva</span>, <span class="hlFld-ContribAuthor ">François  Noël</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting the Pharmacodynamic Uroselectivity of
              α
              1
              -Adrenergic Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>371 </em>
                                    (1)
                                     , 106-112. <a href="https://doi.org/10.1124/jpet.119.260216" title="DOI URL">https://doi.org/10.1124/jpet.119.260216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.260216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.260216%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DRevisiting%252Bthe%252BPharmacodynamic%252BUroselectivity%252Bof%252B%2525CE%2525B1%252B1%252B-Adrenergic%252BReceptor%252BAntagonists%26aulast%3DQuaresma%26aufirst%3DBruna%2BMaria%2BCastro%2BSalom%25C3%25A3o%26date%3D2019%26date%3D2019%26volume%3D371%26issue%3D1%26spage%3D106%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarosh N.  Fatakia</span>, <span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">A collage of cholesterol interaction motifs in the serotonin1A receptor: An evolutionary implication for differential cholesterol interaction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2019,</strong> <em>221 </em>, 184-192. <a href="https://doi.org/10.1016/j.chemphyslip.2019.02.010" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2019.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2019.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2019.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DA%252Bcollage%252Bof%252Bcholesterol%252Binteraction%252Bmotifs%252Bin%252Bthe%252Bserotonin1A%252Breceptor%25253A%252BAn%252Bevolutionary%252Bimplication%252Bfor%252Bdifferential%252Bcholesterol%252Binteraction%26aulast%3DFatakia%26aufirst%3DSarosh%2BN.%26date%3D2019%26volume%3D221%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring membrane organization at varying spatiotemporal resolutions utilizing fluorescence-based approaches: implications in membrane biology. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2019,</strong> <em>21 </em>
                                    (22)
                                     , 11554-11563. <a href="https://doi.org/10.1039/C9CP02087J" title="DOI URL">https://doi.org/10.1039/C9CP02087J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP02087J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP02087J%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DExploring%252Bmembrane%252Borganization%252Bat%252Bvarying%252Bspatiotemporal%252Bresolutions%252Butilizing%252Bfluorescence-based%252Bapproaches%25253A%252Bimplications%252Bin%252Bmembrane%252Bbiology%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D22%26spage%3D11554%26epage%3D11563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Consuelo  Amantini</span>, <span class="hlFld-ContribAuthor ">Maria Beatrice  Morelli</span>, <span class="hlFld-ContribAuthor ">Giorgio  Santoni</span>, <span class="hlFld-ContribAuthor ">Francisco O.  Battiti</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 461-473. <a href="https://doi.org/10.1016/j.ejmech.2019.02.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252Bmanipulations%252Bon%252Bthe%252B1%25252C4-dioxane%252Bring%252Bof%252B5-HT1A%252Breceptor%252Bagonists%252Blead%252Bto%252Bantagonists%252Bendowed%252Bwith%252Bantitumor%252Bactivity%252Bin%252Bprostate%252Bcancer%252Bcells%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2019%26volume%3D168%26spage%3D461%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.R.  Sherin</span>, <span class="hlFld-ContribAuthor ">C.K.  Geethu</span>, <span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">J. John  Mann</span>, <span class="hlFld-ContribAuthor ">J.S.  Dileep Kumar</span>, <span class="hlFld-ContribAuthor ">T.K.  Manojkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR agonists. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>78 </em>, 108-115. <a href="https://doi.org/10.1016/j.compbiolchem.2018.11.015" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bdocking%25252C%252Bdynamics%252Bsimulations%252Band%252B3D-QSAR%252Bmodeling%252Bof%252Barylpiperazine%252Bderivatives%252Bof%252B3%25252C5-dioxo-%2525282H%25252C4H%252529-1%25252C2%25252C4-triazine%252Bas%252B5-HT1AR%252Bagonists%26aulast%3DSherin%26aufirst%3DD.R.%26date%3D2019%26volume%3D78%26spage%3D108%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md.  Jafurulla</span>, <span class="hlFld-ContribAuthor ">G.  Aditya Kumar</span>, <span class="hlFld-ContribAuthor ">Bhagyashree D.  Rao</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">A Critical Analysis of Molecular Mechanisms Underlying Membrane Cholesterol Sensitivity of GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 21-52. <a href="https://doi.org/10.1007/978-3-030-04278-3_2" title="DOI URL">https://doi.org/10.1007/978-3-030-04278-3_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-04278-3_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-04278-3_2%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BCritical%252BAnalysis%252Bof%252BMolecular%252BMechanisms%252BUnderlying%252BMembrane%252BCholesterol%252BSensitivity%252Bof%252BGPCRs%26aulast%3DJafurulla%26aufirst%3DMd.%26date%3D2019%26date%3D2019%26spage%3D21%26epage%3D52%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCholesterol%252BModulation%252Bof%252BProtein%252BFunction%26aulast%3DRosenhouse-Dantsker%26aufirst%3DAvia%26date%3D2019%26volume%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">G. Aditya  Kumar</span>, <span class="hlFld-ContribAuthor ">Sreetama  Pal</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Biophysics of Serotonin and the Serotonin1A Receptor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 3-22. <a href="https://doi.org/10.1016/B978-0-12-800050-2.00001-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-800050-2.00001-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800050-2.00001-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800050-2.00001-2%26sid%3Dliteratum%253Aachs%26atitle%3DBiophysics%252Bof%252BSerotonin%252Band%252Bthe%252BSerotonin1A%252BReceptor%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2019%26spage%3D3%26epage%3D22%26pub%3DElsevier%26atitle%3DSerotonin%26date%3D2019%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sreetama  Pal</span>, <span class="hlFld-ContribAuthor ">Ramdas  Aute</span>, <span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Shroddha  Bose</span>, <span class="hlFld-ContribAuthor ">Mandar V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Constrained dynamics of the sole tryptophan in the third intracellular loop of the serotonin 1 A receptor. </span><span class="cited-content_cbyCitation_journal-name">Biophysical Chemistry</span><span> <strong>2018,</strong> <em>240 </em>, 34-41. <a href="https://doi.org/10.1016/j.bpc.2018.05.008" title="DOI URL">https://doi.org/10.1016/j.bpc.2018.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bpc.2018.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bpc.2018.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBiophysical%2520Chemistry%26atitle%3DConstrained%252Bdynamics%252Bof%252Bthe%252Bsole%252Btryptophan%252Bin%252Bthe%252Bthird%252Bintracellular%252Bloop%252Bof%252Bthe%252Bserotonin%252B1%252BA%252Breceptor%26aulast%3DPal%26aufirst%3DSreetama%26date%3D2018%26volume%3D240%26spage%3D34%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Leda Ivanova  Bencheva</span>, <span class="hlFld-ContribAuthor ">Umberto Maria  Battisti</span>, <span class="hlFld-ContribAuthor ">Annalisa  Tait</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Paola  Fossa</span>, <span class="hlFld-ContribAuthor ">Elena  Cichero</span>, <span class="hlFld-ContribAuthor ">Simone  Ronsisvalle</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Aricò</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Lorenza  Pirona</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT
              1A
              receptor agonists for CNS disorders and neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (18)
                                     , 2137-2154. <a href="https://doi.org/10.4155/fmc-2018-0107" title="DOI URL">https://doi.org/10.4155/fmc-2018-0107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0107%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C3-dioxolane-based%252B5-HT%252B1A%252Breceptor%252Bagonists%252Bfor%252BCNS%252Bdisorders%252Band%252Bneuropathic%252Bpain%26aulast%3DFranchini%26aufirst%3DSilvia%26date%3D2018%26volume%3D10%26issue%3D18%26spage%3D2137%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">GFP fluorescence: A few lesser-known nuggets that make it work. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biosciences</span><span> <strong>2018,</strong> <em>43 </em>
                                    (3)
                                     , 421-430. <a href="https://doi.org/10.1007/s12038-018-9779-9" title="DOI URL">https://doi.org/10.1007/s12038-018-9779-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12038-018-9779-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12038-018-9779-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biosciences%26atitle%3DGFP%252Bfluorescence%25253A%252BA%252Bfew%252Blesser-known%252Bnuggets%252Bthat%252Bmake%252Bit%252Bwork%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D3%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Wen Bo  Xie</span>, <span class="hlFld-ContribAuthor ">Ming  Ru Li</span>, <span class="hlFld-ContribAuthor ">Nan  Teng</span>, <span class="hlFld-ContribAuthor ">Xiao  Liang</span>, <span class="hlFld-ContribAuthor ">Zi Qiang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of polaprezinc on gastric mucosal damage and neurotransmitters in a rat model of chemotherapy-induced vomiting. </span><span class="cited-content_cbyCitation_journal-name">Journal of International Medical Research</span><span> <strong>2018,</strong> <em>46 </em>
                                    (6)
                                     , 2436-2444. <a href="https://doi.org/10.1177/0300060518771492" title="DOI URL">https://doi.org/10.1177/0300060518771492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0300060518771492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0300060518771492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520International%2520Medical%2520Research%26atitle%3DEffects%252Bof%252Bpolaprezinc%252Bon%252Bgastric%252Bmucosal%252Bdamage%252Band%252Bneurotransmitters%252Bin%252Ba%252Brat%252Bmodel%252Bof%252Bchemotherapy-induced%252Bvomiting%26aulast%3DLiu%26aufirst%3DZhao%2BYang%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D6%26spage%3D2436%26epage%3D2444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Md.  Jafurulla</span>, <span class="hlFld-ContribAuthor ">Shrish  Tiwari</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Sphingolipid-binding Motif in G Protein-coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 141-149. <a href="https://doi.org/10.1007/978-981-13-3065-0_10" title="DOI URL">https://doi.org/10.1007/978-981-13-3065-0_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-3065-0_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-3065-0_10%26sid%3Dliteratum%253Aachs%26atitle%3DIdentification%252Bof%252BSphingolipid-binding%252BMotif%252Bin%252BG%252BProtein-coupled%252BReceptors%26aulast%3DShrivastava%26aufirst%3DSandeep%26date%3D2018%26date%3D2019%26spage%3D141%26epage%3D149%26pub%3DSpringer%2520Singapore%26atitle%3DBiochemical%252Band%252BBiophysical%252BRoles%252Bof%252BCell%252BSurface%252BMolecules%26aulast%3DChattopadhyay%26aufirst%3DKausik%26date%3D2018%26volume%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madhura  Mohole</span>, <span class="hlFld-ContribAuthor ">Xavier  Prasanna</span>, <span class="hlFld-ContribAuthor ">Durba  Sengupta</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Signatures of Cholesterol Interaction with Serotonin Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 151-160. <a href="https://doi.org/10.1007/978-981-13-3065-0_11" title="DOI URL">https://doi.org/10.1007/978-981-13-3065-0_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-3065-0_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-3065-0_11%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BSignatures%252Bof%252BCholesterol%252BInteraction%252Bwith%252BSerotonin%252BReceptors%26aulast%3DMohole%26aufirst%3DMadhura%26date%3D2018%26date%3D2019%26spage%3D151%26epage%3D160%26pub%3DSpringer%2520Singapore%26atitle%3DBiochemical%252Band%252BBiophysical%252BRoles%252Bof%252BCell%252BSurface%252BMolecules%26aulast%3DChattopadhyay%26aufirst%3DKausik%26date%3D2018%26volume%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hirak  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Md.  Jafurulla</span>, <span class="hlFld-ContribAuthor ">Andrew H. A.  Clayton</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring oligomeric state of the serotonin
              1A
              receptor utilizing photobleaching image correlation spectroscopy: implications for receptor function. </span><span class="cited-content_cbyCitation_journal-name">Faraday Discussions</span><span> <strong>2018,</strong> <em>207 </em>, 409-421. <a href="https://doi.org/10.1039/C7FD00192D" title="DOI URL">https://doi.org/10.1039/C7FD00192D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7FD00192D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7FD00192D%26sid%3Dliteratum%253Aachs%26jtitle%3DFaraday%2520Discussions%26atitle%3DExploring%252Boligomeric%252Bstate%252Bof%252Bthe%252Bserotonin%252B1A%252Breceptor%252Butilizing%252Bphotobleaching%252Bimage%252Bcorrelation%252Bspectroscopy%25253A%252Bimplications%252Bfor%252Breceptor%252Bfunction%26aulast%3DChakraborty%26aufirst%3DHirak%26date%3D2018%26date%3D2018%26volume%3D207%26spage%3D409%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parijat  Sarkar</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Solubilization of the serotonin 1A  receptor monitored utilizing membrane dipole potential. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2017,</strong> <em>209 </em>, 54-60. <a href="https://doi.org/10.1016/j.chemphyslip.2017.10.001" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2017.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2017.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2017.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DSolubilization%252Bof%252Bthe%252Bserotonin%252B1A%252Breceptor%252Bmonitored%252Butilizing%252Bmembrane%252Bdipole%252Bpotential%26aulast%3DSarkar%26aufirst%3DParijat%26date%3D2017%26volume%3D209%26spage%3D54%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Carlo  Cifani</span>, <span class="hlFld-ContribAuthor ">Fabio Del  Bello</span>, <span class="hlFld-ContribAuthor ">Mario  Giannella</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria Micioni Di  Bonaventura</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>. </span><span class="cited-content_cbyCitation_article-title">4WD to Travel Inside the 5-HT1A Receptor World. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,<a href="https://doi.org/10.5772/intechopen.69348" title="DOI URL">https://doi.org/10.5772/intechopen.69348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.69348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.69348%26sid%3Dliteratum%253Aachs%26atitle%3D4WD%252Bto%252BTravel%252BInside%252Bthe%252B5-HT1A%252BReceptor%252BWorld%26aulast%3DQuaglia%26aufirst%3DWilma%26date%3D2017%26date%3D2017%26pub%3DInTech%26atitle%3DSerotonin%252B-%252BA%252BChemical%252BMessenger%252BBetween%252BAll%252BTypes%252Bof%252BLiving%252BCells%26aulast%3DShad%26aufirst%3DKaneez%2BFatima%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zdzislaw  Chilmonczyk</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Andrzej  Pilc</span>, <span class="hlFld-ContribAuthor ">Ingebrigt  Sylte</span>. </span><span class="cited-content_cbyCitation_article-title">Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2017,</strong> <em>69 </em>
                                    (3)
                                     , 469-478. <a href="https://doi.org/10.1016/j.pharep.2017.01.011" title="DOI URL">https://doi.org/10.1016/j.pharep.2017.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharep.2017.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharep.2017.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DSerotonin%252Btransporter%252Band%252Breceptor%252Bligands%252Bwith%252Bantidepressant%252Bactivity%252Bas%252Bneuroprotective%252Band%252Bproapoptotic%252Bagents%26aulast%3DChilmonczyk%26aufirst%3DZdzislaw%26date%3D2017%26volume%3D69%26issue%3D3%26spage%3D469%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md.  Jafurulla</span>, <span class="hlFld-ContribAuthor ">Suman  Bandari</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Pucadyil</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingolipids modulate the function of human serotonin 1A receptors: Insights from sphingolipid-deficient cells. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2017,</strong> <em>1859 </em>
                                    (4)
                                     , 598-604. <a href="https://doi.org/10.1016/j.bbamem.2016.10.016" title="DOI URL">https://doi.org/10.1016/j.bbamem.2016.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2016.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2016.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3DSphingolipids%252Bmodulate%252Bthe%252Bfunction%252Bof%252Bhuman%252Bserotonin%252B1A%252Breceptors%25253A%252BInsights%252Bfrom%252Bsphingolipid-deficient%252Bcells%26aulast%3DJafurulla%26aufirst%3DMd.%26date%3D2017%26volume%3D1859%26issue%3D4%26spage%3D598%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md.  Jafurulla</span>, <span class="hlFld-ContribAuthor ">Aswan  Nalli</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Membrane cholesterol oxidation in live cells enhances the function of serotonin 1A  receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2017,</strong> <em>203 </em>, 71-77. <a href="https://doi.org/10.1016/j.chemphyslip.2017.01.005" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2017.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2017.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DMembrane%252Bcholesterol%252Boxidation%252Bin%252Blive%252Bcells%252Benhances%252Bthe%252Bfunction%252Bof%252Bserotonin%252B1A%252Breceptors%26aulast%3DJafurulla%26aufirst%3DMd.%26date%3D2017%26volume%3D203%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuko  Yoshimura</span>, <span class="hlFld-ContribAuthor ">Chihiro  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Haruki  Kasegai</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Masuda</span>, <span class="hlFld-ContribAuthor ">Masaaki  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Shiga</span>. </span><span class="cited-content_cbyCitation_article-title">Roles of 5-HT 1A receptor in the expression of AMPA receptor and BDNF in developing mouse cortical neurons. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Research</span><span> <strong>2017,</strong> <em>115 </em>, 13-20. <a href="https://doi.org/10.1016/j.neures.2016.09.008" title="DOI URL">https://doi.org/10.1016/j.neures.2016.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neures.2016.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neures.2016.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Research%26atitle%3DRoles%252Bof%252B5-HT%252B1A%252Breceptor%252Bin%252Bthe%252Bexpression%252Bof%252BAMPA%252Breceptor%252Band%252BBDNF%252Bin%252Bdeveloping%252Bmouse%252Bcortical%252Bneurons%26aulast%3DYoshimura%26aufirst%3DYuko%26date%3D2017%26volume%3D115%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Mario  Giannella</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>, <span class="hlFld-ContribAuthor ">Riccardo  Petrelli</span>, <span class="hlFld-ContribAuthor ">Carlo  Cifani</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Angelica  Mazzolari</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Elena  Poggesi</span>, <span class="hlFld-ContribAuthor ">Rosanna  Matucci</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 233-244. <a href="https://doi.org/10.1016/j.ejmech.2016.09.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Breplacement%252Bof%252Bthe%252B2-methoxy%252Bsubstituent%252Bof%252BN-%252528%2525286%25252C6-diphenyl-1%25252C4-dioxan-2-yl%252529methyl%252529-2-%2525282-methoxyphenoxy%252529ethan-1-amine%252Bimproves%252Bthe%252Bselectivity%252Bfor%252B5-HT1A%252Breceptor%252Bover%252B%2525CE%2525B11-adrenoceptor%252Band%2525C2%2525A0D2-like%252Breceptor%252Bsubtypes%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2017%26volume%3D125%26spage%3D233%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Leda Ivanova  Manasieva</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Umberto M.  Battisti</span>, <span class="hlFld-ContribAuthor ">Paola  Fossa</span>, <span class="hlFld-ContribAuthor ">Elena  Cichero</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Lorenza  Pirona</span>, <span class="hlFld-ContribAuthor ">Simone  Ronsisvalle</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Aricò</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 435-452. <a href="https://doi.org/10.1016/j.ejmech.2016.09.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bof%252B1-oxa-4-thiaspiro-%252Band%252B1%25252C4-dithiaspiro%25255B4.5%25255Ddecane%252Bderivatives%252Bas%2525C2%2525A0potent%252Band%252Bselective%252B5-HT1A%252Breceptor%252Bagonists%26aulast%3DFranchini%26aufirst%3DSilvia%26date%3D2017%26volume%3D125%26spage%3D435%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Guariento</span>, <span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Michele  Tonelli</span>, <span class="hlFld-ContribAuthor ">Paola  Fossa</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Elena  Cichero</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT
              1A
              ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 214-230. <a href="https://doi.org/10.1080/14756366.2016.1247057" title="DOI URL">https://doi.org/10.1080/14756366.2016.1247057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1247057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1247057%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DExhaustive%252BCoMFA%252Band%252BCoMSIA%252Banalyses%252Baround%252Bdifferent%252Bchemical%252Bentities%25253A%252Ba%252Bligand-based%252Bstudy%252Bexploring%252Bthe%252Baffinity%252Band%252Bselectivity%252Bprofiles%252Bof%252B5-HT%252B1A%252Bligands%26aulast%3DGuariento%26aufirst%3DSara%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D214%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhagyashree D.  Rao</span>, <span class="hlFld-ContribAuthor ">Sandeep  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of local anesthetics on serotonin1A receptor function. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2016,</strong> <em>201 </em>, 41-49. <a href="https://doi.org/10.1016/j.chemphyslip.2016.11.001" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2016.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2016.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2016.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DEffect%252Bof%252Blocal%252Banesthetics%252Bon%252Bserotonin1A%252Breceptor%252Bfunction%26aulast%3DRao%26aufirst%3DBhagyashree%2BD.%26date%3D2016%26volume%3D201%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Yang</span>, <span class="hlFld-ContribAuthor ">Gang  Song</span>, <span class="hlFld-ContribAuthor ">Yinghui  Ning</span>, <span class="hlFld-ContribAuthor ">Chi-Sang  Poon</span>. </span><span class="cited-content_cbyCitation_article-title">A latent serotonin-1A receptor-gated spinal afferent pathway inhibiting breathing. </span><span class="cited-content_cbyCitation_journal-name">Brain Structure and Function</span><span> <strong>2016,</strong> <em>221 </em>
                                    (8)
                                     , 4159-4168. <a href="https://doi.org/10.1007/s00429-015-1155-z" title="DOI URL">https://doi.org/10.1007/s00429-015-1155-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00429-015-1155-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00429-015-1155-z%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Structure%2520and%2520Function%26atitle%3DA%252Blatent%252Bserotonin-1A%252Breceptor-gated%252Bspinal%252Bafferent%252Bpathway%252Binhibiting%252Bbreathing%26aulast%3DYang%26aufirst%3DLiang%26date%3D2016%26date%3D2015%26volume%3D221%26issue%3D8%26spage%3D4159%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Antonio  Carrieri</span>, <span class="hlFld-ContribAuthor ">Domenico Claudio  Fasano</span>, <span class="hlFld-ContribAuthor ">Carla  Ghelardini</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Di Cesare Mannelli</span>, <span class="hlFld-ContribAuthor ">Laura  Micheli</span>, <span class="hlFld-ContribAuthor ">Carlo  Santini</span>, <span class="hlFld-ContribAuthor ">Eleonora  Diamanti</span>, <span class="hlFld-ContribAuthor ">Mario  Giannella</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Valerio  Mammoli</span>, <span class="hlFld-ContribAuthor ">Corinne Dalila  Paoletti</span>, <span class="hlFld-ContribAuthor ">Riccardo  Petrelli</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Maria  Pigini</span>. </span><span class="cited-content_cbyCitation_article-title">The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT
              1A
              Receptor. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (20)
                                     , 2287-2298. <a href="https://doi.org/10.1002/cmdc.201600383" title="DOI URL">https://doi.org/10.1002/cmdc.201600383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BVersatile%252B2-Substituted%252BImidazoline%252BNucleus%252Bas%252Ba%252BStructural%252BMotif%252Bof%252BLigands%252BDirected%252Bto%252Bthe%252BSerotonin%252B5-HT%252B1A%252BReceptor%26aulast%3DDel%25E2%2580%2585Bello%26aufirst%3DFabio%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D20%26spage%3D2287%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xavier  Prasanna</span>, <span class="hlFld-ContribAuthor ">Durba  Sengupta</span>, <span class="hlFld-ContribAuthor ">Amitabha  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Cholesterol-dependent Conformational Plasticity in GPCR Dimers. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep31858" title="DOI URL">https://doi.org/10.1038/srep31858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep31858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep31858%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCholesterol-dependent%252BConformational%252BPlasticity%252Bin%252BGPCR%252BDimers%26aulast%3DPrasanna%26aufirst%3DXavier%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Butini</span>, <span class="hlFld-ContribAuthor ">K.  Nikolic</span>, <span class="hlFld-ContribAuthor ">S.  Kassel</span>, <span class="hlFld-ContribAuthor ">H.  Brückmann</span>, <span class="hlFld-ContribAuthor ">S.  Filipic</span>, <span class="hlFld-ContribAuthor ">D.  Agbaba</span>, <span class="hlFld-ContribAuthor ">S.  Gemma</span>, <span class="hlFld-ContribAuthor ">S.  Brogi</span>, <span class="hlFld-ContribAuthor ">M.  Brindisi</span>, <span class="hlFld-ContribAuthor ">G.  Campiani</span>, <span class="hlFld-ContribAuthor ">H.  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology of dopamine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2016,</strong> <em>142 </em>, 68-103. <a href="https://doi.org/10.1016/j.pneurobio.2016.03.011" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2016.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2016.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2016.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DPolypharmacology%252Bof%252Bdopamine%252Breceptor%252Bligands%26aulast%3DButini%26aufirst%3DS.%26date%3D2016%26volume%3D142%26spage%3D68%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana M.  Gamo</span>, <span class="hlFld-ContribAuthor ">Juan A.  González-Vera</span>, <span class="hlFld-ContribAuthor ">Ainoa  Rueda-Zubiaurre</span>, <span class="hlFld-ContribAuthor ">Dulce  Alonso</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>, <span class="hlFld-ContribAuthor ">Lidia  Martín-Couce</span>, <span class="hlFld-ContribAuthor ">Óscar  Palomares</span>, <span class="hlFld-ContribAuthor ">Juan A.  López</span>, <span class="hlFld-ContribAuthor ">Mar  Martín-Fontecha</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Silvia  Ortega-Gutiérrez</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT
              1A
              and 5-HT
              6
              Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (4)
                                     , 1313-1321. <a href="https://doi.org/10.1002/chem.201503101" title="DOI URL">https://doi.org/10.1002/chem.201503101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201503101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201503101%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DChemoproteomic%252BApproach%252Bto%252BExplore%252Bthe%252BTarget%252BProfile%252Bof%252BGPCR%252Bligands%25253A%252BApplication%252Bto%252B5-HT%252B1A%252Band%252B5-HT%252B6%252BReceptors%26aulast%3DGamo%26aufirst%3DAna%2BM.%26date%3D2016%26date%3D2015%26volume%3D22%26issue%3D4%26spage%3D1313%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Puja Panwar  Hazari</span>, <span class="hlFld-ContribAuthor ">Surbhi  Prakash</span>, <span class="hlFld-ContribAuthor ">Virendra Kumar  Meena</span>, <span class="hlFld-ContribAuthor ">Niraj  Singh</span>, <span class="hlFld-ContribAuthor ">Krishna  Chuttani</span>, <span class="hlFld-ContribAuthor ">Nidhi  Chadha</span>, <span class="hlFld-ContribAuthor ">Pooja  Singh</span>, <span class="hlFld-ContribAuthor ">Shrikant  Kukreti</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, preclinical evaluation and molecular modelling of macrocyclic appended 1-(2-methoxyphenyl)piperazine for 5-HT
              1A
              neuroreceptor imaging. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (9)
                                     , 7288-7301. <a href="https://doi.org/10.1039/C5RA13432C" title="DOI URL">https://doi.org/10.1039/C5RA13432C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA13432C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA13432C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%25252C%252Bpreclinical%252Bevaluation%252Band%252Bmolecular%252Bmodelling%252Bof%252Bmacrocyclic%252Bappended%252B1-%2525282-methoxyphenyl%252529piperazine%252Bfor%252B5-HT%252B1A%252Bneuroreceptor%252Bimaging%26aulast%3DHazari%26aufirst%3DPuja%2BPanwar%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D9%26spage%3D7288%26epage%3D7301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G O Casas  K</span>, <span class="hlFld-ContribAuthor ">L G Oliveira  M</span>, <span class="hlFld-ContribAuthor ">D de F aacute tima Silva  G</span>, <span class="hlFld-ContribAuthor ">J Viasus  C</span>, <span class="hlFld-ContribAuthor ">E Burgos  A</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Cu(II) complex with schiff bases derived from aryl-S-benzyildithiocarbazate: Antimicrobial activity and in silico biological properties evaluations. </span><span class="cited-content_cbyCitation_journal-name">African Journal of Pharmacy and Pharmacology</span><span> <strong>2015,</strong> <em>9 </em>
                                    (42)
                                     , 1009-1019. <a href="https://doi.org/10.5897/AJPP2015.4383" title="DOI URL">https://doi.org/10.5897/AJPP2015.4383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5897/AJPP2015.4383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5897%2FAJPP2015.4383%26sid%3Dliteratum%253Aachs%26jtitle%3DAfrican%2520Journal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DSynthesis%252Bof%252BCu%252528II%252529%252Bcomplex%252Bwith%252Bschiff%252Bbases%252Bderived%252Bfrom%252Baryl-S-benzyildithiocarbazate%25253A%252BAntimicrobial%252Bactivity%252Band%252Bin%252Bsilico%252Bbiological%252Bproperties%252Bevaluations%26aulast%3DK%26aufirst%3DG%2BO%2BCasas%26date%3D2015%26date%3D2015%26volume%3D9%26issue%3D42%26spage%3D1009%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zdzisław  Chilmonczyk</span>, <span class="hlFld-ContribAuthor ">Andrzej  Bojarski</span>, <span class="hlFld-ContribAuthor ">Andrzej  Pilc</span>, <span class="hlFld-ContribAuthor ">Ingebrigt  Sylte</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2015,</strong> <em>16 </em>
                                    (8)
                                     , 18474-18506. <a href="https://doi.org/10.3390/ijms160818474" title="DOI URL">https://doi.org/10.3390/ijms160818474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms160818474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms160818474%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DFunctional%252BSelectivity%252Band%252BAntidepressant%252BActivity%252Bof%252BSerotonin%252B1A%252BReceptor%252BLigands%26aulast%3DChilmonczyk%26aufirst%3DZdzis%25C5%2582aw%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D8%26spage%3D18474%26epage%3D18506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Umberto M.  Battisti</span>, <span class="hlFld-ContribAuthor ">Annamaria  Baraldi</span>, <span class="hlFld-ContribAuthor ">Adolfo  Prandi</span>, <span class="hlFld-ContribAuthor ">Paola  Fossa</span>, <span class="hlFld-ContribAuthor ">Elena  Cichero</span>, <span class="hlFld-ContribAuthor ">Annalisa  Tait</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Gabriella  Marucci</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Lorenza  Pirona</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 248-266. <a href="https://doi.org/10.1016/j.ejmech.2014.09.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593affinity%25252Factivity%252Brelationships%252Bof%252B1%25252C4-dioxa-spiro%25255B4.5%25255Ddecane%252Bbased%252Bligands%252Bat%252B%2525CE%2525B11%252Band%252B5-HT1A%252Breceptors%26aulast%3DFranchini%26aufirst%3DSilvia%26date%3D2014%26volume%3D87%26spage%3D248%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ferdinando  Fiorino</span>, <span class="hlFld-ContribAuthor ">Elisa  Magli</span>, <span class="hlFld-ContribAuthor ">Beatrice  Severino</span>, <span class="hlFld-ContribAuthor ">Angela  Corvino</span>, <span class="hlFld-ContribAuthor ">Antonio  Ciano</span>, <span class="hlFld-ContribAuthor ">Elisa  Perissutti</span>, <span class="hlFld-ContribAuthor ">Francesco  Frecentese</span>, <span class="hlFld-ContribAuthor ">Paola  Massarelli</span>, <span class="hlFld-ContribAuthor ">Cristina  Nencini</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Santagada</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Caliendo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and
              In Vitro
              Pharmacological Evaluation of Novel 2-Hydroxypropyl-4-arylpiperazine Derivatives as Serotoninergic Ligands. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2014,</strong> <em>347 </em>
                                    (10)
                                     , 698-706. <a href="https://doi.org/10.1002/ardp.201400174" title="DOI URL">https://doi.org/10.1002/ardp.201400174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400174%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252BPharmacological%252BEvaluation%252Bof%252BNovel%252B2-Hydroxypropyl-4-arylpiperazine%252BDerivatives%252Bas%252BSerotoninergic%252BLigands%26aulast%3DFiorino%26aufirst%3DFerdinando%26date%3D2014%26date%3D2014%26volume%3D347%26issue%3D10%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana P.  Abdala</span>, <span class="hlFld-ContribAuthor ">John M.  Bissonnette</span>, <span class="hlFld-ContribAuthor ">Adrian  Newman-Tancredi</span>. </span><span class="cited-content_cbyCitation_article-title">Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2014,</strong> <em>5 </em><a href="https://doi.org/10.3389/fphys.2014.00205" title="DOI URL">https://doi.org/10.3389/fphys.2014.00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2014.00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2014.00205%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DPinpointing%252Bbrainstem%252Bmechanisms%252Bresponsible%252Bfor%252Bautonomic%252Bdysfunction%252Bin%252BRett%252Bsyndrome%25253A%252Btherapeutic%252Bperspectives%252Bfor%252B5-HT1A%252Bagonists%26aulast%3DAbdala%26aufirst%3DAna%2BP.%26date%3D2014%26date%3D2014%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0019.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Serotonin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overview of 5-HT receptor subtypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 5-HT<sub>1A</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of D<sub>2</sub> antagonists, D<sub>2</sub>/5-HT<sub>2A</sub> antagonists, and D<sub>2</sub> antagonists/5-HT<sub>1A</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure of befiradol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 1-(2-Pyrimidinyl)piperazine and 1-(2-methoxyphenyl)piperazine derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. General structure of long-chain arylpiperazines (LCAPs) and pharmacophoric model of 5-HT<sub>1A</sub> agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. 5-HT<sub>1A</sub> receptor agonists with anxiolytic and antidepressant properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. 5-HT<sub>1A</sub> receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Molecule acting as antipsychotic by combination of D<sub>2</sub> antagonism and 5-HT<sub>1A</sub> agonism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Aripiprazole and some LCAP structural related derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. LCAP derivatives based on indolizine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structure of <b>36</b> a 5-HT<sub>1A</sub> receptor agonist with antinociceptive effect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of some 5-HT<sub>1A</sub> receptor agonists and other molecules useful in Parkinson’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/medium/jm-2013-00533t_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of 5-HT<sub>1A</sub> ligands as antiproliferative agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm400533t/production/images/large/jm-2013-00533t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400533t&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 138 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. D.</span><span> </span><span class="NLM_article-title">Serotonin receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr078224o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1614-1641&author=D.+E.+Nicholsauthor=C.+D.+Nichols&title=Serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin Receptors</span></div><div class="casAuthors">Nichols, David E.; Nichols, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1614-1641</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on phylogeny, structural features, oligomerization, classification and functions of serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnlR5CHbuX7Vg90H21EOLACvtfcHk0ljhMieyc0ndzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D&md5=55b70829f6be71cbfe4de05c5ef665d8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcr078224o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr078224o%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DNichols%26aufirst%3DC.%2BD.%26atitle%3DSerotonin%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1614%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Fredriksson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerström, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundin, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiöth, H. B.</span><span> </span><span class="NLM_article-title">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fmol.63.6.1256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12761335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1256-1272&issue=6&author=R.+Fredrikssonauthor=M.+C.+Lagerstr%C3%B6mauthor=L.+G.+Lundinauthor=H.+B.+Schi%C3%B6th&title=The+G-protein-coupled+receptors+in+the+human+genome+form+five+main+families.+Phylogenetic+analysis%2C+paralogon+groups%2C+and+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span></div><div class="casAuthors">Fredriksson, Robert; Lagerstrom, Malin C.; Lundin, Lars-Gustav; Schioth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-1272</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The superfamily of G-protein-coupled receptors (GPCRs) is very diverse in structure and function and its members are among the most pursued targets for drug development.  We identified more than 800 human GPCR sequences and simultaneously analyzed 342 unique functional nonolfactory human GPCR sequences with phylogenetic analyses.  Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system.  The rhodopsin family is the largest and forms four main groups with 13 subbranches.  Positions of the GPCRs in chromosomal paralogons regions indicate the importance of tetraploidizations or local gene duplication events for their creation.  We also searched for "fingerprint" motifs using Hidden Markov Models delineating the putative inter-relationship of the GRAFS families.  We show several common structural features indicating that the human GPCRs in the GRAFS families share a common ancestor.  This study represents the first overall map of the GPCRs in a single mammalian genome.  Our novel approach of analyzing such large and diverse sequence sets may be useful for studies on GPCRs in other genomes and divergent protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX4VhTsaDzrVg90H21EOLACvtfcHk0ljhMieyc0ndzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D&md5=504ea873ee8469cd0b6016bc94943836</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1256%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DLagerstr%25C3%25B6m%26aufirst%3DM.%2BC.%26aulast%3DLundin%26aufirst%3DL.%2BG.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DThe%2520G-protein-coupled%2520receptors%2520in%2520the%2520human%2520genome%2520form%2520five%2520main%2520families.%2520Phylogenetic%2520analysis%252C%2520paralogon%2520groups%252C%2520and%2520fingerprints%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26issue%3D6%26spage%3D1256%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frielle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang-Feng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2F329075a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=3041227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaL1cXmvFyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=75-79&author=B.+K.+Kobilkaauthor=T.+Frielleauthor=S.+Collinsauthor=T.+Yang-Fengauthor=T.+S.+Kobilkaauthor=U.+Franckeauthor=R.+J.+Lefkowitzauthor=M.+G.+Caron&title=An+intronless+gene+encoding+a+potential+member+of+the+family+of+receptors+coupled+to+guanine+nucleotide+regulatory+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins</span></div><div class="casAuthors">Kobilka, Brian K.; Frielle, Thomas; Collins, Sheila; Yang-Feng, Theresa; Kobilka, Tong Sun; Francke, Uta; Lefkowitz, Robert J.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">6134</span>),
    <span class="NLM_cas:pages">75-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A DNA fragment from a human genomic library was isolated, cloned, and sequenced.  The fragment (G-21) cross-hybridizes with a full-length B2-adrenergic probe at reduced stringency.  The gene is intronless, and contains an uninterrupted long open reading frame which encodes a putative protein in the expected structural features of a G-protein-coupled receptor.  The G-21 locus was localized to chromosome 5.  The corresponding mRNA of 6000 nucleotides was most abundant in lymphatic tissues including lymph node, spleen, and thymus.  This mRNA was also expressed in gut, muscle, and kidney but not in lung, heart, adrenal gland, and placenta.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJGLNLxFcT6bVg90H21EOLACvtfcHk0ljhMieyc0ndzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmvFyktA%253D%253D&md5=d2ad5e28f45bc40ece0fd9aaa96ad61b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F329075a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329075a0%26sid%3Dliteratum%253Aachs%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DFrielle%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DYang-Feng%26aufirst%3DT.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAn%2520intronless%2520gene%2520encoding%2520a%2520potential%2520member%2520of%2520the%2520family%2520of%2520receptors%2520coupled%2520to%2520guanine%2520nucleotide%2520regulatory%2520proteins%26jtitle%3DNature%26date%3D1987%26volume%3D329%26spage%3D75%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fargin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1988&pages=358-360&author=A.+Farginauthor=J.+R.+Raymondauthor=M.+J.+Lohseauthor=B.+K.+Kobilkaauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=The+genomic+clone+G-21+which+resembles+a+%CE%B2-adrenergic+receptor+sequence+encodes+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFargin%26aufirst%3DA.%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520genomic%2520clone%2520G-21%2520which%2520resembles%2520a%2520%25CE%25B2-adrenergic%2520receptor%2520sequence%2520encodes%2520the%25205-HT1A%2520receptor%26jtitle%3DNature%26date%3D1988%26volume%3D335%26spage%3D358%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Albert, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tol, H. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">5825</span><span class="NLM_x">–</span> <span class="NLM_lpage">5832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=5825-5832&issue=10&author=P.+R.+Albertauthor=Q.+Y.+Zhouauthor=H.+H.+M.+Van+Tolauthor=J.+R.+Bunzowauthor=O.+Civelli&title=Cloning%2C+functional+expression%2C+and+mRNA+tissue+distribution+of+the+rat+5-hydroxytryptamine1A+receptor+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DP.%2BR.%26aulast%3DZhou%26aufirst%3DQ.%2BY.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DCloning%252C%2520functional%2520expression%252C%2520and%2520mRNA%2520tissue%2520distribution%2520of%2520the%2520rat%25205-hydroxytryptamine1A%2520receptor%2520gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26issue%3D10%26spage%3D5825%26epage%3D5832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Charest, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainer, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, P. R.</span><span> </span><span class="NLM_article-title">Cloning and differentiation-induced expression of a murine serotonin<sub>1A</sub> receptor in a septal cell line</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5164</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2cXht1Gls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=5164-5171&author=A.+Charestauthor=B.+H.+Wainerauthor=P.+R.+Albert&title=Cloning+and+differentiation-induced+expression+of+a+murine+serotonin1A+receptor+in+a+septal+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line</span></div><div class="casAuthors">Charest, Alain; Wainer, Bruce H.; Albert, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5164-71</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">A neuronal cell model endogenously expressing the 5-HT1A receptor, in which to study the function and regulation of this gene, has yet to be identified.  The authors examd. murine SN-48 cells, a septum x neuroblastoma fusion cell line that proliferates in a nondifferentiated state but can be induced to differentiate into neurofilament-pos. cells following 24-96 h treatment with 10 μM retinoic acid in low serum.  Northern blot anal. demonstrated the presence of a single 10.9 kilobase (kb) 5-HT1A receptor RNA species in differentiated SN-48 cells, which was not detected in undifferentiated SN-48 cells.  The presence of receptor RNA in differentiated SN-48 cells correlated with the appearance of functional responses (i.e., pertussis toxin-sensitive inhibition of cAMP accumulation) to 5-HT1A agonists in differentiated but not in undifferentiated cells.  To verify that the large 10.9 kb RNA species in SN-48 cells truly corresponded to the mouse 5-HT1A receptor RNA, a cDNA fragment from differentiated SN-48 cells was used to clone the corresponding mouse brain cDNA.  The 2.4 kb cDNA contained a single open reading frame that displayed high (>85% predicted amino acid identity) homol. to the human and rat 5-HT1A receptor genes.  When transfected into receptor-neg. Ltk- cells, this cDNA was found to direct expression of a murine 5-HT1A receptor.  Thus, the authors conclude that upon differentiation SN-48 cells express RNA encoding functional 5-HT1A receptors.  The SN-48 septal cells will provide a useful cellular model system for investigating aspects of neuronal differentiation leading to the development of sensitivity to serotonergic input.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7jtec-7H8_rVg90H21EOLACvtfcHk0lhjGEeucR6zOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1Gls78%253D&md5=57ee14b593f0901acb39a2e14230cbbc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharest%26aufirst%3DA.%26aulast%3DWainer%26aufirst%3DB.%2BH.%26aulast%3DAlbert%26aufirst%3DP.%2BR.%26atitle%3DCloning%2520and%2520differentiation-induced%2520expression%2520of%2520a%2520murine%2520serotonin1A%2520receptor%2520in%2520a%2520septal%2520cell%2520line%26jtitle%3DJ.%2520Neurosci.%26date%3D1993%26volume%3D13%26spage%3D5164%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Banerjee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joo, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buse, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, G.</span><span> </span><span class="NLM_article-title">Differential solubilization of lipids along with membrane proteins by different classes of detergents</span> <span class="citation_source-journal">Chem. Phys. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1995&pages=65-78&author=P.+Banerjeeauthor=J.+B.+Jooauthor=J.+T.+Buseauthor=G.+Dawson&title=Differential+solubilization+of+lipids+along+with+membrane+proteins+by+different+classes+of+detergents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DP.%26aulast%3DJoo%26aufirst%3DJ.%2BB.%26aulast%3DBuse%26aufirst%3DJ.%2BT.%26aulast%3DDawson%26aufirst%3DG.%26atitle%3DDifferential%2520solubilization%2520of%2520lipids%2520along%2520with%2520membrane%2520proteins%2520by%2520different%2520classes%2520of%2520detergents%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D1995%26volume%3D77%26spage%3D65%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaput, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrièle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT<sub>1A</sub> receptors as a function of receptor: G-protein stoichiometry</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=451-459&author=A.+Newman-Tancrediauthor=C.+Conteauthor=C.+Chaputauthor=L.+Verri%C3%A8leauthor=M.+J.+Millan&title=Agonist+and+inverse+agonist+efficacy+at+human+recombinant+serotonin+5-HT1A+receptors+as+a+function+of+receptor%3A+G-protein+stoichiometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DConte%26aufirst%3DC.%26aulast%3DChaput%26aufirst%3DC.%26aulast%3DVerri%25C3%25A8le%26aufirst%3DL.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DAgonist%2520and%2520inverse%2520agonist%2520efficacy%2520at%2520human%2520recombinant%2520serotonin%25205-HT1A%2520receptors%2520as%2520a%2520function%2520of%2520receptor%253A%2520G-protein%2520stoichiometry%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D451%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kalipatnapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">A GFP fluorescence-based approach to determine detergent insolubility of the human serotonin<sub>1A</sub> receptor</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=2004&pages=455-460&author=S.+Kalipatnapuauthor=A.+Chattopadhyay&title=A+GFP+fluorescence-based+approach+to+determine+detergent+insolubility+of+the+human+serotonin1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalipatnapu%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DA%2520GFP%2520fluorescence-based%2520approach%2520to%2520determine%2520detergent%2520insolubility%2520of%2520the%2520human%2520serotonin1A%2520receptor%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D576%26spage%3D455%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Paila, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">The human serotonin<sub>1A</sub> receptor expressed in neuronal cells: toward a native environment for neuronal receptors</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2Fs10571-006-9098-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=17120164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtleksb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=925-942&author=Y.+D.+Pailaauthor=A.+Chattopadhyay&title=The+human+serotonin1A+receptor+expressed+in+neuronal+cells%3A+toward+a+native+environment+for+neuronal+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Serotonin1A Receptor Expressed in Neuronal Cells: Toward a Native Environment for Neuronal Receptors</span></div><div class="casAuthors">Paila, Yamuna Devi; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">925-942</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The serotonin1A (5-HT1A) receptor is an important representative of G-protein coupled family of receptors.  It is the most extensively studied among the serotonin receptors, and appears to be involved in various behavioral and cognitive functions.  We report here the pharmacol. and functional characterization of the human serotonin1A receptor stably expressed in HN2 cell line, which is a hybrid cell line between hippocampal cells and mouse neuroblastoma.  Our results show that serotonin1A receptors in HN2-5-HT1AR cells display ligand-binding properties that closely mimic binding properties obsd. with native receptors.  We further demonstrate that the differential discrimination of G-protein coupling by the specific agonist and antagonist, a hallmark of the native receptor, is maintained for the receptor in HN2-5-HT1AR cells.  Importantly, the serotonin1A receptor in HN2-5-HT1AR cells shows efficient downstream signalling by reducing cellular cAMP levels.  We conclude that serotonin1A receptors expressed in HN2-5-HT1AR cells represent a useful model system to study serotonin1A receptor biol., and is a potential system for solubilization and purifn. of the receptor in native-like membrane environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr9u9LxEfCHLVg90H21EOLACvtfcHk0liVoDrp2x5yUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtleksb3I&md5=7f0691bdb52e26100e616eff5e3cd316</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10571-006-9098-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-006-9098-9%26sid%3Dliteratum%253Aachs%26aulast%3DPaila%26aufirst%3DY.%2BD.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DThe%2520human%2520serotonin1A%2520receptor%2520expressed%2520in%2520neuronal%2520cells%253A%2520toward%2520a%2520native%2520environment%2520for%2520neuronal%2520receptors%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2006%26volume%3D26%26spage%3D925%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pucadyil, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalipatnapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">The serotonin<sub>1A</sub> receptor: a representative member of the serotonin receptor family</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2Fs10571-005-3969-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16075379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnslyrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=553-580&author=T.+J.+Pucadyilauthor=S.+Kalipatnapuauthor=A.+Chattopadhyay&title=The+serotonin1A+receptor%3A+a+representative+member+of+the+serotonin+receptor+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin1A receptor: a representative member of the serotonin receptor family</span></div><div class="casAuthors">Pucadyil, Thomas J.; Kalipatnapu, Shanti; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">553-580</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Serotonin is an intrinsically fluorescent biogenic amine that acts as a neurotransmitter and is found in a wide variety of sites in the central and peripheral nervous system.  Serotonergic signaling appears to play a key role in the generation and modulation of various cognitive and behavioral functions.  Serotonin exerts its diverse actions by binding to distinct cell surface receptors which have been classified into many groups.  The serotonin1A (5-HT1A) receptor is the most extensively studied of the serotonin receptors and belongs to the large family of 7-transmembrane domain G-protein coupled receptors.  The tissue and sub-cellular distribution, structural characteristics, signaling of the serotonin1A receptor and its interaction with G-proteins are discussed.  The pharmacol. of serotonin1A receptors is reviewed in terms of binding of agonists and antagonists and sensitivity of their binding to guanine nucleotides.  Membrane biol. of 5-HT1A receptors is presented using the bovine hippocampal serotonin1A receptor as a model system.  The ligand binding activity and G-protein coupling of the receptor is modulated by membrane cholesterol thereby indicating the requirement of cholesterol in maintaining the receptor organization and function.  This, along with the reported detergent resistance characteristics of the receptor, raises important questions on the role of membrane lipids and domains in the function of this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvzwhksrHu17Vg90H21EOLACvtfcHk0liVoDrp2x5yUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnslyrurw%253D&md5=4bf849e2150b81a4525ec381130b70f3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10571-005-3969-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-005-3969-3%26sid%3Dliteratum%253Aachs%26aulast%3DPucadyil%26aufirst%3DT.%2BJ.%26aulast%3DKalipatnapu%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DThe%2520serotonin1A%2520receptor%253A%2520a%2520representative%2520member%2520of%2520the%2520serotonin%2520receptor%2520family%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2005%26volume%3D25%26spage%3D553%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">G protein-coupled receptors. II. Mechanism of agonist activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">17979</span><span class="NLM_x">–</span> <span class="NLM_lpage">17982</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=17979-17982&author=U.+Getherauthor=B.+K.+Kobilka&title=G+protein-coupled+receptors.+II.+Mechanism+of+agonist+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGether%26aufirst%3DU.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DG%2520protein-coupled%2520receptors.%2520II.%2520Mechanism%2520of%2520agonist%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D17979%26epage%3D17982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kalipatnapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, A.</span><span> </span><span class="NLM_article-title">Membrane organization and function of the serotonin<sub>1A</sub> receptor</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2Fs10571-007-9189-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1097-1116&issue=8&author=S.+Kalipatnapuauthor=A.+Chattopadhyay&title=Membrane+organization+and+function+of+the+serotonin1A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Organization and Function of the Serotonin1A Receptor</span></div><div class="casAuthors">Kalipatnapu, Shanti; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1097-1116</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  (1) The serotonin1A receptor is a G-protein coupled receptor involved in several cognitive, behavioral, and developmental functions.  It binds the neurotransmitter serotonin and signals across the membrane through its interactions with heterotrimeric G-proteins.  (2) Lipid-protein interactions in membranes play an important role in the assembly, stability, and function of membrane proteins.  The role of membrane environment in serotonin1A receptor function is beginning to be addressed by exploring the consequences of lipid manipulations on the ligand binding and G-protein coupling of serotonin1A receptors, the ability to functionally solubilize the serotonin1A receptor, and the factors influencing the membrane organization of the serotonin1A receptor.  (3) Recent developments involving the application of detergent-based and detergent-free approaches to understand the membrane organization of the serotonin1A receptor under conditions of ligand activation and modulation of membrane lipid content, with an emphasis on membrane cholesterol, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpef7HfbClvTLVg90H21EOLACvtfcHk0lhqd-ZuZIsGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWluro%253D&md5=6ed5e145c5474a3f6ce12ba293495318</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs10571-007-9189-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-007-9189-2%26sid%3Dliteratum%253Aachs%26aulast%3DKalipatnapu%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DMembrane%2520organization%2520and%2520function%2520of%2520the%2520serotonin1A%2520receptor%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2007%26volume%3D27%26issue%3D8%26spage%3D1097%26epage%3D1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">del Olmo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Giménez, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaró, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengod, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, A.</span><span> </span><span class="NLM_article-title">Early localization of mRNA coding for 5-HT<sub>1A</sub> receptors in human brain during development</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0169-328X%2898%2900149-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=9748536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXlvFeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1998&pages=123-126&author=E.+del+Olmoauthor=J.+F.+L%C3%B3pez-Gim%C3%A9nezauthor=M.+T.+Vilar%C3%B3author=G.+Mengodauthor=J.+M.+Palaciosauthor=A.+Pazos&title=Early+localization+of+mRNA+coding+for+5-HT1A+receptors+in+human+brain+during+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Early localization of mRNA coding for 5-HT1A receptors in human brain during development</span></div><div class="casAuthors">del Olmo, Elena; Lopez-Gimenez, Juan F.; Vilaro, M. Teresa; Mengod, Guadalupe; Palacios, Jose M.; Pazos, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-126</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The distribution of 5-HT1A receptor mRNA in the human brain was studied in neonatal, children and adult cases by in situ hybridization histochem., using an oligonucleotide derived from the coding region of the human receptor.  A prenatal pattern of development was obsd.  The hippocampus, raphe nuclei and neocortex presented high levels of hybridization already at the fetal/neonatal stage, fully comparable to the adult.  A high and transient hybridization signal was found in cerebellum.  These results support a role for 5-HT1A receptors in the regulation of neural development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUli9S7e40CbVg90H21EOLACvtfcHk0lhqd-ZuZIsGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvFeqtrY%253D&md5=3779e8bce67f280c4231da3d92e999e1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2898%2900149-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252898%252900149-1%26sid%3Dliteratum%253Aachs%26aulast%3Ddel%2BOlmo%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez-Gim%25C3%25A9nez%26aufirst%3DJ.%2BF.%26aulast%3DVilar%25C3%25B3%26aufirst%3DM.%2BT.%26aulast%3DMengod%26aufirst%3DG.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26aulast%3DPazos%26aufirst%3DA.%26atitle%3DEarly%2520localization%2520of%2520mRNA%2520coding%2520for%25205-HT1A%2520receptors%2520in%2520human%2520brain%2520during%2520development%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1998%26volume%3D60%26spage%3D123%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Singh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chromy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, P.</span><span> </span><span class="NLM_article-title">Induction of the serotonin<sub>1A</sub> receptor in neuronal cells during prolonged stress and degeneration</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2361</span><span class="NLM_x">–</span> <span class="NLM_lpage">2372</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1046%2Fj.1471-4159.1996.66062361.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK28XjtFCktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=2361-2372&author=J.+K.+Singhauthor=B.+A.+Chromyauthor=M.+J.+Boyersauthor=G.+Dawsonauthor=P.+Banerjee&title=Induction+of+the+serotonin1A+receptor+in+neuronal+cells+during+prolonged+stress+and+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of the serotonin1A receptor in neuronal cells during prolonged stress and degeneration</span></div><div class="casAuthors">Singh, Jyoti K.; Chromy, Brett A.; Boyers, Michael J.; Dawson, Glyn; Banerjee, Probal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2361</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Neuronal migration in brain is followed by differentiation of committed neurons and simultaneous apoptosis of uncommitted preneuronal cells due to a limiting supply of trophic factors and nutrients.  The authors have dissected differentiation and apoptosis by designing a simple in vitro model for this nutrient deprivation using engineered neuronal cell lines stably transfected with a promoterless segment (G-21) of the intronless human serotonin1A receptor (G-21) of the intronless human serotonin1A receptor (5-HT1A-R) gene.  Despite the use of widely different heterologous promoters (cytomegalovirus and Rous sarcoma virus) for the stable expression of G-21, a dramatic increase in expression of the 5-HT1A-R (five- to 15-fold) and its mRNA was always obsd. during degeneration and apoptosis of nutrient-deprived neuronal cells.  Involvement in this induction of a 170-bp 5'-end untranslated sequence (5'-UT) (tail end of the 500-bp natural promoter) of G-21 was confirmed by stable transfection of neuronal cells with an SV-40 promoter-driven construct harboring the 5'-UT and the reporter chloramphenicol acetyltransferase (CAT) cDNA.  Presence of the 5'-UT resulted in a threefold increase in CAT expression during nutrient deprivation in randomly chosen clones.  The induction was also obsd. in the endogenous 5-HT1A-R, expressed by embryonic day 16 mouse hippocampal neurons, subsequent to nutrient deprivation and onset of degeneration.  A trophic role of the 5-HT1A-R has been suggested in early studies.  Considering the example of protective heat shock proteins, which are induced during various types of stress, the results suggest that stressed neuronal cells undergoing degeneration and apoptosis synthesize increased levels of 5-HT1A-R as a final attempt to survive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszVsE0dHwvLVg90H21EOLACvtfcHk0lhqd-ZuZIsGVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFCktbs%253D&md5=f302ba94a7ed5b92d8a4299a92e03f10</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.66062361.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.66062361.x%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BK.%26aulast%3DChromy%26aufirst%3DB.%2BA.%26aulast%3DBoyers%26aufirst%3DM.%2BJ.%26aulast%3DDawson%26aufirst%3DG.%26aulast%3DBanerjee%26aufirst%3DP.%26atitle%3DInduction%2520of%2520the%2520serotonin1A%2520receptor%2520in%2520neuronal%2520cells%2520during%2520prolonged%2520stress%2520and%2520degeneration%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D66%26spage%3D2361%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feingold, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (<i>R</i>)-<i>N</i>-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-<i>N</i>-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.107.133082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=18182558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=134-145&author=W.+D.+Hirstauthor=T.+H.+Andreeauthor=S.+Aschmiesauthor=W.+E.+Childersauthor=T.+A.+Comeryauthor=L.+A.+Dawsonauthor=M.+Dayauthor=I.+B.+Feingoldauthor=S.+M.+Grauerauthor=B.+L.+Harrisonauthor=Z.+A.+Hughesauthor=J.+Kaoauthor=M.+G.+Kellyauthor=H.+van+der+Leeauthor=S.+Rosenzweig-Lipsonauthor=A.+L.+Saabauthor=D.+L.+Smithauthor=K.+Sullivanauthor=S.+J.+Sukoff+Rizzoauthor=C.+Tioauthor=M.+Y.+Zhangauthor=L.+E.+Schechter&title=Correlating+efficacy+in+rodent+cognition+models+with+in+vivo+5-hydroxytryptamine1A+receptor+occupancy+by+a+novel+antagonist%2C+%28R%29-N-%282-methyl-%284-indolyl-1-piperazinyl%29ethyl%29-N-%282-pyridinyl%29-cyclohexane+carboxamide+%28WAY-101405%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span></div><div class="casAuthors">Hirst, Warren D.; Andree, Terrance H.; Aschmies, Suzan; Childers, Wayne E.; Comery, Thomas A.; Dawson, Lee A.; Day, Mark; Feingold, Irene B.; Grauer, Steven M.; Harrison, Boyd L.; Hughes, Zoe A.; Kao, John; Kelly, Michael G.; van der Lee, Heidi; Rosenzweig-Lipson, Sharon; Saab, Annmarie L.; Smith, Deborah L.; Sullivan, Kelly; Rizzo, Stacey J. Sukoff; Tio, Cesario; Zhang, Mei-Yi; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-145</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)1A receptors play an important role in multiple cognitive processes, and compelling evidence suggests that 5-HT1A antagonists can reverse cognitive impairment.  We have examd. the therapeutic potential of a potent (Ki = 1.1 nM), selective (>100-fold), orally bioavailable, silent 5-HT1A receptor antagonist (KB = 1.3 nM) (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)-ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).  Oral administration of WAY-101405 was shown to be effective in multiple rodent models of learning and memory.  In a novel object recognition paradigm, 1 mg/kg enhanced retention (memory) for previously learned information, and it was able to reverse the memory deficits induced by scopolamine.  WAY-101405 (1 mg/kg) was also able to reverse scopolamine-induced deficits in a rat contextual fear conditioning model.  In the Morris water maze, WAY-101405 (3 mg/kg) significantly improved learning in a paradigm of increasing task difficulty.  In vivo microdialysis studies in the dorsal hippocampus of freely moving adult rats demonstrated that acute administration of WAY-101405 (10 mg/kg) increased extracellular acetylcholine levels.  The selective radioligand [3H]WAY-100635, administered i.v., was used for in vivo receptor occupancy studies, where WAY-101405 occupied 50HT1A receptors in the rat cortex, with an ED50 value of 0.1 mg/kg p.o.  Taken together, these studies demonstrate that WAY-101405 is a potent and selective, brain penetrant, orally bioavailable 5-HT1A receptor "silent" antagonist that is effective in preclin. memory paradigms at doses where approx. 90% of the postsynaptic 5-HT1A receptors are occupied.  These results further support the rationale for use of this compd. class in the treatment of cognitive dysfunction assocd. with psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHA4lNdFCubVg90H21EOLACvtfcHk0lhB1uNtvd0Pyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D&md5=32bf330b68ae1b11a2013e4563b8f686</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133082%26sid%3Dliteratum%253Aachs%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DFeingold%26aufirst%3DI.%2BB.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3Dvan%2Bder%2BLee%26aufirst%3DH.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSaab%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DTio%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DCorrelating%2520efficacy%2520in%2520rodent%2520cognition%2520models%2520with%2520in%2520vivo%25205-hydroxytryptamine1A%2520receptor%2520occupancy%2520by%2520a%2520novel%2520antagonist%252C%2520%2528R%2529-N-%25282-methyl-%25284-indolyl-1-piperazinyl%2529ethyl%2529-N-%25282-pyridinyl%2529-cyclohexane%2520carboxamide%2520%2528WAY-101405%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D134%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Whitaker-Azmitia, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauder, J. M.</span><span> </span><span class="NLM_article-title">Serotonin as a developmental signal</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=19-29&author=P.+M.+Whitaker-Azmitiaauthor=M.+Druseauthor=P.+Walkerauthor=J.+M.+Lauder&title=Serotonin+as+a+developmental+signal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitaker-Azmitia%26aufirst%3DP.%2BM.%26aulast%3DDruse%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DP.%26aulast%3DLauder%26aufirst%3DJ.%2BM.%26atitle%3DSerotonin%2520as%2520a%2520developmental%2520signal%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1996%26volume%3D73%26spage%3D19%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bordukalo-Niksic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrovic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefulj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernej, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicin-Sain, L.</span><span> </span><span class="NLM_article-title">5HT<sub>1A</sub> receptors and anxiety-like behaviours: studies in rats with constitutionally upregulated/downregulated serotonin transporter</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2010&pages=238-245&issue=2&author=T.+Bordukalo-Niksicauthor=G.+Mokrovicauthor=J.+Stefuljauthor=M.+Zivinauthor=B.+Jernejauthor=L.+Cicin-Sain&title=5HT1A+receptors+and+anxiety-like+behaviours%3A+studies+in+rats+with+constitutionally+upregulated%2Fdownregulated+serotonin+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBordukalo-Niksic%26aufirst%3DT.%26aulast%3DMokrovic%26aufirst%3DG.%26aulast%3DStefulj%26aufirst%3DJ.%26aulast%3DZivin%26aufirst%3DM.%26aulast%3DJernej%26aufirst%3DB.%26aulast%3DCicin-Sain%26aufirst%3DL.%26atitle%3D5HT1A%2520receptors%2520and%2520anxiety-like%2520behaviours%253A%2520studies%2520in%2520rats%2520with%2520constitutionally%2520upregulated%252Fdownregulated%2520serotonin%2520transporter%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D213%26issue%3D2%26spage%3D238%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Cuisiat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdiol, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacharme, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span> </span><span class="NLM_article-title">Towards a new generation of potential antipsychotic agents combining D<sub>2</sub> and 5-HT<sub>1A</sub> receptor activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061180b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=865-876&issue=4&author=S.+Cuisiatauthor=N.+Bourdiolauthor=V.+Lacharmeauthor=A.+Newman-Tancrediauthor=F.+Colpaertauthor=B.+Vacher&title=Towards+a+new+generation+of+potential+antipsychotic+agents+combining+D2+and+5-HT1A+receptor+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm061180b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061180b%26sid%3Dliteratum%253Aachs%26aulast%3DCuisiat%26aufirst%3DS.%26aulast%3DBourdiol%26aufirst%3DN.%26aulast%3DLacharme%26aufirst%3DV.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DVacher%26aufirst%3DB.%26atitle%3DTowards%2520a%2520new%2520generation%2520of%2520potential%2520antipsychotic%2520agents%2520combining%2520D2%2520and%25205-HT1A%2520receptor%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D4%26spage%3D865%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Huot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprich, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkelmolen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span> </span><span class="NLM_article-title">Regulation of cortical and striatal 5-HT<sub>1A</sub> receptors in the MPTP-lesioned macaque</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">207.e9</span><span class="NLM_x">–</span> <span class="NLM_lpage">207.e19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=207.e9-207.e19&author=P.+Huotauthor=T.+H.+Johnstonauthor=J.+B.+Koprichauthor=L.+Winkelmolenauthor=S.+H.+Foxauthor=J.+M.+Brotchie&title=Regulation+of+cortical+and+striatal+5-HT1A+receptors+in+the+MPTP-lesioned+macaque"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuot%26aufirst%3DP.%26aulast%3DJohnston%26aufirst%3DT.%2BH.%26aulast%3DKoprich%26aufirst%3DJ.%2BB.%26aulast%3DWinkelmolen%26aufirst%3DL.%26aulast%3DFox%26aufirst%3DS.%2BH.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26atitle%3DRegulation%2520of%2520cortical%2520and%2520striatal%25205-HT1A%2520receptors%2520in%2520the%2520MPTP-lesioned%2520macaque%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D207.e9%26epage%3D207.e19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Nadeson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodchild, C. S.</span><span> </span><span class="NLM_article-title">Antinociceptive role of 5-HT<sub>1A</sub> receptors in rat spinal cord</span> <span class="citation_source-journal">Br. J. Anaesth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1093%2Fbja%2F88.5.679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlSjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2002&pages=679-684&author=R.+Nadesonauthor=C.+S.+Goodchild&title=Antinociceptive+role+of+5-HT1A+receptors+in+rat+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive role of 5-HT1A receptors in rat spinal cord</span></div><div class="casAuthors">Nadeson, R.; Goodchild, C. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">679-684</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">0007-0912</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Intrathecal administration of 5-hydroxytryptamine (5-HT) is antinociceptive to noxious heat and elec. stimuli.  The contributions of different receptor subtypes to the antinociceptive effects of 5-HT are controversial.  The main reasons for this are the poor receptor subtype selectivity of some agonist drugs and the difficulty of restricting drug action to the spinal cord in some exptl. paradigms.  This study investigated the roles of different 5-HT receptor subtypes involved in the spinal cord control of the nociception produced by these two nociceptive testing paradigms.  Tail-flick latency and elec. current threshold for nociception were measured in an acute pain model that allowed the study of the antinociceptive effects of intrathecally administered drugs that were due to actions of these drugs at spinal cord receptors.  Expts. were performed in male Wistar rats with chronically implanted lumbar subarachnoid catheters.  Dose-response curves for spinally mediated antinociceptive effects of agonists selective for 5-HT receptor subtypes were constructed.  The 5-HT1 agonist 1-(3-chlorophenyl)-piperazine dihydrochloride caused a dose-dependent antinociceptive effect, measured by both nociceptive tests.  However, 8-hydroxy-DPAT (selective 5-HT1A agonist) produced antinociception assessed by elec. current but not tail flick.  A 5-HT1A-selective antagonist, 4-[3-(benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)-piperazine, reversed the antinociception in the elec. test produced by both of these agonists but the tail-flick latency effects after intrathecal 1-(3-chlorophenyl)-piperazine were not suppressed by this antagonist.  We conclude that 5-HT1A receptors in the spinal cord are involved in the nociceptive mechanisms assessed by noxious elec. stimuli.  Other 5-HT1 receptors (non 5-HT1A receptors) are involved in the spinally mediated antinociception assessed by thermal noxious stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPyW-6tsoRSbVg90H21EOLACvtfcHk0lhB1uNtvd0Pyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlSjtb0%253D&md5=55ee82893851a55544cd0b0efecff7ea</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fbja%2F88.5.679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252F88.5.679%26sid%3Dliteratum%253Aachs%26aulast%3DNadeson%26aufirst%3DR.%26aulast%3DGoodchild%26aufirst%3DC.%2BS.%26atitle%3DAntinociceptive%2520role%2520of%25205-HT1A%2520receptors%2520in%2520rat%2520spinal%2520cord%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2002%26volume%3D88%26spage%3D679%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zhang, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. Q.</span><span> </span><span class="NLM_article-title">Expression of 5-HT<sub>1A</sub> receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2002&pages=287-295&author=Y.+Q.+Zhangauthor=X.+Gaoauthor=G.+C.+Jiauthor=Y.+L.+Huangauthor=G.+C.+Wuauthor=Z.+Q.+Zhao&title=Expression+of+5-HT1A+receptor+mRNA+in+rat+lumbar+spinal+dorsal+horn+neurons+after+peripheral+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DG.%2BC.%26aulast%3DHuang%26aufirst%3DY.%2BL.%26aulast%3DWu%26aufirst%3DG.%2BC.%26aulast%3DZhao%26aufirst%3DZ.%2BQ.%26atitle%3DExpression%2520of%25205-HT1A%2520receptor%2520mRNA%2520in%2520rat%2520lumbar%2520spinal%2520dorsal%2520horn%2520neurons%2520after%2520peripheral%2520inflammation%26jtitle%3DPain%26date%3D2002%26volume%3D98%26spage%3D287%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Pithadiaa, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine receptor subtypes and their modulators with therapeutic potentials</span> <span class="citation_source-journal">J. Clin. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=72-80&issue=2&author=A.+B.+Pithadiaaauthor=S.+M.+Jain&title=5-Hydroxytryptamine+receptor+subtypes+and+their+modulators+with+therapeutic+potentials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPithadiaa%26aufirst%3DA.%2BB.%26aulast%3DJain%26aufirst%3DS.%2BM.%26atitle%3D5-Hydroxytryptamine%2520receptor%2520subtypes%2520and%2520their%2520modulators%2520with%2520therapeutic%2520potentials%26jtitle%3DJ.%2520Clin.%2520Med.%2520Res.%26date%3D2009%26volume%3D1%26issue%3D2%26spage%3D72%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Shinka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onodera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, T.</span><span> </span><span class="NLM_article-title">Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line</span> <span class="citation_source-journal">Oncol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=211-215&issue=2&author=T.+Shinkaauthor=D.+Onoderaauthor=T.+Tanakaauthor=N.+Shojiauthor=T.+Miyazakiauthor=T.+Moriuchiauthor=T.+Fukumoto&title=Serotonin+synthesis+and+metabolism-related+molecules+in+a+human+prostate+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line</span></div><div class="casAuthors">Shinka, Toshiaki; Onodera, Dai; Tanaka, Tetsuji; Shoji, Noriaki; Miyazaki, Tadaaki; Moriuchi, Tetsuya; Fukumoto, Takahiro</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-215</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most common tumors in males and its incidence is steadily increasing worldwide.  Serotonin or 5-hydroxytryptamine (5-HT) is a well-known neurotransmitter that mediates a wide variety of physiol. effects.  An increase in the no. of 5-HT-releasing neuroendocrine (NE) cells has been correlated with tumor progression.  However, it is particularly unclear whether released 5-HT or the release of 5-HT has a role in tumor cell growth.  We hypothesized that 5-HT synthesis and metab. in NE cells regulate the growth of prostate cancer cells.  In the present study, 5-HT was found to play a role as a cell growth factor in prostate cancer cells.  Moreover, the pharmacol. inhibition of 5-HT synthesis and metab. interrupted the growth of prostate cancer cells.  To confirm the existence of 5-HT in prostate cancer cells, we performed ELISA, HPLC, RT-PCR and immunohistochem. analyses.  A high expression of tryptophan hydroxylase (TPH-1), dopa decarboxylase (DDC) and monoamine oxidase A (MAO-A) was noted in the prostate cancer cells when compared with normal prostate cells.  Previous studies showed that 5-HT stimulated the proliferation of prostate cancer cells mediated by 5-HT receptors 5-HTR1A and R1B.  However, cell proliferation was significantly inhibited when siRNA for both DDC and TPH-1 was transfected to the cells.  Consequently, we propose that the secretion system of prostate NE cells capable of 5-HT synthesis and metab. plays a significant role in prostate tumor generation and progression.  These findings provide crucial clues for the development of potential pharmacotherapeutics to slow prostate tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJqJqWdseDrVg90H21EOLACvtfcHk0lh-ujSMP-nLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSht7c%253D&md5=df3bf2023889085c2cea0a9d4c63e205</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShinka%26aufirst%3DT.%26aulast%3DOnodera%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DMoriuchi%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DT.%26atitle%3DSerotonin%2520synthesis%2520and%2520metabolism-related%2520molecules%2520in%2520a%2520human%2520prostate%2520cancer%2520cell%2520line%26jtitle%3DOncol.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D2%26spage%3D211%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pham-Le, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span> </span><span class="NLM_article-title">Activation of GABA<sub>A</sub> or 5HT<sub>1A</sub> receptors in the raphe pallidus abolish the cardiovascular responses to exogenous stress in conscious rats</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.brainresbull.2011.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOhurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2011&pages=360-366&author=N.+M.+Pham-Leauthor=C.+Cockburnauthor=K.+Nowellauthor=J.+Brown&title=Activation+of+GABAA+or+5HT1A+receptors+in+the+raphe+pallidus+abolish+the+cardiovascular+responses+to+exogenous+stress+in+conscious+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of GABAA or 5HT1A receptors in the raphe pallidus abolish the cardiovascular responses to exogenous stress in conscious rats</span></div><div class="casAuthors">Pham-Le, Nhut Minh; Cockburn, Chelsea; Nowell, Katherine; Brown, Justin</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">360-366</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysfunction in serotonin (5HT) neurotransmission in the brainstem of infants may disrupt protective responses to stress and increase the risk for Sudden Infant Death Syndrome (SIDS).  The raphe pallidus (NRP) and other brainstem nuclei are rich in 5HT and are thought to mediate stress responses, including increases in blood pressure (BP) and heart rate (HR).  Detg. how 5HT neurotransmission in the brainstem mediates responses to stress will help to explain how dysfunction in neurotransmission could increase the risk of SIDS.  It was hypothesized that alterations in neurotransmission in the NRP, specifically activation of the 5HT1A receptor subtype, would block cardiovascular responses to various types of exogenous stress.  Using aseptic techniques, male Sprague-Dawley rats were instrumented with radiotelemetry probes which enabled non-invasive measurement of BP and HR.  An indwelling microinjection cannula was also stereotaxically implanted into the NRP for injection of drugs that altered local 5HT neurotransmission.  Following a one week recovery period, rats were microinjected with either muscimol (GABAA receptor agonist), 8-OH-DPAT (agonist to the inhibitory 5HT1A receptor), or a vehicle control (artificial cerebral spinal fluid; ACSF) immediately prior to exposure to one of three stressors: handling, air jet, or restraint.  Phys. handling and restraint of the animal were designed to elicit a mild and a maximal stress response resp.; while an air jet directed at the rat's face was used to provoke a psychol. stress that did not require phys. contact.  All three stressors elicited similar and significant elevations in HR and BP following ACSF that persisted for at least 15 min with BP and HR elevated by ∼14.0 mmHg and ∼56.3 bpm resp.  The similarity in the stress responses suggest even mild handling of a rat elicits a maximal sympathoexcitatory response.  The stress response was abolished following 8-OH-DPAT or muscimol microinjection suggesting the cardiovascular responses to stress are mediated by the NRP and likely involve the 5HT1A receptor.  Impairment in 5HT1A receptor function in the NRP likely impairs the normal cardioprotective responses to stress and may contribute to the etiol. of SIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmVRD6gJYo97Vg90H21EOLACvtfcHk0lh-ujSMP-nLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOhurbK&md5=91f48ced5bcdc19a122bd663ca6cf4f9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2011.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2011.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DPham-Le%26aufirst%3DN.%2BM.%26aulast%3DCockburn%26aufirst%3DC.%26aulast%3DNowell%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520GABAA%2520or%25205HT1A%2520receptors%2520in%2520the%2520raphe%2520pallidus%2520abolish%2520the%2520cardiovascular%2520responses%2520to%2520exogenous%2520stress%2520in%2520conscious%2520rats%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2011%26volume%3D86%26spage%3D360%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ahlenius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, K.</span><span> </span><span class="NLM_article-title">Specific involvement of central 5-HT<sub>1A</sub> receptors in the mediation of male rat ejaculatory behavior</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1023%2FA%3A1022443413745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2sXkslyjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=1065-1070&author=S.+Ahleniusauthor=K.+Larsson&title=Specific+involvement+of+central+5-HT1A+receptors+in+the+mediation+of+male+rat+ejaculatory+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior</span></div><div class="casAuthors">Ahlenius, Sven; Larsson, Knut</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1065-1070</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A review, with 34 refs.  The aminotetralin 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), pharmacol. characterized as a 5-HT1A receptor agonist, produces a pronounced decrease in ejaculation latency in the male rat.  Stimulation of 5-HT receptors by a pharmacol. induced increase in the synaptic availability of 5-HT has been shown to produce the opposite effect.  The 8-OH-DPAT-induced decrease in ejaculation latency is specific for this compd., and some chem. related ergot derivs.  In this paper the authors review the evidence in support for stimulation of serotonergic autoreceptors of the 5-HT1A receptor subtype as a mechanism of action for effects by 8-OH-DPAT on male rat ejaculatory behavior.  The authors also present the questions posed by the fact that quinpirole and lisuride both produce 8-OH-DPAT-like effects on male rat ejaculatory behavior.  The effects by quinpirole, lisuride or 8-OH-DPAT are not sensitive to pretreatment with the DA D2/3 receptor antagonist raclopride.  Continued studies will show whether the effects of quinpirole and lisuride can be related to stimulation of 5-HT1A receptors, or if all these compds. have as yet undefined common properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF47hHBWDOAbVg90H21EOLACvtfcHk0lh-ujSMP-nLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslyjsbo%253D&md5=1a9b2576476368323dc078bf240febbe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022443413745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022443413745%26sid%3Dliteratum%253Aachs%26aulast%3DAhlenius%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DK.%26atitle%3DSpecific%2520involvement%2520of%2520central%25205-HT1A%2520receptors%2520in%2520the%2520mediation%2520of%2520male%2520rat%2520ejaculatory%2520behavior%26jtitle%3DNeurochem.%2520Res.%26date%3D1997%26volume%3D22%26spage%3D1065%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ahlenius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, P.</span><span> </span><span class="NLM_article-title">Effects of a new type of 5-HT receptor agonist on male rat sexual behaviour</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1981&pages=785-788&author=S.+Ahleniusauthor=K.+Larssonauthor=L.+Svenssonauthor=S.+Hjorthauthor=A.+Carlssonauthor=P.+Lindberg&title=Effects+of+a+new+type+of+5-HT+receptor+agonist+on+male+rat+sexual+behaviour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhlenius%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DK.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindberg%26aufirst%3DP.%26atitle%3DEffects%2520of%2520a%2520new%2520type%2520of%25205-HT%2520receptor%2520agonist%2520on%2520male%2520rat%2520sexual%2520behaviour%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1981%26volume%3D15%26spage%3D785%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Stafford, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coote, J. H.</span><span> </span><span class="NLM_article-title">Activation of lumbosacral 5-HT (2C) receptors induces bursts of rhythmic activity in sympathetic nerves to the vas deferens in male rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0706814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=1083-1090&author=S.+A.+Staffordauthor=K.+Tangauthor=J.+H.+Coote&title=Activation+of+lumbosacral+5-HT+%282C%29+receptors+induces+bursts+of+rhythmic+activity+in+sympathetic+nerves+to+the+vas+deferens+in+male+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of lumbosacral 5-HT2C receptors induces bursts of rhythmic activity in sympathetic nerves to the vas deferens in male rats</span></div><div class="casAuthors">Stafford, Stuart A.; Tang, Kim; Coote, John H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-1090</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We previously demonstrated that p-chloroamphetamine (PCA) i.v. evokes a specific patterned bursting response in the vas deferens nerve (VDN) of anesthetized male rats that is assocd. with contraction of the vas deferens, and ejaculation and contraction of the bulbospongiosus muscles.  The present study used selective 5-HT agonists to induce similar rhythmic bursting responses in the VDN in order to reveal the 5-HT receptor subtypes involved.  The 5-HT2C receptor agonist (1.0 mg kg-1 Ro600175 i.v.) evoked the characteristic bursting pattern responses in the VDN.  The 5-HT1A receptor agonist (1.0 mg kg-1 8-OH-DPAT i.v.) failed to elicit any responses.  However, 8-OH-DPAT coadministered in combination with Ro600175 induced a potentiation of the responses.  Responses were also evoked in rats with a mid-thoracic spinalization, with a more predictable response being obsd. following the combination of agonists.  This suggests an action of both agonists in the lumbosacral spinal cord.  Responses were blocked by 0.5 mg kg-1 SB206553 i.v. (5-HT2B/C receptor antagonist) or 0.5 mg kg-1 WAY100635 i.v. (5-HT1A receptor antagonist), but not 0.1 or 1.0 mg kg-1 SB269970 i.v. (5-HT7 receptor antagonist).  We suggest that activation of 5-HT2C and 5-HT1A receptor subtypes synergistically elicits contraction of the vas deferens through the activation of sympathetic preganglionic neurons in the spinal cord.  These data support the idea of a proejaculatory action of 5-HT2C receptors in the lumbosacral spinal cord, suggesting a descending 5-HT excitatory pathway in addn. to a 5-HT inhibitory pathway.  An excitatory action of 8-OH-DPAT at lumbosacral sites is also evident.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofM5qm2FbkZ7Vg90H21EOLACvtfcHk0liVVo1MwRicnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVylsL4%253D&md5=8a5bfcbf24ffb474fafa87e7f2d93ca5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706814%26sid%3Dliteratum%253Aachs%26aulast%3DStafford%26aufirst%3DS.%2BA.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DCoote%26aufirst%3DJ.%2BH.%26atitle%3DActivation%2520of%2520lumbosacral%25205-HT%2520%25282C%2529%2520receptors%2520induces%2520bursts%2520of%2520rhythmic%2520activity%2520in%2520sympathetic%2520nerves%2520to%2520the%2520vas%2520deferens%2520in%2520male%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D1083%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yonezawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutsuwa, M.</span><span> </span><span class="NLM_article-title">Differential effects of yohimbine, naloxone and 8-OH-DPAT on ejaculatory response in male dogs</span> <span class="citation_source-journal">Methods Find. Exp. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1358%2Fmf.2004.26.1.793472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1WksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=47-51&author=A.+Yonezawaauthor=R.+Andoauthor=M.+Imaiauthor=C.+Watanabeauthor=S.+Furutaauthor=M.+Kutsuwa&title=Differential+effects+of+yohimbine%2C+naloxone+and+8-OH-DPAT+on+ejaculatory+response+in+male+dogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of yohimbine, naloxone and 8-OH-DPAT on ejaculatory response in male dogs</span></div><div class="casAuthors">Yonezawa, A.; Ando, R.; Imai, M.; Watanabe, C.; Furuta, S.; Kutsuwa, M.; Kimura, Y.; Sakurada, S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods and Findings in Experimental and Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-51</span>CODEN:
                <span class="NLM_cas:coden">MFEPDX</span>;
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">The aim of this study was to compare the effects of the α2-adrenergic-receptor antagonist yohimbine, the 5-HT1A-receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and the opioid-receptor antagonist naloxone (all of which have been shown to stimulate male sexual arousal/motivation in rats) on sexual responses in male dogs.  Sexual responses (i.e., ejaculation, penile erection and pelvic thrusting behavior) were elicited by manual penile stimulation.  Systemic administration of yohimbine (0.03-1.0 mg/kg) produced a biphasic dose response curve for the amt. of ejaculated semen collected during genital stimulation (for 5 min), whereas 8-OH-DPAT (0.03-0.3 mg/kg) dose-dependently decreased the amt. of ejaculated semen.  Thus, yohimbine increased the amt. of ejaculated semen at lower doses (0,03-0.3 mg/kg), but decreased it at the highest dose (1.0 mg/kg).  The highest dose of yohimbine (1.0 mg/kg) and 8-OH-DPAT (0.3 mg/kg) also produced a significant delay of onset in both ejaculation and penile erection latency (tune from starting the stimulation to the first ejaculation and full erection), and a decrease in the incidence of pelvic thrusting behavior.  In contrast, administration of naloxone (0.03-1.0 mg/kg) did not affect the sexual responses elicited by genital stimulation.  These results indicate that yohimbine and 8-OH-DPAT, but not naloxone, affect sexual responses, particularly ejaculation, and that the drugs which stimulate the mechanisms regulating sexual arousal/motivation in male rats do not show identical effects for sexual function in male dogs.  The present findings also confirm our previous observations that the ejaculatory capacity in dogs can be stimulated by lower doses of yohimbine, as evidenced by an increase in the amt. of ejaculated semen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkosd0jjoTtLVg90H21EOLACvtfcHk0liVVo1MwRicnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1WksL4%253D&md5=85d35eeba81996d8244fbd05b75a0894</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1358%2Fmf.2004.26.1.793472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2004.26.1.793472%26sid%3Dliteratum%253Aachs%26aulast%3DYonezawa%26aufirst%3DA.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DC.%26aulast%3DFuruta%26aufirst%3DS.%26aulast%3DKutsuwa%26aufirst%3DM.%26atitle%3DDifferential%2520effects%2520of%2520yohimbine%252C%2520naloxone%2520and%25208-OH-DPAT%2520on%2520ejaculatory%2520response%2520in%2520male%2520dogs%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D26%26spage%3D47%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Amstislavskaya, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, N. K.</span><span> </span><span class="NLM_article-title">The roles of different types of serotonin receptors in activation of the hypophyseal-testicular complex induced in mice by the presence of a female</span> <span class="citation_source-journal">Neurosci. Behav. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=833-837&author=T.+G.+Amstislavskayaauthor=N.+K.+Popova&title=The+roles+of+different+types+of+serotonin+receptors+in+activation+of+the+hypophyseal-testicular+complex+induced+in+mice+by+the+presence+of+a+female"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmstislavskaya%26aufirst%3DT.%2BG.%26aulast%3DPopova%26aufirst%3DN.%2BK.%26atitle%3DThe%2520roles%2520of%2520different%2520types%2520of%2520serotonin%2520receptors%2520in%2520activation%2520of%2520the%2520hypophyseal-testicular%2520complex%2520induced%2520in%2520mice%2520by%2520the%2520presence%2520of%2520a%2520female%26jtitle%3DNeurosci.%2520Behav.%2520Physiol.%26date%3D2004%26volume%3D34%26spage%3D833%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Popova, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amstislavskaya, T. G.</span><span> </span><span class="NLM_article-title">Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=609-618&author=N.+K.+Popovaauthor=T.+G.+Amstislavskaya&title=Involvement+of+the+5-HT%281A%29+and+5-HT%281B%29+serotonergic+receptor+subtypes+in+sexual+arousal+in+male+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopova%26aufirst%3DN.%2BK.%26aulast%3DAmstislavskaya%26aufirst%3DT.%2BG.%26atitle%3DInvolvement%2520of%2520the%25205-HT%25281A%2529%2520and%25205-HT%25281B%2529%2520serotonergic%2520receptor%2520subtypes%2520in%2520sexual%2520arousal%2520in%2520male%2520mice%26jtitle%3DPsychoneuroendocrinology%26date%3D2002%26volume%3D27%26spage%3D609%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Motofei, I. G.</span><span> </span><span class="NLM_article-title">A dual physiological character for sexual function: the role of serotonergic receptors</span> <span class="citation_source-journal">BJU Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1464-410X.2007.07255.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=531-534&author=I.+G.+Motofei&title=A+dual+physiological+character+for+sexual+function%3A+the+role+of+serotonergic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-410X.2007.07255.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-410X.2007.07255.x%26sid%3Dliteratum%253Aachs%26aulast%3DMotofei%26aufirst%3DI.%2BG.%26atitle%3DA%2520dual%2520physiological%2520character%2520for%2520sexual%2520function%253A%2520the%2520role%2520of%2520serotonergic%2520receptors%26jtitle%3DBJU%2520Int.%26date%3D2007%26volume%3D101%26spage%3D531%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Riblet, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eison, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, H. C.</span><span> </span><span class="NLM_article-title">Pharmacology and neurochemistry of buspirone</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaL3sXhtFyqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1982&pages=11-18&issue=12&author=L.+A.+Ribletauthor=D.+P.+Taylorauthor=M.+S.+Eisonauthor=H.+C.+Stanton&title=Pharmacology+and+neurochemistry+of+buspirone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and neurochemistry of buspirone</span></div><div class="casAuthors">Riblet, Leslie A.; Taylor, Duncan P.; Eison, Michael S.; Stanton, Hubert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12, Sec. 2</span>),
    <span class="NLM_cas:pages">11-18</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    </div><div class="casAbstract">A review with 18 refs. of the pharmacol. and neurochem. of buspirone (I)  [36505-84-7].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-focGUKC6Z7Vg90H21EOLACvtfcHk0ljSGOrls4BL8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhtFyqsLw%253D&md5=e88e75fce78ee4d1f2573dc4d09e7f31</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiblet%26aufirst%3DL.%2BA.%26aulast%3DTaylor%26aufirst%3DD.%2BP.%26aulast%3DEison%26aufirst%3DM.%2BS.%26aulast%3DStanton%26aufirst%3DH.%2BC.%26atitle%3DPharmacology%2520and%2520neurochemistry%2520of%2520buspirone%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1982%26volume%3D43%26issue%3D12%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span> </span><span class="NLM_article-title">Derivatives as 5-HT<sub>1A</sub> receptor ligands—past and present</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.2174%2F0929867054367220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16029144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1721-1753&author=G.+Caliendoauthor=V.+Santagadaauthor=E.+Perissuttiauthor=F.+Fiorino&title=Derivatives+as+5-HT1A+receptor+ligands%E2%80%94past+and+present"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives as 5HT1A receptor ligands-past and present</span></div><div class="casAuthors">Caliendo, G.; Santagada, V.; Perissutti, E.; Fiorino, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1721-1753</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, depression and, insomnia as well as in normal human function such as sleep, sexual activity and appetite.  In this way, serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists and pharmaceutical companies.  Among 5-HTRs, the 5-HT1A subtype is the best studied, and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1A receptor sites such as aminotetralins, ergolines, arylpiperazines, indolylalkylamines, aporphines and aryloxyalkylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNq1YopI8Ho7Vg90H21EOLACvtfcHk0ljSGOrls4BL8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D&md5=42c78fb99de63e801880ae4577fe3583</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F0929867054367220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054367220%26sid%3Dliteratum%253Aachs%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26atitle%3DDerivatives%2520as%25205-HT1A%2520receptor%2520ligands%25E2%2580%2594past%2520and%2520present%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D1721%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viso, A.</span><span> </span><span class="NLM_article-title">Arylpiperazine derivatives acting at 5-HT<sub>1A</sub> receptors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.2174%2F0929867023371030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=11945120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=443-469&author=M.+L.+L%C3%B3pez-Rodr%C3%ADguezauthor=D.+Ayalaauthor=B.+Benham%C3%BAauthor=M.+J.+Morcilloauthor=A.+Viso&title=Arylpiperazine+derivatives+acting+at+5-HT1A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Arylpiperazine derivatives acting at 5-HT1A receptors</span></div><div class="casAuthors">Lopez-Rodriguez, M. L.; Ayala, D.; Benhamu, B.; Morcillo, M. J.; Viso, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists.  Among 5-HTRs, the 5-HT1A subtype is the best studied and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1AR sites.  Among these, arylpiperazine derivs. represent one of the most important classes of 5-HT1AR ligands.  This article will review the development of arylpiperazine derivs. acting at 5-HT1ARs with an emphasis on structure-affinity relationships of agonists and antagonists, ligand-receptor interactions and pharmacol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp08_YI2jco87Vg90H21EOLACvtfcHk0ljSGOrls4BL8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D&md5=88125d9e44708938260bdadeb73c6efb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F0929867023371030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023371030%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26aulast%3DAyala%26aufirst%3DD.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DViso%26aufirst%3DA.%26atitle%3DArylpiperazine%2520derivatives%2520acting%2520at%25205-HT1A%2520receptors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D443%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">5-HT<sub>1A</sub> receptor, an old target for new therapeutic agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.2174%2F156802608785161385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=18691130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1024-1034&author=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Berardiauthor=R.+Perrone&title=5-HT1A+receptor%2C+an+old+target+for+new+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A receptor, an old target for new therapeutic agents</span></div><div class="casAuthors">Lacivita, Enza; Leopoldo, Marcello; Berardi, Francesco; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1024-1034</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacol. characterized.  Over the last twenty years the 5-HT1A receptor has been the object of intense research efforts as witnessed by the 5-HT1A acting drugs marketed as anxiolytics.  In recent years, several new chem. entities targeting the 5-HT1A receptor (alone or in combination with other mol. targets) have been proposed for novel therapeutic indications (neuroprotection, cognitive impairment, Parkinson Disease and related disorders, pain treatment).  The present review will focus on those 5-HT1A receptor agents that entered preclin. trials starting from 2000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquGiFKFKnqLrVg90H21EOLACvtfcHk0ljSGOrls4BL8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D&md5=cd19fc17c1edcfec3977fffe3920480d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156802608785161385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161385%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D5-HT1A%2520receptor%252C%2520an%2520old%2520target%2520for%2520new%2520therapeutic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1024%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Pessoa-Mahana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araya-Maturana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitz, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessoa-Mahana, C. D.</span><span> </span><span class="NLM_article-title">A synthetic overview of new molecules with 5-HT<sub>1A</sub> binding affinities</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=77-93&author=H.+Pessoa-Mahanaauthor=R.+Araya-Maturanaauthor=C.+B.+Saitzauthor=C.+D.+Pessoa-Mahana&title=A+synthetic+overview+of+new+molecules+with+5-HT1A+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPessoa-Mahana%26aufirst%3DH.%26aulast%3DAraya-Maturana%26aufirst%3DR.%26aulast%3DSaitz%26aufirst%3DC.%2BB.%26aulast%3DPessoa-Mahana%26aufirst%3DC.%2BD.%26atitle%3DA%2520synthetic%2520overview%2520of%2520new%2520molecules%2520with%25205-HT1A%2520binding%2520affinities%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D77%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wieland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Antidepressant-like activity of 5-HT<sub>1A</sub> agonists measured with the forced swim test</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2FBF02244228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1990&pages=497-504&author=S.+Wielandauthor=I.+Lucki&title=Antidepressant-like+activity+of+5-HT1A+agonists+measured+with+the+forced+swim+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test</span></div><div class="casAuthors">Wieland, Scott; Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-304</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">This study examd. the abilities of 5-hydroxytryptamine (5-HT) agonists with varying selectivity for different subtypes of 5-HT receptors to produce antidepressant-like behavioral effects in the forced swim test in rats.  The 5-HT1A agonists 8-OH-DPAT (0.125-1.0 mg/kg, s.c.) and tandospirone (SM-3997) (5-20 mg/kg, s.c.) both produced dose-related decreases in immobility time following subchronic treatment in rats.  These effects were similar to those of the tricyclic antidepressants imipramine (5-15 mg/kg) and desipramine (5-15 mg/kg).  In addn., the 5-HT1A agonists, buspirone (20 mg/kg), gepirone (20 mg/kg) and ipsapirone (10 and 20 mg/kg) demonstrated antidepressant-like effects.  Other groups of rats treated subchronically with each of the 5-HT1A agonists or antidepressants showed no increase in locomotor activity, so that general changes in activity could not account for the redn. of immobility time in the forced swim test.  5-HT agonists selective for other receptor subtypes, such as the 5-HT1B/1C agonist m-CPP (5 mg/kg) and the 5-HT2/1C agonist DOB (1 mg/kg), were not effective in this behavioral test.  The benzodiazepine diazepam (5 mg/kg) also failed to reduce immobility time, suggesting that anxiolytic properties of 5-HT1A agonists did not mediate this behavioral effect.  A common metabolite of some of the 5-HT1A agonists, 1-PP, was ineffective in reducing immobility time.  The stimulant d-amphetamine (2 mg/kg) significantly reduced immobility time but also significantly increased locomotor activity.  Pretreatment with the 5-HT synthesis inhibitor PCPA alone did not alter immobility time, and did not alter the antidepressant-like effects of 8-OH-DPAT or tandospirone, suggesting that the 5-HT1A agonists are producing their antidepressant-like effects through postsynaptic 5-HT1A receptors.  These results suggest that 5-HT1A agonists may have antidepressant efficacy and act as a novel class of antidepressant drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKxkymPp89XLVg90H21EOLACvtfcHk0lhdQf-0US0sOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVCmtLo%253D&md5=853b6bffc0150426eed355f715947168</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF02244228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02244228%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DS.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAntidepressant-like%2520activity%2520of%25205-HT1A%2520agonists%2520measured%2520with%2520the%2520forced%2520swim%2520test%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D1990%26volume%3D101%26spage%3D497%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, N. M.</span><span> </span><span class="NLM_article-title">Is there a role for 5-HT<sub>1A</sub> agonists in the treatment of depression?</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0006-3223%2802%2901643-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12559651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=193-203&author=P.+Blierauthor=N.+M.+Ward&title=Is+there+a+role+for+5-HT1A+agonists+in+the+treatment+of+depression%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a role for 5-HT1A agonists in the treatment of depression?</span></div><div class="casAuthors">Blier, Pierre; Ward, Nick M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The role of serotonin (5-hydroxytryptamine; 5-HT) in the treatment of depressive and anxiety disorders is underscored by the therapeutic action of selective 5-HT reuptake inhibitors acting to enhance the degree of activation of various 5-HT receptor subtypes.  The 5-HT1A receptors are particularly relevant to the antidepressant and anxiolytic responses in human beings.  They are located presynaptically in the raphe nuclei, where they act as cell body autoreceptors to inhibit the firing rate of 5-HT neurons, and are located postsynaptically in limbic and cortical regions, where they also attenuate firing activity.  The azapirones are full agonists at 5-HT1A autoreceptors and are generally, but not exclusively, partial agonists at postsynaptic 5-HT1A receptors.  Some of these drugs, including gepirone and other 5-HT1A agonists such as buspirone, have been reported to exert anxiolytic and antidepressive activity in double-blind, placebo-controlled, and comparative trials.  Their delayed therapeutic activity is believed to result from increased activation of postsynaptic 5-HT1A receptors occurring only after 5-HT neurons regain their normal firing activity.  The recovery of this parameter, which is attributable to 5-HT1A autoreceptor desensitization, also restores 5-HT release.  At this point, the summed effects of a normalized level of synaptic 5-HT and the exogenous 5-HT1A agonist can be exerted on postsynaptic 5-HT1A receptors.  The widespread recognition of the clin. efficacy of such agents has largely been hampered by their undesirable pharmacokinetic properties.  Most 5-HT1A agonists are indeed readily absorbed but are also rapidly eliminated, thereby often producing either suboptimal therapeutic responses at low doses, or cumbersome adverse effects at higher doses.  Extended-release formulations allow once-daily dosing regimens, thus avoiding sharp peak plasma concns.  This improves compliance and permits the use of higher dosages, which may be assocd. with enhanced efficacy and better tolerability relative to the immediate-release formulations.  In sum, 5-HT1A receptor agonism represents a valuable and efficacious therapeutic approach to major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqave4phsEojLVg90H21EOLACvtfcHk0lhdQf-0US0sOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D&md5=94f64a33cbc40a67fc0a4ae347dc36bd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2802%2901643-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252802%252901643-8%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DN.%2BM.%26atitle%3DIs%2520there%2520a%2520role%2520for%25205-HT1A%2520agonists%2520in%2520the%2520treatment%2520of%2520depression%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D2003%26volume%3D53%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Montigny, C.</span><span> </span><span class="NLM_article-title">Modification of 5-HT neuron properties by sustained administration of the 5-HT<sub>1A</sub> agonist gepirone: electrophysiological studies in the rat brain</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1987&pages=470-480&author=P.+Blierauthor=C.+de+Montigny&title=Modification+of+5-HT+neuron+properties+by+sustained+administration+of+the+5-HT1A+agonist+gepirone%3A+electrophysiological+studies+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3Dde%2BMontigny%26aufirst%3DC.%26atitle%3DModification%2520of%25205-HT%2520neuron%2520properties%2520by%2520sustained%2520administration%2520of%2520the%25205-HT1A%2520agonist%2520gepirone%253A%2520electrophysiological%2520studies%2520in%2520the%2520rat%2520brain%26jtitle%3DSynapse%26date%3D1987%26volume%3D1%26spage%3D470%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozlan, H.</span><span> </span><span class="NLM_article-title">Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK3MXnsFGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1990&pages=1335-1347&author=L.+E.+Schechterauthor=F.+J.+Bolanosauthor=H.+Gozlan&title=Alterations+of+central+serotoninergic+and+dopaminergic+neurotransmission+in+rats+chronically+treated+with+ipsapirone%3A+biochemical+and+electrophysiological+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone:  biochemical and electrophysiological studies</span></div><div class="casAuthors">Schechter, L. E.; Bolanos, F. J.; Gozlan, H.; Lanfumey, L.; Haj-Dahmane, S.; Laporte, A. M.; Fattaccini, C. M.; Hamon, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1335-47</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Inasmuch as sustained treatment with the 5-HT1A agonist, ipsapirone, is necessary for inducing anxiolytic and antidepressant effects in the clinic, investigations were performed for assessing the possible changes in serotoninergic and dopaminergic neurotransmission in the brain of rats 24 h after a 2-wk treatment with this drug.  Receptor binding assays with membranes and quant. autoradiog. indicated that the twice-daily administration of ipsapirone (5 mg/kg, i.p.) for 14 days did not alter the characteristics of 5-HT1A sites in the hippocampus, septum and dorsal raphe nucleus.  In contrast, decreases in the Bmax values for 5-HT2 sites (-24%) and 5-HT3 sites (-19%) were found in the frontal and posterior cortex, resp.  As expected from unchanged postsynaptic 5-HT1A receptors, inhibition of forskolin-stimulated adenylate cyclase by 5-HT1A agonists (8-hydroxy-2-(dipropylamino)tetralin, ipsapirone) exhibited the same characteristics in hippocampal homogenates from both control and ipsapirone-treated animals.  An acute administration of 8-hydroxy-2-(dipropylamino)tetralin (0.5 mg/kg i.p.) or ipsapirone (1 or 5 mg/kg i.p.) 24 h after the last injection for the chronic treatment produced a similar decrease in the rate of 5-HT turnover in various brain areas in rats treated for 2 wk with saline or ipsapirone.  At the highest dose (5 mg/kg i.p.), acute ipsapirone also increased the rate of dopamine turnover in the striatum and cerebral cortex approx. to the same extent in both treatment groups.  In vitro recording of the firing of serotoninergic neurons in brain stem slices revealed a desensitization of the somatodendritic 5-HT1A receptors, which might be responsible for the increased 5-HT turnover in the brain stem and striatum of rats chronically treated with ipsapirone as compared with controls.  Thus, chronically administered ipsapirone produces adaptive changes in central serotoninergic neurotransmission which might account for the anxiolytic and antidepressant properties of this drug after sustained treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9OkZF1loZN7Vg90H21EOLACvtfcHk0lhdQf-0US0sOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXnsFGkug%253D%253D&md5=249e10fa3e6b5a1967aaa0f70a4fd873</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DBolanos%26aufirst%3DF.%2BJ.%26aulast%3DGozlan%26aufirst%3DH.%26atitle%3DAlterations%2520of%2520central%2520serotoninergic%2520and%2520dopaminergic%2520neurotransmission%2520in%2520rats%2520chronically%2520treated%2520with%2520ipsapirone%253A%2520biochemical%2520and%2520electrophysiological%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1990%26volume%3D255%26spage%3D1335%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Citrome, L.</span><span> </span><span class="NLM_article-title">Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant—What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1742-1241.2011.02885.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=22284853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=356-368&author=L.+Citrome&title=Vilazodone+for+major+depressive+disorder%3A+a+systematic+review+of+the+efficacy+and+safety+profile+for+this+newly+approved+antidepressant%E2%80%94What+is+the+number+needed+to+treat%2C+number+needed+to+harm+and+likelihood+to+be+helped+or+harmed%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?</span></div><div class="casAuthors">Citrome, L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-368</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1742-1241</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Objective: To describe the efficacy and safety of vilazodone for the treatment of major depressive disorder (MDD).  Data sources: The pivotal registration trials were accessed by querying http://www.ncbi.nlm.nih.gov/pubmed/, http://www.fda.gov and http://www.clinicaltrials.gov for the search term "vilazodone".  Product labeling provided addnl. information.  Study selection: All available clin. reports of studies were identified.  Data extn.: Descriptions of the principal results and calcn. of no. needed to treat (NNT) and no. needed to harm (NNH) for relevant dichotomous outcomes were extd. from the available study reports and other sources of information.  Data synthesis: Vilazodone is a specific serotonin reuptake inhibitor and serotonin 5HT1A receptor partial agonist.  In needs to be administered with food to ensure adequate bioavailability.  Approval for the treatment of MDD was based on a clin. development program that included two 8-wk placebo-controlled randomised clin. trials in outpatients with MDD where vilazodone was titrated to a target dose of 40 mg/d over the first 2 wk.  Both trials evidenced efficacy for vilazodone as measured by the Montgomery Asberg Depression Rating Scale.  NNT for response vs. placebo was 8 (95% CI 6-16) and for remission was 14 (95% CI 8-55).  NNH vs. placebo for discontinuation because of an adverse event (AE) was 27 (95% CI 15-104).  The most commonly encountered AEs (incidence ≥ 5% and at least twice the rate of placebo) were diarrhoea, nausea, vomiting and insomnia, with NNH values vs. placebo of 6 (95% CI 5-8), 6 (95% CI 5-8), 30 (95% CI 18-82) and 26 (95% CI 16-78), resp.  NNH vs. placebo for any sexual AB was 12 (95% CI 9-18), but systematically collected data using rating scales of sexual function did not reveal treatment assocd. effects.  Vilazodone was not assocd. with clin. relevant wt. change in the short-term trials.  In an open-label 1-yr study of vilazodone, mean wt. increased by 1.7 kg among the obsd. cases.  Conclusions: Vilazodone represents another option for the treatment of MDD.  Vilazodone appears to have a favorable wt.-gain profile based on short-term studies.  Sexual side-effects were not consistently demonstrated when assessed using clin. rating scales but spontaneously reported AEs related to sexual functioning were obsd.  Addnl. controlled data regarding long-term efficacy and effectiveness will help characterize this new agent when used in maintenance treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-IWZwfNBy7LVg90H21EOLACvtfcHk0ljCvtL6jq3dqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKhsrw%253D&md5=13f82826149cf353ff2e218096d8fed3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2011.02885.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2011.02885.x%26sid%3Dliteratum%253Aachs%26aulast%3DCitrome%26aufirst%3DL.%26atitle%3DVilazodone%2520for%2520major%2520depressive%2520disorder%253A%2520a%2520systematic%2520review%2520of%2520the%2520efficacy%2520and%2520safety%2520profile%2520for%2520this%2520newly%2520approved%2520antidepressant%25E2%2580%2594What%2520is%2520the%2520number%2520needed%2520to%2520treat%252C%2520number%2520needed%2520to%2520harm%2520and%2520likelihood%2520to%2520be%2520helped%2520or%2520harmed%253F%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2012%26volume%3D66%26spage%3D356%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span> </span><span class="NLM_article-title">Silent 5-HT<sub>1A</sub> receptor antagonists: utility as research tools and therapeutic agents</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1993&pages=441-448&author=A.+Fletcherauthor=I.+Cliffeauthor=C.+T.+Dourish&title=Silent+5-HT1A+receptor+antagonists%3A+utility+as+research+tools+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DCliffe%26aufirst%3DI.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26atitle%3DSilent%25205-HT1A%2520receptor%2520antagonists%253A%2520utility%2520as%2520research%2520tools%2520and%2520therapeutic%2520agents%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1993%26volume%3D14%26spage%3D441%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Assie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koek, W.</span><span> </span><span class="NLM_article-title">Effects of 5-HT<sub>1A</sub> receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=1996&pages=15-21&author=M.+B.+Assieauthor=W.+Koek&title=Effects+of+5-HT1A+receptor+antagonists+on+hippocampal+5-hydroxytryptamine+levels%3A+%28S%29-WAY100135%2C+but+not+WAY100635%2C+has+partial+agonist+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssie%26aufirst%3DM.%2BB.%26aulast%3DKoek%26aufirst%3DW.%26atitle%3DEffects%2520of%25205-HT1A%2520receptor%2520antagonists%2520on%2520hippocampal%25205-hydroxytryptamine%2520levels%253A%2520%2528S%2529-WAY100135%252C%2520but%2520not%2520WAY100635%252C%2520has%2520partial%2520agonist%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D304%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Arborelius, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomikos, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hook, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, T. H.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>1A</sub> receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1007%2FBF00167182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=8738296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK28XjtlChsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1996&pages=630-640&author=L.+Arboreliusauthor=G.+G.+Nomikosauthor=P.+Hertelauthor=P.+Salmiauthor=P.+Grillnerauthor=B.+B.+Hookauthor=U.+Hacksellauthor=T.+H.+Svensson&title=The+5-HT1A+receptor+antagonist+%28S%29-UH-301+augments+the+increase+in+extracellular+concentrations+of+5-HT+in+the+frontal+cortex+produced+by+both+acute+and+chronic+treatment+with+citalopram"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram</span></div><div class="casAuthors">Arborelius, Lotta; Nomikos, George G.; Hertel, Peter; Salmi, Peter; Grillner, Pernilla; Hoeoek, Berit Backlund; Hacksell, Uli; Svensson, Torgny H.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">630-640</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In a recent study, utilizing single cell recording technique, we have shown that administration of 5-HT1A receptor antagonists, e.g. (S)-UH-301, to rats concomitantly treated, acute or chronically, with the selective serotonin reuptake inhibitor (SSRI) citalopram significantly increases the activity of 5-hydroxytryptamine (5-HT) contg. neurons in the dorsal raphe nucleus (DRN).  Here we report correlative expts. using microdialysis in freely moving animals to measure extracellular levels of 5-HT and its metabolite 5-hydroxyindole acetic acid (5-HIAA) in the frontal cortex, a major projection area for DRN-5-HT neurons.  Acute administration of (S)-UH-301 (2.5 mg/kg s.c.) or citalopram (2.0 mg/kg s.c.) increased 5-HT concns. with a max. of about 70% and 185%, resp., above baseline.  However, when (S)-UH-301 was administered 30 min before citalopram the maximal increase in 5-HT levels was approx. 400%.  In rats chronically treated with citalopram (20 mg/kg/day i.p. for 14 days) basal 5-HT concns. in the frontal cortex were significantly increased and 5-HIAA concns. were decreased when measured 10-12 h, but not 18-20 h, after the last injection of citalopram, as compared to basal 5-HT and 5-HIAA concns. in chronic saline-treated rats.  When (S)-UH-301 (2.5 mg/kg s.c.) was administered 12 h, but not 20 h, after the last dose of citalopram it produced a significantly larger increase in extracellular concns. of 5-HT than in control rats.  However, in rats pretreated with a single, very high dose of citalopram, 20 mg/kg i.p., administration of (S)-UH-301 at 12 h after citalopram did not increase 5-HT levels.  The augmentation by (S)-UH-301 of the increase in brain 5-HT output produced by acute administration of citalopram is probably by acute administration of citalopram is probably due to antagonism of the citalopram induced feedback inhibition of 5-HT cells in the DRN, as previously suggested.  However, the capacity of (S)-UH-301 to further increase the already elevated extracellular concns. of 5-HT in brain in animals maintained on a chronic citalopram regimen, in which significant tolerance to the initial feedback inhibition of DRN-5-HT cells had developed, represents a novel finding.  Generally, the reduced feedback inhibition of DRN-5-HT cells had developed, represents a novel finding.  Generally, the reduced feedback inhibition of 5-HT neurons obtained with chronic citalopram treatment, and the assocd. elevation of brain 5-HT concns., may be related to functional desensitization of somatodendritic 5-HT1A autoreceptors in the DRN.  This phenomenon may also largely explain the larger increase in 5-HT output produced by (S)-UH-301 in chronic citalopram treated animals as compared to its effect in control animals.  Yet, a contributory factor may be a slight, remaining feedback inhibition of the 5-HT cells caused by residual citalopram at 12, but not 20 h after its last administration.  Previous clin. studies suggest that addn. of a 5-HT1A receptor antagonist to an SSRI in the treatment of depression may accelerate the onset of clin. effects.  Moreover, in therapy-resistant cases maintained on SSRI treatment, addn. of a 5-HT1A receptor antagonist may improve clin. efficacy.  Since the therapeutic effect of SSRIs in depression has been found to be critically linked to the availability of 5-HT in brain, our exptl. results support, in principle, both of the above clin. based notions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnXgeuYpoK8rVg90H21EOLACvtfcHk0ljCvtL6jq3dqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtlChsLY%253D&md5=a2f277e5dc827cc08ed82335e7be960c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2FBF00167182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00167182%26sid%3Dliteratum%253Aachs%26aulast%3DArborelius%26aufirst%3DL.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26aulast%3DHertel%26aufirst%3DP.%26aulast%3DSalmi%26aufirst%3DP.%26aulast%3DGrillner%26aufirst%3DP.%26aulast%3DHook%26aufirst%3DB.%2BB.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DSvensson%26aufirst%3DT.%2BH.%26atitle%3DThe%25205-HT1A%2520receptor%2520antagonist%2520%2528S%2529-UH-301%2520augments%2520the%2520increase%2520in%2520extracellular%2520concentrations%2520of%25205-HT%2520in%2520the%2520frontal%2520cortex%2520produced%2520by%2520both%2520acute%2520and%2520chronic%2520treatment%2520with%2520citalopram%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1996%26volume%3D353%26spage%3D630%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Grignaschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Invernizzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fracasso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanin, R.</span><span> </span><span class="NLM_article-title">Citalopram-induced hypophagia is enhanced by blockade of 5-HT<sub>1A</sub> receptors: role of 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0702028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=9756397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXlslKnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=1781-1787&author=G.+Grignaschiauthor=R.+Invernizziauthor=R.+Fanelliauthor=C.+Fracassoauthor=S.+Cacciaauthor=R.+Samanin&title=Citalopram-induced+hypophagia+is+enhanced+by+blockade+of+5-HT1A+receptors%3A+role+of+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Citalopram-induced hypophagia is enhanced by blockade of 5-HT1A receptors: role of 5-HT2C receptors</span></div><div class="casAuthors">Grignaschi, G.; Invernizzi, R. W.; Fanelli, E.; Fracasso, C.; Caccia, S.; Samanin, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1781-1787</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The selective 5-hydroxytryptamine reuptake inhibitor citalopram (10 and 20 mg kg-1, i.p.) significantly reduced food intake in male rats (CD-COBS) habituated to eat their daily food during a 4-h period.  The 5-HT1A receptor antagonist WAY100635 (0.3 mg kg-1) administered systemically did not modify feeding but significantly potentiated the redn. in food intake caused by 10 mg kg-1 i.p. citalopram.  The dose of 5 mg kg-1 i.p. citalopram was not active in animals pretreated with vehicle but significantly reduced feeding in animals pretreated with WAY100635.  WAY100635 (0.1 μg 0.5 μL-1) injected into the dorsal raphe significantly potentiated the hypophagic effect of 10 mg kg-1 citalopram.  WAY100635 (1.0 μg 0.5 μL-1) injected into the median raphe did not modify feeding or the hypophagic effect of 10 mg kg-1 citalopram.  The 5-HT2B/2C receptor antagonist SB206553 (10 mg kg-1, p.o.) slightly reduced feeding by itself but partially antagonized the effect of WAY100635 administered systemically (0.3 mg kg-1, s.c.) or into the dorsal raphe (0.1 μg 0.5 μL-1) in combination with 10 mg kg-1 i.p. citalopram.  The hypophagic effect of 10 mg kg-1 i.p. citalopram alone was not significantly modified by SB206553.  Brain concns. of citalopram and its metabolite desmethylcitalopram in rats pretreated with SB206553, WAY100635 and their combination were comparable to those of vehicle-pretreated rats, 90 min after citalopram injection.  The hypophagic effect of citalopram was potentiated by blocking 5-HT1A receptors.  Only the effect of the WAY100635/citalopram combination seemed to be partially mediated by central 5-HT2C receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobRKhurUe8MLVg90H21EOLACvtfcHk0liFSADnzMfDPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslKnt78%253D&md5=63b5e4d37a720d5f15e2553cb33f63d6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702028%26sid%3Dliteratum%253Aachs%26aulast%3DGrignaschi%26aufirst%3DG.%26aulast%3DInvernizzi%26aufirst%3DR.%26aulast%3DFanelli%26aufirst%3DR.%26aulast%3DFracasso%26aufirst%3DC.%26aulast%3DCaccia%26aufirst%3DS.%26aulast%3DSamanin%26aufirst%3DR.%26atitle%3DCitalopram-induced%2520hypophagia%2520is%2520enhanced%2520by%2520blockade%2520of%25205-HT1A%2520receptors%253A%2520role%2520of%25205-HT2C%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D124%26spage%3D1781%26epage%3D1787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czachura, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreshfield-Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemrick-Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zgombick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. C.</span><span> </span><span class="NLM_article-title">The novel 5-hydroxytryptamine 1A antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=10900249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2000&pages=688-700&author=K.+Rasmussenauthor=D.+O.+Calligaroauthor=J.+F.+Czachuraauthor=L.+J.+Dreshfield-Ahmadauthor=D.+C.+Evansauthor=S.+K.+Hemrick-Lueckeauthor=M.+J.+Kallmanauthor=W.+T.+Kendrickauthor=J.+D.+Leanderauthor=D.+L.+Nelsonauthor=C.+D.+Overshinerauthor=D.+B.+Wainscottauthor=M.+C.+Wolffauthor=D.+T.+Wongauthor=T.+A.+Branchekauthor=J.+M.+Zgombickauthor=Y.+C.+Xu&title=The+novel+5-hydroxytryptamine+1A+antagonist+LY426965%3A+effects+on+nicotine+withdrawal+and+interactions+with+fluoxetine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The novel 5-hydroxytryptamine1A antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine</span></div><div class="casAuthors">Rasmussen, Kurt; Calligaro, David O.; Czachura, Janet F.; Dreshfield-Ahmad, Laura J.; Evans, David C.; Hemrick-Luecke, Susan K.; Kallman, Mary Jeanne; Kendrick, William T.; Leander, J. David; Nelson, David L.; Overshiner, Carl D.; Wainscott, David B.; Wolff, Mary C.; Wong, David T.; Branchek, Theresa A.; Zgombick, John M.; Xu, Yao-Chang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">688-700</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">LY426965 [(2S)-(+)-1-cyclohexyl-4-[4-(2-methoxyphenyl)-1-piperazinyl]2-methyl-2-phenyl-1-butanone monohydrochloride] is a novel compd. with high affinity for the cloned human 5-hydroxytryptamine (HT)1A receptor (Ki = 4.66 nM) and 20-fold or greater selectivity over other serotonin and nonserotonin receptor subtypes.  Both in vitro and in vivo studies indicate that LY426965 is a full antagonist and has no partial agonist properties.  LY426965 did not stimulate [35S]guanosine-5'-O-(3-thio) triphosphate (GTPγS) binding to homogenates of cells expressing the cloned human 5-HT1A receptor in vitro but did inhibit 300 nM 5-HT-stimulated [35S]GTPγS binding with a Ki value of 3.07 nM.  After both p.o. and s.c. administration, LY426965 blocked the lower lip retraction, flat body posture, hypothermia, and increase in rat serum corticosterone induced by the 5-HT1A agonist 8-OH-DPAT (8-hydroxy-2-dipropylaminotetralin).  In pigeons, LY426965 dose-dependently blocked the stimulus cue induced by 8-OH-DPAT but had no 8-OH-DPAT-like discriminative properties.  LY426965 completely reversed the effects of nicotine withdrawal on the auditory startle reflex in rats.  In microdialysis expts., LY426965 administered together with fluoxetine significantly increased extracellular levels of serotonin above those achievable with fluoxetine alone.  In electrophysiol. studies, the administration of LY426965 produced a slight elevation of the firing rate of 5-HT neurons in the dorsal raphe nucleus of anesthetized rats and both blocked and reversed the effects of fluoxetine on 5-HT neuronal activity.  These preclin. results indicate that LY426965 is a selective, full 5-HT1A antagonist that may have clin. use as pharmacotherapy for smoking cessation and depression and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnUG4icAtQrVg90H21EOLACvtfcHk0liFSADnzMfDPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKgtro%253D&md5=c88befd68b6102f11fb3a543fbb4d0ec</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCzachura%26aufirst%3DJ.%2BF.%26aulast%3DDreshfield-Ahmad%26aufirst%3DL.%2BJ.%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DHemrick-Luecke%26aufirst%3DS.%2BK.%26aulast%3DKallman%26aufirst%3DM.%2BJ.%26aulast%3DKendrick%26aufirst%3DW.%2BT.%26aulast%3DLeander%26aufirst%3DJ.%2BD.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DWolff%26aufirst%3DM.%2BC.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DZgombick%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DY.%2BC.%26atitle%3DThe%2520novel%25205-hydroxytryptamine%25201A%2520antagonist%2520LY426965%253A%2520effects%2520on%2520nicotine%2520withdrawal%2520and%2520interactions%2520with%2520fluoxetine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D294%26spage%3D688%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hibert, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gittos, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00401a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hibert%2C+M.+F.%3B+Gittos%2C+M.+W.%3B+Middlemiss%2C+D.+N.%3B+Mir%2C+A.+K.%3B+Fozard%2C+J.+R.J.+Med.+Chem.+1988%2C+31%2C+1087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm00401a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00401a007%26sid%3Dliteratum%253Aachs%26aulast%3DHibert%26aufirst%3DM.%2BF.%26aulast%3DGittos%26aufirst%3DM.%2BW.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DMir%26aufirst%3DA.%2BK.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, Y.</span><span> </span><span class="NLM_article-title">Role of cortical and striatal 5-HT<sub>1A</sub> receptors in alleviating antipsychotic-induced extrapyramidal disorders</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.pnpbp.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=20398719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1KrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2010&pages=877-881&author=S.+Shimizuauthor=A.+Tataraauthor=J.+Imakiauthor=Y.+Ohno&title=Role+of+cortical+and+striatal+5-HT1A+receptors+in+alleviating+antipsychotic-induced+extrapyramidal+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders</span></div><div class="casAuthors">Shimizu, Saki; Tatara, Ayaka; Imaki, Junta; Ohno, Yukihiro</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">877-881</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have revealed that 5-HT1A agonists ameliorate antipsychotic-induced extrapyramidal symptoms (EPS) through postsynaptic 5-HT1A receptors.  Here, we conducted an intracerebral microinjection study of (±)-8-hydroxy-2-(di-n-propylamino)-tetralin ((±)8-OH-DPAT) to det. the action site of the 5-HT1A agonist in alleviating EPS.  Bilateral microinjection of(±)8-OH-DPAT (5 μg/1 μL per side) either into the primary motor cortex (MC) or the dorsolateral striatum (dlST) significantly attenuated haloperidol-induced catalepsy in rats.  The anticataleptic action of (±)8-OH-DPAT was more prominent with the MC injection than with the dlST injection.  WAY-100135 (a selective 5-HT1A antagonist) completely antagonized the reversal of haloperidol-induced catalepsy both by intracortical and intrastriatal (±)8-OH-DPAT.  Furthermore, lesioning of dopamine neurons with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (30 mg/kg/day, i.p., for 4 days) did not alter the anti-EPS actions of (±)8-OH-DPAT in a mouse pole test.  The present results strongly suggest that 5-HT1A agonist alleviates antipsychotic-induced EPS by activating postsynaptic 5-HT1A receptors in the MC and dlST, probably through non-dopaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPAjyUQFCgNLVg90H21EOLACvtfcHk0liFSADnzMfDPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1KrsbY%253D&md5=87f7b69d93c44b1d9d4dc10a92309493</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DTatara%26aufirst%3DA.%26aulast%3DImaki%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DY.%26atitle%3DRole%2520of%2520cortical%2520and%2520striatal%25205-HT1A%2520receptors%2520in%2520alleviating%2520antipsychotic-induced%2520extrapyramidal%2520disorders%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2010%26volume%3D34%26spage%3D877%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Madjid, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottie, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttgen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzmin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiedl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ögren, S. O.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.105.092262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=581-591&author=N.+Madjidauthor=E.+E.+Tottieauthor=M.+Luttgenauthor=B.+Meisterauthor=J.+Sandinauthor=A.+Kuzminauthor=O.+Stiedlauthor=S.+O.+%C3%96gren&title=5-Hydroxytryptamine1A+receptor+blockade+facilitates+aversive+learning+in+mice%3A+interactions+with+cholinergic+and+glutamatergic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms</span></div><div class="casAuthors">Madjid, Nather; Tottie, Elin Elvander; Luttgen, Maria; Meister, Bjoern; Sandin, Johan; Kuzmin, Alexander; Stiedl, Oliver; Oegren, Sven Ove</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">581-591</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of 5-hydroxytryptamine 1A (5-HT1A) receptor ligands on aversive learning were examd. in the passive avoidance (PA) task in mice.  Anxiety and autonomic functions were investigated using the elevated plus-maze and heart rate measurements.  The main findings from this study are as follows.  Pretraining administration of the 5-HT1A receptor agonist 8-OH-DPAT [8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide] facilitated PA retention at low doses (0.01 and 0.03 mg/kg) but impaired PA retention at higher doses (0.1-1.0 mg/kg), consistent with previous findings in the rat.  Similar to the acetylcholinesterase inhibitor physostigmine, pretraining administration of the 5-HT1A receptor antagonists NAD-299 (0.1-2 mg/kg) and WAY-100635 (0.3-3 mg/kg) enhanced PA retention.  The impairment (1 mg/kg) but not the facilitation (0.03 mg/kg) induced by 8-OH-DPAT was fully blocked by NAD-299 (0.3 mg/kg).  5-HT1A receptor ligands given immediate post-training failed to alter PA retention.  NAD-299 (0.3-1 mg/kg) blocked the impairment of PA retention caused by (a) the nonselective muscarinic receptor antagonist scopolamine and (b) the non-competitive N-methyl-D-aspartate receptor antagonist MK-801.  A subthreshold dose of scopolamine completely blocked the facilitatory effect of NAD-299 on PA retention.  Anxiety-related behaviors and autonomic function were unchanged by NAD-299.  In situ hybridization showed that septal neurons expressing 5-HT1A receptor mRNA were codistributed with markers for cholinergic, GABAergic, and glutamatergic neurons.  These results indicate that systemic administration of 5-HT1A receptor antagonists can facilitate cognitive performance, most likely by enhancing hippocampal/cortical cholinergic and glutamatergic neurotransmissions.  Selective 5-HT1A receptor antagonists may be useful in the treatment of cognitive deficits such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1uEd4tiUMZbVg90H21EOLACvtfcHk0li7OXthwPPfJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLg%253D&md5=b3af2af582c8bd5ae5f1501d9f0e7c14</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092262%26sid%3Dliteratum%253Aachs%26aulast%3DMadjid%26aufirst%3DN.%26aulast%3DTottie%26aufirst%3DE.%2BE.%26aulast%3DLuttgen%26aufirst%3DM.%26aulast%3DMeister%26aufirst%3DB.%26aulast%3DSandin%26aufirst%3DJ.%26aulast%3DKuzmin%26aufirst%3DA.%26aulast%3DStiedl%26aufirst%3DO.%26aulast%3D%25C3%2596gren%26aufirst%3DS.%2BO.%26atitle%3D5-Hydroxytryptamine1A%2520receptor%2520blockade%2520facilitates%2520aversive%2520learning%2520in%2520mice%253A%2520interactions%2520with%2520cholinergic%2520and%2520glutamatergic%2520mechanisms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D581%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bhat, L.; Mohapatra, P. P.; Adiey, K.</span><span> </span><span class="NLM_article-title">Composition, Synthesis, and Methods of Utilizing Arylpiperazine Derivatives</span>.WO/2010/099502,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Reviva Pharmaceuticals, Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+Bhat&author=P.+P.+Mohapatra&author=K.+Adiey&title=Composition%2C+Synthesis%2C+and+Methods+of+Utilizing+Arylpiperazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DL.%26atitle%3DComposition%252C%2520Synthesis%252C%2520and%2520Methods%2520of%2520Utilizing%2520Arylpiperazine%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Bhat, L.; Mohapatra, P. P.; Adiey, K.</span><span> </span><span class="NLM_article-title">Compositions, Synthesis, and Methods of Using Piperazine Based Antipsychotic Agents</span>. US 20090298819,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Reviva Pharmaceuticals, Inc</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Bhat&author=P.+P.+Mohapatra&author=K.+Adiey&title=Compositions%2C+Synthesis%2C+and+Methods+of+Using+Piperazine+Based+Antipsychotic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DL.%26atitle%3DCompositions%252C%2520Synthesis%252C%2520and%2520Methods%2520of%2520Using%2520Piperazine%2520Based%2520Antipsychotic%2520Agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Favor, D. A.; Repine, J. T.</span><span> </span><span class="NLM_article-title">7-(4-(4-[3-Chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-naphthyridin-2(1H)-one</span>. US 20080167319,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Pfizer, Inc.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+A.+Favor&author=J.+T.+Repine&title=7-%284-%284-%5B3-Chloro-2-%28trifluoromethyl%29phenyl%5Dpiperazin-1-yl%29butoxy%29-%5B1%2C8%5D-naphthyridin-2%281H%29-one"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFavor%26aufirst%3DD.%2BA.%26atitle%3D7-%25284-%25284-%255B3-Chloro-2-%2528trifluoromethyl%2529phenyl%255Dpiperazin-1-yl%2529butoxy%2529-%255B1%252C8%255D-naphthyridin-2%25281H%2529-one%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Peters, D.; Rønn, L. C.; Nielsen, K. S.; Scheel-Krüger, J.</span><span> </span><span class="NLM_article-title">Novel Quinolinylamide Derivatives Useful As Modulators of Dopamine and Serotonin Receptors</span>.WO/2009/112568,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>NeuroSearch A/S.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Peters&author=L.+C.+R%C3%B8nn&author=K.+S.+Nielsen&author=J.+Scheel-Kr%C3%BCger&title=Novel+Quinolinylamide+Derivatives+Useful+As+Modulators+of+Dopamine+and+Serotonin+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DD.%26atitle%3DNovel%2520Quinolinylamide%2520Derivatives%2520Useful%2520As%2520Modulators%2520of%2520Dopamine%2520and%2520Serotonin%2520Receptors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Gmeiner, P.; Huebner, H.; Skultety, M.</span><span> </span><span class="NLM_article-title">Indolizines and Aza-Analog Derivatives Thereof as CNS Active Compounds</span>. WO/2008/113559,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Schwarz Pharma AG.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Gmeiner&author=H.+Huebner&author=M.+Skultety&title=Indolizines+and+Aza-Analog+Derivatives+Thereof+as+CNS+Active+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DIndolizines%2520and%2520Aza-Analog%2520Derivatives%2520Thereof%2520as%2520CNS%2520Active%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Forster, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bill, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dover, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span> </span><span class="NLM_article-title">A pharmacological profile of the selective silent 5-HT<sub>1A</sub> receptor antagonist, WAY-100635</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2F0014-2999%2895%2900234-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=8566121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2MXntFCktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1995&pages=81-88&author=E.+A.+Forsterauthor=I.+A.+Cliffeauthor=D.+J.+Billauthor=G.+M.+Doverauthor=D.+Jonesauthor=Y.+Reillyauthor=A.+Fletcher&title=A+pharmacological+profile+of+the+selective+silent+5-HT1A+receptor+antagonist%2C+WAY-100635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635</span></div><div class="casAuthors">Forster, Elaine A.; Cliffe, Ian A.; Bill, David J.; Dover, Gillian M.; Jones, Deborah; Reilly, Yvonne; Fletcher, Allan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">WAY-100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohex anecarboxamide trihydrochloride) is an achiral phenylpiperazine deriv. that binds with high affinity and selectivity to the 5-HT1A receptor.  WAY-100635 displaced specific binding of the 5-HT1A radioligand, [3H]8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin), to rat hippocampal membranes with a pIC50 of 8.87.  This represented a greater than 100-fold selectivity relative to binding at other 5-HT receptor subtypes and major neurotransmitter receptor, reuptake and ion channel sites.  In functional assays, WAY-100635 was a potent 5-HT1A receptor antagonist, with no evidence of any 5-HT1A receptor agonist or partial agonist activity.  In the isolated guinea-pig ileum WAY-100635 was a potent and, at high concns., an insurmountable antagonist of the 5-HT1A receptor agonist action of 5-carboxamidotryptamine, with an apparent pA2 value (at 0.3 nM) of 9.71.  WAY-100635 blocked the inhibitory action of 8-OH-DPAT on dorsal raphe neuronal firing in the anesthetized rat at doses which had no inhibitory action per se.  In behavioral models, WAY-100635 itself induced no overt behavioral changes but potently antagonized the behavioral syndrome induced by 8-OH-DPAT in the rat and guinea-pig (min. ED = 0.003 mg/kg s.c. and ID50 = 0.01 mg/kg s.c., resp.).  WAY-100635 also blocked the hypothermia induced by 8-OH-DPAT in the mouse and rat with ID50 values of 0.01 mg/kg s.c.  These data indicate that WAY-100635 will be used as a std. antagonist in further studies of 5-HT1A receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgPJI4KdQUp7Vg90H21EOLACvtfcHk0li7OXthwPPfJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFCktbg%253D&md5=6b28ceb6b6f1ae1d7ff44dc14c56d42f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900234-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900234-C%26sid%3Dliteratum%253Aachs%26aulast%3DForster%26aufirst%3DE.%2BA.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DBill%26aufirst%3DD.%2BJ.%26aulast%3DDover%26aufirst%3DG.%2BM.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DReilly%26aufirst%3DY.%26aulast%3DFletcher%26aufirst%3DA.%26atitle%3DA%2520pharmacological%2520profile%2520of%2520the%2520selective%2520silent%25205-HT1A%2520receptor%2520antagonist%252C%2520WAY-100635%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D281%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Björk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewander, T.</span><span> </span><span class="NLM_article-title">Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2F0924-977X%2892%2990024-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=1385999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADyaK38zjvVKrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=141-147&author=L.+Bj%C3%B6rkauthor=A.+Fredrikssonauthor=U.+Hacksellauthor=T.+Lewander&title=Effects+of+%28R%29-8-OH-DPAT+and+the+enantiomers+of+UH-301+on+motor+activities+in+the+rat%3A+antagonism+of+%28R%29-8-OH-DPAT-induced+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects</span></div><div class="casAuthors">Bjork L; Fredriksson A; Hacksell U; Lewander T</div><div class="citationInfo"><span class="NLM_cas:title">European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-7</span>
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    </div><div class="casAbstract">The effects of the enantiomers of 5-fluoro-8-hydroxy-2-(dipropylamino)tetralin, UH-301 and the potent 5-HT1A-receptor agonist (R)-8-hydroxy-2-(dipropylamino)tetralin, (R)-8-OH-DPAT, on locomotion, rearing and total activity were studied in rats.  The experiments were performed as tests either of exploratory activity in non-habituated rats or of motor activity of rats habituated to the environment for 2 h before drug injection. (R)-8-OH-DPAT increased locomotion and total activity and decreased rearing in both conditions. (R)-UH-301 increased locomotion and slightly also total activity in habituated rats and decreased rearing in both conditions. (S)-UH-301 decreased locomotion and rearing in both conditions but only in doses of 10 mumol/kg and above.  Lower doses of (S)-UH-301 (10 mumol/kg) antagonized (R)-8-OH-DPAT-induced increases of locomotion and total activity.  As (S)-UH-301 decreased rearing, per se, it was not able to antagonize the (R)-8-OH-DPAT induced decrease.  These results further support previous data that (S)-UH-301 is a 5-HT1A antagonist while (R)-UH-301 is a 5-HT1A agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTA-SBGiRSYuCXXDYhVZBdlfW6udTcc2eZ0HFq_yx2Dgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zjvVKrsw%253D%253D&md5=ff6897f48e48677c49934fe3277692fb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0924-977X%2892%2990024-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0924-977X%252892%252990024-3%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B6rk%26aufirst%3DL.%26aulast%3DFredriksson%26aufirst%3DA.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DLewander%26aufirst%3DT.%26atitle%3DEffects%2520of%2520%2528R%2529-8-OH-DPAT%2520and%2520the%2520enantiomers%2520of%2520UH-301%2520on%2520motor%2520activities%2520in%2520the%2520rat%253A%2520antagonism%2520of%2520%2528R%2529-8-OH-DPAT-induced%2520effects%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D1992%26volume%3D2%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kayser, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elfassi, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melfort, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgoin, S.</span><span> </span><span class="NLM_article-title">Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT<sub>1A</sub>–/–, 5-HT<sub>1B</sub>–/–, 5-HT<sub>2A</sub>–/–, 5-HT<sub>3A</sub>–/– and 5-HTT–/– knock-out male mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=235-248&author=V.+Kayserauthor=I.+E.+Elfassiauthor=B.+Aubelauthor=M.+Melfortauthor=D.+Juliusauthor=J.+A.+Gingrichauthor=M.+Hamonauthor=S.+Bourgoin&title=Mechanical%2C+thermal+and+formalin-induced+nociception+is+differentially+altered+in+5-HT1A%E2%80%93%2F%E2%80%93%2C+5-HT1B%E2%80%93%2F%E2%80%93%2C+5-HT2A%E2%80%93%2F%E2%80%93%2C+5-HT3A%E2%80%93%2F%E2%80%93+and+5-HTT%E2%80%93%2F%E2%80%93+knock-out+male+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKayser%26aufirst%3DV.%26aulast%3DElfassi%26aufirst%3DI.%2BE.%26aulast%3DAubel%26aufirst%3DB.%26aulast%3DMelfort%26aufirst%3DM.%26aulast%3DJulius%26aufirst%3DD.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DBourgoin%26aufirst%3DS.%26atitle%3DMechanical%252C%2520thermal%2520and%2520formalin-induced%2520nociception%2520is%2520differentially%2520altered%2520in%25205-HT1A%25E2%2580%2593%252F%25E2%2580%2593%252C%25205-HT1B%25E2%2580%2593%252F%25E2%2580%2593%252C%25205-HT2A%25E2%2580%2593%252F%25E2%2580%2593%252C%25205-HT3A%25E2%2580%2593%252F%25E2%2580%2593%2520and%25205-HTT%25E2%2580%2593%252F%25E2%2580%2593%2520knock-out%2520male%2520mice%26jtitle%3DPain%26date%3D2007%26volume%3D130%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Madhavan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anantharam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthasamy, A. G.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine 1A receptor activation protects against <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.102.044370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12604665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1ejurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=913-923&author=L.+Madhavanauthor=W.+J.+Freedauthor=V.+Anantharamauthor=A.+G.+Kanthasamy&title=5-Hydroxytryptamine+1A+receptor+activation+protects+against+N-methyl-d-aspartate-induced+apoptotic+cell+death+in+striatal+and+mesencephalic+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures</span></div><div class="casAuthors">Madhavan, Lalitha; Freed, William J.; Anantharam, Vellareddy; Kanthasamy, Anumantha G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913-923</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Apoptosis and glutamate-mediated excitotoxicity may play a role in the pathogenesis of many neurodegenerative disorders, including Parkinson's disease (PD).  In the present study, we investigated whether stimulation of the 5-hydroxytryptamine 1A (5-HT1A) receptor attenuates N-methyl-D-asparate- (NMDA) and 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in cell culture models.  A brief exposure (20 min) of M213-20 striatal cells to NMDA and glutamate produced a delayed increase in caspase-3 activity and DNA fragmentation in a dose- and time-dependent manner.  NMDA-induced caspase-3 activity and DNA fragmentation were almost completely blocked by the 5-HT1A agonists 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and (R)-5-fluoro-8 hydroxy-2-(dipropylamino)-tetralin (R-UH-301).  Addnl., the protective effects of 8-OH-DPAT and R-UH-301 on NMDA-induced caspase-3 activation and apoptosis were reversed by pretreatment with the 5-HT1A antagonists N-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) and S-UH-301, resp.  Similarly, dose- and time-dependent increases in caspase-3 activity and DNA fragmentation were obsd. in rat primary mesencephalic neurons after a brief exposure to NMDA and glutamate.  Caspase-3 activation and DNA fragmentation in primary mesencephalic neurons were almost completely inhibited by 8-OH-DPAT.  This neuroprotective effect of 8-OH-DPAT was reversed by WAY 100635.  Addnl., 8-OH-DPAT blocked tyrosine hydroxylase (TH)-pos. cell death after NMDA exposure and also almost completely attenuated the NMDA-induced Ca2+ influx in primary mesencephalic cultures.  Furthermore, 8-OH-DPAT and R-UH-301 blocked apoptotic cell death in the primary mesencephalic neurons that were exposed to the Parkinsonian toxin MPP+.  Together, these results suggest that 5-HT1A receptor stimulation may be a promising pharmacol. approach in the development of neuroprotective agents for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCFc3hc_8NbVg90H21EOLACvtfcHk0ljVs6rYS1CqgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1ejurs%253D&md5=18d463de2d78fbbcde2ce0cc014e6d9d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.044370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.044370%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavan%26aufirst%3DL.%26aulast%3DFreed%26aufirst%3DW.%2BJ.%26aulast%3DAnantharam%26aufirst%3DV.%26aulast%3DKanthasamy%26aufirst%3DA.%2BG.%26atitle%3D5-Hydroxytryptamine%25201A%2520receptor%2520activation%2520protects%2520against%2520N-methyl-d-aspartate-induced%2520apoptotic%2520cell%2520death%2520in%2520striatal%2520and%2520mesencephalic%2520cultures%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D913%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Nakata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogure, K.</span><span> </span><span class="NLM_article-title">Role of hippocampal serotonergic neurons in ischemic neuronal death</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1997&pages=217-220&author=N.+Nakataauthor=H.+Sudaauthor=J.+Izumiauthor=Y.+Tanakaauthor=Y.+Ikedaauthor=H.+Katoauthor=Y.+Itoyamaauthor=K.+Kogure&title=Role+of+hippocampal+serotonergic+neurons+in+ischemic+neuronal+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakata%26aufirst%3DN.%26aulast%3DSuda%26aufirst%3DH.%26aulast%3DIzumi%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DItoyama%26aufirst%3DY.%26aulast%3DKogure%26aufirst%3DK.%26atitle%3DRole%2520of%2520hippocampal%2520serotonergic%2520neurons%2520in%2520ischemic%2520neuronal%2520death%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1997%26volume%3D83%26spage%3D217%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Oosterink, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korte, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luiten, P. G.</span><span> </span><span class="NLM_article-title">Neuroprotection against <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT<sub>1A</sub> receptor agonist 8-OH-DPAT</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0014-2999%2898%2900614-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=9808263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXmt1emtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1998&pages=147-152&author=B.+J.+Oosterinkauthor=S.+M.+Korteauthor=C.+Nyakasauthor=J.+Korfauthor=P.+G.+Luiten&title=Neuroprotection+against+N-methyl-d-aspartate-induced+excitotoxicity+in+rat+magnocellular+nucleus+basalis+by+the+5-HT1A+receptor+agonist+8-OH-DPAT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection against N-methyl-D-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT1A receptor agonist 8-OH-DPAT</span></div><div class="casAuthors">Oosterink, Bart J.; Mechiel Korte, S.; Nyakas, Csaba; Korf, Jakob; Luiten, Paul G. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study reports the neuroprotective efficacy of the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone against in vivo excitotoxic neuronal injury.  Excitotoxic cell death was induced by injections of N-methyl-D-aspartate (NMDA) in the rat magnocellular nucleus basalis.  The neurodegenerative effects were quantified by image anal. of the axonal d. of the nucleus basalis projection to the somatosensory cortex visualized with acetylcholinesterase histochem.  Pretreatment with 8-OH-DPAT, but not ipsapirone, 1 h prior to NMDA infusion showed significant preservation of cortical cholinergic innervation in all doses tested.  Furthermore, 8-OH-DPAT exhibited sustained efficacy under homeothermic conditions in which the body temp. was maintained at 36.8±0.1. These data indicate that selective 5-HT1A receptor activation by 8-OH-DPAT protects against NMDA-induced excitotoxic neuronal damage, probably as a result of 5-HT1A receptor-mediated neuronal hyperpolarization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2JhhIbSjGLVg90H21EOLACvtfcHk0lhbLbvOVqYANQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmt1emtrg%253D&md5=965e32db1705c4fe91f1f0c26aebf4fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900614-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900614-1%26sid%3Dliteratum%253Aachs%26aulast%3DOosterink%26aufirst%3DB.%2BJ.%26aulast%3DKorte%26aufirst%3DS.%2BM.%26aulast%3DNyakas%26aufirst%3DC.%26aulast%3DKorf%26aufirst%3DJ.%26aulast%3DLuiten%26aufirst%3DP.%2BG.%26atitle%3DNeuroprotection%2520against%2520N-methyl-d-aspartate-induced%2520excitotoxicity%2520in%2520rat%2520magnocellular%2520nucleus%2520basalis%2520by%2520the%25205-HT1A%2520receptor%2520agonist%25208-OH-DPAT%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D358%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Carr, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spruston, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span> </span><span class="NLM_article-title">Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6846</span><span class="NLM_x">–</span> <span class="NLM_lpage">6855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1523%2FJNEUROSCI.22-16-06846.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=12177182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2gsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=6846-6855&author=D.+B.+Carrauthor=D.+C.+Cooperauthor=S.+L.+Ulrichauthor=N.+Sprustonauthor=D.+J.+Surmeier&title=Serotonin+receptor+activation+inhibits+sodium+current+and+dendritic+excitability+in+prefrontal+cortex+via+a+protein+kinase+C-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism</span></div><div class="casAuthors">Carr, David B.; Cooper, Donald C.; Ulrich, Sasha L.; Spruston, Nelson; Surmeier, D. James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6846-6855</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The serotonin (5-HT) innervation of the prefrontal cortex (PFC) exerts a powerful modulatory influence on neuronal activity in this cortical region, although the mechanisms through which 5-HT modulates cellular activity are unclear.  Voltage-dependent Na+ channels are one potential target of 5-HT receptor signaling that have wide-ranging effects on activity.  Mol. and electrophysiol. studies were used to test this potential linkage.  Single cell RT-PCR profiling revealed that the vast majority of pyramidal neurons expressed detectable levels of 5-HT2a and/or 5-HT2c receptor mRNA with half of the cells expressing both mRNAs.  Whole-cell voltage-clamp recordings of dissocd. pyramidal neurons showed that 5-HT2a/c receptor activation reduced rapidly inactivating Na+ currents by reducing maximal current amplitude and shifting fast inactivation voltage dependence.  These effects were mediated by Gq activation of phospholipase C, leading to activation of protein kinase C (PKC).  5-HT2a/c receptor stimulation also reduced the amplitude of persistent Na+ current without altering its activation voltage dependence.  This modulation was also mediated by PKC.  Although 5-HT2a,c receptor activation did not affect somatic action potentials of layer V pyramidal neurons in PFC slices, it did reduce the amplitude of action potentials back-propagating into the apical dendrite.  These findings show that 5-HT2a,c receptor activation reduces dendritic excitability and may neg. modulate activity-dependent dendritic synaptic plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIXRSDdUhvObVg90H21EOLACvtfcHk0lhbLbvOVqYANQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2gsrw%253D&md5=37cb9f88335aa780a3973ed92d87fe88</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-16-06846.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-16-06846.2002%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DD.%2BB.%26aulast%3DCooper%26aufirst%3DD.%2BC.%26aulast%3DUlrich%26aufirst%3DS.%2BL.%26aulast%3DSpruston%26aufirst%3DN.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26atitle%3DSerotonin%2520receptor%2520activation%2520inhibits%2520sodium%2520current%2520and%2520dendritic%2520excitability%2520in%2520prefrontal%2520cortex%2520via%2520a%2520protein%2520kinase%2520C-dependent%2520mechanism%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D6846%26epage%3D6855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Namura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, M. A.</span><span> </span><span class="NLM_article-title">Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3659</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVWltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=3659-3668&author=S.+Namuraauthor=J.+Zhuauthor=K.+Finkauthor=M.+Endresauthor=A.+Srinivasanauthor=K.+J.+Tomaselliauthor=J.+Yuanauthor=M.+A.+Moskowitz&title=Activation+and+cleavage+of+caspase-3+in+apoptosis+induced+by+experimental+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia</span></div><div class="casAuthors">Namura, Shobu; Zhu, Jinmin; Fink, Klaus; Endres, Matthias; Srinivasan, Anu; Tomaselli, Kevin J.; Yuan, Junying; Moskowitz, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3659-3668</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We examd. the expression, activation, and cellular localization of caspase-3 (CPP32) using immunohistochem., immunoblots, and cleavage of the fluorogenic substrate N-benzyloxycarbonyl-Asp-Glu-Val-Asp-7-amino-4-trifluoro-Me coumarin (zDEVD-afc) in adult mouse brain after temporary (2 h) middle cerebral artery occlusion produced by filament insertion into the carotid artery.  Immunoreactive caspase-3p32 but not its cleavage product caspase-3p20 was constitutively expressed in neurons throughout brain and was most prominent in neuronal perikarya within piriform cortex.  Caspase-like enzyme activity was elevated in brain homogenate 0-3 h after reperfusion and reached a peak within 30 to 60 min.  Caspase-3p20 immunoreactivity became prominent in neuronal perikarya within the middle cerebral artery territory at the time of reperfusion and on immunoblots 1-12 h later.  DNA laddering (agarose gels) and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL)- stained cells were detected 6-24 h after reperfusion.  At 12-24 h, immunoreactive p20 was visualized in TUNEL-pos. cells, a finding also obsd. in apoptotic mouse cerebellar granule cells on postnatal day 5.  These observations suggest the existence of a time-dependent evolution of ischemic injury characterized by the close correspondence between caspase-like enzyme activation and an assocd. increase in immunoreactive product (caspase-3p20) beginning at or before reperfusion and followed several hours later by morphol. and biochem. features of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFqzDjk4dQQLVg90H21EOLACvtfcHk0lhbLbvOVqYANQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVWltL8%253D&md5=1369145597dc93720b24bd2e3215ae1e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNamura%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DK.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26atitle%3DActivation%2520and%2520cleavage%2520of%2520caspase-3%2520in%2520apoptosis%2520induced%2520by%2520experimental%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D3659%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Galter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unsicker, K.</span><span> </span><span class="NLM_article-title">Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1006%2Fmcne.2000.0841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs12gsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=446-455&author=D.+Galterauthor=K.+Unsicker&title=Sequential+activation+of+the+5-HT1%28A%29+serotonin+receptor+and+TrkB+induces+the+serotonergic+neuronal+phenotype"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential Activation of the 5-HT1A Serotonin Receptor and TrkB Induces the Serotonergic Neuronal Phenotype</span></div><div class="casAuthors">Galter, Dagmar; Unsicker, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-455</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Serotonin (5-HT) is an important factor controlling survival, differentiation, and plasticity of neurons in serotonergic target regions of the brain and has been implicated in major psychiatric and autonomic disorders.  Relatively little is known, however, of factors controlling differentiation and plasticity of developing and adult 5-HT neurons.  We show now that 5-HT, the 5-HT1A receptor, brain-derived neurotrophic factor (BDNF), and its receptor, trkB, form an auto/paracrine loop for the regulation of the serotonergic phenotype.  Serotonin applied to cultures from E14 rat raphe increased nos. of neurons expressing serotonergic markers in a dose-dependent manner.  Agonists of the 5-HT1A receptor, BP-554 and 8-OH-DPAT, but not agonists of the 5-HT1B and 5-HT1D receptors, mimicked this effect, while the specific 5-HT1A antagonist, WAY-100635, inhibited it.  Serotonin also increased BDNF mRNA and protein in embryonic raphe cultures.  Induction of serotonergic markers by serotonin was suppressed by a trkB-IgG fusion protein but not by trkC-IgG.  Taken together, our data indicate that serotonin acts on 5-HT1A autoreceptors, causing up-regulation of BDNF, which activates trkB to promote serotonergic phenotype-specific markers.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX6KmFBoWodLVg90H21EOLACvtfcHk0lhbLbvOVqYANQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs12gsr0%253D&md5=99ce48798ee363b60a28b5a8986ee070</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1006%2Fmcne.2000.0841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.2000.0841%26sid%3Dliteratum%253Aachs%26aulast%3DGalter%26aufirst%3DD.%26aulast%3DUnsicker%26aufirst%3DK.%26atitle%3DSequential%2520activation%2520of%2520the%25205-HT1%2528A%2529%2520serotonin%2520receptor%2520and%2520TrkB%2520induces%2520the%2520serotonergic%2520neuronal%2520phenotype%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2000%26volume%3D15%26spage%3D446%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Fahn, S.</span><span> </span><span class="NLM_article-title">The history of dopamine and levodopa in the treatment of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">S497</span><span class="NLM_x">–</span> <span class="NLM_lpage">S508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=S497-S508&author=S.+Fahn&title=The+history+of+dopamine+and+levodopa+in+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFahn%26aufirst%3DS.%26atitle%3DThe%2520history%2520of%2520dopamine%2520and%2520levodopa%2520in%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3DS497%26epage%3DS508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiglieri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picconi, B.</span><span> </span><span class="NLM_article-title">Molecular mechanisms underlying levodopa-induced dyskinesia</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">S570</span><span class="NLM_x">–</span> <span class="NLM_lpage">S579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=S570-S579&author=P.+Calabresiauthor=M.+Di+Filippoauthor=V.+Ghiglieriauthor=B.+Picconi&title=Molecular+mechanisms+underlying+levodopa-induced+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DGhiglieri%26aufirst%3DV.%26aulast%3DPicconi%26aufirst%3DB.%26atitle%3DMolecular%2520mechanisms%2520underlying%2520levodopa-induced%2520dyskinesia%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3DS570%26epage%3DS579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Calcagno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Invernizzi, R. W.</span><span> </span><span class="NLM_article-title">The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1471-4159.2005.03600.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16405507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=853-860&author=E.+Calcagnoauthor=M.+Carliauthor=R.+W.+Invernizzi&title=The+5-HT%281A%29+receptor+agonist+8-OH-DPAT+prevents+prefrontocortical+glutamate+and+serotonin+release+in+response+to+blockade+of+cortical+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT1A receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors</span></div><div class="casAuthors">Calcagno, E.; Carli, M.; Invernizzi, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">853-860</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">We studied the role of 5-HT1A receptors in controlling the release of glutamate (GLU) in the medial prefrontal cortex (mPFC) of conscious rats with the in vivo microdialysis technique.  The effect of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin infused in the prefrontal cortex was examd. under basal conditions and on the rise of extracellular GLU (+106%) induced by co-infusion of the competitive N-methyl-D-aspartate receptor antagonist 3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP).  8-OH-DPAT (0.3 and 3 μM) had no effect on basal extracellular GLU, but the higher concn. completely abolished the rise of extracellular GLU induced by CPP.  CPP also increased extracellular serotonin (5-HT) in the mPFC (+50%) and this effect was antagonized by 3 μM 8-OH-DPAT which, by itself, had no effect on basal 5-HT release.  The effects of 8-OH-DPAT on extracellular GLU and 5-HT were reversed by the 5-HT1A receptor antagonist WAY 100635 (100 μM), indicating a selective involvement of 5-HT1A receptors.  WAY 100635 had no effect by itself.  These results show that the stimulation of cortical 5-HT1A receptors prevents the CPP-evoked rise of extracellular GLU and 5-HT and suggest that these effects may contribute to the ability of intracortical 8-OH-DPAT to counteract cognitive deficits caused by the blockade of NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkcOIp3b72pbVg90H21EOLACvtfcHk0lhRqVJxi4oiqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCnu7c%253D&md5=09601c189b2d9b0609929627e04819e7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03600.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03600.x%26sid%3Dliteratum%253Aachs%26aulast%3DCalcagno%26aufirst%3DE.%26aulast%3DCarli%26aufirst%3DM.%26aulast%3DInvernizzi%26aufirst%3DR.%2BW.%26atitle%3DThe%25205-HT%25281A%2529%2520receptor%2520agonist%25208-OH-DPAT%2520prevents%2520prefrontocortical%2520glutamate%2520and%2520serotonin%2520release%2520in%2520response%2520to%2520blockade%2520of%2520cortical%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D96%26spage%3D853%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Carta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span> </span><span class="NLM_article-title">Serotonin–dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0079-6123%2808%2900922-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=18772046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2isbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2008&pages=465-478&author=M.+Cartaauthor=T.+Carlssonauthor=A.+Munozauthor=D.+Kirikauthor=A.+Bjorklund&title=Serotonin%E2%80%93dopamine+interaction+in+the+induction+and+maintenance+of+L-DOPA-induced+dyskinesias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias</span></div><div class="casAuthors">Carta, Manolo; Carlsson, Thomas; Munoz, Ana; Kirik, Deniz; Bjoerklund, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">Serotonin-Dopamine Interaction</span>),
    <span class="NLM_cas:pages">465-478</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Appearance of dyskinesia is a common problem of long-term Levodopa (L-DOPA) treatment in Parkinson's disease (PD) patients and represents a major limitation for the pharmacol. management of the motor symptoms in the advanced stages of disease.  An increasing body of evidence points to dopamine released as a false neurotransmitter from the striatal serotonin terminals as the main pre-synaptic determinant of L-DOPA-induced dyskinesia.  Here we review the animal exptl. and human clin. data in support of this view, which point to the serotonin system as a promising target for anti-dyskinetic therapy in PD patients under L-DOPA medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMSuUVOwFKIrVg90H21EOLACvtfcHk0lhRqVJxi4oiqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2isbjJ&md5=550e213a75ccfd9650431d48c7533cf5</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900922-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900922-9%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DM.%26aulast%3DCarlsson%26aufirst%3DT.%26aulast%3DMunoz%26aufirst%3DA.%26aulast%3DKirik%26aufirst%3DD.%26aulast%3DBjorklund%26aufirst%3DA.%26atitle%3DSerotonin%25E2%2580%2593dopamine%2520interaction%2520in%2520the%2520induction%2520and%2520maintenance%2520of%2520L-DOPA-induced%2520dyskinesias%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D172%26spage%3D465%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Iravani, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayarani-Binazir, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1A agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.106.110429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=16959959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1225-1234&author=M.+M.+Iravaniauthor=K.+Tayarani-Binazirauthor=W.+B.+Chuauthor=M.+J.+Jacksonauthor=P.+Jenner&title=In+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-treated+primates%2C+the+selective+5-hydroxytryptamine+1A+agonist+%28R%29-%28%2B%29-8-OHDPAT+inhibits+levodopa-induced+dyskinesia+but+only+with%5C+increased+motor+disability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with increased motor disability</span></div><div class="casAuthors">Iravani, Mahmoud M.; Tayarani-Binazir, Kayhan; Chu, Wing B.; Jackson, Michael J.; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1234</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine 1a (5-HT1a) receptor agonists, such as sarizotan and tandospirone, are reported to reduce levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaques and in Parkinson's disease without worsening motor disability.  However, these compds. are not specific for 5-HT1a receptors and also possess dopamine antagonist actions.  We now report on the effects of (2R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin [(R)-(+)-8-OHDPAT], a selective 5-HT1a agonist lacking dopaminergic activity, on motor disability and dyskinesia (chorea and dystonia) in levodopa-primed MPTP-treated common marmosets.  Administration of (R)-(+)-8-OHDPAT (0.2, 0.6, and 2.0 mg/kg s.c), in conjunction with levodopa/carbidopa (12.5 mg/kg each p.o.) to levodopa-primed animals, dose-dependently reduced levodopa-induced chorea but did not affect dystonic movements.  However, (R)-(+)-8-OHDPAT treatment also reduced locomotor activity and the reversal of motor disability.  Administration of (R)-(+)-8-OHDPAT alone had no effects of motor behaviors.  The effects of (R)-(+)-8-OHDPAT on levodopa-induced motor behaviors were antagonized by the 5-HT1a receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide maleate (WAY-100635) (1.0 mg/kg s.c.).  Administration of (R)-(+)-8-OHDPAT (0.6 mg/kg s.c.) also reduced chorea produced by the administration of the D2/D3 dopamine receptor agonist pramipexole (0.06 mg/kg p.o.) to levodopa-primed MPTP-treated animals.  However, again the increase in locomotor activity and reversal of motor disability produced by pramipexole were also inhibited.  These data suggest that selective 5-HT1a agonists do not provide an effective means of suppressing levodopa-induced dyskinesia, except with worsening of parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp6G1H1kUDUbVg90H21EOLACvtfcHk0lhRqVJxi4oiqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltLzL&md5=bee8d68da27e297314db4142acdc0acb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.110429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.110429%26sid%3Dliteratum%253Aachs%26aulast%3DIravani%26aufirst%3DM.%2BM.%26aulast%3DTayarani-Binazir%26aufirst%3DK.%26aulast%3DChu%26aufirst%3DW.%2BB.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DIn%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-treated%2520primates%252C%2520the%2520selective%25205-hydroxytryptamine%25201A%2520agonist%2520%2528R%2529-%2528%252B%2529-8-OHDPAT%2520inhibits%2520levodopa-induced%2520dyskinesia%2520but%2520only%2520with%255C%2520increased%2520motor%2520disability%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1225%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Gregoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paolo, T.</span><span> </span><span class="NLM_article-title">Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.parkreldis.2008.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=19196540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BD1MvktlCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=445-452&author=L.+Gregoireauthor=P.+Samadiauthor=J.+Grahamauthor=P.+J.+Bedardauthor=G.+D.+Bartoszykauthor=T.+Di+Paolo&title=Low+doses+of+sarizotan+reduce+dyskinesias+and+maintain+antiparkinsonian+efficacy+of+L-Dopa+in+parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys</span></div><div class="casAuthors">Gregoire Laurent; Samadi Pershia; Graham Julie; Bedard Paul J; Bartoszyk Gerd D; Di Paolo Therese</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyskinesia is an important complication of treatment in Parkinson's disease (PD).  Sarizotan, a 5-HT(1A) agonist with high affinity for D3 and D4 receptors was investigated on L-Dopa-induced dyskinesia (LID) in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model of PD.  Five MPTP female cynomolgus monkeys (Macaca fascicularis) with a moderate to severe parkinsonian syndrome and LID were used.  Sarizotan 0.2, 1, and 2 mg/kg administered alone did not worsen parkinsonian symptoms; there were no effect on locomotor counts or on normal behavior of the monkeys.  Sarizotan 0.2, 1, and 2 mg/kg administered 30 min before a fixed dose of L-Dopa (25-30 mg/kg s.c.) + benserazide (50 mg) did not affect the antiparkinsonian response to L-Dopa.  However, mean dyskinetic scores were significantly reduced with sarizotan 1 and 2 mg/kg but not at 0.2 mg/kg.  Higher doses of sarizotan (4 and 8 mg/kg, administered immediately before L-Dopa) reduced L-Dopa-induced locomotor response in all monkeys.  A pharmacokinetic investigation in these monkeys showed a dose-dependent increase in mean plasma sarizotan concentrations with similar mean plasma concentrations for sarizotan 1 mg/kg alone or with L-Dopa, indicating a lack of sarizotan/L-Dopa interaction.  The time course of plasma sarizotan concentrations was associated with time of maximal reduction of dyskinesias.  When administered daily for two weeks in combination with L-Dopa in the same MPTP monkeys, sarizotan 1 mg/kg had a sustained antidyskinetic effect while maintaining the antiparkinsonian and locomotor effect of L-Dopa.  This detailed sarizotan investigation in MPTP monkeys supports the antidyskinetic activity of this drug and for 5-HT(1A) agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvhMMzFaaX52Zyxfu64m4ffW6udTcc2eaUG0B2nomyYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvktlCgsw%253D%253D&md5=970beb3ee233df876b1bc52b1ccfa558</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.parkreldis.2008.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parkreldis.2008.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DGregoire%26aufirst%3DL.%26aulast%3DSamadi%26aufirst%3DP.%26aulast%3DGraham%26aufirst%3DJ.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26aulast%3DDi%2BPaolo%26aufirst%3DT.%26atitle%3DLow%2520doses%2520of%2520sarizotan%2520reduce%2520dyskinesias%2520and%2520maintain%2520antiparkinsonian%2520efficacy%2520of%2520L-Dopa%2520in%2520parkinsonian%2520monkeys%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2009%26volume%3D15%26spage%3D445%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Goetz, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoulson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurgans, S.</span><span> </span><span class="NLM_article-title">Placebo response in Parkinson’s disease: comparisons among 11 trials covering medical and surgical interventions</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=690-699&author=C.+G.+Goetzauthor=J.+Wuuauthor=M.+P.+McDermottauthor=C.+H.+Adlerauthor=S.+Fahnauthor=C.+R.+Freedauthor=R.+A.+Hauserauthor=W.+C.+Olanowauthor=I.+Shoulsonauthor=P.+K.+Tandonauthor=S.+Leurgans&title=Placebo+response+in+Parkinson%E2%80%99s+disease%3A+comparisons+among+11+trials+covering+medical+and+surgical+interventions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DWuu%26aufirst%3DJ.%26aulast%3DMcDermott%26aufirst%3DM.%2BP.%26aulast%3DAdler%26aufirst%3DC.%2BH.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DFreed%26aufirst%3DC.%2BR.%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DOlanow%26aufirst%3DW.%2BC.%26aulast%3DShoulson%26aufirst%3DI.%26aulast%3DTandon%26aufirst%3DP.%2BK.%26aulast%3DLeurgans%26aufirst%3DS.%26atitle%3DPlacebo%2520response%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520comparisons%2520among%252011%2520trials%2520covering%2520medical%2520and%2520surgical%2520interventions%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3D690%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Kuzhikandathil, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span> </span><span class="NLM_article-title">The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2006&pages=873-884&author=E.+V.+Kuzhikandathilauthor=G.+D.+Bartoszyk&title=The+novel+antidyskinetic+drug+sarizotan+elicits+different+functional+responses+at+human+D2-like+dopamine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuzhikandathil%26aufirst%3DE.%2BV.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26atitle%3DThe%2520novel%2520antidyskinetic%2520drug%2520sarizotan%2520elicits%2520different%2520functional%2520responses%2520at%2520human%2520D2-like%2520dopamine%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2006%26volume%3D51%26spage%3D873%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Assie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carilla-Durand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depoortere, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleven, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colpaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1-14&author=M.+B.+Assieauthor=L.+Bardinauthor=A.+L.+Auclairauthor=E.+Carilla-Durandauthor=R.+Depoortereauthor=W.+Koekauthor=M.+S.+Klevenauthor=F.+Colpaertauthor=B.+Vacherauthor=A.+Newman-Tancredi&title=F15599%2C+a+highly+selective+post-synaptic+5-HT1A+receptor+agonist%3A+in-vivo+profile+in+behavioural+models+of+antidepressant+and+serotonergic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssie%26aufirst%3DM.%2BB.%26aulast%3DBardin%26aufirst%3DL.%26aulast%3DAuclair%26aufirst%3DA.%2BL.%26aulast%3DCarilla-Durand%26aufirst%3DE.%26aulast%3DDepoortere%26aufirst%3DR.%26aulast%3DKoek%26aufirst%3DW.%26aulast%3DKleven%26aufirst%3DM.%2BS.%26aulast%3DColpaert%26aufirst%3DF.%26aulast%3DVacher%26aufirst%3DB.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DF15599%252C%2520a%2520highly%2520selective%2520post-synaptic%25205-HT1A%2520receptor%2520agonist%253A%2520in-vivo%2520profile%2520in%2520behavioural%2520models%2520of%2520antidepressant%2520and%2520serotonergic%2520activity%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2010%26volume%3D11%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Carta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span> </span><span class="NLM_article-title">Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1819</span><span class="NLM_x">–</span> <span class="NLM_lpage">1833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=1819-1833&author=M.+Cartaauthor=T.+Carlssonauthor=D.+Kirikauthor=A.+Bjorklund&title=Dopamine+released+from+5-HT+terminals+is+the+cause+of+L-DOPA-induced+dyskinesia+in+parkinsonian+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DM.%26aulast%3DCarlsson%26aufirst%3DT.%26aulast%3DKirik%26aufirst%3DD.%26aulast%3DBjorklund%26aufirst%3DA.%26atitle%3DDopamine%2520released%2520from%25205-HT%2520terminals%2520is%2520the%2520cause%2520of%2520L-DOPA-induced%2520dyskinesia%2520in%2520parkinsonian%2520rats%26jtitle%3DBrain%26date%3D2007%26volume%3D130%26spage%3D1819%26epage%3D1833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Munoz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Luca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, M.</span><span> </span><span class="NLM_article-title">Combined 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor agonists for the treatment of L-DOPA-induced dyskinesia</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3380</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2008&pages=3380-3394&author=A.+Munozauthor=Q.+Liauthor=F.+Gardoniauthor=E.+Marcelloauthor=C.+Qinauthor=T.+Carlssonauthor=D.+Kirikauthor=M.+Di+Lucaauthor=A.+Bjorklundauthor=E.+Bezardauthor=M.+Carta&title=Combined+5-HT1A+and+5-HT1B+receptor+agonists+for+the+treatment+of+L-DOPA-induced+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DGardoni%26aufirst%3DF.%26aulast%3DMarcello%26aufirst%3DE.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DCarlsson%26aufirst%3DT.%26aulast%3DKirik%26aufirst%3DD.%26aulast%3DDi%2BLuca%26aufirst%3DM.%26aulast%3DBjorklund%26aufirst%3DA.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DCarta%26aufirst%3DM.%26atitle%3DCombined%25205-HT1A%2520and%25205-HT1B%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520L-DOPA-induced%2520dyskinesia%26jtitle%3DBrain%26date%3D2008%26volume%3D131%26spage%3D3380%26epage%3D3394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tronci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pioli, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, M.</span><span> </span><span class="NLM_article-title">Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=1088-1096&author=E.+Bezardauthor=E.+Tronciauthor=E.+Y.+Pioliauthor=Q.+Liauthor=G.+Porrasauthor=A.+Bj%C3%B6rklundauthor=M.+Carta&title=Study+of+the+antidyskinetic+effect+of+eltoprazine+in+animal+models+of+levodopa-induced+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DTronci%26aufirst%3DE.%26aulast%3DPioli%26aufirst%3DE.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DPorras%26aufirst%3DG.%26aulast%3DBj%25C3%25B6rklund%26aufirst%3DA.%26aulast%3DCarta%26aufirst%3DM.%26atitle%3DStudy%2520of%2520the%2520antidyskinetic%2520effect%2520of%2520eltoprazine%2520in%2520animal%2520models%2520of%2520levodopa-induced%2520dyskinesia%26jtitle%3DMov.%2520Disord.%26date%3D2013%26volume%3D28%26spage%3D1088%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Paquette, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brudney, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshul, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. P.</span><span> </span><span class="NLM_article-title">The sigma-1 antagonist BMY-14802 inhibits L-DOPAinduced abnormal involuntary movements by a WAY-100635-sensitive mechanism</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2009&pages=743-754&author=M.+A.+Paquetteauthor=K.+Foleyauthor=E.+G.+Brudneyauthor=C.+K.+Meshulauthor=S.+W.+Johnsonauthor=S.+P.+Berger&title=The+sigma-1+antagonist+BMY-14802+inhibits+L-DOPAinduced+abnormal+involuntary+movements+by+a+WAY-100635-sensitive+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaquette%26aufirst%3DM.%2BA.%26aulast%3DFoley%26aufirst%3DK.%26aulast%3DBrudney%26aufirst%3DE.%2BG.%26aulast%3DMeshul%26aufirst%3DC.%2BK.%26aulast%3DJohnson%26aufirst%3DS.%2BW.%26aulast%3DBerger%26aufirst%3DS.%2BP.%26atitle%3DThe%2520sigma-1%2520antagonist%2520BMY-14802%2520inhibits%2520L-DOPAinduced%2520abnormal%2520involuntary%2520movements%2520by%2520a%2520WAY-100635-sensitive%2520mechanism%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D204%26spage%3D743%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Bhide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindenbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surrena, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, M. A.</span><span> </span><span class="NLM_article-title">The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2013&pages=533-544&issue=3&author=N.+Bhideauthor=D.+Lindenbachauthor=M.+A.+Surrenaauthor=A.+A.+Goldenbergauthor=C.+Bishopauthor=S.+P.+Bergerauthor=M.+A.+Paquette&title=The+effects+of+BMY-14802+against+L-DOPA-+and+dopamine+agonist-induced+dyskinesia+in+the+hemiparkinsonian+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DN.%26aulast%3DLindenbach%26aufirst%3DD.%26aulast%3DSurrena%26aufirst%3DM.%2BA.%26aulast%3DGoldenberg%26aufirst%3DA.%2BA.%26aulast%3DBishop%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DS.%2BP.%26aulast%3DPaquette%26aufirst%3DM.%2BA.%26atitle%3DThe%2520effects%2520of%2520BMY-14802%2520against%2520L-DOPA-%2520and%2520dopamine%2520agonist-induced%2520dyskinesia%2520in%2520the%2520hemiparkinsonian%2520rat%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D227%26issue%3D3%26spage%3D533%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Goetz, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicking, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rascol, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russ, H.</span><span> </span><span class="NLM_article-title">Sarizotan as a treatment for dyskinesias in Parkinson’s disease: a double-blind placebo-controlled trial</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=179-186&author=C.+G.+Goetzauthor=P.+Damierauthor=C.+Hickingauthor=E.+Laskaauthor=T.+Mullerauthor=C.+W.+Olanowauthor=O.+Rascolauthor=H.+Russ&title=Sarizotan+as+a+treatment+for+dyskinesias+in+Parkinson%E2%80%99s+disease%3A+a+double-blind+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoetz%26aufirst%3DC.%2BG.%26aulast%3DDamier%26aufirst%3DP.%26aulast%3DHicking%26aufirst%3DC.%26aulast%3DLaska%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DT.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DRascol%26aufirst%3DO.%26aulast%3DRuss%26aufirst%3DH.%26atitle%3DSarizotan%2520as%2520a%2520treatment%2520for%2520dyskinesias%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520double-blind%2520placebo-controlled%2520trial%26jtitle%3DMov.%2520Disord.%26date%3D2007%26volume%3D22%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Hillegaart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlenius, S.</span><span> </span><span class="NLM_article-title">Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1733</span><span class="NLM_x">–</span> <span class="NLM_lpage">1743</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0702239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Kiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1998&pages=1733-1743&author=V.+Hillegaartauthor=S.+Ahlenius&title=Facilitation+and+inhibition+of+male+rat+ejaculatory+behaviour+by+the+respective+5-HT1A+and+5-HT1B+receptor+agonists+8-OH-DPAT+and+anpirtoline%2C+as+evidenced+by+use+of+the+corresponding+new+and+selective+receptor+antagonists+NAD-299+and+NAS-181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Facilitation and inhibition of male rat ejaculatory behavior by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181</span></div><div class="casAuthors">Hillegaart, Viveka; Ahlenius, Sven</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1733-1743</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Ejaculatory problems and anorgasmia are well-known side-effects of the SSRI (selective serotonin reuptake inhibitor) antidepressants, and a pharmacol. induced increase in serotonergic neurotransmission inhibits ejaculatory behavior in the rat.  In the present study the role of 5-HT1A and 5-HT1B receptors in the mediation of male rat ejaculatory behavior was examd. by use of selective agonists and antagonists acting at these 5-HT receptor subtypes.  The 5-HT1A receptor agonist 8-OH-DPAT (0.25-4.00 μmol kg-1 s.c.) produced an expected facilitation of the male rat ejaculatory behavior, and this effect was fully antagonized by pretreatment with the new selective 5-HT1A receptor antagonist (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R) tartrate monohydrate (NAD-299) (1.0 μmol kg-1 s.c.).  NAD-299 by itself (0.75-3.00 μmol kg-1 s.c.) did not affect the male rat ejaculatory behavior.  The 5-HT1B receptor agonist anpirtoline (0.25-4.00 μmol kg-1 s.c.) produced a dose-dependent inhibition of the male rat ejaculatory behavior, and this effect was fully antagonized by pretreatment with the 5-HT1B receptor antagonist isamoltane (16 μmol kg-1 s.c.) as well as by the new and selective antagonist (R)-(+)-2-(3-morpholinomethyl-2H-chromene-8-yl)oxymethylmorpholino methanesulfonate (NAS-181) (16 μmol kg-1 s.c.).  Isamoltane (1.0-16.0 μmol kg-1 s.c.) and NAD-181 (1.0-16.0 μmol kg-1 s.c.) had no, or weakly facilitatory effects on the male rat ejaculatory behavior.  The non-selective 5-HT1 receptor antagonist (-)-pindolol (8 μmol kg-1 s.c.), did not antagonize the inhibition produced by anpirtoline.  The present results demonstrate opposite effects, facilitation and inhibition, of male rat ejaculatory behavior by stimulation of 5-HT1A and 5-HT1B receptors, resp., suggesting that the SSRI-induced inhibition of male ejaculatory dysfunction is due to 5-HT1B receptor stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMNI5gg-0YSLVg90H21EOLACvtfcHk0ljU0RzFfUuHFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Kiug%253D%253D&md5=a5866ffaa97c37cb6412b6146268e81b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702239%26sid%3Dliteratum%253Aachs%26aulast%3DHillegaart%26aufirst%3DV.%26aulast%3DAhlenius%26aufirst%3DS.%26atitle%3DFacilitation%2520and%2520inhibition%2520of%2520male%2520rat%2520ejaculatory%2520behaviour%2520by%2520the%2520respective%25205-HT1A%2520and%25205-HT1B%2520receptor%2520agonists%25208-OH-DPAT%2520and%2520anpirtoline%252C%2520as%2520evidenced%2520by%2520use%2520of%2520the%2520corresponding%2520new%2520and%2520selective%2520receptor%2520antagonists%2520NAD-299%2520and%2520NAS-181%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D125%26spage%3D1733%26epage%3D1743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Waldinger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengeveld, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwinderman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span> </span><span class="NLM_article-title">Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebocontrolled study with fluoxetine, fluvoxamine, paroxetine, and sertraline</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=291-297&author=M.+D.+Waldingerauthor=M.+W.+Hengeveldauthor=A.+H.+Zwindermanauthor=B.+Olivier&title=Effect+of+SSRI+antidepressants+on+ejaculation%3A+a+double-blind%2C+randomized%2C+placebocontrolled+study+with+fluoxetine%2C+fluvoxamine%2C+paroxetine%2C+and+sertraline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldinger%26aufirst%3DM.%2BD.%26aulast%3DHengeveld%26aufirst%3DM.%2BW.%26aulast%3DZwinderman%26aufirst%3DA.%2BH.%26aulast%3DOlivier%26aufirst%3DB.%26atitle%3DEffect%2520of%2520SSRI%2520antidepressants%2520on%2520ejaculation%253A%2520a%2520double-blind%252C%2520randomized%252C%2520placebocontrolled%2520study%2520with%2520fluoxetine%252C%2520fluvoxamine%252C%2520paroxetine%252C%2520and%2520sertraline%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2001%26volume%3D21%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Schnur, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, J. M.</span><span> </span><span class="NLM_article-title">A component analysis of the effects of DPAT on male rat sexual behavior</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=897-901&author=S.+L.+Schnurauthor=E.+R.+Smithauthor=R.+L.+Leeauthor=M.+Masauthor=J.+M.+Davidson&title=A+component+analysis+of+the+effects+of+DPAT+on+male+rat+sexual+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchnur%26aufirst%3DS.%2BL.%26aulast%3DSmith%26aufirst%3DE.%2BR.%26aulast%3DLee%26aufirst%3DR.%2BL.%26aulast%3DMas%26aufirst%3DM.%26aulast%3DDavidson%26aufirst%3DJ.%2BM.%26atitle%3DA%2520component%2520analysis%2520of%2520the%2520effects%2520of%2520DPAT%2520on%2520male%2520rat%2520sexual%2520behavior%26jtitle%3DPhysiol.%2520Behav.%26date%3D1989%26volume%3D45%26spage%3D897%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Rosen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shifren, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monz, B. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odom, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannes, C. B.</span><span> </span><span class="NLM_article-title">Correlates of sexually related personal distress in women with low sexual desire</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1743-6109.2009.01252.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BD1MvjtFSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1549-1560&author=R.+C.+Rosenauthor=J.+L.+Shifrenauthor=B.+U.+Monzauthor=D.+M.+Odomauthor=P.+A.+Russoauthor=C.+B.+Johannes&title=Correlates+of+sexually+related+personal+distress+in+women+with+low+sexual+desire"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Correlates of sexually related personal distress in women with low sexual desire</span></div><div class="casAuthors">Rosen Raymond C; Shifren Jan L; Monz Brigitta U; Odom Dawn M; Russo Patricia A; Johannes Catherine B</div><div class="citationInfo"><span class="NLM_cas:title">The journal of sexual medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1549-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Sexual distress is an important component of diagnostic criteria for sexual dysfunctions, but little is known about the factors associated with sexual distress in women with low sexual desire.  AIM:  To investigate the correlates of sexual distress in women with self-reported low sexual desire.  METHODS:  The Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking study was a cross-sectional, nationally representative, mailed survey of U.S. adult women.  There were 31,581 respondents (response rate 63.2%) to the 42-item questionnaire that measured sexual function, sexual distress, demographic, and health-related factors.  Multivariable logistic regression was used to explore the correlates of distress.  MAIN OUTCOME MEASURES:  Low sexual desire was defined as a response of "never" or "rarely" to the question, "How often do you desire to engage in sexual activity?" Sexual distress was measured with the Female Sexual Distress Scale (range 0-48), with a score of 15 or higher indicating presence of distress.  RESULTS:  Of 10,429 women with low desire, 2,868 (27.5%) had sexual distress (mean age 48.6 years, 81% with a current partner).  Women without distress were 10 years older on average, and 44% had a current partner.  Having a partner was strongly related to distress (odds ratio 4.6, 95% confidence interval 4.1-5.2).  Other correlates were age, race, current depression, anxiety, lower social functioning, hormonal medication use, urinary incontinence, and concurrent sexual problems (arousal or orgasm).  Dissatisfaction with sex life was more common in women with low desire and distress (65%) than in those without distress (20%).  CONCLUSIONS:  Age has a curvilinear relationship with distress, and the strongest correlate of sexual distress was having a current partner.  Sexual distress and dissatisfaction with sex life are strongly correlated.  Distress is higher in women with low sexual desire in a partner relationship; further research on this factor is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNU9oC2uYrlrGbPKh4T9eAfW6udTcc2ebWxoQEPmkCkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvjtFSisA%253D%253D&md5=0795da66f4251a9c958d0fa27d6d40d2</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2009.01252.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2009.01252.x%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DR.%2BC.%26aulast%3DShifren%26aufirst%3DJ.%2BL.%26aulast%3DMonz%26aufirst%3DB.%2BU.%26aulast%3DOdom%26aufirst%3DD.%2BM.%26aulast%3DRusso%26aufirst%3DP.%2BA.%26aulast%3DJohannes%26aufirst%3DC.%2BB.%26atitle%3DCorrelates%2520of%2520sexually%2520related%2520personal%2520distress%2520in%2520women%2520with%2520low%2520sexual%2520desire%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2009%26volume%3D6%26spage%3D1549%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Rosen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maserejian, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krychman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, I.</span><span> </span><span class="NLM_article-title">Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the hypoactive sexual desire disorder registry for women</span> <span class="citation_source-journal">Menopause</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1097%2Fgme.0b013e318230e286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BC38zntlOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=396-405&author=R.+C.+Rosenauthor=N.+N.+Maserejianauthor=M.+K.+Connorauthor=M.+L.+Krychmanauthor=C.+S.+Brownauthor=I.+Goldstein&title=Characteristics+of+premenopausal+and+postmenopausal+women+with+acquired%2C+generalized+hypoactive+sexual+desire+disorder%3A+the+hypoactive+sexual+desire+disorder+registry+for+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder:  the Hypoactive Sexual Desire Disorder Registry for women</span></div><div class="casAuthors">Rosen Raymond C; Maserejian Nancy N; Connor Megan K; Krychman Michael L; Brown Candace S; Goldstein Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Menopause (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">396-405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Little is known about the natural history of hypoactive sexual desire disorder (HSDD).  We examined the sociodemographic, relationship, help seeking, sexual function, and medical characteristics of women with a clinical diagnosis of generalized, acquired HSDD by menopause status.  METHODS:  This study was a cross-sectional baseline data analysis from the HSDD Registry for Women (N = 1,574, from 33 US clinical sites).  HSDD was clinically diagnosed and confirmed.  Validated measures of sexual function, relationship factors, and health, as well as newly developed questions on help seeking were assessed using the questionnaire.  RESULTS:  Participants were predominantly married or living with a partner (81.7%) and represented a range of race/ethnic backgrounds and ages (mean ± SD, 42.9 ± 11.9 y).  Most (56.8%) described their HSDD severity as "moderate to severe," with 26.5% rating the problem severe.  Nonetheless, most women (69.8%) reported being happy in their relationship, and 61.8% were satisfied with their partner communication.  Postmenopausal women had lower Female Sexual Function Index total scores, indicating worse sexual function (14.0 ± 7.5) than premenopausal women (16.7 ± 6.8, P < 0.001), although both groups had similarly low scores on the sexual desire domain (3.4 ± 1.3 vs 3.3 ± 1.4).  Less than half of the overall sample had sought professional help, among whom hormonal treatments had been used by 23.7% of postmenopausal women and by 7.6% of premenopausal women.  CONCLUSIONS:  Most women with HSDD were in long-term partner relationships with high levels of overall relationship satisfaction.  Postmenopausal women were more likely to seek help for their disorder, despite similarly high levels of distress associated with HSDD.  Further research is needed to examine treatment outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5EvAbyjoY9TEC-75aqa5AfW6udTcc2ebWxoQEPmkCkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zntlOisg%253D%253D&md5=57d2696345f0661e59b34610542f9d7b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1097%2Fgme.0b013e318230e286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fgme.0b013e318230e286%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DR.%2BC.%26aulast%3DMaserejian%26aufirst%3DN.%2BN.%26aulast%3DConnor%26aufirst%3DM.%2BK.%26aulast%3DKrychman%26aufirst%3DM.%2BL.%26aulast%3DBrown%26aufirst%3DC.%2BS.%26aulast%3DGoldstein%26aufirst%3DI.%26atitle%3DCharacteristics%2520of%2520premenopausal%2520and%2520postmenopausal%2520women%2520with%2520acquired%252C%2520generalized%2520hypoactive%2520sexual%2520desire%2520disorder%253A%2520the%2520hypoactive%2520sexual%2520desire%2520disorder%2520registry%2520for%2520women%26jtitle%3DMenopause%26date%3D2012%26volume%3D19%26spage%3D396%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Allers, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dremencov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cremers, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span> </span><span class="NLM_article-title">Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1743-6109.2010.01763.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=20163532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1aku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1757-1767&author=K.+A.+Allersauthor=E.+Dremencovauthor=A.+Ceciauthor=G.+Flikauthor=B.+Fergerauthor=T.+I.+Cremersauthor=C.+Ittrichauthor=B.+Sommer&title=Acute+and+repeated+flibanserin+administration+in+female+rats+modulates+monoamines+differentially+across+brain+areas%3A+a+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study</span></div><div class="casAuthors">Allers, Kelly A.; Dremencov, Eliyahu; Ceci, Angelo; Flik, Gunnar; Ferger, Boris; Cremers, Thomas I. F. H.; Ittrich, Carina; Sommer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Sexual Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1757-1767</span>CODEN:
                <span class="NLM_cas:coden">JSMOAN</span>;
        ISSN:<span class="NLM_cas:issn">1743-6095</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Introduction: Hypoactive sexual desire disorder (HSDD) is defined as persistent lack of sexual fantasies or desire marked by distress.  With a prevalence of 10% it is the most common form of female sexual dysfunction.  Recently, the serotonin-1A (5-HT1A) receptor agonist and the serotonin-2A (5-HT2A) receptor antagonist flibanserin were shown to be safe and efficacious in premenopausal women suffering from HSDD in phase III clin. trials.  Aim: The current study aims to assess the effect of flibanserin on neurotransmitters serotonin (5-HT), norepinephrine (NE), dopamine (DA), glutamate, and γ-aminobutyric acid (GABA) in brain areas assocd. with sexual behavior.  Methods: Flibanserin was administered to female Wistar rats (280-350 g).  Microdialysis probes were stereotactically inserted into the mPFC, NAC, or MPOA, under isoflurane anesthesia.  The extracellular levels of neurotransmitters were assessed in freely moving animals, 24 h after the surgery.  Main Outcome Measures: Dialyzate levels of DA, NE, and serotonin from medial prefrontal cortex (mPFC), nucleus accumbens (NAC), and hypothalamic medial preoptic area (MPOA) from female rats.  Results: Acute flibanserin administration decreased 5-HT and increased NE levels in all tested areas.  DA was increased in mPFC and MPOA, but not in the NAC.  Basal levels of NE in mPFC and NAC and of DA in mPFC were increased upon repeated flibanserin administration, when compared to vehicle-treated animals.  The basal levels of 5-HT were not altered by repeated flibanserin administration, but basal DA and NE levels were increased in the mPFC.  Glutamate and GABA levels remained unchanged following either repeated or acute flibanserin treatment.  Conclusions: Systemic administration of flibanserin to female rats differentially affects the monoamine systems of the brain.  This may be the mechanistic underpinning of flibanserin's therapeutic efficacy in HSDD, as sexual behavior is controlled by an intricate interplay between stimulatory (catecholaminergic) and inhibitory (serotonergic) systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9NN2p_MmISbVg90H21EOLACvtfcHk0lhE6ULMgI72Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1aku7s%253D&md5=bd81ec60f65adb6749cc8250071351cf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2010.01763.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2010.01763.x%26sid%3Dliteratum%253Aachs%26aulast%3DAllers%26aufirst%3DK.%2BA.%26aulast%3DDremencov%26aufirst%3DE.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DFlik%26aufirst%3DG.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DCremers%26aufirst%3DT.%2BI.%26aulast%3DIttrich%26aufirst%3DC.%26aulast%3DSommer%26aufirst%3DB.%26atitle%3DAcute%2520and%2520repeated%2520flibanserin%2520administration%2520in%2520female%2520rats%2520modulates%2520monoamines%2520differentially%2520across%2520brain%2520areas%253A%2520a%2520microdialysis%2520study%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2010%26volume%3D7%26spage%3D1757%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollentier, S.</span><span> </span><span class="NLM_article-title">Pharmacology of flibanserin</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=117-142&author=F.+Borsiniauthor=K.+Evansauthor=K.+Jasonauthor=F.+Rohdeauthor=B.+Alexanderauthor=S.+Pollentier&title=Pharmacology+of+flibanserin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DK.%26aulast%3DJason%26aufirst%3DK.%26aulast%3DRohde%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DB.%26aulast%3DPollentier%26aufirst%3DS.%26atitle%3DPharmacology%2520of%2520flibanserin%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2002%26volume%3D8%26spage%3D117%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladinsky, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monferini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turconi, M.</span><span> </span><span class="NLM_article-title">Flibanserin: antidepressant, 5-HT<sub>1A</sub> receptor agonist, 5-HT<sub>2</sub> receptor antagonist</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1358%2Fdof.1998.023.01.439435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK1cXit1SntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=9-16&author=F.+Borsiniauthor=A.+Brambillaauthor=A.+Ceciauthor=R.+Cesanaauthor=E.+Giraldoauthor=H.+Ladinskyauthor=E.+Monferiniauthor=M.+Turconi&title=Flibanserin%3A+antidepressant%2C+5-HT1A+receptor+agonist%2C+5-HT2+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Flibanserin: antidepressant 5-HT1A receptor agonist 5-HT2 receptor agonist</span></div><div class="casAuthors">Borsini, Franco; Brambilla, Alessandro; Ceci, Angelo; Cesana, Raffaele; Giraldo, Ettore; Ladinsky, Herbert; Monferini, Eugenia; Turconi, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">J. R. Prous, S.A.</span>)
        </div><div class="casAbstract">Review with 36 refs. of the synthesis and inhibitory effects of flibanserin are given.  Flibanserin not only mimics antidepressant-like action but also induces after a single dose some of the effects exerted by antidepressants after repeated administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcKFLYu4kjZbVg90H21EOLACvtfcHk0licrH9i2bVL4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1SntL0%253D&md5=4932ae08e81ed5e862d5f2a81d55df47</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1358%2Fdof.1998.023.01.439435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.1998.023.01.439435%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DBrambilla%26aufirst%3DA.%26aulast%3DCeci%26aufirst%3DA.%26aulast%3DCesana%26aufirst%3DR.%26aulast%3DGiraldo%26aufirst%3DE.%26aulast%3DLadinsky%26aufirst%3DH.%26aulast%3DMonferini%26aufirst%3DE.%26aulast%3DTurconi%26aufirst%3DM.%26atitle%3DFlibanserin%253A%2520antidepressant%252C%25205-HT1A%2520receptor%2520agonist%252C%25205-HT2%2520receptor%2520antagonist%26jtitle%3DDrugs%2520Future%26date%3D1998%26volume%3D23%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesana, R.</span><span> </span><span class="NLM_article-title">Mechanism of action of flibanserin in the learned helplessness paradigm in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">433</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2FS0014-2999%2801%2901495-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=433&publication_year=2001&pages=81-89&author=F.+Borsiniauthor=R.+Cesana&title=Mechanism+of+action+of+flibanserin+in+the+learned+helplessness+paradigm+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of flibanserin in the learned helplessness paradigm in rats</span></div><div class="casAuthors">Borsini, Franco; Cesana, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">433</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The mechanism of action of flibanserin, a 5-HT1A receptor agonist and a 5-HT2A receptor antagonist, was investigated in learned helplessness in rats.  The effect of flibanserin (32 mg/kg, i.p. 30 min before testing) on learned helplessness was not antagonized by the (a) 5-HT synthesis inhibitor parachlorophenylalanine (pCPA; 150 mg/kg p.o. ×3 times), which reduced brain 5-HT by 89%; (b) 5-HT1A receptor antagonists ()-N-tert-butyl-3-4-(2-ethoxyphenyl)piperazin-1yl-2-Ph propionamide [WAY100135; 10 mg/kg, i.p. 30 min before flibanserin, or 40 mg/kg, s.c. 15 min before flibanserin] and tertatolol (2.5 and 5 mg/kg, i.p. 30 min before flibanserin); and (c) 5-HT receptor agonist ()-2,5-dimethoxy-4-iodoamphetamine (DOI; 3 mg/kg, s.c. simultaneously with flibanserin).  The effect of flibanserin on learned helplessness was antagonized by the dopamine D1 receptor antagonist [R]-3-methyl-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390; 0.1 mg/kg, i.p. 30 min before flibanserin) and by the opioid receptor antagonist naloxone (3 mg/kg, s.c. 15 min before flibanserin).  Flibanserin (32 and 64 mg/kg) did not induce conditioned place preference.  In conclusion, flibanserin improved rats' performance in the learned helplessness paradigm, by stimulating dopamine D1 and opioid receptors, probably indirectly, since flibanserin has a low affinity for these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGtnvEybcNybVg90H21EOLACvtfcHk0licrH9i2bVL4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVei&md5=9cc3e131089f9c542ec45b9d9d5a559d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901495-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901495-9%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DCesana%26aufirst%3DR.%26atitle%3DMechanism%2520of%2520action%2520of%2520flibanserin%2520in%2520the%2520learned%2520helplessness%2520paradigm%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D433%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Invernizzi, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acconcia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanin, R.</span><span> </span><span class="NLM_article-title">Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0705341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2003&pages=1281-1288&author=R.+W.+Invernizziauthor=G.+Sacchettiauthor=S.+Pariniauthor=S.+Acconciaauthor=R.+Samanin&title=Flibanserin%2C+a+potential+antidepressant+drug%2C+lowers+5-HT+and+raises+dopamine+and+noradrenaline+in+the+rat+prefrontal+cortex+dialysate%3A+role+of+5-HT%281A%29+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: Role of 5-HT1A receptors</span></div><div class="casAuthors">Invernizzi, Roberto William; Sacchetti, Giuseppina; Parini, Stefania; Acconcia, Sabrina; Samanin, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1281-1288</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using in vivo intracerebral microdialysis in conscious, freely moving rats, we examd. the effect of flibanserin, a potential antidepressant drug with high affinity for human 5-HT1A receptors and four-50-fold lower affinity for 5-HT2A and D4 receptors, on basal extracellular concns. of serotonin (5-hydroxytryptamine, 5-HT), dopamine (DA) and noradrenaline (NA) in selected regions of the rat brain.  Flibanserin at 3 and 10 mg kg-1 significantly reduced extracellular 5-HT in the prefrontal cortex (by 30 and 45%) and dorsal raphe (35 and 44%), but had no effect on extracellular 5-HT in the ventral hippocampus.  The 3 and 10 mg kg-1 doses raised extracellular NA to a similar extent in the prefrontal cortex (47 and 50%).  In all, 10 mg kg-1 raised extracellular DA in the prefrontal cortex (63%) whereas 3 mg kg-1 had no significant effect.  Pretreatment with the selective 5-HT1A receptor antagonist WAY100,635 (0.3 mg kg-1) 30 min before 10 mg kg-1 flibanserin completely antagonized the latter's effects on extracellular 5-HT, DA and NA in the prefrontal cortex.  WAY100,635 by itself had no effect on cortical extracellular monoamines.  The results show that the stimulation of 5-HT1A receptors plays a major role in the effect of flibanserin on brain extracellular 5-HT, DA and NA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPOldOt5xkzLVg90H21EOLACvtfcHk0licrH9i2bVL4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVCisro%253D&md5=e8efcdc38f53f5deefc61a7678b99ab1</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705341%26sid%3Dliteratum%253Aachs%26aulast%3DInvernizzi%26aufirst%3DR.%2BW.%26aulast%3DSacchetti%26aufirst%3DG.%26aulast%3DParini%26aufirst%3DS.%26aulast%3DAcconcia%26aufirst%3DS.%26aulast%3DSamanin%26aufirst%3DR.%26atitle%3DFlibanserin%252C%2520a%2520potential%2520antidepressant%2520drug%252C%2520lowers%25205-HT%2520and%2520raises%2520dopamine%2520and%2520noradrenaline%2520in%2520the%2520rat%2520prefrontal%2520cortex%2520dialysate%253A%2520role%2520of%25205-HT%25281A%2529%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D139%26spage%3D1281%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Scandroglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monferini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span> </span><span class="NLM_article-title">Ex vivo binding of flibanserin to serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1006%2Fphrs.2000.0762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsl2jt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2001&pages=179-183&author=A.+Scandroglioauthor=E.+Monferiniauthor=F.+Borsini&title=Ex+vivo+binding+of+flibanserin+to+serotonin+5-HT1A+and+5-HT2A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors</span></div><div class="casAuthors">Scandroglio, Alessandro; Monferini, Eugenia; Borsini, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-183</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Flibanserin was reported to be an agonist at 5-HT1A-receptors and an antagonist at 5-HT2A-receptors, with higher affinity for 5-HT1A receptors.  Despite the fact that less receptor occupation is required by full agonists than by antagonists to exert their effects, flibanserin was shown to exert 5-HT2A antagonism at doses (4-5 mg kg-1) that are lower or equal to those required to stimulate 5-HT1A receptors.  To understand this phenomenon, the interaction of flibanserin with 5-HT1A and 5-HT2A receptors was evaluated in ex vivo binding studies.  This interaction was evaluated in the prefrontal cortex, hippocampus, and midbrain by [3H]8-OH-DPAT and [3H]ketanserin to label 5-HT1A and 5-HT2A receptors, resp.  Flibanserin was given at 1, 10, and 30 mg kg-1 i.p.  The dose of 1 mg kg-1 displaced both radioligands preferentially in the frontal cortex.  The doses of 10 and 30 mg kg-1 reduced the binding of both radioligands in all the 3 brain regions non-selectively by about 50 and 70%, resp.  The displacement was maximal after 0.5 h and was reduced or not evident after 3 h.  The authors conclude that 5-HT2 antagonism brought about by low doses of flibanserin may reflect functional mechanisms more than receptor-mediated effects.  (c) 2001 The Italian Pharmacological Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeG3QC8I1t8bVg90H21EOLACvtfcHk0lgLTziOSc5qTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsl2jt7o%253D&md5=b4538108e5b28d18a19d5dd177a8affe</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1006%2Fphrs.2000.0762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fphrs.2000.0762%26sid%3Dliteratum%253Aachs%26aulast%3DScandroglio%26aufirst%3DA.%26aulast%3DMonferini%26aufirst%3DE.%26aulast%3DBorsini%26aufirst%3DF.%26atitle%3DEx%2520vivo%2520binding%2520of%2520flibanserin%2520to%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%26jtitle%3DPharmacol.%2520Res.%26date%3D2001%26volume%3D43%26spage%3D179%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Arnow, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millheiser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightbody, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, J. E.</span><span> </span><span class="NLM_article-title">Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=484-502&author=B.+A.+Arnowauthor=L.+Millheiserauthor=A.+Garrettauthor=P.+M.+Lakeauthor=G.+H.+Gloverauthor=K.+R.+Hillauthor=A.+Lightbodyauthor=C.+Watsonauthor=L.+Bannerauthor=T.+Smartauthor=T.+Buchananauthor=J.+E.+Desmond&title=Women+with+hypoactive+sexual+desire+disorder+compared+to+normal+females%3A+a+functional+magnetic+resonance+imaging+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnow%26aufirst%3DB.%2BA.%26aulast%3DMillheiser%26aufirst%3DL.%26aulast%3DGarrett%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DP.%2BM.%26aulast%3DGlover%26aufirst%3DG.%2BH.%26aulast%3DHill%26aufirst%3DK.%2BR.%26aulast%3DLightbody%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DBanner%26aufirst%3DL.%26aulast%3DSmart%26aufirst%3DT.%26aulast%3DBuchanan%26aufirst%3DT.%26aulast%3DDesmond%26aufirst%3DJ.%2BE.%26atitle%3DWomen%2520with%2520hypoactive%2520sexual%2520desire%2520disorder%2520compared%2520to%2520normal%2520females%253A%2520a%2520functional%2520magnetic%2520resonance%2520imaging%2520study%26jtitle%3DNeuroscience%26date%3D2009%26volume%3D158%26spage%3D484%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allers, K. A.</span><span> </span><span class="NLM_article-title">Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1743-6109.2010.02032.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFajtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=15-27&author=S.+M.+Stahlauthor=B.+Sommerauthor=K.+A.+Allers&title=Multifunctional+pharmacology+of+flibanserin%3A+possible+mechanism+of+therapeutic+action+in+hypoactive+sexual+desire+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder</span></div><div class="casAuthors">Stahl, Stephen M.; Sommer, Bernd; Allers, Kelly A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Sexual Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JSMOAN</span>;
        ISSN:<span class="NLM_cas:issn">1743-6095</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Introduction. Flibanserin is a novel pharmacol. agent in late-stage clin. testing for hypoactive sexual desire disorder (HSDD) in premenopausal women.  Aim. The aim of this article is to review the hypothetical mechanism of action of flibanserin in HSDD.  Methods. A literature review was conducted of all published works on flibanserin and on related studies of serotonin (5-HT)1A receptors and 5-HT2A receptors, including their actions on monoamines and on sexual function.  Main Outcome Measures. The main outcome measures are preclin. pharmacol. actions, esp. changes in regional monoamines following treatment with flibanserin.  Results. At clin. relevant doses, flibanserin acts predominantly at 5-HT1A receptors as an agonist and secondarily at 5-HT2A receptors as an antagonist.  Addnl. binding actions within an order of magnitude of its 5-HT1A affinity, which are not likely to be clin. relevant, include weaker antagonist actions at 5-HT2C and 5-HT2B receptors, and less defined activity at dopamine (DA) D4 receptors.  The 5-HT1A actions of flibanserin are only seen postsynaptically, which is unlike other agents such as buspirone that act at presynaptic 5-HT1A receptors.  Furthermore, the postsynaptic actions of chronic flibanserin administration appear to demonstrate a preference for some populations of postsynaptic 5-HT receptors, particularly those that are located on the prefrontal cortex (PFC) pyramidal neurons, which regulate monoamine release in certain selective brain regions.  Conclusions. The regional selectivity of flibanserin results in a unique pattern of monoamine modulation.  Sustained increases in baseline of DA and norepinephrine (NE) are obsd. in the PFC, and flibanserin dosing increases DA and NE levels above the basal changes.  Conversely, flibanserin induces transient decreases in 5-HT levels in some brain areas such as the PFC, nucleus accumbens, and hypothalamus, but not in other brain areas such as the hippocampus.  Therefore, since DA and NE are excitatory and 5-HT is inhibitory to sexual desire and arousal, it is tempting to postulate that the actions of flibanserin on serotonin receptors at the PFC pyramidal neurons, resulting in increased DA and NE yet reduced 5-HT in the PFC, are the mechanistic underpinnings of enhancing sexual desire in HSDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol4qKWeNXtjLVg90H21EOLACvtfcHk0lgLTziOSc5qTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFajtbc%253D&md5=5bbf7d2ba38e2d28c7c32ed6033e59ae</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2010.02032.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2010.02032.x%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DSommer%26aufirst%3DB.%26aulast%3DAllers%26aufirst%3DK.%2BA.%26atitle%3DMultifunctional%2520pharmacology%2520of%2520flibanserin%253A%2520possible%2520mechanism%2520of%2520therapeutic%2520action%2520in%2520hypoactive%2520sexual%2520desire%2520disorder%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2011%26volume%3D8%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pilato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span> </span><span class="NLM_article-title">The therapeutic potential of 5-HT<sub>1A</sub> receptors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1517%2F13543776.2012.703654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=887-902&issue=8&author=E.+Lacivitaauthor=P.+Di+Pilatoauthor=P.+De+Giorgioauthor=N.+A.+Colabufoauthor=F.+Berardiauthor=R.+Perroneauthor=M.+Leopoldo&title=The+therapeutic+potential+of+5-HT1A+receptors%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of 5-HT1A receptors: a patent review</span></div><div class="casAuthors">Lacivita, Enza; Di Pilato, Pantaleo; De Giorgio, Paola; Colabufo, Nicola A.; Berardi, Francesco; Perrone, Roberto; Leopoldo, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">887-902</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The 5-HT1A receptors are implicated in mood disorders (anxiety, depression), in cognition, and in modulation of pain.  Nearly 30 years of research in this field, there is still interest in developing new chem. entities capable of 5-HT1A receptor activation or blockade.Areas covered: This review article will highlight and review the research advances published in the patent literature between Jan. 2007 and Dec. 2011, giving emphasis to the medicinal chemist's standpoint.  Literature search methodol. included search in Scifinder and PubMed Databases and browsing clin. trials.gov website.Expert opinion: Almost no new therapeutic applications have been proposed for mols. targeting the 5-HT1A receptor, during the years covered by the present review.  The discovery that stimulation of 5-HT1A receptor can promote neurogenesis will likely renew the interest for selective 5-HT1A receptor agonists as therapeutics to replace neural populations damaged by disease or injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBIFI285-n_7Vg90H21EOLACvtfcHk0lgLTziOSc5qTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKgtLfF&md5=ceb93bd2bc5c6b22924a15dc32732f76</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.703654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.703654%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DDi%2BPilato%26aufirst%3DP.%26aulast%3DDe%2BGiorgio%26aufirst%3DP.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DLeopoldo%26aufirst%3DM.%26atitle%3DThe%2520therapeutic%2520potential%2520of%25205-HT1A%2520receptors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D887%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Brown, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirlin, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnall, R. A.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors in medullary raphe disrupts sleep and decreases shivering during cooling in the conscious piglet</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00655.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=884-894&issue=3&author=J.+W.+Brownauthor=E.+A.+Sirlinauthor=A.+M.+Benoitauthor=J.+M.+Hoffmanauthor=R.+A.+Darnall&title=Activation+of+5-HT1A+receptors+in+medullary+raphe+disrupts+sleep+and+decreases+shivering+during+cooling+in+the+conscious+piglet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00655.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00655.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BW.%26aulast%3DSirlin%26aufirst%3DE.%2BA.%26aulast%3DBenoit%26aufirst%3DA.%2BM.%26aulast%3DHoffman%26aufirst%3DJ.%2BM.%26aulast%3DDarnall%26aufirst%3DR.%2BA.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520in%2520medullary%2520raphe%2520disrupts%2520sleep%2520and%2520decreases%2520shivering%2520during%2520cooling%2520in%2520the%2520conscious%2520piglet%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2008%26volume%3D294%26issue%3D3%26spage%3D884%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Vianna, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrive, P.</span><span> </span><span class="NLM_article-title">Cardiovascular and behavioral responses to conditioned fear after medullary raphe neuronal blockade</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=1344-1353&issue=4&author=D.+M.+Viannaauthor=C.+Allenauthor=P.+Carrive&title=Cardiovascular+and+behavioral+responses+to+conditioned+fear+after+medullary+raphe+neuronal+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVianna%26aufirst%3DD.%2BM.%26aulast%3DAllen%26aufirst%3DC.%26aulast%3DCarrive%26aufirst%3DP.%26atitle%3DCardiovascular%2520and%2520behavioral%2520responses%2520to%2520conditioned%2520fear%2520after%2520medullary%2520raphe%2520neuronal%2520blockade%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D153%26issue%3D4%26spage%3D1344%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">van den Buuse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegener, N.</span><span> </span><span class="NLM_article-title">Involvement of serotonin<sub>1A</sub> receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">507</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.ejphar.2004.11.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVChsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2005&pages=187-198&issue=1%E2%80%933&author=M.+van+den+Buuseauthor=N.+Wegener&title=Involvement+of+serotonin1A+receptors+in+cardiovascular+responses+to+stress%3A+a+radio-telemetry+study+in+four+rat+strains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of serotonin1A receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains</span></div><div class="casAuthors">van den Buuse, Maarten; Wegener, Nico</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">187-198</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We studied the effect of treatment with the serotonin-1A (5-HT1A) receptor ligands buspirone, 8-hydroxy-di-propyl-aminotetralin (8-OH-DPAT), and (8-[2-(2,3-dihydro-1,4-benzodioxin-2-yl-methylamino)ethyl]-8-azaspiro[4,5]decane-7,9-dione Me sulfonate) (MDL73,005EF) on blood pressure and heart rate increases to open field stress.  We compared Spontaneously Hypertensive Rats (SHR), Fawn-Hooded (FH) rats, Wistar-Kyoto (WKY) rats, and Sprague-Dawley (SD) rats instrumented with radio-telemetry probes.  Buspirone treatment reduced the blood pressure increase in SHR, FH rats, and WKY rats and heart rate increase in FH rats and WKY rats. 8-OH-DPAT treatment reduced the blood pressure increase in FH rats and WKY rats, but had no effect in SHR and enhanced the pressor response in SD rats.  This treatment reduced the heart rate increase in FH rats and WKY rats only.  Similarly, MDL73,005EF treatment reduced the blood pressure increase in FH rats and WKY rats, but had no effect in SHR and enhanced this response in SD rats.  Little effect of this treatment was seen on heart rate changes.  For comparison, diazepam treatment abolished the pressor response in SD rats and reduced it in FH rats and WKY rats, but not SHR.  Differential effects of the treatments were also seen between strains for locomotor activity in the open field, although behavioral changes could not explain the effects of the drugs on cardiovascular responses.  These data suggest that 5-HT1A receptors are involved in cardiovascular stress responses; however, the extent of this involvement differs between rat strains and the drugs used.  These results could be important for our understanding of possible anxiolytic properties of antipsychotic drugs with affinity for the 5-HT1A receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoozDCIWn5x_LVg90H21EOLACvtfcHk0lgeEWJ-kfdKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVChsw%253D%253D&md5=246e52fff9e1b5efd9c6fe3259a5ccc3</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.11.048%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bden%2BBuuse%26aufirst%3DM.%26aulast%3DWegener%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520serotonin1A%2520receptors%2520in%2520cardiovascular%2520responses%2520to%2520stress%253A%2520a%2520radio-telemetry%2520study%2520in%2520four%2520rat%2520strains%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D507%26issue%3D1%25E2%2580%25933%26spage%3D187%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Ootsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing, W. W.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1073–1074</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.brainres.2005.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1073%E2%80%931074&publication_year=2006&pages=252-261&author=Y.+Ootsukaauthor=W.+W.+Blessing&title=Activation+of+5-HT1A+receptors+in+rostral+medullary+raph%C3%A9+inhibits+cutaneous+vasoconstriction+elicited+by+cold+exposure+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT1A receptors in rostral medullary raphe inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits</span></div><div class="casAuthors">Ootsuka, Youichirou; Blessing, William W.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1073-1074</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In both conscious and anesthetized rabbits, we detd. whether microinjection of a 5-hydroxytryptamine (5-HT) 1A receptor agonist 8-hydroxy-2-(di-n-propylaminio) tetralin (8-OH-DPAT) into the medullary raphe/parapyramidal region inhibits thermoregulatory vasoconstriction and whether microinjection of a 5-HT1A receptor antagonist N-2-4-(2-methoxyphenyl)-(1-piperazinylethyl)-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY-100635) into the raphe reverses the cutaneous vasomotor changes induced by i.v. administration of 8-OH-DPAT.  In conscious rabbits with measuring ear pinna blood flow, after microinjection of 8-OH-DPAT (3-5 nmol in 300-500 nl) into the raphe, transferring the animal from a warm cage (25-28°) to a cold cage (5-10°) did not reduce the ear pinna flow (from 57±7 cm/s to 59±3 cm/s, P > 0.05, n = 5), unlike Ringer-treated animals.  Microinjection of WAY-100635 (5 nmol in 500 nl) into the raphe reversed ear pinna flow changes induced by i.v. administration of 8-OH-DPAT (0.1 mg/kg, i.v.).  In anesthetized rabbits with measuring postganglionic ear pinna sympathetic nerve activity, microinjection of 8-OH-DPAT (1-2 nmol in 100-200 nl) into the raphe reduced resting ear pinna sympathetic nerve activity to 14±4% of pre-injection level (P < 0.01, n = 12) and attenuated increases in ear pinna sympathetic nerve activity normally elicited by cooling the animal's trunk.  WAY-100635 (2 nmol into 200 nl) into the raphe reversed inhibition of ear pinna sympathetic nerve activity elicited by 8-OH-DPAT (0.1 mg/kg, i.v.).  The activation of 5-HT1A receptors expressed on the medullary raphe neurons results in reversal of cold-elicited cutaneous vasoconstriction possibly through inhibition of sympathetic premotor neurons that innervate sympathetic preganglionic neurons controlling cutaneous vasomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqtFzFwQchTLVg90H21EOLACvtfcHk0lgeEWJ-kfdKag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7k%253D&md5=105e1b6bfaf1de2b8f42004498030ba3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DOotsuka%26aufirst%3DY.%26aulast%3DBlessing%26aufirst%3DW.%2BW.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520in%2520rostral%2520medullary%2520raph%25C3%25A9%2520inhibits%2520cutaneous%2520vasoconstriction%2520elicited%2520by%2520cold%2520exposure%2520in%2520rabbits%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1073%25E2%2580%25931074%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Nalivaiko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ootsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing, W. W.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors in the medullary raphé reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00845.2004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2005&pages=596-604&author=E.+Nalivaikoauthor=Y.+Ootsukaauthor=W.+W.+Blessing&title=Activation+of+5-HT1A+receptors+in+the+medullary+raph%C3%A9+reduces+cardiovascular+changes+elicited+by+acute+psychological+and+inflammatory+stresses+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00845.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00845.2004%26sid%3Dliteratum%253Aachs%26aulast%3DNalivaiko%26aufirst%3DE.%26aulast%3DOotsuka%26aufirst%3DY.%26aulast%3DBlessing%26aufirst%3DW.%2BW.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520in%2520the%2520medullary%2520raph%25C3%25A9%2520reduces%2520cardiovascular%2520changes%2520elicited%2520by%2520acute%2520psychological%2520and%2520inflammatory%2520stresses%2520in%2520rabbits%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2005%26volume%3D289%26spage%3D596%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Ngampramuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beig, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotchabhakdi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalivaiko, E.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>1A</sub> receptors attenuates tachycardia induced by restraint stress in rats</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00464.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=132-141&author=S.+Ngampramuanauthor=M.+Baumertauthor=M.+I.+Beigauthor=N.+Kotchabhakdiauthor=E.+Nalivaiko&title=Activation+of+5-HT1A+receptors+attenuates+tachycardia+induced+by+restraint+stress+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00464.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00464.2007%26sid%3Dliteratum%253Aachs%26aulast%3DNgampramuan%26aufirst%3DS.%26aulast%3DBaumert%26aufirst%3DM.%26aulast%3DBeig%26aufirst%3DM.%2BI.%26aulast%3DKotchabhakdi%26aufirst%3DN.%26aulast%3DNalivaiko%26aufirst%3DE.%26atitle%3DActivation%2520of%25205-HT1A%2520receptors%2520attenuates%2520tachycardia%2520induced%2520by%2520restraint%2520stress%2520in%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3D132%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Vianna, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrive, P.</span><span> </span><span class="NLM_article-title">Inhibition of the cardiovascular response to stress by systemic 5-HT<sub>1A</sub> activation: sympathoinhibition or anxiolysis?</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00232.2009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=495-501&author=D.+M.+Viannaauthor=P.+Carrive&title=Inhibition+of+the+cardiovascular+response+to+stress+by+systemic+5-HT1A+activation%3A+sympathoinhibition+or+anxiolysis%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00232.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00232.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVianna%26aufirst%3DD.%2BM.%26aulast%3DCarrive%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520the%2520cardiovascular%2520response%2520to%2520stress%2520by%2520systemic%25205-HT1A%2520activation%253A%2520sympathoinhibition%2520or%2520anxiolysis%253F%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3D495%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Di Micco, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretskaia, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretsky, D. V.</span><span> </span><span class="NLM_article-title">The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=469-480&author=J.+A.+Di+Miccoauthor=B.+C.+Samuelsauthor=M.+V.+Zaretskaiaauthor=D.+V.+Zaretsky&title=The+dorsomedial+hypothalamus+and+the+response+to+stress%3A+part+renaissance%2C+part+revolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DJ.%2BA.%26aulast%3DSamuels%26aufirst%3DB.%2BC.%26aulast%3DZaretskaia%26aufirst%3DM.%2BV.%26aulast%3DZaretsky%26aufirst%3DD.%2BV.%26atitle%3DThe%2520dorsomedial%2520hypothalamus%2520and%2520the%2520response%2520to%2520stress%253A%2520part%2520renaissance%252C%2520part%2520revolution%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D71%26spage%3D469%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Di Micco, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretskaia, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretsky, D. V.</span><span> </span><span class="NLM_article-title">Stress-induced cardiac stimulation and fever: common hypothalamic origins and brainstem mechanisms</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126–127</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.autneu.2006.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126%E2%80%93127&publication_year=2006&pages=106-119&author=J.+A.+Di+Miccoauthor=S.+Sarkarauthor=M.+V.+Zaretskaiaauthor=D.+V.+Zaretsky&title=Stress-induced+cardiac+stimulation+and+fever%3A+common+hypothalamic+origins+and+brainstem+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2006.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2006.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DJ.%2BA.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DZaretskaia%26aufirst%3DM.%2BV.%26aulast%3DZaretsky%26aufirst%3DD.%2BV.%26atitle%3DStress-induced%2520cardiac%2520stimulation%2520and%2520fever%253A%2520common%2520hypothalamic%2520origins%2520and%2520brainstem%2520mechanisms%26jtitle%3DAuton.%2520Neurosci.%26date%3D2006%26volume%3D126%25E2%2580%2593127%26spage%3D106%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Di Micco, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaretsky, D. V.</span><span> </span><span class="NLM_article-title">The dorsomedial hypothalamus: a new player in thermoregulation</span> <span class="citation_source-journal">Am. J. Physiol.: Regul., Integr. Comp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1152%2Fajpregu.00498.2006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=47-63&author=J.+A.+Di+Miccoauthor=D.+V.+Zaretsky&title=The+dorsomedial+hypothalamus%3A+a+new+player+in+thermoregulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00498.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00498.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DJ.%2BA.%26aulast%3DZaretsky%26aufirst%3DD.%2BV.%26atitle%3DThe%2520dorsomedial%2520hypothalamus%253A%2520a%2520new%2520player%2520in%2520thermoregulation%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Regul.%252C%2520Integr.%2520Comp.%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3D47%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Horiuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dampney, R. A. L.</span><span> </span><span class="NLM_article-title">Activation of 5-hydroxytryptamine<sub>1A</sub> receptors suppresses the cardiovascular response evoked from the dorsomedial hypothalamic nucleus</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=173-179&author=J.+Horiuchiauthor=S.+Wakabayashiauthor=R.+A.+L.+Dampney&title=Activation+of+5-hydroxytryptamine1A+receptors+suppresses+the+cardiovascular+response+evoked+from+the+dorsomedial+hypothalamic+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DJ.%26aulast%3DWakabayashi%26aufirst%3DS.%26aulast%3DDampney%26aufirst%3DR.%2BA.%2BL.%26atitle%3DActivation%2520of%25205-hydroxytryptamine1A%2520receptors%2520suppresses%2520the%2520cardiovascular%2520response%2520evoked%2520from%2520the%2520dorsomedial%2520hypothalamic%2520nucleus%26jtitle%3DHypertension%26date%3D2005%26volume%3D46%26spage%3D173%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Pattij, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenink, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijzen, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosting, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Gugten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span> </span><span class="NLM_article-title">Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=380-390&issue=3&author=T.+Pattijauthor=L.+Groeninkauthor=T.+H.+Hijzenauthor=R.+S.+Oostingauthor=R.+A.+Maesauthor=J.+van+der+Gugtenauthor=B.+Olivier&title=Autonomic+changes+associated+with+enhanced+anxiety+in+5-HT%281A%29+receptor+knockout+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPattij%26aufirst%3DT.%26aulast%3DGroenink%26aufirst%3DL.%26aulast%3DHijzen%26aufirst%3DT.%2BH.%26aulast%3DOosting%26aufirst%3DR.%2BS.%26aulast%3DMaes%26aufirst%3DR.%2BA.%26aulast%3Dvan%2Bder%2BGugten%26aufirst%3DJ.%26aulast%3DOlivier%26aufirst%3DB.%26atitle%3DAutonomic%2520changes%2520associated%2520with%2520enhanced%2520anxiety%2520in%25205-HT%25281A%2529%2520receptor%2520knockout%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2002%26volume%3D27%26issue%3D3%26spage%3D380%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Horiuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dampney, R. A.</span><span> </span><span class="NLM_article-title">Role of 5-HT<sub>1A</sub> receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation</span> <span class="citation_source-journal">Auton. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.autneu.2008.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ejtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2008&pages=71-76&author=J.+Horiuchiauthor=L.+M.+McDowallauthor=R.+A.+Dampney&title=Role+of+5-HT1A+receptors+in+the+lower+brainstem+on+the+cardiovascular+response+to+dorsomedial+hypothalamus+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of 5-HT1A receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation</span></div><div class="casAuthors">Horiuchi, Jouji; McDowall, Lachlan M.; Dampney, Roger A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Autonomic Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">71-76</span>CODEN:
                <span class="NLM_cas:coden">ANUEB2</span>;
        ISSN:<span class="NLM_cas:issn">1566-0702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dorsomedial hypothalamus (DMH) is an essential brain region for the integration of the physiol. response to psychol. stressors.  The cardiovascular components of the response include increases in blood pressure, heart rate and the activity of sympathetic nerves to the kidney, skin, brown adipose tissue, and heart.  Neurons in the rostral ventrolateral medulla (RVLM) and in the region of the medullary raphe are important components of the descending pathways that mediate the cardiovascular response to the DMH activation.  Activation of 5-hydroxytryptamine 1A (5-HT1A) receptors in the brain leads to a suppression of the cardiac and sympathetic vasomotor components of the DMH-evoked response and of the response to acute psychol. stress.  In this study we showed that intracisternal injection of a low dose (1 μg/kg) of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), significantly reduced the increases in heart rate and renal sympathetic nerve activity evoked by disinhibition of the DMH, but had no effect on these responses when injected i.v.  Subsequent intracisternal administration of the 5-HT1A receptor antagonist WAY-100635 restored the DMH-evoked cardiovascular responses to levels obsd. before 8-OH-DPAT administration.  Bilateral microinjections of 8-OH-DPAT (200pmol on each side) into the RVLM, however, did not significantly affect the cardiovascular response to disinhibition of the DMH.  These observations demonstrate that activation of 5-HT1A receptors within the lower brainstem, but not in the RVLM, can powerfully suppress the cardiovascular response evoked from the DMH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt5lhaP1gvxLVg90H21EOLACvtfcHk0lh2McUYlDbYKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ejtb%252FN&md5=5d57b0661c80416fdebf82b000f38f74</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2008.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2008.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DJ.%26aulast%3DMcDowall%26aufirst%3DL.%2BM.%26aulast%3DDampney%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%25205-HT1A%2520receptors%2520in%2520the%2520lower%2520brainstem%2520on%2520the%2520cardiovascular%2520response%2520to%2520dorsomedial%2520hypothalamus%2520activation%26jtitle%3DAuton.%2520Neurosci.%26date%3D2008%26volume%3D142%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Ootsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blessing, W. W.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine<sub>1A</sub> receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">552</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1113%2Fjphysiol.2003.048041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2003&pages=303-314&author=Y.+Ootsukaauthor=W.+W.+Blessing&title=5-Hydroxytryptamine1A+receptors+inhibit+cold-induced+sympathetically+mediated+cutaneous+vasoconstriction+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits</span></div><div class="casAuthors">Ootsuka, Y.; Blessing, W. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">303-314</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">5-HT1A receptor agonists lower body temp.  The authors have investigated whether activation of 5-HT1A receptors inhibits cutaneous sympathetic discharge so that dilatation of the cutaneous vascular bed lowers body temp. by increasing heat transfer to the environment.  The authors measured ear pinna blood flow in conscious rabbits (with chronically implanted Doppler ultrasound flow probes), and postganglionic sympathetic vasomotor nerve activity in anesthetized rabbits.  Recordings from conscious rabbits were made in a cage at 26°C and the rabbit was then transferred to a cage at 10°C.  The ear pinna Doppler signal fell from 56±4 cm s-1 in the 26°C cage to 4±1 cm s-1 (P < 0.0001, n = 24) after 30 min in the 10°C cage, and body temp. increased from 38.8±0.2 to 39.0±0.2°C (P < 0.01, n = 24).  The 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT;0.1 mg kg-1 I.V.) reversed the cold-induced fall in ear pinna blood flow (Doppler signal increased from 5±1 to 55±8 cm s-1, P < 0.001, n = 7) within 5 min when administered 30 min after transfer to the 10°C cage, and prevented the fall in ear pinna blood flow when administered before the rabbit was transferred to the 10°C cage.  Body temp. decreased after administration of 8-OH-DPAT.  These changes were abolished by the specific 5-HT1A antagonist WAY-100635 (0.1 mg kg-1 I.V.).  In anesthetized rabbits, 8-OH-DPAT (0.1 mg kg-1 I.V.) reduced resting postganglionic cutaneous sympathetic vasomotor discharge, and prevented the increase normally elicited by cooling the trunk.  The authors' expts. constitute the first demonstration that activation of 5-HT1A receptors powerfully inhibits cold-induced increases in cutaneous sympathetic vasomotor discharge, thereby dilating the cutaneous vascular bed and increasing transfer of heat to the environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozevnbZqNkRLVg90H21EOLACvtfcHk0lh2McUYlDbYKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCns7g%253D&md5=e89636925d64dbdf2fbdc594e5010855</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2003.048041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2003.048041%26sid%3Dliteratum%253Aachs%26aulast%3DOotsuka%26aufirst%3DY.%26aulast%3DBlessing%26aufirst%3DW.%2BW.%26atitle%3D5-Hydroxytryptamine1A%2520receptors%2520inhibit%2520cold-induced%2520sympathetically%2520mediated%2520cutaneous%2520vasoconstriction%2520in%2520rabbits%26jtitle%3DJ.%2520Physiol.%26date%3D2003%26volume%3D552%26spage%3D303%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Thomas, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatfield, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krülle, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, J. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>1A</sub> activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats</span> <span class="citation_source-journal">Obesity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Foby.2008.550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=467-473&issue=3&author=G.+H.+Thomasauthor=A.+J.+Babbsauthor=R.+E.+Chatfieldauthor=T.+M.+Kr%C3%BClleauthor=P.+S.+Widdowsonauthor=D.+Provostauthor=J.+G.+McCormack&title=5-HT1A+activation+counteracts+cardiovascular+but+not+hypophagic+effects+of+sibutramine+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A Activation Counteracts Cardiovascular But Not Hypophagic Effects of Sibutramine in Rats</span></div><div class="casAuthors">Thomas, Gerard H.; Babbs, Adam J.; Chatfield, Rosemary E.; Kruelle, Thomas M.; Widdowson, Peter S.; Provost, Daniel; McCormack, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-473</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The noradrenaline (NA) and serotonin reuptake inhibitor, sibutramine, gives effective wt. loss, but full efficacy cannot be attained at approved doses due to cardiovascular side effects.  We assessed in rats the contributions of NA and serotonin transporters to sibutramine's hypophagic and cardiovascular effects, and whether selective 5-hydroxytryptamine (5-HT1A) receptor activation could counteract the latter without affecting the former.  Food intake was assessed in freely feeding rats and cardiovascular parameters in conscious telemetered rats.  Ex vivo radioligand binding was used to est. brain monoamine transporter occupancy.  Sibutramine (1-10 mg/kg p.o.) dose-dependently reduced food intake; however, 10 mg/kg p.o. markedly elevated blood pressure and heart rate.  Sibutramine gave greater occupancy of NA than serotonin reuptake sites.  Coadministration of the selective 5-HT1A agonist F-11440 (2.5 mg/kg p.o.) attenuated sibutramine-induced hypertension and tachycardia without altering its food intake effects.  The selective NA reuptake inhibitors, nisoxetine or reboxetine, did not alter food intake alone, but each reduced food intake when combined with F-11440.  These results suggest that sibutramine-induced hypophagic and cardiovascular effects are largely due to increased brain synaptic NA via NA reuptake inhibition, and that 5-HT1A activation can counter the undesirable cardiovascular effects resulting from increased sympathetic activity.  Selective NA reuptake inhibitors did not reduce food intake alone but did when combined with 5-HT1A activation.  Hence increased synaptic serotonin, via serotonin reuptake inhibition or 5-HT1A activation, together with increased NA, would appear to produce hypophagia.  Thus wt. loss with minimal cardiovascular risk could be achieved by 5-HT1A activation combined with NA transporter blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohNXqUyviRwrVg90H21EOLACvtfcHk0lh2McUYlDbYKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7o%253D&md5=699f2b3ad9fb8bdfeb6202c882f140b3</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Foby.2008.550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2008.550%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DG.%2BH.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DChatfield%26aufirst%3DR.%2BE.%26aulast%3DKr%25C3%25BClle%26aufirst%3DT.%2BM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DProvost%26aufirst%3DD.%26aulast%3DMcCormack%26aufirst%3DJ.%2BG.%26atitle%3D5-HT1A%2520activation%2520counteracts%2520cardiovascular%2520but%2520not%2520hypophagic%2520effects%2520of%2520sibutramine%2520in%2520rats%26jtitle%3DObesity%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Ramage, A. G.</span><span> </span><span class="NLM_article-title">The role of central 5-hydtroxytryrptamine (5-HT, serotonin) receptors in the control of micturition</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1038%2Fsj.bjp.0706504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=120-131&author=A.+G.+Ramage&title=The+role+of+central+5-hydtroxytryrptamine+%285-HT%2C+serotonin%29+receptors+in+the+control+of+micturition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition</span></div><div class="casAuthors">Ramage, Andrew G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S120-S131</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  At present the most investigated 5-HT receptor that has been shown to play a role in the control of micturition is the 5-HT1A receptor followed by 5-HT7, 5-HT2 and 5-HT3 receptors.  Most expts. focus on the control these receptors have on the parasympathetic outflow to the bladder and the somatic outflow to the external urethral sphincter (EUS) in the rat.  Furthermore, 5-HT1A and 5-HT7 receptors have been identified as having an excitatory physiol. role in the control of bladder function. 5-HT1A receptors act, at least in the rat, at both a spinal (probably a heteroreceptor) and supraspinal (probably an autoreceptor) level, while 5-HT7 receptors only act at a supraspinal level.  Addnl., in the rat, 5-HT administered at a spinal or supraspinal site has an excitatory action, although earlier expts. have shown that activating 5-HT-contg. brain areas causes inhibition of the bladder.  Recent expts. have also indicated that blockade of the 5-HT1A receptor pathway shows rapid tolerance.  However, no data exist for the development of tolerance for the 5-HT7 receptor pathway.  Neither receptor seems to play a role in the control of the urethra.  Regarding 5-HT2 receptors, activation of this receptor subtype inhibits micturition, and this inhibitory action may occur at a spinal, supraspinal or both levels.  Although no physiol. role for 5-HT2C receptors can yet be identified, 5-HT2C receptors have been implicated in the proposed supraspinal tonically active 5-HT1A autoreceptor (neg. feedback) pathway.  This proposition reconciles the data that central 5-HT-contg. pathways are inhibitory to micturition, while 5-HT1A receptors, although inhibitory to adenylyl cyclase, have an excitatory function.  This is because activation of 5-HT1A autoreceptors reduces the release of 5-HT thus reducing the activation of the 5-HT2C receptors, which are inhibitory in the control of micturition (disinhibition).  Furthermore, 5-HT2A receptors in the rat and 5-HT2C receptors in the guinea pig cause activation of the EUS.  In this respect, 5-ht5A receptors have also been identified in Onuf's nucleus, the site of somatic motoneurons controlling this sphincter.  In the cat there is very little evidence to indicate that 5-HT receptors are involved in micturition except under pathol. conditions in which activation of 5-HT1A receptors causes inhibition of micturition.  Interestingly, under such conditions 5-HT1A receptors cause excitation of the EUS.  Nevertheless, spinal 5HT3 receptors have been implicated in the physiol. control of micturition in the cat, but not yet in the rat.  Overall, the data support the view that 5-HT receptors are important in the control of micturition.  However, many more studies are required to fully understand these roles and why there are such species differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZsLw-jq6iNLVg90H21EOLACvtfcHk0lh2McUYlDbYKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGqsLo%253D&md5=61bda5e1c99af5ddd9f35998f2fac710</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706504%26sid%3Dliteratum%253Aachs%26aulast%3DRamage%26aufirst%3DA.%2BG.%26atitle%3DThe%2520role%2520of%2520central%25205-hydtroxytryrptamine%2520%25285-HT%252C%2520serotonin%2529%2520receptors%2520in%2520the%2520control%2520of%2520micturition%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3D120%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, H.</span><span> </span><span class="NLM_article-title">Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">700</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.ejphar.2012.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislyntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=700&publication_year=2013&pages=194-200&author=T.+Sakaiauthor=K.+Kasaharaauthor=K.+Tomitaauthor=I.+Ikegakiauthor=H.+Kuriyama&title=Naftopidil+inhibits+5-hydroxytryptamine-induced+bladder+contraction+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats</span></div><div class="casAuthors">Sakai, Takumi; Kasahara, Ken-ichi; Tomita, Ken-ichi; Ikegaki, Ichiro; Kuriyama, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">700</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">194-200</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Naftopidil is an α1D and α1A subtype-selective α1-adrenoceptor antagonist that has been used to treat lower urinary tract symptoms of benign prostatic hyperplasia.  In this study, we investigated the effects of naftopidil on 5-hydroxytryptamine (5-HT)-induced rat bladder contraction (10-8-10-4 M).  Naftopidil (0.3, 1, and 3 μM) inhibited 5-HT-induced bladder contraction in a concn.-dependent manner.  On the other hand, other α1-adrenoceptor antagonists, tamsulosin, silodosin or prazosin, did not inhibit 5-HT-induced bladder contraction.  The 5-HT-induced bladder contraction was inhibited by both ketanserin and 4-(4-fluoronaphthalen-1-yl)-6-propan-2-ylpyrimidin-2-amine (RS127445), serotonin 5-HT2A and 5-HT2B receptor antagonists, resp.  In addn., 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and α-methyl-5-HT, 5-HT2A and 5-HT2 receptor agonists, resp., induced bladder contraction.  The 5-HT-induced bladder contraction was not inhibited by N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-yl-cyclohexanecarboxamide (WAY-100635), [1-[2[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl-1-methyl-1H-indole-3-carboxylate (GR113808) or (R)-3-[2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol (SB269970), 5-HT1A, 5-HT4 and 5-HT7 receptor antagonists, resp.  Naftopidil inhibited both the 5-HT2A and 5-HT2 receptor agonists-induced bladder contractions.  Naftopidil binds to the human 5-HT2A and 5-HT2B receptors with pKi values of 6.55 and 7.82, resp.  These results suggest that naftopidil inhibits 5-HT-induced bladder contraction via blockade of the 5-HT2A and 5-HT2B receptors in rats.  Furthermore, 5-HT-induced bladder contraction was enhanced in bladder strips obtained from bladder outlet obstructed rats, with this contraction inhibited by naftopidil.  The beneficial effects of naftopidil on storage symptoms such as urinary frequency and nocturia in patients with benign prostatic hyperplasia may be due, in part, to the blockade of the 5-HT2A and 5-HT2B receptors in the bladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCBrhpwW3ri7Vg90H21EOLACvtfcHk0liS5MHdFv2dCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislyntLY%253D&md5=79984b8d7fdd80f9c965a6cb153eafa6</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DKasahara%26aufirst%3DK.%26aulast%3DTomita%26aufirst%3DK.%26aulast%3DIkegaki%26aufirst%3DI.%26aulast%3DKuriyama%26aufirst%3DH.%26atitle%3DNaftopidil%2520inhibits%25205-hydroxytryptamine-induced%2520bladder%2520contraction%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D700%26spage%3D194%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Sorbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tait, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasili, L.</span><span> </span><span class="NLM_article-title">1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure–affinity/activity relationships at α<sub>1</sub> and 5-HT<sub>1A</sub> receptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=393-399&author=C.+Sorbiauthor=S.+Franchiniauthor=A.+Taitauthor=A.+Prandiauthor=R.+Gallesiauthor=P.+Angeliauthor=G.+Marucciauthor=L.+Pironaauthor=E.+Poggesiauthor=L.+Brasili&title=1%2C3-Dioxolane-based+ligands+as+rigid+analogues+of+naftopidil%3A+structure%E2%80%93affinity%2Factivity+relationships+at+%CE%B11+and+5-HT1A+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorbi%26aufirst%3DC.%26aulast%3DFranchini%26aufirst%3DS.%26aulast%3DTait%26aufirst%3DA.%26aulast%3DPrandi%26aufirst%3DA.%26aulast%3DGallesi%26aufirst%3DR.%26aulast%3DAngeli%26aufirst%3DP.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DPirona%26aufirst%3DL.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DBrasili%26aufirst%3DL.%26atitle%3D1%252C3-Dioxolane-based%2520ligands%2520as%2520rigid%2520analogues%2520of%2520naftopidil%253A%2520structure%25E2%2580%2593affinity%252Factivity%2520relationships%2520at%2520%25CE%25B11%2520and%25205-HT1A%2520receptors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D393%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">de Groat, W. C.</span><span> </span><span class="NLM_article-title">Influence of central serotonergic mechanisms on lower urinary tract function</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=30-36&author=W.+C.+de+Groat&title=Influence+of+central+serotonergic+mechanisms+on+lower+urinary+tract+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGroat%26aufirst%3DW.%2BC.%26atitle%3DInfluence%2520of%2520central%2520serotonergic%2520mechanisms%2520on%2520lower%2520urinary%2520tract%2520function%26jtitle%3DUrology%26date%3D2002%26volume%3D59%26spage%3D30%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Gu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K. E.</span><span> </span><span class="NLM_article-title">Improving voiding efficiency in the diabetic rat by a 5-HT<sub>1A</sub> serotonin receptor agonist</span> <span class="citation_source-journal">Neurourol. Urodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1002%2Fnau.21182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=168-173&author=B.+Guauthor=G.+Wuauthor=J.+Siauthor=Y.+Xuauthor=K.+E.+Andersson&title=Improving+voiding+efficiency+in+the+diabetic+rat+by+a+5-HT1A+serotonin+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist</span></div><div class="casAuthors">Gu, Baojun; Wu, Gang; Si, Jieming; Xu, Yuemin; Andersson, Karl-Erik</div><div class="citationInfo"><span class="NLM_cas:title">Neurourology and Urodynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-173</span>CODEN:
                <span class="NLM_cas:coden">NEUREM</span>;
        ISSN:<span class="NLM_cas:issn">0733-2467</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Serotonin affects micturition in the normal rat through actions not only on ascending and descending spinal pathways and supraspinal centers but also on the lumbosacral spinal cord level.  The selective 5-HT1A receptor agonist, 8-OH-DPAT((R)-(+)-8-hydroxy-2-(di-n-propylamino) tetralin), reversed detrusor-sphincter dyssynergia (DSD) in the spinal cord injury (SCI) rat.  Rats with exptl. diabetes mellitus (DM) have been shown to have both bladder and urethral dysfunction during reflex voiding.  We therefore examd. the effects of 8-OH-DPAT on micturition in DM rats.  Female Sprague-Dawley rats were used.  DM was induced by an i.p. injection of streptozotocin (STZ, 65 mg/kg) and a cystometric study was performed 8 wk post-injection.  External urethral sphincter electromyog. (EUS-EMG) was also measured.  The 5-HT1A antagonist WAY-100635(N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide) was administered after each 8-OH-DPAT dose-response.  Compared to controls, DM rats had a higher bladder capacity, residual vol., and a lower voiding efficiency.  In DM rats, 8-OH-DPAT (3-1,000 μg/kg, i.v.) induced significant dose-dependent increases in micturition vol., and decreases in residual vol., resulting in increases in voiding efficiency.  During the micturition, there was a dose-dependent increased phasic EUS activity correlated with the improved voiding efficiency.  WAY-100635 (300 μg/kg, i.v.) reversed the 8-OH-DPAT-induced changes.  Both the bladder voiding efficiency and the periodic EUS activity were decreased in DM rats.  5-HT1A receptor agonism promoted periodic EUS activity, thereby improving voiding efficiency.  Whether or not these results may have implications for the future treatment of voiding dysfunction in DM patients remains to be studied.  Neurourol. Urodynam. 31:168-173, 2012. © 2011 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4swchT9qxBLVg90H21EOLACvtfcHk0liS5MHdFv2dCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSju7o%253D&md5=9423022d75874f7c218831b83fe0b5ab</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fnau.21182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fnau.21182%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DSi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DAndersson%26aufirst%3DK.%2BE.%26atitle%3DImproving%2520voiding%2520efficiency%2520in%2520the%2520diabetic%2520rat%2520by%2520a%25205-HT1A%2520serotonin%2520receptor%2520agonist%26jtitle%3DNeurourol.%2520Urodyn.%26date%3D2012%26volume%3D31%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Dizeyi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjartell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleanu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span> </span><span class="NLM_article-title">Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=328-336&author=N.+Dizeyiauthor=A.+Bjartellauthor=E.+Nilssonauthor=J.+Hanssonauthor=V.+Gadaleanuauthor=N.+Crossauthor=P.+A.+Abrahamsson&title=Expression+of+serotonin+receptors+and+role+of+serotonin+in+human+prostate+cancer+tissue+and+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDizeyi%26aufirst%3DN.%26aulast%3DBjartell%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DE.%26aulast%3DHansson%26aufirst%3DJ.%26aulast%3DGadaleanu%26aufirst%3DV.%26aulast%3DCross%26aufirst%3DN.%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520serotonin%2520receptors%2520and%2520role%2520of%2520serotonin%2520in%2520human%2520prostate%2520cancer%2520tissue%2520and%2520cell%2520lines%26jtitle%3DProstate%26date%3D2004%26volume%3D59%26spage%3D328%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Cattaneo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicentini, L. M.</span><span> </span><span class="NLM_article-title">Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT<sub>1A</sub> and 5-HT<sub>1D</sub> receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol., Mol. Pharmacol. Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2F0922-4106%2895%2990145-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADyaK2MXovVygtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1995&pages=209-211&author=M.+G.+Cattaneoauthor=R.+Fesceauthor=L.+M.+Vicentini&title=Mitogenic+effect+of+serotonin+in+human+small+cell+lung+carcinoma+cells+via+both+5-HT1A+and+5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors</span></div><div class="casAuthors">Cattaneo, Maria G.; Fesce, Riccardo; Vicentini, Lucia M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-11</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The authors have recently shown that the mitogenic effect of serotonin (5-hydroxytryptamine, 5-HT) on human small cell lung carcinoma (SCLC) cells is at least partly due to stimulation of a 5-HT1D receptor type.  The authors now report that the 5-HT1A receptor agonist R(+)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) is also capable of stimulating [3H]thymidine incorporation into SCLC GLC-8 cells, although with lower efficacy than 5-HT.  The simultaneous administration of maximal doses of 8-OH-DPAT and the 5-HT1D receptor agonist sumatriptan reproduced the maximal [3H]thymidine incorporation obsd. with 5-HT alone.  The 5-HT1A receptor antagonists spiperone and SDZ 216-525 completely abolished the effect of 8-OH-DPAT (IC50 30 nM for both drugs) behaving as pure antagonists.  Accordingly, the two drugs partially inhibited the mitogenic effect of 5-HT.  These data indicate that the mitogenic effect of 5-HT in SCLC cells involves both 5-HT1A and 5-HT1D receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokjO1J7SmRWLVg90H21EOLACvtfcHk0lgxO8WB-R8Usw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovVygtbw%253D&md5=84bae9da43b08974186e7b3d702c22ff</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2895%2990145-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252895%252990145-0%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DM.%2BG.%26aulast%3DFesce%26aufirst%3DR.%26aulast%3DVicentini%26aufirst%3DL.%2BM.%26atitle%3DMitogenic%2520effect%2520of%2520serotonin%2520in%2520human%2520small%2520cell%2520lung%2520carcinoma%2520cells%2520via%2520both%25205-HT1A%2520and%25205-HT1D%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1995%26volume%3D291%26spage%3D209%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Chin, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, S. S.</span><span> </span><span class="NLM_article-title">A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BC3c3nsVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=24-29&author=S.+N.+Chinauthor=L.+Wangauthor=M.+Mooreauthor=S.+S.+Sridhar&title=A+review+of+the+patterns+of+docetaxel+use+for+hormone-resistant+prostate+cancer+at+the+Princess+Margaret+Hospital"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital</span></div><div class="casAuthors">Chin S N; Wang L; Moore M; Sridhar S S</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology (Toronto, Ont.)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">24-9</span>
        ISSN:<span class="NLM_cas:issn">1198-0052</span>.
    </div><div class="casAbstract">BACKGROUND:  Based on the TAX 327 phase III trial, docetaxel-based chemotherapy is the standard first-line treatment for hormone-resistant prostate cancer (HRPC); however, there is some heterogeneity in the use of this agent in routine clinical practice.  The aim of the present study was to examine the patterns of docetaxel use in routine clinical practice at our institution and to compare them with docetaxel use in the TAX 327 clinical trial.  METHODS:  We conducted a retrospective chart review of HRPC patients treated with first-line docetaxel between 2005 and 2007 at the Princess Margaret Hospital.  RESULTS:  In the first-line setting, 88 patients with HRPC received docetaxel.  The main reasons for initiating docetaxel were rising prostate-specific antigen (PSA, 98%) and progressive symptoms (77%).  The PSA response rate was 67%; median time to response was 1.5 months, and duration of response was 6.8 months.  Median survival was 15.9 months (95% confidence interval: 12.4 to 20.5 months).  Patients received a median of 7 cycles of treatment, and the main toxicities were fatigue (35%) and neuropathy (24%).  Post docetaxel, 36 patients received second-line treatment with a 22% response rate.  CONCLUSIONS:  In routine clinical practice, HRPC patients received docetaxel mainly because of symptomatic disease progression.  Overall response rates and toxicities were comparable to those in the TAX 327 trial.  However, our patients received a median of only 7 cycles of treatment versus the 9.5 administered on trial, and survival was slightly shorter in our single-institution study.  A larger prospective multicentre analysis, including performance status and quality-of-life parameters, may be warranted to determine if docetaxel performs as well in routine clinical practice as it does in the clinical trial setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZq5iNynRg0LZpSb_XWfMrfW6udTcc2eZUBv5ypQ8E5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3nsVKrsA%253D%253D&md5=5dd45f26f4938b4c32375ded3126a9ff</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DS.%2BN.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DSridhar%26aufirst%3DS.%2BS.%26atitle%3DA%2520review%2520of%2520the%2520patterns%2520of%2520docetaxel%2520use%2520for%2520hormone-resistant%2520prostate%2520cancer%2520at%2520the%2520Princess%2520Margaret%2520Hospital%26jtitle%3DCurr.%2520Oncol.%26date%3D2010%26volume%3D17%26spage%3D24%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span> </span><span class="NLM_article-title">Prostate cancer and active surveillance</span> <span class="citation_source-journal">Front. Radiat. Ther. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1159%2F000139867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A280%3ADC%252BD1czns1yitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1-6&author=P.+A.+Abrahamsson&title=Prostate+cancer+and+active+surveillance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate cancer and active surveillance</span></div><div class="casAuthors">Abrahamsson Per-Anders</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers of radiation therapy and oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>
        ISSN:<span class="NLM_cas:issn">0071-9676</span>.
    </div><div class="casAbstract">This review outlines the different treatment options in localized prostate cancer.  This information can be considered alongside other important factors, such as the individual patient's values and situation as well as the potential impact of treatment on his quality of life, in the treatment decision-making process.  Taking all these factors into consideration, the data support active surveillance as an appropriate choice in patients with well or moderately differentiated, low-volume prostate cancer who have a life expectancy of less than 10 years.  Men with higher-grade tumors and longer life expectancy may be at excess risk of death from prostate cancer managed with active surveillance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRw9cirtAUkpbxanA7vODO6fW6udTcc2eZUBv5ypQ8E5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czns1yitA%253D%253D&md5=760dff61d21224051ba199d790e3ab0f</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1159%2F000139867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000139867%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26atitle%3DProstate%2520cancer%2520and%2520active%2520surveillance%26jtitle%3DFront.%2520Radiat.%2520Ther.%2520Oncol.%26date%3D2008%26volume%3D41%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Waguespack, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Ramirez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, C.</span><span> </span><span class="NLM_article-title">A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1210%2Fjc.2009-2830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFegtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=2023-2037&author=S.+G.+Waguespackauthor=T.+Richauthor=E.+Grubbsauthor=A.+K.+Yingauthor=N.+D.+Perrierauthor=M.+Ayala-Ramirezauthor=C.+Jimenez&title=A+current+review+of+the+etiology%2C+diagnosis%2C+and+treatment+of+pediatric+pheochromocytoma+and+paraganglioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma</span></div><div class="casAuthors">Waguespack, S. G.; Rich, T.; Grubbs, E.; Ying, A. K.; Perrier, N. D.; Ayala-Ramirez, M.; Jimenez, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2023-2037</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Pheochromocytomas and paragangliomas (PHEO/PGL) are neuroendocrine tumors that arise from sympathetic and parasympathetic paraganglia.  Diagnosed rarely during childhood, PHEO/PGL are nonetheless important clin. entities, particularly given our evolving understanding of their pathophysiol.  Evidence Acquisition: We identified articles through the U.S. National Library of Medicine by using the search terms pheochromocytoma and paraganglioma.  Results were narrowed to manuscripts that included children and studies related to the genetics of PHEO/PGL.  Web-based resources for genetic disorders were also used.  For all articles, we performed subsequent ref. searches and verification of source data.  Evidence Synthesis: Up to 20% of PHEO/PGL are diagnosed in children.  Most are functional tumors, and clin. presentation includes symptoms related to catecholamine hypersecretion and/or tumor mass effect.  Increasingly, PHEO/PGL are identified during presymptomatic screening in children with genetic syndromes assocd. with PHEO/PGL (multiple endocrine neoplasia type 2, von Hippel-Lindau disease, and the paraganglioma syndromes).  Plasma and/or urine metanephrines are the best diagnostic test for a functional tumor, and the management of pediatric patients is similar to adults.  Genetic counseling should be undertaken in all cases.  Although most pediatric PHEO/PGL are benign, these tumors can occasionally metastasize, a condition for which no curative treatment exists.  Conclusions: Although PHEO/PGL are rarely diagnosed during childhood, the pediatric provider should be able to recognize and screen for such tumors, particularly in the context of a known genetic predisposition.  Optimal care of these children includes a multidisciplinary team approach at centers experienced in the evaluation and treatment of these uncommon yet fascinating endocrine neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNz5hXqE3A2LVg90H21EOLACvtfcHk0lgxO8WB-R8Usw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFegtLc%253D&md5=56052358436a554319d04da9f8cbc54a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1210%2Fjc.2009-2830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2009-2830%26sid%3Dliteratum%253Aachs%26aulast%3DWaguespack%26aufirst%3DS.%2BG.%26aulast%3DRich%26aufirst%3DT.%26aulast%3DGrubbs%26aufirst%3DE.%26aulast%3DYing%26aufirst%3DA.%2BK.%26aulast%3DPerrier%26aufirst%3DN.%2BD.%26aulast%3DAyala-Ramirez%26aufirst%3DM.%26aulast%3DJimenez%26aufirst%3DC.%26atitle%3DA%2520current%2520review%2520of%2520the%2520etiology%252C%2520diagnosis%252C%2520and%2520treatment%2520of%2520pediatric%2520pheochromocytoma%2520and%2520paraganglioma%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2010%26volume%3D95%26spage%3D2023%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Siddiqui, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikhailidis, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumtaz, F. H.</span><span> </span><span class="NLM_article-title">The role of serotonin (5-hydroxytryptamine<sub>1A</sub> and <sub>1B</sub>) receptors in prostate cancer cell proliferation</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">1648</span><span class="NLM_x">–</span> <span class="NLM_lpage">1653</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1016%2Fj.juro.2006.06.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCht7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1648-1653&author=E.+J.+Siddiquiauthor=M.+Shabbirauthor=D.+P.+Mikhailidisauthor=C.+S.+Thompsonauthor=F.+H.+Mumtaz&title=The+role+of+serotonin+%285-hydroxytryptamine1A+and+1B%29+receptors+in+prostate+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation</span></div><div class="casAuthors">Siddiqui, Emad J.; Shabbir, Majid; Mikhailidis, Dimitri P.; Thompson, Cecil S.; Mumtaz, Faiz H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">4, Pt. 1</span>),
    <span class="NLM_cas:pages">1648-1653</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine), a monoamine neurotransmitter released by prostate neuroendocrine cells, has a fundamental role in tumor growth, differentiation and gene expression.  We investigated the effect of 5-hydroxytryptamine and 5-hydroxytryptamine antagonists on the growth of prostate cancer cells and we identified 5-hydroxytryptamine receptor expression in PC3 cells and in human hormone refractory prostate cancer tissue.  A total of 12 prepns. of hormone refractory PC3 human prostate cancer cells were incubated with 5-hydroxytryptamine or the 5-hydroxytryptamine receptor antagonists 5-hydroxytryptamine1A, 1B, 1D, 2, 3 or 4.  After 72 h cell viability was assessed using the crystal violet assay.  PC3 cells treated with 5-hydroxytryptamine1A and 1B antagonists were investigated for apoptosis using flow cytometry.  PC3 cells and sections of hormone refractory human prostate cancer tissue were studied by immunohistochem. and Western blot anal.  In PC3 cells 5-hydroxytryptamine caused dose dependent proliferation with a max. increase of 15% in 12 prepns. at a concn. of 10-8 M at 72 h compared to controls (p < 0.0001).  At a concn. of 10-4 M at 72 h the 5HT1A antagonist NAN-190 and the 5-hydroxytryptamine1B antagonist SB224289 (Tocris Labs., Bristol, United Kingdom) induced a 20% and 78% inhibitory effect, resp., on PC3 cell growth compared to that in controls (p < 0.0001).  In PC3 cells 5-hydroxytryptamine1A and 1B antagonists demonstrated apoptosis after 24 and 48 h of incubation.  Immunostaining for 5-hydroxytryptamine1A and 1B receptors was seen in PC3 cells and prostate cancer tissue.  Western blot anal. demonstrated 5-hydroxytryptamine1A and 1B receptor proteins with 46 and 43 kDa bands, resp.  In PC3 prostate cancer cells 5-hydroxytryptamine1A and to a greater extent 5-hydroxytryptamine1B antagonists significantly inhibit growth and induce apoptosis.  To our knowledge growth inhibition caused by the 5-hydroxytryptamine1B antagonist SB224289 is a novel finding, as is apoptosis caused by the 2 antagonists 5-hydroxytryptamine1A and 1B.  This effect is most likely mediated via 5-hydroxytryptamine1A and 1B receptors.  Therefore, our results imply that 5-hydroxytryptamine1A and in particular 5-hydroxytryptamine1B receptor antagonists warrant further investigations as potential anti-neoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDpkrkMuG7rLVg90H21EOLACvtfcHk0lhisq_yFKWjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCht7fK&md5=5f3cce17e4a13b77c4259586d1189081</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.06.087%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DE.%2BJ.%26aulast%3DShabbir%26aufirst%3DM.%26aulast%3DMikhailidis%26aufirst%3DD.%2BP.%26aulast%3DThompson%26aufirst%3DC.%2BS.%26aulast%3DMumtaz%26aufirst%3DF.%2BH.%26atitle%3DThe%2520role%2520of%2520serotonin%2520%25285-hydroxytryptamine1A%2520and%25201B%2529%2520receptors%2520in%2520prostate%2520cancer%2520cell%2520proliferation%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D1648%26epage%3D1653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Hsiung, S-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.-p.</span><span> </span><span class="NLM_article-title">Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-κB-dependent cell survival after serotonin 1A receptor activation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1471-4159.2005.03496.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=1653-1666&issue=6&author=S-c.+Hsiungauthor=H.+Tamirauthor=T.+F.+Frankeauthor=K.-p.+Liu&title=Roles+of+extracellular+signal-regulated+kinase+and+Akt+signaling+in+coordinating+nuclear+transcription+factor-%CE%BAB-dependent+cell+survival+after+serotonin+1A+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-κB-dependent cell survival after serotonin 1A receptor activation</span></div><div class="casAuthors">Hsiung, Shu-chi; Tamir, Hadassah; Franke, Thomas F.; Liu, Kuo-peing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1653-1666</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">To investigate the functional consequences of cross-talk between multiple effectors of serotonin (5-HT) 1A receptor, the authors employed transfected Chinese hamster ovary cells.  Activation of 5-HT1A receptor stimulated extracellular signal-regulated kinase (ERK)1/2, Akt and nuclear transcription factor-κB (NF-κB).  Stimulation of cells with 5-HT1A receptor agonist induced a rapid but transient ERK1/2 phosphorylation followed by increased phosphorylation of Akt.  Elevated Akt activity in turn suppressed Raf activity and induced a decline in ERK activation.  The activation of ERK and Akt downstream of 5-HT1A receptor was sensitive to inhibitors of Ras, Raf and phosphatidylinositol 3-kinase (PI3K).  Stimulation of 5-HT1A receptor also resulted in activation of NF-κB through a decrease in inhibitor of nuclear transcription factor-κB.  In support of the importance of 5-HT1A receptor signaling for cell survival, inhibition of NF-κB facilitated caspase 3 activation and cleavage of poly (ADP-ribose) polymerase, while treatment of cells with agonist inhibited caspase 3, DNA fragmentation and cell death.  Both agonist-dependent NF-κB activation and cell survival were decreased by Akt Inhibitor II or by overexpression of dominant-neg. Akt.  These findings suggest a role for 5-HT1A receptor signaling in the Ras/Raf-dependent regulation of multiple intracellular signaling pathways that include ERK and PI3K/Akt.  Of these, only PI3K/Akt and NF-κB activation were required for 5-HT1A receptor-dependent cell survival, implying that the relative distribution of signals between competing transduction pathways dets. the functional outcome of 5-HT1A receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrGjOJ846-SLVg90H21EOLACvtfcHk0lhisq_yFKWjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVKitQ%253D%253D&md5=c29e7f16d848b1e29e587475cb880bf0</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03496.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03496.x%26sid%3Dliteratum%253Aachs%26aulast%3DHsiung%26aufirst%3DS-c.%26aulast%3DTamir%26aufirst%3DH.%26aulast%3DFranke%26aufirst%3DT.%2BF.%26aulast%3DLiu%26aufirst%3DK.-p.%26atitle%3DRoles%2520of%2520extracellular%2520signal-regulated%2520kinase%2520and%2520Akt%2520signaling%2520in%2520coordinating%2520nuclear%2520transcription%2520factor-%25CE%25BAB-dependent%2520cell%2520survival%2520after%2520serotonin%25201A%2520receptor%2520activation%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26issue%3D6%26spage%3D1653%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incisivo, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Gennaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cintio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2206-2216&issue=6&author=F.+Fiorinoauthor=E.+Magliauthor=E.+Perissuttiauthor=B.+Severinoauthor=F.+Frecenteseauthor=A.+Espositoauthor=F.+De+Angelisauthor=G.+M.+Incisivoauthor=P.+Massarelliauthor=C.+Nenciniauthor=E.+Di+Gennaroauthor=A.+Budillonauthor=A.+Di+Cintioauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+of+1-naphtylpiperazine+derivatives+as+serotoninergic+ligands+and+their+evaluation+as+antiproliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DMagli%26aufirst%3DE.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DA.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DIncisivo%26aufirst%3DG.%2BM.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DNencini%26aufirst%3DC.%26aulast%3DDi%2BGennaro%26aufirst%3DE.%26aulast%3DBudillon%26aufirst%3DA.%26aulast%3DDi%2BCintio%26aufirst%3DA.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25201-naphtylpiperazine%2520derivatives%2520as%2520serotoninergic%2520ligands%2520and%2520their%2520evaluation%2520as%2520antiproliferative%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2206%26epage%3D2216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Bonifazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piergentili, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Bello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farande, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pigini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amantini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabissi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farfariello, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menegon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quaglia, W.</span><span> </span><span class="NLM_article-title">Structure–activity relationships in 1,4-benzodioxan-related compounds. 11. Reversed enantioselectivity of 1,4-dioxane derivatives in α<sub>1</sub>-adrenergic and 5-HT<sub>1A</sub> receptor binding sites recognition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301525w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=584-588&author=A.+Bonifaziauthor=A.+Piergentiliauthor=F.+Del+Belloauthor=Y.+Farandeauthor=M.+Giannellaauthor=M.+Piginiauthor=C.+Amantiniauthor=M.+Nabissiauthor=V.+Farfarielloauthor=G.+Santoniauthor=E.+Poggesiauthor=A.+Leonardiauthor=S.+Menegonauthor=W.+Quaglia&title=Structure%E2%80%93activity+relationships+in+1%2C4-benzodioxan-related+compounds.+11.+Reversed+enantioselectivity+of+1%2C4-dioxane+derivatives+in+%CE%B11-adrenergic+and+5-HT1A+receptor+binding+sites+recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm301525w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301525w%26sid%3Dliteratum%253Aachs%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DPiergentili%26aufirst%3DA.%26aulast%3DDel%2BBello%26aufirst%3DF.%26aulast%3DFarande%26aufirst%3DY.%26aulast%3DGiannella%26aufirst%3DM.%26aulast%3DPigini%26aufirst%3DM.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DFarfariello%26aufirst%3DV.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DPoggesi%26aufirst%3DE.%26aulast%3DLeonardi%26aufirst%3DA.%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DQuaglia%26aufirst%3DW.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520in%25201%252C4-benzodioxan-related%2520compounds.%252011.%2520Reversed%2520enantioselectivity%2520of%25201%252C4-dioxane%2520derivatives%2520in%2520%25CE%25B11-adrenergic%2520and%25205-HT1A%2520receptor%2520binding%2520sites%2520recognition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D584%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collavoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5495</span><span class="NLM_x">–</span> <span class="NLM_lpage">5503</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050246k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5495-5503&author=F.+Fiorinoauthor=E.+Perissuttiauthor=B.+Severinoauthor=V.+Santagadaauthor=D.+Cirilloauthor=S.+Terraccianoauthor=P.+Massarelliauthor=G.+Bruniauthor=E.+Collavoliauthor=C.+Rennerauthor=G.+Caliendo&title=New+5-hydroxytryptamine%281A%29+receptor+ligands+containing+a+norbornene+nucleus%3A+synthesis+and+in+vitro+pharmacological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm050246k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050246k%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCirillo%26aufirst%3DD.%26aulast%3DTerracciano%26aufirst%3DS.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DBruni%26aufirst%3DG.%26aulast%3DCollavoli%26aufirst%3DE.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DNew%25205-hydroxytryptamine%25281A%2529%2520receptor%2520ligands%2520containing%2520a%2520norbornene%2520nucleus%253A%2520synthesis%2520and%2520in%2520vitro%2520pharmacological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5495%26epage%3D5503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collavoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis and in-vitro pharmacological evaluation of new 5-HT<sub>1A</sub> receptor ligands containing a benzotriazinone nucleus</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1002%2Fardp.200700151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2rtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=20-27&author=F.+Fiorinoauthor=B.+Severinoauthor=F.+De+Angelisauthor=E.+Perissuttiauthor=F.+Frecenteseauthor=P.+Massarelliauthor=G.+Bruniauthor=E.+Collavoliauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+and+in-vitro+pharmacological+evaluation+of+new+5-HT1A+receptor+ligands+containing+a+benzotriazinone+nucleus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus</span></div><div class="casAuthors">Fiorino, Ferdinando; Severino, Beatrice; De Angelis, Francesca; Perissutti, Elisa; Frecentese, Francesco; Massarelli, Paola; Bruni, Giancarlo; Collavoli, Elga; Santagada, Vincenzo; Caliendo, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-27</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In order to identify selective ligands for the 5-HT1A subtype receptor, the microwave-assisted synthesis and the binding assays on the 5-HT1A, 5-HT2A and 5-HT2C receptors of new benzotriazinone derivs. were reported.  Conventional and microwave heating of the reactions were compared.  Good yields and short reaction times were the main advantages of our synthetic route.  More active compds. were selected and further evaluated for their binding affinities on D1, D2 dopaminergic and α1, α2 adrenergic receptors.  The 3-(2-(4-(naphthalen-1-yl)piperazin-1-yl)ethyl)benzo[d][1,2,3]triazin-4(3H)-one I with Ki = 0.000178 nM was the most active and selective deriv. for the 5-HT1A receptor with respect to other serotonin receptors and the most selective deriv. compared to dopaminergic and adrenergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmvaxBNh5msbVg90H21EOLACvtfcHk0lifiqpv_MxJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2rtr8%253D&md5=8f92c8c9ed2c1633e40e444ba6ebaaae</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700151%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DBruni%26aufirst%3DG.%26aulast%3DCollavoli%26aufirst%3DE.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520in-vitro%2520pharmacological%2520evaluation%2520of%2520new%25205-HT1A%2520receptor%2520ligands%2520containing%2520a%2520benzotriazinone%2520nucleus%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2008%26volume%3D341%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">New 5-HT<sub>1A</sub> receptor ligands containing a <i>N</i>′-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2978</span><span class="NLM_x">–</span> <span class="NLM_lpage">2982</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2978-2982&issue=9&author=F.+Fiorinoauthor=B.+Severinoauthor=F.+De+Angelisauthor=E.+Perissuttiauthor=E.+Magliauthor=F.+Frecenteseauthor=A.+Espositoauthor=P.+Massarelliauthor=C.+Nenciniauthor=V.+Santagadaauthor=G.+Caliendo&title=New+5-HT1A+receptor+ligands+containing+a+N%E2%80%B2-cyanoisonicotinamidine+nucleus%3A+synthesis+and+in+vitro+pharmacological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DMagli%26aufirst%3DE.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DA.%26aulast%3DMassarelli%26aufirst%3DP.%26aulast%3DNencini%26aufirst%3DC.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DNew%25205-HT1A%2520receptor%2520ligands%2520containing%2520a%2520N%25E2%2580%25B2-cyanoisonicotinamidine%2520nucleus%253A%2520synthesis%2520and%2520in%2520vitro%2520pharmacological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D9%26spage%3D2978%26epage%3D2982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Czopek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrtus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko1aczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paw1owski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatarczynska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chojnacka-Wojcik, E.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT<sub>1A</sub> receptor agonist with potential antidepressant and anxiolytic activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1295-1303&author=A.+Czopekauthor=H.+Byrtusauthor=M.+Ko1aczkowskiauthor=M.+Paw1owskiauthor=M.+Dybalaauthor=G.+Nowakauthor=E.+Tatarczynskaauthor=A.+Wesolowskaauthor=E.+Chojnacka-Wojcik&title=Synthesis+and+pharmacological+evaluation+of+new+5-%28cyclo%29alkyl-5-phenyl-+and+5-spiroimidazolidine-2%2C4-dione+derivatives.+Novel+5-HT1A+receptor+agonist+with+potential+antidepressant+and+anxiolytic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzopek%26aufirst%3DA.%26aulast%3DByrtus%26aufirst%3DH.%26aulast%3DKo1aczkowski%26aufirst%3DM.%26aulast%3DPaw1owski%26aufirst%3DM.%26aulast%3DDybala%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DG.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DWesolowska%26aufirst%3DA.%26aulast%3DChojnacka-Wojcik%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520new%25205-%2528cyclo%2529alkyl-5-phenyl-%2520and%25205-spiroimidazolidine-2%252C4-dione%2520derivatives.%2520Novel%25205-HT1A%2520receptor%2520agonist%2520with%2520potential%2520antidepressant%2520and%2520anxiolytic%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1295%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Prandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova Manasieva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasili, L.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α<sub>1</sub>- and serotonine 5-HT<sub>1A</sub> Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200421e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=23-36&author=A.+Prandiauthor=S.+Franchiniauthor=L.+Ivanova+Manasievaauthor=P.+Fossaauthor=E.+Cicheroauthor=G.+Marucciauthor=M.+Buccioniauthor=A.+Ciliaauthor=L.+Pironaauthor=L.+Brasili&title=Synthesis%2C+biological+evaluation%2C+and+docking+studies+of+tetrahydrofuran-+cyclopentanone-+and+cyclopentanol-based+ligands+acting+at+adrenergic+%CE%B11-+and+serotonine+5-HT1A+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm200421e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200421e%26sid%3Dliteratum%253Aachs%26aulast%3DPrandi%26aufirst%3DA.%26aulast%3DFranchini%26aufirst%3DS.%26aulast%3DIvanova%2BManasieva%26aufirst%3DL.%26aulast%3DFossa%26aufirst%3DP.%26aulast%3DCichero%26aufirst%3DE.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DCilia%26aufirst%3DA.%26aulast%3DPirona%26aufirst%3DL.%26aulast%3DBrasili%26aufirst%3DL.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520docking%2520studies%2520of%2520tetrahydrofuran-%2520cyclopentanone-%2520and%2520cyclopentanol-based%2520ligands%2520acting%2520at%2520adrenergic%2520%25CE%25B11-%2520and%2520serotonine%25205-HT1A%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D23%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span>IUPHAR Database. <a href="http://www.iuphar-db.org" class="extLink">http://www.iuphar-db.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IUPHAR+Database.+http%3A%2F%2Fwww.iuphar-db.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Van Aar, M. P. M.; Van Amsterdam, P. H.; Barf, G. A.; Bakker, J. A.; Den Besten, C.; Herremans, A. H. J.; Zorgdrager, J.</span><span> </span><span class="NLM_article-title"><i>N</i>-Oxides of Pyridylmethylpiperazine and -piperidine Derivatives</span>. WO2007128694,<span class="NLM_x"> </span><span class="NLM_year">2007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+P.+M.+Van+Aar&author=P.+H.+Van+Amsterdam&author=G.+A.+Barf&author=J.+A.+Bakker&author=C.+Den+Besten&author=A.+H.+J.+Herremans&author=J.+Zorgdrager&title=N-Oxides+of+Pyridylmethylpiperazine+and+-piperidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BAar%26aufirst%3DM.%2BP.%2BM.%26atitle%3DN-Oxides%2520of%2520Pyridylmethylpiperazine%2520and%2520-piperidine%2520Derivatives%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkheimer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udo de Haes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl] butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a [11C] [O-methyl-3H]-n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.301.3.1144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1144-1150&issue=3&author=E.+A.+Rabinerauthor=M.+R.+Wilkinsauthor=F.+Turkheimerauthor=R.+N.+Gunnauthor=J.+Udo+de+Haesauthor=M.+De+Vriesauthor=P.+M.+Grasby&title=5-Hydroxytryptamine1A+receptor+occupancy+by+novel+full+antagonist+2-%5B4-%5B4-%287-chloro-2%2C3-dihydro-1%2C4-benzdioxyn-5-yl%29-1-piperazinyl%5D+butyl%5D-1%2C2-benzisothiazol-3-%282H%29-one-1%2C1-dioxide%3A+a+%5B11C%5D+%5BO-methyl-3H%5D-n-%282-%284-%282-methoxyphenyl%29-1-piperazinyl%29ethyl%29-N-%282pyridinyl%29cyclohexanecarboxamide+trihydrochloride+%28WAY-100635%29+positron+emission+tomography+study+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl] -1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: A [11C][O-methyl-3H]-n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl) -N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans</span></div><div class="casAuthors">Rabiner, Eugenii A.; Wilkins, Martin R.; Turkheimer, Federico; Gunn, Roger N.; Udo de Haes, Joanna; De Vries, Michiel; Grasby, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1144-1150</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine1A (5-HT1A) receptors have been implicated in the pathophysiol. and treatment of anxiety and depression, and are a target for novel drug development.  This is the first study examg. the human brain in vivo occupancy by a novel, selective, silent 5-HT1A antagonist.  2-[4-[4-(7-Chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl] butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide (DU 125530), a compd. in clin. development, has potential applications in the treatment of anxiety and mood disorders.  Positron emission tomog. (PET) and [11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl) -N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635), were used to assess 5-HT1A autoreceptor and postsynaptic receptor occupancy in 12 healthy male volunteers.  Over a 10- to 40-mg daily dose range, DU 125530 was well tolerated, and exhibited a dose-dependent occupancy from 0 to 72% at 2 h post the last dose.  Occupancy correlated significantly with plasma levels of DU 125530, and a fitting of the data to a std. single-site binding model gave a max. occupancy of ∼80%, and a half-satn. concn. (ED50) of ∼7 ng/mL.  At 24 h after the last dose 5-HT1A occupancy was ∼50% of that achieved at 2 h.  This study demonstrates that high occupancy of the human brain 5-HT1A receptor can be achieved at doses producing minimal acute side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnL-RXF0Mhi7Vg90H21EOLACvtfcHk0ljIFBJBk5p8kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrs%253D&md5=ab580b421d1a185f187fccc8dbdd4fa4</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1144%26sid%3Dliteratum%253Aachs%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DWilkins%26aufirst%3DM.%2BR.%26aulast%3DTurkheimer%26aufirst%3DF.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DUdo%2Bde%2BHaes%26aufirst%3DJ.%26aulast%3DDe%2BVries%26aufirst%3DM.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3D5-Hydroxytryptamine1A%2520receptor%2520occupancy%2520by%2520novel%2520full%2520antagonist%25202-%255B4-%255B4-%25287-chloro-2%252C3-dihydro-1%252C4-benzdioxyn-5-yl%2529-1-piperazinyl%255D%2520butyl%255D-1%252C2-benzisothiazol-3-%25282H%2529-one-1%252C1-dioxide%253A%2520a%2520%255B11C%255D%2520%255BO-methyl-3H%255D-n-%25282-%25284-%25282-methoxyphenyl%2529-1-piperazinyl%2529ethyl%2529-N-%25282pyridinyl%2529cyclohexanecarboxamide%2520trihydrochloride%2520%2528WAY-100635%2529%2520positron%2520emission%2520tomography%2520study%2520in%2520humans%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26issue%3D3%26spage%3D1144%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Vilazodone: a 5-HT<sub>1A</sub> receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1755-5949.2008.00067.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=107-117&issue=2&author=L.+A.+Dawsonauthor=J.+M.+Watson&title=Vilazodone%3A+a+5-HT1A+receptor+agonist%2Fserotonin+transporter+inhibitor+for+the+treatment+of+affective+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Vilazodone: A 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders</span></div><div class="casAuthors">Dawson, Lee A.; Watson, Jeannette M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Vilazodone (EMD 68843; 5-{4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide hydrochloride) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clin. evaluation for the treatment of major depression.  This mol. was designed based on the premise that neg. feedback circuitry, mediated via 5-HT1 receptors, limits the acute SSRI-induced enhancements in serotonergic neurotransmission.  If the hypothesis is correct, combination of SSRI with 5-HT1A partial agonism should temporally enhance the neuroplastic adaptation and subsequently hasten therapeutic efficacy compared to current treatments.  Preclin. in vitro evaluation has confirmed vilazodone's primary pharmacol. profile both in clonal and native systems, i.e., serotonin reuptake blockade and 5-HT1A partial agonism.  However, in vivo and in contrast to combination of 8-OH-DPAT and paroxetine, vilazodone selectively enhanced serotonergic output in the prefrontal cortex of rats.  Behavioral evaluations, in the ultrasonic vocalization model of anxiety in rats, demonstrated anxiolytic efficacy.  In the forced swim test (a putative model of depression), vilazodone also showed efficacy but at a single dose only.  In man, vilazodone abolished REM sleep and demonstrated clin. antidepressant efficacy equiv. to an SSRI.  Ongoing clin. evaluations will hopefully reveal whether the founding hypothesis was valid and if vilazodone will produce a more rapid onset of antidepressant efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCgrflmbxrcLVg90H21EOLACvtfcHk0ljIFBJBk5p8kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVyis7w%253D&md5=d08600166737197fc1114ff031bba81b</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2008.00067.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2008.00067.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DVilazodone%253A%2520a%25205-HT1A%2520receptor%2520agonist%252Fserotonin%2520transporter%2520inhibitor%2520for%2520the%2520treatment%2520of%2520affective%2520disorders%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2009%26volume%3D15%26issue%3D2%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Shiwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, N.</span><span> </span><span class="NLM_article-title">Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1254%2Fjphs.93.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVWntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=114-117&issue=1&author=T.+Shiwaauthor=T.+Amanoauthor=H.+Matsubayashiauthor=T.+Sekiauthor=M.+Sasaauthor=N.+Sakai&title=Perospirone%2C+a+novel+antipsychotic+agent%2C+hyperpolarizes+rat+dorsal+raphe+neurons+via+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor</span></div><div class="casAuthors">Shiwa, Tsuguka; Amano, Taku; Matsubayashi, Hiroaki; Seki, Takahiro; Sasa, Masashi; Sakai, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-117</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">To investigate the effect of cis-N-[4-[4-(1,2-benz-isozole-3-yl)-1-piperazinyl]butyl] cyclohexane-1,2-dicarboximide hydrochloride (perospirone), a novel antipsychotic agent with high affinities for D2/5-HT2 receptors, on the rat dorsal raphe (DR) neurons, an electrophysiol. study was performed using the tight-seal whole-cell patch-clamp technique.  Applications of perospirone at the concn. between 10-9 and 10-5 M hyperpolarized the membrane potential and inhibited spontaneous action potentials of the DR neurons in a concn.-dependent manner.  This effect of perospirone on DR neurons is similar to that of typical 5HT1A-receptor agonists, including 8-OH-DPAT or tandospirone.  In addn., WAY100635, a 5-HT1A-receptor antagonist, inhibited this perospirone-induced hyperpolarization of DR neurons, suggesting that perospirone physiol. acts on DR neurons as a 5HT1A-receptor agonist.  These results provide new profiles of perospirone as an antipsychotic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKXrv7SwNIELVg90H21EOLACvtfcHk0ljIFBJBk5p8kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVWntrg%253D&md5=4f69fa1798745ace5d9d0691bff5e297</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1254%2Fjphs.93.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.93.114%26sid%3Dliteratum%253Aachs%26aulast%3DShiwa%26aufirst%3DT.%26aulast%3DAmano%26aufirst%3DT.%26aulast%3DMatsubayashi%26aufirst%3DH.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DSasa%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DN.%26atitle%3DPerospirone%252C%2520a%2520novel%2520antipsychotic%2520agent%252C%2520hyperpolarizes%2520rat%2520dorsal%2520raphe%2520neurons%2520via%25205-HT1A%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D93%26issue%3D1%26spage%3D114%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Ishibashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span> </span><span class="NLM_article-title">Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT<sub>7</sub>) and 5-HT<sub>1A</sub> receptor activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.110.167346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1KltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=171-181&issue=1&author=T.+Ishibashiauthor=T.+Horisawaauthor=K.+Tokudaauthor=T.+Ishiyamaauthor=M.+Ogasaauthor=R.+Tagashiraauthor=K.+Matsumotoauthor=H.+Nishikawaauthor=Y.+Uedaauthor=S.+Tomaauthor=H.+Okiauthor=N.+Tannoauthor=I.+Sajiauthor=A.+Itoauthor=Y.+Ohnoauthor=M.+Nakamura&title=Pharmacological+profile+of+lurasidone%2C+a+novel+antipsychotic+agent+with+potent+5-hydroxytryptamine+7+%285-HT7%29+and+5-HT1A+receptor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity</span></div><div class="casAuthors">Ishibashi, Tadashi; Horisawa, Tomoko; Tokuda, Kumiko; Ishiyama, Takeo; Ogasa, Masaaki; Tagashira, Rie; Matsumoto, Kenji; Nishikawa, Hiroyuki; Ueda, Yoko; Toma, Satoko; Oki, Hitomi; Tanno, Norihiko; Saji, Ikutaro; Ito, Akira; Ohno, Yukihiro; Nakamura, Mitsutaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lurasidone [(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; SM-13496] is an azapirone deriv. and a novel antipsychotic candidate.  The objective of the current studies was to investigate the in vitro and in vivo pharmacol. properties of lurasidone.  Receptor binding affinities of lurasidone and several antipsychotic drugs were tested under comparable assay conditions using cloned human receptors or membrane fractions prepd. from animal tissue.  Lurasidone was found to have potent binding affinity for dopamine D2, 5-hydroxytryptamine 2A (5-HT2A), 5-HT7, 5-HT1A, and noradrenaline α2C receptors.  Affinity for noradrenaline α1, α2A, and 5-HT2C receptors was weak, whereas affinity for histamine H1 and muscarinic acetylcholine receptors was negligible.  In vitro functional assays demonstrated that lurasidone acts as an antagonist at D2 and 5-HT7 receptors and as a partial agonist at the 5-HT1A receptor subtype.  Lurasidone showed potent effects predictive of antipsychotic activity, such as inhibition of methamphetamine-induced hyperactivity and apomorphine-induced stereotyped behavior in rats, similar to other antipsychotics.  Furthermore, lurasidone had only weak extrapyramidal effects in rodent models.  In animal models of anxiety disorders and depression, treatment with lurasidone was assocd. with significant improvement.  Lurasidone showed a preferential effect on the frontal cortex (vs. striatum) in increasing dopamine turnover.  Anti-α1-noradrenergic, anticholinergic, and central nervous system (CNS) depressant actions of lurasidone were also very weak.  These results demonstrate that lurasidone possesses antipsychotic activity and antidepressant- or anxiolytic-like effects with potentially reduced liability for extrapyramidal and CNS depressant side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYVWqS8Us3N7Vg90H21EOLACvtfcHk0lhXa8Fi0kOVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1KltLo%253D&md5=3f589915df9e66cc86ee90924a509bc2</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167346%26sid%3Dliteratum%253Aachs%26aulast%3DIshibashi%26aufirst%3DT.%26aulast%3DHorisawa%26aufirst%3DT.%26aulast%3DTokuda%26aufirst%3DK.%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DOgasa%26aufirst%3DM.%26aulast%3DTagashira%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DToma%26aufirst%3DS.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DTanno%26aufirst%3DN.%26aulast%3DSaji%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DOhno%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DM.%26atitle%3DPharmacological%2520profile%2520of%2520lurasidone%252C%2520a%2520novel%2520antipsychotic%2520agent%2520with%2520potent%25205-hydroxytryptamine%25207%2520%25285-HT7%2529%2520and%25205-HT1A%2520receptor%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26issue%3D1%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horváth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Némethy, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugovics, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazekas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orosz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyán, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ágai-Csongor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domány, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a dopamine D<sub>3</sub> receptor preferring, D<sub>3</sub>/D<sub>2</sub> dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm400533t&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horv%C3%A1thauthor=Z.+N%C3%A9methyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyerty%C3%A1nauthor=E.+%C3%81gai-Csongorauthor=G.+Dom%C3%A1nyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+dopamine+D3+receptor+preferring%2C+D3%2FD2+dopamine+receptor+antagonist-partial+agonist+antipsychotic+candidate%3A+in+vitro+and+neurochemical+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0lhXa8Fi0kOVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorv%25C3%25A1th%26aufirst%3DA.%26aulast%3DN%25C3%25A9methy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyerty%25C3%25A1n%26aufirst%3DI.%26aulast%3D%25C3%2581gai-Csongor%26aufirst%3DE.%26aulast%3DDom%25C3%25A1ny%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520dopamine%2520D3%2520receptor%2520preferring%252C%2520D3%252FD2%2520dopamine%2520receptor%2520antagonist-partial%2520agonist%2520antipsychotic%2520candidate%253A%2520in%2520vitro%2520and%2520neurochemical%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Concepts for the design of 5-HT1A serotonin agonists and antagonists</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1992&pages=251-274&author=R.+A.+Glennon&title=Concepts+for+the+design+of+5-HT1A+serotonin+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DConcepts%2520for%2520the%2520design%2520of%25205-HT1A%2520serotonin%2520agonists%2520and%2520antagonists%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1992%26volume%3D26%26spage%3D251%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">5-HT receptor ligands—update 1992</span> <span class="citation_source-journal">Curr. Drugs Serotonin</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1993&pages=1-45&author=R.+A.+Glennonauthor=M.+Dukat&title=5-HT+receptor+ligands%E2%80%94update+1992"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3D5-HT%2520receptor%2520ligands%25E2%2580%2594update%25201992%26jtitle%3DCurr.%2520Drugs%2520Serotonin%26date%3D1993%26volume%3D1%26spage%3D1%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Scorza, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llado-Pelfort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puigdemont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portella, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Egea, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artigas, F.</span><span> </span><span class="NLM_article-title">Preclinical and clinical characterization of the selective 5-HT<sub>1A</sub> receptor antagonist DU-125530 for antidepressant treatment</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm400533t&amp;key=10.1111%2Fj.1476-5381.2011.01770.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm400533t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1021-1034&issue=5&author=M.+C.+Scorzaauthor=L.+Llado-Pelfortauthor=S.+Ollerauthor=R.+Cortesauthor=D.+Puigdemontauthor=M.+J.+Portellaauthor=R.+Perez-Egeaauthor=E.+Alvarezauthor=P.+Celadaauthor=V.+Perezauthor=F.+Artigas&title=Preclinical+and+clinical+characterization+of+the+selective+5-HT1A+receptor+antagonist+DU-125530+for+antidepressant+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical characterization of the selective 5-HT1A receptor antagonist DU-125530 for antidepressant treatment</span></div><div class="casAuthors">Scorza, M. C.; Llado-Pelfort, L.; Oller, S.; Cortes, R.; Puigdemont, D.; Portella, M. J.; Perez-Egea, R.; Alvarez, E.; Celada, P.; Perez, V.; Artigas, F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antidepressant efficacy of selective 5-HT reuptake inhibitors (SSRI) and other 5-HT-enhancing drugs is compromised by a neg. feedback mechanism involving 5-HT1A autoreceptor activation by the excess 5-HT produced by these drugs in the somatodendritic region of 5-HT neurons.  5-HT1A receptor antagonists augment antidepressant-like effects in rodents by preventing this neg. feedback, and the mixed β-adrenoceptor/5-HT1A receptor antagonist pindolol improves clin. antidepressant effects by preferentially interacting with 5-HT1A autoreceptors.  However, it is unclear whether 5-HT1A receptor antagonists not discriminating between pre- and post-synaptic 5-HT1A receptors would be clin. effective.  We characterized the pharmacol. properties of the 5-HT1A receptor antagonist DU-125530 using receptor autoradiog., intracerebral microdialysis and electrophysiol. recordings.  Its capacity to accelerate/enhance the clin. effects of fluoxetine was assessed in a double-blind, randomized, 6 wk placebo-controlled trial in 50 patients with major depression.  DU-125530 showed equal (low nM) potency to displace agonist and antagonist binding to pre- and post-synaptic 5-HT1A receptors in rat and human brain.  It antagonized suppression of 5-hydroxytryptaminergic activity evoked by 8-OH-DPAT and SSRIs in vivo.  DU-125530 augmented SSRI-induced increases in extracellular 5-HT as effectively as in mice lacking 5-HT1A receptors, indicating a silent, maximal occupancy of pre-synaptic 5-HT1A receptors at the dose used.  However, DU-125530 addn. to fluoxetine did not accelerate nor augment its antidepressant effects.  DU-125530 is an excellent pre- and post-synaptic 5-HT1A receptor antagonist.  However, blockade of post-synaptic 5- HT1A receptors by DU-125530 cancels benefits obtained by enhancing pre-synaptic 5-hydroxytryptaminergic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop-FHgJ63zZbVg90H21EOLACvtfcHk0lgw2NbTEQoDpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bL&md5=19d3e3d51dcfdd92ac29a229cb9f8208</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01770.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01770.x%26sid%3Dliteratum%253Aachs%26aulast%3DScorza%26aufirst%3DM.%2BC.%26aulast%3DLlado-Pelfort%26aufirst%3DL.%26aulast%3DOller%26aufirst%3DS.%26aulast%3DCortes%26aufirst%3DR.%26aulast%3DPuigdemont%26aufirst%3DD.%26aulast%3DPortella%26aufirst%3DM.%2BJ.%26aulast%3DPerez-Egea%26aufirst%3DR.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DCelada%26aufirst%3DP.%26aulast%3DPerez%26aufirst%3DV.%26aulast%3DArtigas%26aufirst%3DF.%26atitle%3DPreclinical%2520and%2520clinical%2520characterization%2520of%2520the%2520selective%25205-HT1A%2520receptor%2520antagonist%2520DU-125530%2520for%2520antidepressant%2520treatment%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26issue%3D5%26spage%3D1021%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orteca, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandager-Nielsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheel-Kruger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D<sub>3</sub> and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4803</span><span class="NLM_x">–</span> <span class="NLM_lpage">4807</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100294b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4803-4807&author=S.+Butiniauthor=G.+Campianiauthor=S.+Franceschiniauthor=F.+Trottaauthor=V.+Kumarauthor=E.+Guarinoauthor=G.+Borrelliauthor=I.+Fioriniauthor=E.+Novellinoauthor=C.+Fattorussoauthor=M.+Persicoauthor=N.+Ortecaauthor=K.+Sandager-Nielsenauthor=T.+A.+Jacobsenauthor=K.+Madsenauthor=J.+Scheel-Krugerauthor=S.+Gemma&title=Discovery+of+bishomo%28hetero%29arylpiperazines+as+novel+multifunctional+ligands+targeting+dopamine+D3+and+serotonin+5-HT1A+and+5-HT2A+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm100294b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100294b%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DGuarino%26aufirst%3DE.%26aulast%3DBorrelli%26aufirst%3DG.%26aulast%3DFiorini%26aufirst%3DI.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DPersico%26aufirst%3DM.%26aulast%3DOrteca%26aufirst%3DN.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DJacobsen%26aufirst%3DT.%2BA.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520bishomo%2528hetero%2529arylpiperazines%2520as%2520novel%2520multifunctional%2520ligands%2520targeting%2520dopamine%2520D3%2520and%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4803%26epage%3D4807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400533t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm400533t%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400533t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aa10ffd873d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
